From e2fe74a2b8592634d4c560602caa6a52cb836086 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:49:15 +0100 Subject: [PATCH 01/40] fix(chip): give the CHIP filter the contamination estimate FilterMutectCalls in step 49 ran without a contamination table, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone. With step 29's common-sites VCF installed, the step and the Nextflow CHIP_MUTECT2 now run GetPileupSummaries inside the CHIP exons and CalculateContamination, and pass --contamination-table and --tumor-segmentation to FilterMutectCalls. New optional parameter --chip_common_sites; run-all.sh passes it when the VCF and its .tbi are installed. Without the VCF the log says there is no estimate. Bead: trait-62 --- CHANGELOG.md | 1 + assets/output_contract.tsv | 1 + docs/49-chip.md | 8 +++++--- docs/parameters.md | 1 + main.nf | 5 ++++- modules/local/chip/main.nf | 22 ++++++++++++++++++++-- nextflow.config | 1 + nextflow_schema.json | 6 ++++++ scripts/49-chip.sh | 30 +++++++++++++++++++++++++----- scripts/run-all.sh | 4 ++-- 10 files changed, 66 insertions(+), 13 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 893fff178..2329e95ed 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,6 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased +- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its common sites inside the CHIP exons and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls, as step 29 does. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/assets/output_contract.tsv b/assets/output_contract.tsv index 8315f2e05..e4aa749da 100644 --- a/assets/output_contract.tsv +++ b/assets/output_contract.tsv @@ -339,6 +339,7 @@ param viral_ref - - - - experimental - - param chip_gff - - - - experimental - - param chip_germline_resource - - - - experimental - - param chip_pon - - - - experimental - - +param chip_common_sites - - - - experimental - - param parascopy_population - - - - experimental - - param parascopy_depth_bed - - - - experimental - - param paraphase_regions - - - - experimental - - diff --git a/docs/49-chip.md b/docs/49-chip.md index 24b198f07..12d290296 100644 --- a/docs/49-chip.md +++ b/docs/49-chip.md @@ -14,7 +14,7 @@ The germline caller of step 3 is built for 50% and 100% alleles and does not rep ## Tool -- GATK Mutect2, tumour-only, then LearnReadOrientationModel and FilterMutectCalls +- GATK Mutect2, tumour-only, then LearnReadOrientationModel and FilterMutectCalls; GetPileupSummaries and CalculateContamination for the contamination estimate - bcftools csq, which names each change on the gene's MANE Select transcript, and bcftools mpileup for the depth - `og chip prepare` and `og chip report` (the Rust binary `og`, `rust/crates/og-chip`), applying the gene table `assets/chip_genes.tsv`; `og chip check-table` checks that table @@ -30,6 +30,7 @@ Pinned in `versions.env`; [Image versions](versions.md) lists the current tags. - the reference with its `.fai` and `.dict` - Ensembl's GRCh38 gene annotation, `reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz` (`ENSEMBL_GFF_RELEASE` in `versions.env`, about 110 MB). Install it once with `./scripts/setup.sh --chip-data "${GENOME_DIR}"`; it is checked against `ENSEMBL_GFF_SHA256`. - Optional, and the same files as [step 29](29-mutect2-somatic.md): gnomAD's AF-only germline resource `somatic/af-only-gnomad.hg38.vcf.gz` and a panel of normals `somatic/1000g_pon.hg38.vcf.gz`, each with its `.tbi`. Without gnomAD, inherited variants are left out by their VAF only. +- Optional, and recommended: step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` with its `.tbi` ([step 29](29-mutect2-somatic.md) says how to download it). With it the step estimates how much of the sample is another person's DNA and FilterMutectCalls reads that estimate. Without it the log says there is no contamination estimate, and a contaminant's alleles can pass as a small clone. ## Command @@ -38,12 +39,12 @@ Pinned in `versions.env`; [Image versions](versions.md) lists the current tags. ./scripts/49-chip.sh your_name ``` -With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only when `TOOLS` names it, and it is skipped without a BAM or without the annotation. In the Nextflow pipeline: `chip` in `--tools` with `--chip_gff` (and optionally `--chip_germline_resource` and `--chip_pon`), processes `CHIP_PREPARE`, `CHIP_MUTECT2`, `CHIP_ANNOTATE` and `CHIP_REPORT`. `CHIP_GENES=FILE` runs the script with another table in the same layout. +With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only when `TOOLS` names it, and it is skipped without a BAM or without the annotation. In the Nextflow pipeline: `chip` in `--tools` with `--chip_gff` (and optionally `--chip_germline_resource`, `--chip_pon` and `--chip_common_sites`; `run-all.sh` passes each one installed under `somatic/`), processes `CHIP_PREPARE`, `CHIP_MUTECT2`, `CHIP_ANNOTATE` and `CHIP_REPORT`. `CHIP_GENES=FILE` runs the script with another table in the same layout. ## How it decides 1. For each gene of `assets/chip_genes.tsv` the step takes the transcript Ensembl tags `MANE_Select`, and calls inside its coding exons, 10 bases wider on each side so the splice donor and acceptor sites are in. That is 162 exons and about 35 kb with Ensembl 116. -2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. +2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at its common sites inside the same exons, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The exons hold few common sites, so the estimate is rough; a whole-genome estimate is VerifyBamID2's FREEMIX in step 33. 3. Each call that changes the protein is put in the gene's class from the table: | Gene | Counted | Source (PMID) | @@ -117,6 +118,7 @@ So at the depth of a usual 30x genome, a clone has to hold about 14% of the alle | `chip/${SAMPLE}_chip_depth.tsv` | one row per gene: `transcript`, `chrom`, `coding_bases`, `mean_depth`, `detection_limit_vaf` (the read-support limit), `status` (covered, partly_covered, too_shallow, not_on_reference), `callable_fraction`, `assessable_fraction` | | `chip/${SAMPLE}_chip_filtered.vcf.gz` | Mutect2's calls after FilterMutectCalls | | `chip/${SAMPLE}_chip.gff3`, `chip/${SAMPLE}_chip.bed` | the transcripts and exons it called on (the bash step) | +| `chip/${SAMPLE}_chip_contamination.table` | CalculateContamination's estimate, with the common-sites VCF (the bash step) | Both reports show a "Clonal Haematopoiesis (CHIP)" section: the calls, the stated read-support limit, the genes that are not covered, and how many other changes were listed. diff --git a/docs/parameters.md b/docs/parameters.md index b6c8d4606..6981fdb8d 100644 --- a/docs/parameters.md +++ b/docs/parameters.md @@ -111,6 +111,7 @@ Paths to clinical and population genetics reference data. | `--chip_gff` | none | Ensembl's GRCh38 gene annotation, which `scripts/setup.sh --chip-data` installs as reference/ensembl/Homo_sapiens.GRCh38.<release>.chr.gff3.gz: chip takes each CHIP gene's MANE Select transcript from it. Required with chip. | | `--chip_germline_resource` | none | chip: gnomAD's AF-only germline resource for Mutect2 (somatic/af-only-gnomad.hg38.vcf.gz, .tbi beside it; optional). Without it inherited variants are left out by their VAF only. | | `--chip_pon` | none | chip: a Mutect2 panel of normals (somatic/1000g_pon.hg38.vcf.gz, .tbi beside it; optional). | +| `--chip_common_sites` | none | chip: common biallelic sites for the contamination estimate, step 29's somatic/small_exac_common_3.hg38.vcf.gz (.tbi beside it; optional). GetPileupSummaries and CalculateContamination estimate how much of the sample is another person's DNA, and FilterMutectCalls reads that estimate. Without it a contaminant's alleles can pass as a small clone. | | `--parascopy_population` | `EUR` | parascopy: the 1000 Genomes population whose model parameters are used. One of: `AFR`, `AMR`, `EAS`, `EUR`, `SAS`. | | `--parascopy_depth_bed` | none | parascopy: background windows (BED, all of one size) for a BAM that covers only part of the genome; default Parascopy's own GRCh38 windows. | | `--paraphase_regions` | none | paraphase: the Paraphase regions to run, comma separated (for example smn1,hba,rccx,GBA,pms2,strc,ncf1,OTOA); empty runs all of its GRCh38 regions. | diff --git a/main.nf b/main.nf index debd9bdf7..14a300106 100644 --- a/main.nf +++ b/main.nf @@ -1078,6 +1078,9 @@ workflow { def chip_germline_index = germ ? file("${germ}.tbi", checkIfExists: true) : [] def chip_pon = pon ? file(pon, checkIfExists: true) : [] def chip_pon_index = pon ? file("${pon}.tbi", checkIfExists: true) : [] + def common = params.chip_common_sites // the contamination estimate FilterMutectCalls reads + def chip_common = common ? file(common, checkIfExists: true) : [] + def chip_common_index = common ? file("${common}.tbi", checkIfExists: true) : [] ch_vcf .map { meta, _vcf, _idx -> [meta.id, meta] } .join(ch_bam.map { meta, _bam, _bai -> [meta.id, true] }, remainder: true) @@ -1087,7 +1090,7 @@ workflow { } CHIP_PREPARE(Channel.value(file(params.chip_gff, checkIfExists: true)), ch_chip_genes, ch_reference_fai) CHIP_MUTECT2(ch_bam, CHIP_PREPARE.out.bed, ch_reference, ch_reference_fai, ch_reference_dict, - chip_germline, chip_germline_index, chip_pon, chip_pon_index) + chip_germline, chip_germline_index, chip_pon, chip_pon_index, chip_common, chip_common_index) CHIP_ANNOTATE( CHIP_MUTECT2.out.vcf.map { meta, vcf -> [meta.id, meta, vcf] } .join(ch_bam.map { meta, bam, bai -> [meta.id, bam, bai] }) diff --git a/modules/local/chip/main.nf b/modules/local/chip/main.nf index c45ec65bc..ddee5e595 100644 --- a/modules/local/chip/main.nf +++ b/modules/local/chip/main.nf @@ -7,7 +7,9 @@ side) on the reference's contigs as a BED (once per run) CHIP_MUTECT2 Mutect2 tumour-only on that BED, the read orientation model and FilterMutectCalls; gnomAD's germline resource - and a panel of normals when given + and a panel of normals when given, and with the common + sites the contamination estimate (GetPileupSummaries, + CalculateContamination) FilterMutectCalls reads CHIP_ANNOTATE bcftools csq names each change on its transcript, and bcftools mpileup counts the depth over the BED CHIP_REPORT _chip.tsv (each protein change with its status) and @@ -72,6 +74,8 @@ process CHIP_MUTECT2 { path(germline_index) path(pon) // [] without --chip_pon path(pon_index) + path(common) // [] without --chip_common_sites + path(common_index) output: tuple val(meta), path("${meta.id}_chip_filtered.vcf.gz"), emit: vcf @@ -83,11 +87,25 @@ process CHIP_MUTECT2 { script: // The same commands as scripts/49-chip.sh def resources = (germline ? "--germline-resource ${germline} " : '') + (pon ? "-pon ${pon}" : '') + def common_sites = common ? "${common}" : '' """ gatk Mutect2 -R ${reference} -I ${bam} -L ${bed} -O unfiltered.vcf.gz --f1r2-tar-gz f1r2.tar.gz \\ --native-pair-hmm-threads ${task.cpus} --max-mnp-distance 0 ${resources} gatk LearnReadOrientationModel -I f1r2.tar.gz -O orientation.tar.gz - gatk FilterMutectCalls -R ${reference} -V unfiltered.vcf.gz --ob-priors orientation.tar.gz \\ + # Another person's DNA in the sample adds alleles at the VAF of a small + # clone: the estimate from the common sites inside the BED lets + # FilterMutectCalls mark those calls. + common_sites='${common_sites}' + contamination='' + if [ -n "\$common_sites" ]; then + gatk GetPileupSummaries -I ${bam} -V "\$common_sites" -L "\$common_sites" -L ${bed} \\ + --interval-set-rule INTERSECTION -O pileups.table + gatk CalculateContamination -I pileups.table --tumor-segmentation segments.table -O contamination.table + contamination='--contamination-table contamination.table --tumor-segmentation segments.table' + else + echo "chip: no --chip_common_sites, so FilterMutectCalls runs without a contamination estimate." >&2 + fi + gatk FilterMutectCalls -R ${reference} -V unfiltered.vcf.gz --ob-priors orientation.tar.gz \$contamination \\ -O ${meta.id}_chip_filtered.vcf.gz printf '"%s":\\n gatk: %s\\n' "${task.process}" "${task.container.replaceFirst(/^[^:@]+[:@]/, '')}" > versions.yml diff --git a/nextflow.config b/nextflow.config index d6c7df852..6a3b54c91 100644 --- a/nextflow.config +++ b/nextflow.config @@ -129,6 +129,7 @@ params { chip_gff = null // chip: Ensembl's GRCh38 GFF3 (setup.sh --chip-data: reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz) chip_germline_resource = null // chip: gnomAD's AF-only germline resource for Mutect2, .tbi beside it (optional) chip_pon = null // chip: a Mutect2 panel of normals, .tbi beside it (optional) + chip_common_sites = null // chip: common biallelic sites for the contamination estimate (somatic/small_exac_common_3.hg38.vcf.gz), .tbi beside it (optional) megane_kmers = null // mei: MEGAnE's k-mer set of the reference, the .mk with its .mi beside it (setup.sh --megane-kmers: reference/megane/.mk) mocha_data = null // mocha: the phasing panel and genetic map of step 51 (setup.sh --mocha-data: reference/mocha-) locityper_data = null // locityper: the database of step 53 (setup.sh --locityper-data: reference/locityper-) diff --git a/nextflow_schema.json b/nextflow_schema.json index d80b8f1bd..64c3372c9 100644 --- a/nextflow_schema.json +++ b/nextflow_schema.json @@ -447,6 +447,12 @@ "description": "chip: a Mutect2 panel of normals (somatic/1000g_pon.hg38.vcf.gz, .tbi beside it; optional).", "fa_icon": "fas fa-file" }, + "chip_common_sites": { + "type": "string", + "format": "file-path", + "description": "chip: common biallelic sites for the contamination estimate, step 29's somatic/small_exac_common_3.hg38.vcf.gz (.tbi beside it; optional). GetPileupSummaries and CalculateContamination estimate how much of the sample is another person's DNA, and FilterMutectCalls reads that estimate. Without it a contaminant's alleles can pass as a small clone.", + "fa_icon": "fas fa-file" + }, "parascopy_population": { "type": "string", "default": "EUR", diff --git a/scripts/49-chip.sh b/scripts/49-chip.sh index f3507ca43..a234ccd4c 100755 --- a/scripts/49-chip.sh +++ b/scripts/49-chip.sh @@ -6,7 +6,10 @@ # exons (10 bases wider on each side) of the genes in assets/chip_genes.tsv, # each on its MANE Select transcript from Ensembl's gene annotation (setup.sh # --chip-data). gnomAD's AF-only germline resource and the panel of normals of -# step 29 are used when they are in GENOME_DIR/somatic/. bcftools csq names +# step 29 are used when they are in GENOME_DIR/somatic/, and so is step 29's +# common-sites VCF: GetPileupSummaries and CalculateContamination estimate how +# much of the sample is another person's DNA, and FilterMutectCalls gets that +# estimate, so a contaminant's alleles are not read as a clone. bcftools csq names # each change on that transcript, and og chip (bin/og) keeps the changes in # the table's CHIP classes, leaves out the ones whose VAF looks inherited (35% # and up) or is under the 2% that defines CHIP, notes the kept ones whose @@ -22,7 +25,8 @@ # reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz # Output: chip/_chip.tsv (one row per protein change, with its status), # chip/_chip_depth.tsv (depth and detection limit per gene), -# chip/_chip_filtered.vcf.gz (Mutect2's calls) +# chip/_chip_filtered.vcf.gz (Mutect2's calls), +# chip/_chip_contamination.table (the estimate, with the common-sites VCF) # CHIP_GENES=FILE uses another gene table with the columns of assets/chip_genes.tsv. set -euo pipefail @@ -43,6 +47,7 @@ OUTDIR="${S}/chip" P="${OUTDIR}/${SAMPLE}_chip" GNOMAD_VCF="${GENOME_DIR}/somatic/af-only-gnomad.hg38.vcf.gz" PON_VCF="${GENOME_DIR}/somatic/1000g_pon.hg38.vcf.gz" +COMMON_VCF="${GENOME_DIR}/somatic/small_exac_common_3.hg38.vcf.gz" echo "============================================" echo " Step 49: Clonal haematopoiesis (CHIP)" @@ -83,8 +88,23 @@ fi run_in --cpus "$THREADS" --memory 8g "$GATK_IMAGE" "${M2[@]}" run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk LearnReadOrientationModel -I "$(cpath "${P}_f1r2.tar.gz")" \ -O "$(cpath "${P}_orientation.tar.gz")" -run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered.vcf.gz")" \ - --ob-priors "$(cpath "${P}_orientation.tar.gz")" -O "$(cpath "${P}_filtered.vcf.gz")" +FILTER=(gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered.vcf.gz")" + --ob-priors "$(cpath "${P}_orientation.tar.gz")" -O "$(cpath "${P}_filtered.vcf.gz")") +# Another person's DNA in the sample adds alleles at a low VAF, the VAF of a +# small clone. The contamination estimate comes from the common sites inside +# the same exons, as in step 29, and lets FilterMutectCalls mark those calls. +rm -f "${P}_contamination.table" "${P}_segments.table" +if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then + echo " contamination estimate: common sites ${COMMON_VCF}" + run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk GetPileupSummaries -I "$(cpath "$BAM")" -V "$(cpath "$COMMON_VCF")" \ + -L "$(cpath "$COMMON_VCF")" -L "$(cpath "${P}.bed")" --interval-set-rule INTERSECTION -O "$(cpath "${P}_pileups.table")" + run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk CalculateContamination -I "$(cpath "${P}_pileups.table")" \ + --tumor-segmentation "$(cpath "${P}_segments.table")" -O "$(cpath "${P}_contamination.table")" + FILTER+=(--contamination-table "$(cpath "${P}_contamination.table")" --tumor-segmentation "$(cpath "${P}_segments.table")") +else + echo " no common-sites VCF (${COMMON_VCF}): no contamination estimate, so another person's DNA in the sample can pass as a small clone (docs/49-chip.md says how to install it)." +fi +run_in --cpus 2 --memory 4g "$GATK_IMAGE" "${FILTER[@]}" echo "[3/4] Naming each change on its transcript (bcftools csq) and counting the depth (bcftools mpileup)..." # norm splits multi-allelic records, so AD and AF hold one ALT each; csq @@ -105,7 +125,7 @@ echo "[4/4] CHIP classes, germline exclusion and detection limit..." "${OG[@]}" report --genes "$(cpath "${OUTDIR}/chip_genes.tsv")" --gff "$(cpath "${P}.gff3")" --bed "$(cpath "${P}.bed")" \ --calls "$(cpath "${P}_calls.tsv")" --depth "$(cpath "${P}_pileup.tsv")" --sample "$SAMPLE" \ --out "$(cpath "${P}.tsv")" --depth-out "$(cpath "${P}_depth.tsv")" -rm -f "${P}_pileup.tsv" "${P}_f1r2.tar.gz" "${P}_orientation.tar.gz" +rm -f "${P}_pileup.tsv" "${P}_f1r2.tar.gz" "${P}_orientation.tar.gz" "${P}_pileups.table" "${P}_segments.table" echo "" echo "Possible CHIP calls, not a diagnosis (${P}.tsv):" diff --git a/scripts/run-all.sh b/scripts/run-all.sh index dfa11e549..0e32cd3a2 100755 --- a/scripts/run-all.sh +++ b/scripts/run-all.sh @@ -289,10 +289,10 @@ if [[ ",${T// /}," == *",bloodtype,"* ]]; then plan "41 Blood groups" bloodtype if [[ ",${T// /}," == *",lpa,"* ]]; then plan "46 Lp(a) KIV-2 count" lpa "$([ -n "$NOBAM" ] || echo 'no BAM')" || true; else KNOWN+=" lpa"; fi # Step 52 (MUC1 VNTR frameshifts, VNtyper) is opt-in and listed only when TOOLS names it; it reads the BAM. if [[ ",${T// /}," == *",vntyper,"* ]]; then plan "52 MUC1 VNTR (VNtyper)" vntyper "$([ -n "$NOBAM" ] || echo 'no BAM')" || true; else KNOWN+=" vntyper"; fi -# Step 49 (CHIP) is opt-in and listed only when TOOLS names it: Mutect2 on the BAM, with step 29's gnomAD and panel of normals when installed. +# Step 49 (CHIP) is opt-in and listed only when TOOLS names it: Mutect2 on the BAM, with step 29's gnomAD, panel of normals and common sites when installed. CG="${G}/reference/ensembl/Homo_sapiens.GRCh38.${ENSEMBL_GFF_RELEASE}.chr.gff3.gz" if [[ ",${T// /}," == *",chip,"* ]]; then plan "49 CHIP (clonal blood cells)" chip "$(need "$CG")" && NF+=(--chip_gff "$CG") \ - && for r in chip_germline_resource:af-only-gnomad chip_pon:1000g_pon; do f="${G}/somatic/${r#*:}.hg38.vcf.gz"; [ ! -e "${f}.tbi" ] || arg "--${r%%:*}" "$f"; done + && for r in chip_germline_resource:af-only-gnomad chip_pon:1000g_pon chip_common_sites:small_exac_common_3; do f="${G}/somatic/${r#*:}.hg38.vcf.gz"; [ ! -e "${f}.tbi" ] || arg "--${r%%:*}" "$f"; done else KNOWN+=" chip"; fi # Step 42 reads the gVCF only: DeepVariant writes one for a FASTQ or BAM row, a BAM+VCF row has one when it lies beside the VCF. plan "42 Traits panel" traits "$([ -z "$fv" ] || [ -n "$GROW" ] || echo "no gVCF: ${GV#"$G"/}")" || true From e927d0ea9ccc2d64eeb0a2edc4b0409249cfefaa Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:49:15 +0100 Subject: [PATCH 02/40] test(chip): check that every CHIP path hands FilterMutectCalls the contamination table The fake-docker case runs step 49 without the common-sites VCF, with it, and with it but no .tbi; renders CHIP_MUTECT2's script block with a fake gatk with and without --chip_common_sites; and checks that run-all.sh passes the VCF to the pipeline only with its .tbi. Bead: trait-62 --- tests/fake-docker/i411-chip-contamination.sh | 138 +++++++++++++++++++ 1 file changed, 138 insertions(+) create mode 100755 tests/fake-docker/i411-chip-contamination.sh diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh new file mode 100755 index 000000000..87be7d528 --- /dev/null +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -0,0 +1,138 @@ +#!/usr/bin/env bash +# Step 49 (CHIP) gives FilterMutectCalls the contamination estimate when step +# 29's common-sites VCF is installed with its .tbi: GetPileupSummaries at the +# common sites inside the CHIP exons, CalculateContamination, then +# FilterMutectCalls with --contamination-table and --tumor-segmentation. +# Without the VCF, or without its .tbi, there is no estimate and the log says +# so. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run +# here with a fake gatk, passes the table when it gets --chip_common_sites and +# not without it; main.nf hands it the file, and run-all.sh passes the VCF +# under somatic/ to the pipeline only with its .tbi. +# shellcheck source=../../scripts/ci/fake-docker/lib.sh +. "${REPO_ROOT:?}/scripts/ci/fake-docker/lib.sh" +# shellcheck source=../../versions.env +. "${REPO_ROOT}/versions.env" + +export GENOME_DIR="${CASE_WORK}/genome" +G=$GENOME_DIR +seed_reference "$G" +seed_sample "$G" sample1 +printf '@HD\tVN:1.6\n@SQ\tSN:chr1\tLN:248956422\n' > "${G}/reference/GRCh38_no_alt_analysis_set.dict" +GFF="${G}/reference/ensembl/Homo_sapiens.GRCh38.${ENSEMBL_GFF_RELEASE}.chr.gff3.gz" +mkdir -p "$(dirname "$GFF")" +printf 'placeholder\n' > "$GFF" +COMMON="${G}/somatic/small_exac_common_3.hg38.vcf.gz" + +# og chip prepare writes a BED with one exon and og chip report an empty table, +# so the step goes on past its checks; every other call writes its -O output. +use_output_hook +cat > "${CASE_WORK}/hook-chip" <<'HOOK' +#!/usr/bin/env bash +set -euo pipefail +. "${CASE_WORK:?}/host-path.sh" +args=" $* " +# arg OPTION: the value after OPTION in this call +arg() { sed -E "s/.* $1 ([^ ]+) .*/\\1/" <<<"$args"; } +case "$args" in + *"/og chip prepare "*) printf 'chr2\t25234268\t25234430\tDNMT3A\n' > "$(host_path "$(arg --out-bed)")" ;; + *"/og chip report "*) : > "$(host_path "$(arg --out)")" ;; +esac +exec "${CASE_WORK}/hook-outputs" "$@" +HOOK +chmod +x "${CASE_WORK}/hook-chip" +export FAKE_DOCKER_RUN_HOOK="${CASE_WORK}/hook-chip" +C=/genome/sample1/chip/sample1_chip + +# --- the bash step --------------------------------------------------------------------- +# No common-sites VCF: no estimate, and the log says so. +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-no-common "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has '^run image=[^ ]*gatk.* FilterMutectCalls .*--ob-priors ' "step 49 did not run FilterMutectCalls" +if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$FAKE_DOCKER_LOG"; then + fail "step 49 estimated contamination without the common-sites VCF" +fi +output_has chip-no-common 'no common-sites VCF .*: no contamination estimate' + +# The common-sites VCF with its .tbi: the estimate, and FilterMutectCalls reads it. +mkdir -p "${G}/somatic" +printf 'placeholder\n' > "$COMMON" +printf 'placeholder\n' > "${COMMON}.tbi" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-common "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has "^run image=[^ ]*gatk.* GetPileupSummaries -I /genome/sample1/aligned/sample1_sorted\\.bam -V /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L ${C}\\.bed --interval-set-rule INTERSECTION -O ${C}_pileups\\.table" \ + "step 49 did not summarise the pileups at the common sites inside the CHIP exons" +docker_log_has "^run image=[^ ]*gatk.* CalculateContamination -I ${C}_pileups\\.table --tumor-segmentation ${C}_segments\\.table -O ${C}_contamination\\.table" \ + "step 49 did not estimate contamination from those pileups" +docker_log_has "^run image=[^ ]*gatk.* FilterMutectCalls .*--contamination-table ${C}_contamination\\.table --tumor-segmentation ${C}_segments\\.table" \ + "FilterMutectCalls did not get the contamination table" +# The estimate comes before the filter that reads it. +awk '/ CalculateContamination / { c = NR } / FilterMutectCalls / { f = NR } END { exit !(c && f > c) }' "$FAKE_DOCKER_LOG" \ + || fail "FilterMutectCalls ran before CalculateContamination" +output_lacks chip-common 'no contamination estimate' +output_has chip-common 'contamination estimate: common sites ' + +# The VCF without its .tbi is not used. +rm -f "${COMMON}.tbi" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-common-no-tbi "${SCRIPTS}/49-chip.sh" sample1 +if grep -q -- '--contamination-table' "$FAKE_DOCKER_LOG"; then fail "step 49 used the common-sites VCF without its .tbi"; fi +output_has chip-common-no-tbi 'no contamination estimate' +printf 'placeholder\n' > "${COMMON}.tbi" + +# --- CHIP_MUTECT2 (Nextflow) ------------------------------------------------------------- +# The shell of the module's script block, with its Groovy values filled in. +MOD="${REPO_ROOT}/modules/local/chip/main.nf" +# shellcheck disable=SC2016 # the dollar signs are Groovy placeholders, matched literally +render_mutect2() { + awk '/^process CHIP_MUTECT2/ { p = 1 } p && /^ script:/ { on = 1; next } on && /^ """/ { n++; if (n == 2) exit; next } on && n == 1' "$MOD" \ + | sed -e 's/\${reference}/ref.fa/g' -e 's/\${bam}/in.bam/g' -e 's/\${bed}/chip.bed/g' -e 's/\${task\.cpus}/2/g' \ + -e 's/\${resources}//g' -e 's/\${meta\.id}/s1/g' -e "s|\\\${common_sites}|$1|g" -e '/versions\.yml/d' \ + -e 's/\\\$/$/g' -e 's/\\\\/\\/g' +} +NFW="${CASE_WORK}/chip-nf" +mkdir -p "${NFW}/bin" +cat > "${NFW}/bin/gatk" <<'FAKE' +#!/usr/bin/env bash +printf 'gatk %s\n' "$*" >> "${NFW_LOG:?}" +FAKE +chmod +x "${NFW}/bin/gatk" +# run_module COMMON_SITES: run the rendered block in $NFW, with the gatk calls in gatk.log +run_module() { + render_mutect2 "$1" > "${NFW}/script.sh" + : > "${NFW}/gatk.log" + (cd "$NFW" && PATH="${NFW}/bin:${PATH}" NFW_LOG="${NFW}/gatk.log" bash -euo pipefail script.sh) > "${NFW}/out.txt" 2>&1 \ + || { cat "${NFW}/script.sh" "${NFW}/out.txt"; fail "CHIP_MUTECT2's script block failed with common sites '$1'"; } + cat "${NFW}/gatk.log" "${NFW}/out.txt" +} +run_module common.vcf.gz +grep -q '^gatk GetPileupSummaries -I in\.bam -V common\.vcf\.gz -L common\.vcf\.gz -L chip\.bed --interval-set-rule INTERSECTION -O pileups\.table$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2 did not summarise the pileups at the common sites inside the BED, as step 49 does" +grep -q '^gatk CalculateContamination -I pileups\.table --tumor-segmentation segments\.table -O contamination\.table$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2 did not estimate contamination" +grep -q '^gatk FilterMutectCalls .*--contamination-table contamination\.table --tumor-segmentation segments\.table .*-O s1_chip_filtered\.vcf\.gz$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2's FilterMutectCalls did not get the contamination table" +run_module "" +grep -q '^gatk FilterMutectCalls .*-O s1_chip_filtered\.vcf\.gz$' "${NFW}/gatk.log" || fail "CHIP_MUTECT2 without common sites did not filter" +if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "${NFW}/gatk.log"; then + fail "CHIP_MUTECT2 estimated contamination without --chip_common_sites" +fi +grep -q 'no --chip_common_sites' "${NFW}/out.txt" || fail "CHIP_MUTECT2 without common sites does not say it has no estimate" +# main.nf hands the module the file and its index, in the order of its inputs. +grep -qF 'def chip_common = common ? file(common, checkIfExists: true) : []' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not read --chip_common_sites" +grep -qF 'chip_pon, chip_pon_index, chip_common, chip_common_index)' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not pass the common sites to CHIP_MUTECT2" + +# --- run-all.sh -------------------------------------------------------------------------- +# TOOLS=chip passes the installed common-sites VCF to the pipeline, only with its .tbi. +export SKIP_VALIDATION=true +seed_clinvar "$G" +: > "$FAKE_DOCKER_LOG" +TOOLS=chip run_expect 0 run-all-common "${SCRIPTS}/run-all.sh" sample1 male +docker_log_has "^nextflow :: .* --chip_common_sites ${COMMON//./\\.} " "run-all.sh did not pass the installed common-sites VCF" +rm -f "${COMMON}.tbi" +: > "$FAKE_DOCKER_LOG" +TOOLS=chip run_expect 0 run-all-no-tbi "${SCRIPTS}/run-all.sh" sample1 male +docker_log_has '^nextflow :: .* --tools ' "run-all.sh did not run the pipeline" +if grep -q -- '--chip_common_sites' "$FAKE_DOCKER_LOG"; then fail "run-all.sh passed the common-sites VCF without its .tbi"; fi +echo "Step 49, CHIP_MUTECT2 and run-all.sh give FilterMutectCalls the contamination estimate with the common sites, and only then." From 395bef2f8625ef62cc0a6ddf3d3cb081edfd8cb3 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:57:48 +0100 Subject: [PATCH 03/40] fix(chip): estimate contamination from every common site, not only the CHIP exons The CHIP coding exons hold 8 of the 59,295 sites of the common-sites VCF, too few for CalculateContamination to estimate anything. Contamination is a property of the sample, so GetPileupSummaries now reads every common site of the VCF in both the step and CHIP_MUTECT2. The fake-docker case checks the table first, so main fails it on the --contamination-table check. Bead: trait-62 --- CHANGELOG.md | 2 +- docs/49-chip.md | 4 +-- modules/local/chip/main.nf | 7 ++-- scripts/49-chip.sh | 12 ++++--- tests/fake-docker/i411-chip-contamination.sh | 38 ++++++++++---------- 5 files changed, 33 insertions(+), 30 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 2329e95ed..7a4a48b57 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its common sites inside the CHIP exons and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls, as step 29 does. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). +- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its 59,295 sites across the genome and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls. The pileups do not stop at the CHIP exons, which hold only 8 of those sites, too few for an estimate. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/docs/49-chip.md b/docs/49-chip.md index 12d290296..35ff6cf00 100644 --- a/docs/49-chip.md +++ b/docs/49-chip.md @@ -44,7 +44,7 @@ With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only w ## How it decides 1. For each gene of `assets/chip_genes.tsv` the step takes the transcript Ensembl tags `MANE_Select`, and calls inside its coding exons, 10 bases wider on each side so the splice donor and acceptor sites are in. That is 162 exons and about 35 kb with Ensembl 116. -2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at its common sites inside the same exons, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The exons hold few common sites, so the estimate is rough; a whole-genome estimate is VerifyBamID2's FREEMIX in step 33. +2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at every one of its 59,295 sites across the genome, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The pileups do not stop at the CHIP exons, as step 29's do at its intervals: the exons hold 8 of the 59,295 sites, too few for an estimate. Step 33's VerifyBamID2 gives a second, separate estimate (FREEMIX). 3. Each call that changes the protein is put in the gene's class from the table: | Gene | Counted | Source (PMID) | @@ -124,7 +124,7 @@ Both reports show a "Clonal Haematopoiesis (CHIP)" section: the calls, the state ## Runtime -Not measured on a whole genome. Mutect2 reads about 35 kb of the BAM, which takes minutes, not hours. +Not measured on a whole genome. Mutect2 reads about 35 kb of the BAM, which takes minutes, not hours. With the common-sites VCF, GetPileupSummaries also reads the BAM at the VCF's 59,295 sites. ## Notes diff --git a/modules/local/chip/main.nf b/modules/local/chip/main.nf index ddee5e595..483f35417 100644 --- a/modules/local/chip/main.nf +++ b/modules/local/chip/main.nf @@ -93,13 +93,12 @@ process CHIP_MUTECT2 { --native-pair-hmm-threads ${task.cpus} --max-mnp-distance 0 ${resources} gatk LearnReadOrientationModel -I f1r2.tar.gz -O orientation.tar.gz # Another person's DNA in the sample adds alleles at the VAF of a small - # clone: the estimate from the common sites inside the BED lets - # FilterMutectCalls mark those calls. + # clone. The estimate reads every common site across the genome (the BED + # holds too few) and lets FilterMutectCalls mark those calls. common_sites='${common_sites}' contamination='' if [ -n "\$common_sites" ]; then - gatk GetPileupSummaries -I ${bam} -V "\$common_sites" -L "\$common_sites" -L ${bed} \\ - --interval-set-rule INTERSECTION -O pileups.table + gatk GetPileupSummaries -I ${bam} -V "\$common_sites" -L "\$common_sites" -O pileups.table gatk CalculateContamination -I pileups.table --tumor-segmentation segments.table -O contamination.table contamination='--contamination-table contamination.table --tumor-segmentation segments.table' else diff --git a/scripts/49-chip.sh b/scripts/49-chip.sh index a234ccd4c..b7f412ab1 100755 --- a/scripts/49-chip.sh +++ b/scripts/49-chip.sh @@ -7,8 +7,8 @@ # each on its MANE Select transcript from Ensembl's gene annotation (setup.sh # --chip-data). gnomAD's AF-only germline resource and the panel of normals of # step 29 are used when they are in GENOME_DIR/somatic/, and so is step 29's -# common-sites VCF: GetPileupSummaries and CalculateContamination estimate how -# much of the sample is another person's DNA, and FilterMutectCalls gets that +# common-sites VCF: GetPileupSummaries at its sites across the genome and +# CalculateContamination estimate how much of the sample is another person's DNA, and FilterMutectCalls gets that # estimate, so a contaminant's alleles are not read as a clone. bcftools csq names # each change on that transcript, and og chip (bin/og) keeps the changes in # the table's CHIP classes, leaves out the ones whose VAF looks inherited (35% @@ -91,13 +91,15 @@ run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk LearnReadOrientationModel -I "$(c FILTER=(gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered.vcf.gz")" --ob-priors "$(cpath "${P}_orientation.tar.gz")" -O "$(cpath "${P}_filtered.vcf.gz")") # Another person's DNA in the sample adds alleles at a low VAF, the VAF of a -# small clone. The contamination estimate comes from the common sites inside -# the same exons, as in step 29, and lets FilterMutectCalls mark those calls. +# small clone. CalculateContamination estimates that share from the reads at +# every site of the common-sites VCF, across the genome: the CHIP exons hold +# only 8 of its 59,295 sites, too few for an estimate. FilterMutectCalls then +# marks the calls contamination explains. rm -f "${P}_contamination.table" "${P}_segments.table" if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then echo " contamination estimate: common sites ${COMMON_VCF}" run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk GetPileupSummaries -I "$(cpath "$BAM")" -V "$(cpath "$COMMON_VCF")" \ - -L "$(cpath "$COMMON_VCF")" -L "$(cpath "${P}.bed")" --interval-set-rule INTERSECTION -O "$(cpath "${P}_pileups.table")" + -L "$(cpath "$COMMON_VCF")" -O "$(cpath "${P}_pileups.table")" run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk CalculateContamination -I "$(cpath "${P}_pileups.table")" \ --tumor-segmentation "$(cpath "${P}_segments.table")" -O "$(cpath "${P}_contamination.table")" FILTER+=(--contamination-table "$(cpath "${P}_contamination.table")" --tumor-segmentation "$(cpath "${P}_segments.table")") diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh index 87be7d528..cbed00513 100755 --- a/tests/fake-docker/i411-chip-contamination.sh +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -1,7 +1,7 @@ #!/usr/bin/env bash # Step 49 (CHIP) gives FilterMutectCalls the contamination estimate when step -# 29's common-sites VCF is installed with its .tbi: GetPileupSummaries at the -# common sites inside the CHIP exons, CalculateContamination, then +# 29's common-sites VCF is installed with its .tbi: GetPileupSummaries at every +# site of that VCF (not only inside the CHIP exons), CalculateContamination, then # FilterMutectCalls with --contamination-table and --tumor-segmentation. # Without the VCF, or without its .tbi, there is no estimate and the log says # so. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run @@ -44,27 +44,18 @@ export FAKE_DOCKER_RUN_HOOK="${CASE_WORK}/hook-chip" C=/genome/sample1/chip/sample1_chip # --- the bash step --------------------------------------------------------------------- -# No common-sites VCF: no estimate, and the log says so. -: > "$FAKE_DOCKER_LOG" -run_expect 0 chip-no-common "${SCRIPTS}/49-chip.sh" sample1 -docker_log_has '^run image=[^ ]*gatk.* FilterMutectCalls .*--ob-priors ' "step 49 did not run FilterMutectCalls" -if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$FAKE_DOCKER_LOG"; then - fail "step 49 estimated contamination without the common-sites VCF" -fi -output_has chip-no-common 'no common-sites VCF .*: no contamination estimate' - # The common-sites VCF with its .tbi: the estimate, and FilterMutectCalls reads it. mkdir -p "${G}/somatic" printf 'placeholder\n' > "$COMMON" printf 'placeholder\n' > "${COMMON}.tbi" : > "$FAKE_DOCKER_LOG" run_expect 0 chip-common "${SCRIPTS}/49-chip.sh" sample1 -docker_log_has "^run image=[^ ]*gatk.* GetPileupSummaries -I /genome/sample1/aligned/sample1_sorted\\.bam -V /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L ${C}\\.bed --interval-set-rule INTERSECTION -O ${C}_pileups\\.table" \ - "step 49 did not summarise the pileups at the common sites inside the CHIP exons" -docker_log_has "^run image=[^ ]*gatk.* CalculateContamination -I ${C}_pileups\\.table --tumor-segmentation ${C}_segments\\.table -O ${C}_contamination\\.table" \ - "step 49 did not estimate contamination from those pileups" docker_log_has "^run image=[^ ]*gatk.* FilterMutectCalls .*--contamination-table ${C}_contamination\\.table --tumor-segmentation ${C}_segments\\.table" \ "FilterMutectCalls did not get the contamination table" +docker_log_has "^run image=[^ ]*gatk.* GetPileupSummaries -I /genome/sample1/aligned/sample1_sorted\\.bam -V /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -L /genome/somatic/small_exac_common_3\\.hg38\\.vcf\\.gz -O ${C}_pileups\\.table" \ + "step 49 did not summarise the pileups at every common site" +docker_log_has "^run image=[^ ]*gatk.* CalculateContamination -I ${C}_pileups\\.table --tumor-segmentation ${C}_segments\\.table -O ${C}_contamination\\.table" \ + "step 49 did not estimate contamination from those pileups" # The estimate comes before the filter that reads it. awk '/ CalculateContamination / { c = NR } / FilterMutectCalls / { f = NR } END { exit !(c && f > c) }' "$FAKE_DOCKER_LOG" \ || fail "FilterMutectCalls ran before CalculateContamination" @@ -76,7 +67,18 @@ rm -f "${COMMON}.tbi" : > "$FAKE_DOCKER_LOG" run_expect 0 chip-common-no-tbi "${SCRIPTS}/49-chip.sh" sample1 if grep -q -- '--contamination-table' "$FAKE_DOCKER_LOG"; then fail "step 49 used the common-sites VCF without its .tbi"; fi -output_has chip-common-no-tbi 'no contamination estimate' +output_has chip-common-no-tbi 'no common-sites VCF .*: no contamination estimate' + +# No common-sites VCF: no estimate, and the log says so. +rm -f "$COMMON" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-no-common "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has '^run image=[^ ]*gatk.* FilterMutectCalls .*--ob-priors ' "step 49 did not run FilterMutectCalls" +if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$FAKE_DOCKER_LOG"; then + fail "step 49 estimated contamination without the common-sites VCF" +fi +output_has chip-no-common 'no common-sites VCF .*: no contamination estimate' +printf 'placeholder\n' > "$COMMON" printf 'placeholder\n' > "${COMMON}.tbi" # --- CHIP_MUTECT2 (Nextflow) ------------------------------------------------------------- @@ -105,8 +107,8 @@ run_module() { cat "${NFW}/gatk.log" "${NFW}/out.txt" } run_module common.vcf.gz -grep -q '^gatk GetPileupSummaries -I in\.bam -V common\.vcf\.gz -L common\.vcf\.gz -L chip\.bed --interval-set-rule INTERSECTION -O pileups\.table$' "${NFW}/gatk.log" \ - || fail "CHIP_MUTECT2 did not summarise the pileups at the common sites inside the BED, as step 49 does" +grep -q '^gatk GetPileupSummaries -I in\.bam -V common\.vcf\.gz -L common\.vcf\.gz -O pileups\.table$' "${NFW}/gatk.log" \ + || fail "CHIP_MUTECT2 did not summarise the pileups at every common site, as step 49 does" grep -q '^gatk CalculateContamination -I pileups\.table --tumor-segmentation segments\.table -O contamination\.table$' "${NFW}/gatk.log" \ || fail "CHIP_MUTECT2 did not estimate contamination" grep -q '^gatk FilterMutectCalls .*--contamination-table contamination\.table --tumor-segmentation segments\.table .*-O s1_chip_filtered\.vcf\.gz$' "${NFW}/gatk.log" \ From 3ae8eccbd809c6fd2e6239e7aae70bad8fe20f11 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:59:02 +0100 Subject: [PATCH 04/40] fix(carrier): keep the low-confidence mark and the zygosity on every carrier row The carrier list parsed each hit with the default call floor (GQ 30, DP 10) and dropped the floor the hits file states, and it wrote no call quality at all, so a weak call read like a sure one. Each row now has zygosity, gq, dp and low_confidence, judged against the file's own ##PGP_CALL_FLOOR, as the ClinVar section judges the same hit. A homozygous or hemizygous P/LP row has no unchanged copy, so it moves from carriers to a new list, hom_or_hemizygous. Two different heterozygous hits in one recessive gene get pair and phase from the haplotype rule of the secondary-findings card (two hits, possible two hits, or one copy in cis). A pair resting on a low-confidence call, and a deletion plus a low-confidence call (two_hits), is at most possible. The schema describes the carrier section; the summary-collect goldens change only in the carrier section. og-render's hemizygous tests read the row from its new list. Bead: clin-15 Bead: clin-19 --- rust/crates/og-render/tests/clinical.rs | 13 +- rust/crates/og-summary/src/collect/carrier.rs | 231 +++++++++++- .../crates/og-summary/src/collect/two_hits.rs | 24 +- .../tests/i411_carrier_confidence.rs | 335 ++++++++++++++++++ .../all-history/all-history.json | 56 ++- .../golden/summary-collect/all-nf/all-nf.json | 60 +++- .../golden/summary-collect/all/all.json | 56 ++- .../summary-collect/cb-full/cb-full.json | 64 +++- .../golden/summary-collect/cb-nf/cb-nf.json | 60 +++- .../summary-collect/cb-nfbad/cb-nfbad.json | 56 ++- .../summary-collect/cb-notbi/cb-notbi.json | 56 ++- .../cb-quoted-dosage/cb-quoted-dosage.json | 64 +++- .../cb-quoted-interval.json | 64 +++- .../cb-quoted-smn/cb-quoted-smn.json | 64 +++- .../cb-unicode-contig/cb-unicode-contig.json | 64 +++- tests/schema/summary.schema.json | 177 +++++++++ 16 files changed, 1309 insertions(+), 135 deletions(-) create mode 100644 rust/crates/og-summary/tests/i411_carrier_confidence.rs diff --git a/rust/crates/og-render/tests/clinical.rs b/rust/crates/og-render/tests/clinical.rs index 6bbd24cee..a235a8eea 100644 --- a/rust/crates/og-render/tests/clinical.rs +++ b/rust/crates/og-render/tests/clinical.rs @@ -812,7 +812,7 @@ fn a_homozygous_call_inside_a_deletion_is_hemizygous() { Some(&del("0/1", None)), ); let c = carrier_of(&d); - let item: Vec<&Value> = list(at(&c, &["carriers"])) + let item: Vec<&Value> = list(at(&c, &["hom_or_hemizygous"])) .iter() .filter(|x| s(at(x, &["gene"])) == "MUTYH") .collect(); @@ -836,7 +836,7 @@ fn a_homozygous_call_inside_a_deletion_is_hemizygous() { Some(&del("0/1", None)), ); let c = carrier_of(&d); - list(at(&c, &["carriers"])) + list(at(&c, &["hom_or_hemizygous"])) .iter() .find(|x| s(at(x, &["gene"])) == "MUTYH") .map(|x| s(at(x, &["genotype"])).to_owned()) @@ -923,8 +923,13 @@ fn both_reports_print_the_two_hit_line_and_the_hemizygous_genotype() { let (txt, html) = reports(&collect(&d)); assert!(txt.contains("Biallelic: MUTYH")); assert!(html.contains("Biallelic: MUTYH")); - assert!(html.contains("hemizygous (called homozygous inside DEL")); - assert!(txt.contains("hemizygous (called homozygous inside DEL")); + // The hit has no unchanged copy, so the summary lists it apart from the + // carriers (hom_or_hemizygous); the two-hit line still names it. + assert!( + html.replace(">", ">") + .contains("chr1:45336000 G>A hemizygous") + ); + assert!(txt.contains("chr1:45336000 G>A hemizygous")); assert!(txt.contains("biallelic with DEL chr1:45335000-45337000")); assert!(html.contains("biallelic with DEL chr1:45335000-45337000")); } diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index e02396a91..bafa8a8cd 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -6,18 +6,177 @@ //! called homozygous inside a deletion is shown as hemizygous. A hit that //! is part of step 06's combined allele, or the combined allele itself, //! carries the note the ClinVar table prints for it. +//! +//! Each row keeps its zygosity and step 06's call quality: GQ, DP and the +//! low-confidence mark against the hits file's own call floor. A carrier +//! has one changed copy, so a row called homozygous or hemizygous is listed +//! apart (`hom_or_hemizygous`), never as a carrier. Two different +//! heterozygous hits in one recessive gene are counted as copies, the way +//! the secondary-findings card counts them: read-backed phase on different +//! copies is two hits, phase unknown is possible two hits, both on one copy +//! is one hit. use super::assets::carrier_genes; -use super::clinvar::{Floor, Hit, HitRecords, allele_copies, carrier_genotype, obj}; +use super::clinvar::{ + Floor, Hit, HitRecords, VarKey, allele_copies, carrier_genotype, obj, opt_int, zygosity_word, +}; use super::text::{self, gt_field}; -use super::two_hits::{DeletionInputs, Spans, Variant, gene_deletions, two_hits}; +use super::two_hits::{DeletionInputs, Spans, Variant, gene_deletions, phase_haps, two_hits_with}; use indexmap::IndexMap; use pycompat::json::Value; +use std::collections::{BTreeSet, HashSet}; /// The section's data: the list, or why it could not be made. #[derive(Debug, Clone, PartialEq)] pub struct Carrier(pub Value); +/// One heterozygous carrier hit of a recessive gene, as the pair rule +/// counts it. +#[derive(Clone)] +struct Het { + key: VarKey, + gt: String, + ps: Option, + /// The parts of a combined allele (step 06's `PGP_JOINED_FROM`). + joined: Vec, + low: bool, +} + +impl Het { + /// The copies read-backed phase puts the alt allele on, with its phase + /// set: only a `|` GT with every copy called and a non-empty PS. + fn phased(&self) -> Option<(&str, BTreeSet)> { + let ps = self.ps.as_deref().filter(|p| !p.is_empty())?; + let h = phase_haps(Some(&self.gt)).filter(|h| !h.is_empty())?; + Some((ps, h)) + } + + /// The copy a half call (`1/.`, `./1`) puts its alt allele on. + fn half(&self) -> Option { + let a: Vec<&str> = self.gt.split(['/', '|']).collect(); + match a.as_slice() { + [x, "."] if !matches!(*x, "0" | ".") => Some(0), + [".", y] if !matches!(*y, "0" | ".") => Some(1), + _ => None, + } + } +} + +/// `CHROM:POS:REF:ALT` joined by `|`, as step 06 writes `PGP_JOINED_FROM`. +fn joined_keys(r: &[String]) -> Vec { + let info = r.get(7).map(String::as_str).unwrap_or(""); + let v = text::info_map(info) + .get("PGP_JOINED_FROM") + .copied() + .unwrap_or(""); + v.split('|') + .filter_map(|p| { + let mut it = p.rsplitn(4, ':'); + let (alt, rf, pos, chrom) = (it.next()?, it.next()?, it.next()?, it.next()?); + let pos = crate::int(pos).ok()?; + Some((chrom.to_owned(), pos, rf.to_owned(), alt.to_owned())) + }) + .collect() +} + +/// How two or more different heterozygous hits of one gene pair up: the +/// pair word (`two hits`, `possible two hits`, none when they sit on one +/// copy) and why. `None` when fewer than two distinct alleles are left +/// once a combined allele and its parts count once. +fn het_pair(hets: &[Het]) -> Option<(Option, String)> { + // A combined allele and its parts count once, under the combined + // allele, when its call is phased or at most one part is here; an + // unphased one with two or more parts here counts through its parts, + // which may sit on different copies. + let present: HashSet<&VarKey> = hets.iter().map(|h| &h.key).collect(); + let mut gone: HashSet<&VarKey> = HashSet::new(); + for h in hets.iter().filter(|h| !h.joined.is_empty()) { + let parts: Vec<&VarKey> = h.joined.iter().filter(|k| present.contains(k)).collect(); + if h.phased().is_some() || parts.len() <= 1 { + gone.extend(parts); + } else { + gone.insert(&h.key); + } + } + let kept: Vec<&Het> = hets.iter().filter(|h| !gone.contains(&h.key)).collect(); + if kept.len() < 2 { + return None; + } + let mut n = 0; + let mut sets: IndexMap<&str, (BTreeSet, usize)> = IndexMap::new(); + let mut halves: IndexMap<(&str, i128), (BTreeSet, usize)> = IndexMap::new(); + for h in &kept { + if let Some((ps, hs)) = h.phased() { + let s = sets.entry(ps).or_default(); + s.0.extend(hs); + s.1 += 1; + } else if let Some(i) = h.half() { + let s = halves.entry((h.key.0.as_str(), h.key.1)).or_default(); + s.0.insert(i); + s.1 += 1; + } else { + n += 1; + } + } + let mut proof: Option = None; + let mut cis: Option<&str> = None; + for (ps, (h, count)) in &sets { + n += h.len(); + if h.len() >= 2 { + proof.get_or_insert_with(|| { + format!( + "in trans: read-backed phase puts them on different copies (phase set {ps})" + ) + }); + } else if *count >= 2 { + cis.get_or_insert(ps); + } + } + for ((chrom, pos), (h, count)) in &halves { + if h.len() >= 2 { + n += 2 + count - h.len(); + proof.get_or_insert_with(|| { + format!("in trans: the two alt alleles of one call at {chrom}:{pos}") + }); + } else { + n += count; + } + } + let (word, why) = match (proof, cis) { + (Some(p), _) => ("two hits", p), + (None, _) if n >= 2 => ( + "possible two hits", + "phase unknown: no read-backed phase links the variants, so they may sit on the same \ + copy (cis)" + .to_owned(), + ), + (None, Some(ps)) => { + return Some(( + None, + format!( + "two heterozygous variants in cis: read-backed phase puts them on the same \ + copy (phase set {ps}), so one copy is hit" + ), + )); + } + (None, None) => { + return Some(( + None, + "the variants sit on one copy, so one copy is hit".to_owned(), + )); + } + }; + if kept.iter().any(|h| h.low) { + return Some(( + Some("possible two hits (low-confidence call)".to_owned()), + format!( + "a call below the call floor (low confidence) is one of them, so confirm it first; {why}" + ), + )); + } + Some((Some(word.to_owned()), why)) +} + impl Carrier { /// `carrier_list_or_note`. An `Err` is the collector's note (a hit /// whose POS is no integer). @@ -31,16 +190,22 @@ impl Carrier { Ok(g) => g, Err(e) => return Ok(unavailable(e)), }; - let recs = match hits { - Ok((_, r)) => r, + // The hits file's own call floor (`##PGP_CALL_FLOOR`), as the + // ClinVar section judges the same rows. + let (floor, recs): (Floor, _) = match hits { + Ok((f, r)) => (*f, r), Err(e) => return Ok(unavailable(e.clone())), }; let mut items: Vec> = Vec::new(); // Which list each item is on: carriers (false) or set aside (true). let mut aside: Vec = Vec::new(); let mut variants: Vec<(Variant, usize)> = Vec::new(); + let mut low: HashSet<(String, VarKey)> = HashSet::new(); + // The heterozygous carrier hits of each recessive gene, with the + // items they are. + let mut hets: IndexMap> = IndexMap::new(); for r in recs.iter().filter(|r| r.len() >= 8) { - let row = Hit::parse(r, Floor::default())?; + let row = Hit::parse(r, floor)?; let gt = text::gt_of(r).to_owned(); let (copies, ploidy) = allele_copies(>); let key = row.key(); @@ -50,8 +215,15 @@ impl Carrier { item.insert("gene".into(), Value::Str(g.to_owned())); item.insert("variant".into(), Value::Str(row.variant())); item.insert("genotype".into(), Value::Str(carrier_genotype(>, &row))); + item.insert( + "zygosity".into(), + Value::Str(zygosity_word(copies, ploidy).into()), + ); item.insert("significance".into(), Value::Str(row.significance.clone())); item.insert("stars".into(), Value::Int(row.stars.into())); + item.insert("gq".into(), opt_int(row.gq)); + item.insert("dp".into(), opt_int(row.dp)); + item.insert("low_confidence".into(), Value::Bool(row.low_confidence)); item.insert("inheritance".into(), Value::Str(x.inheritance.clone())); item.insert("condition".into(), Value::Str(x.condition.clone())); if row.combined_allele != "." { @@ -74,6 +246,21 @@ impl Carrier { }; items.push(item); aside.push(sev.is_some()); + if row.low_confidence { + low.insert((g.to_owned(), key.clone())); + } + if sev.is_none() && x.inheritance == "AR" && copies == 1 && ploidy == 2 { + hets.entry(g.to_owned()).or_default().push(( + Het { + key: key.clone(), + gt: gt.clone(), + ps: gt_field(r, "PS"), + joined: joined_keys(r), + low: row.low_confidence, + }, + items.len() - 1, + )); + } // A record with no alt copy called is no hit to pair. if copies > 0 && sev.is_none_or(|s| s.kind.as_deref() == Some("hypomorph")) { variants.push(( @@ -95,17 +282,39 @@ impl Carrier { } } } + for list in hets.values() { + // The same record twice (a duplicate line) is one allele. + let mut seen = HashSet::new(); + let distinct: Vec = list + .iter() + .filter(|(h, _)| seen.insert(h.key.clone())) + .map(|(h, _)| h.clone()) + .collect(); + let Some((word, why)) = het_pair(&distinct) else { + continue; + }; + for (_, at) in list { + let item = &mut items[*at]; + if let Some(w) = &word { + item.insert("pair".into(), Value::Str(w.clone())); + } + item.insert("phase".into(), Value::Str(why.clone())); + } + } let spans: Spans = genes .iter() .map(|(g, x)| (g.clone(), x.span.clone())) .collect(); let (dels, read, unread) = gene_deletions(deletions, &spans); let vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); - let found = two_hits(&vs, &dels); + let found = two_hits_with(&vs, &dels, |v| { + low.contains(&(v.gene.clone(), v.key.clone())) + }); for (v, at) in &variants { if let Some(t) = found.hemi.get(&(v.gene.clone(), v.key.clone())) { let item = &mut items[*at]; item.insert("genotype".into(), Value::Str("hemizygous".into())); + item.insert("zygosity".into(), Value::Str("hemizygous".into())); item.insert( "hemizygous".into(), Value::Str(format!("called homozygous inside {t}")), @@ -124,10 +333,17 @@ impl Carrier { Value::Object(m) }) .collect(); - let (mut carriers, mut set_aside) = (Vec::new(), Vec::new()); + let (mut carriers, mut both, mut set_aside) = (Vec::new(), Vec::new(), Vec::new()); for (item, a) in items.into_iter().zip(aside) { + let zyg = match item.get("zygosity") { + Some(Value::Str(z)) => z.clone(), + _ => String::new(), + }; if a { set_aside.push(Value::Object(item)); + } else if matches!(zyg.as_str(), "hom" | "hemizygous") { + // No unchanged copy left: not the pattern of a carrier. + both.push(Value::Object(item)); } else { carriers.push(Value::Object(item)); } @@ -137,6 +353,7 @@ impl Carrier { ("genes_on_list", Value::Int(genes.len() as i128)), ("list", Value::Str("assets/carrier_genes.tsv".into())), ("carriers", Value::Array(carriers)), + ("hom_or_hemizygous", Value::Array(both)), ("set_aside", Value::Array(set_aside)), ( "two_hits", diff --git a/rust/crates/og-summary/src/collect/two_hits.rs b/rust/crates/og-summary/src/collect/two_hits.rs index 3841788ac..0e273ddef 100644 --- a/rust/crates/og-summary/src/collect/two_hits.rs +++ b/rust/crates/og-summary/src/collect/two_hits.rs @@ -76,6 +76,9 @@ pub enum Verdict { Biallelic, /// Phase unknown, or the calls disagree: possibly both copies. PossiblyBiallelic, + /// A pair that would count, but the small variant's call is below + /// step 06's call floor: confirm the call first. + LowConfidence, /// Both on the same copy: no second hit. Cis, } @@ -85,6 +88,7 @@ impl Verdict { match self { Verdict::Biallelic => "biallelic", Verdict::PossiblyBiallelic => "possibly biallelic", + Verdict::LowConfidence => "possibly biallelic (low-confidence call)", Verdict::Cis => "cis", } } @@ -229,12 +233,23 @@ pub struct TwoHits { /// The genes hit twice. pub fn two_hits(variants: &[Variant], dels: &HashMap>) -> TwoHits { + two_hits_with(variants, dels, |_| false) +} + +/// [`two_hits`], where a pair built on a variant `low` calls low +/// confidence (below step 06's call floor) is never more than +/// [`Verdict::LowConfidence`]. +pub fn two_hits_with( + variants: &[Variant], + dels: &HashMap>, + low: impl Fn(&Variant) -> bool, +) -> TwoHits { let mut out = TwoHits::default(); let mut best: HashMap<(String, VKey), Verdict> = HashMap::new(); for v in variants { let k = (v.gene.clone(), v.key.clone()); for dl in dels.get(&v.gene).map_or(&[][..], Vec::as_slice) { - let (verdict, why) = pair_phase(dl, v); + let (mut verdict, mut why) = pair_phase(dl, v); if verdict == Verdict::Biallelic && why.starts_with("the variant is called homozygous") { out.hemi.insert(k.clone(), dl.text.clone()); @@ -242,6 +257,13 @@ pub fn two_hits(variants: &[Variant], dels: &HashMap>) -> if verdict == Verdict::Cis { continue; } + if low(v) { + verdict = Verdict::LowConfidence; + why = format!( + "the variant's call is below the call floor (low confidence), so confirm it \ + first; {why}" + ); + } let e = Entry { gene: v.gene.clone(), verdict, diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs new file mode 100644 index 000000000..54c716aaf --- /dev/null +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -0,0 +1,335 @@ +//! The carrier list keeps each hit's call quality and zygosity, and counts +//! two hits in one gene as copies. +//! +//! The list used to judge every hit at GQ 30 and DP 10, whatever floor the +//! hits file states, and it dropped the low-confidence mark the ClinVar +//! section shows for the same row. It listed a homozygous or hemizygous +//! P/LP row as a carrier beside the heterozygous ones, two different +//! heterozygous hits of one recessive gene as two plain carrier rows, and a +//! deletion plus a low-confidence call as a confident two-hit gene. These +//! cases run the list on synthetic hits with the shipped +//! `assets/carrier_genes.tsv`. + +use indexmap::IndexMap; +use og_summary::collect::carrier::Carrier; +use og_summary::collect::clinvar::{Floor, HitRecords, HitsVcf}; +use og_summary::collect::two_hits::{DeletionInputs, SvRow}; +use pycompat::json::Value; + +const ASSETS: &str = concat!(env!("CARGO_MANIFEST_DIR"), "/../../../assets"); + +// MUTYH and CFTR spans in assets/carrier_genes.tsv: chr1:45329163-45340893 +// and chr7:117287120-117715971. MUTYH is on the ACMG SF list, CFTR is not. +const MUTYH_A: (&str, i128, &str, &str) = ("chr1", 45_331_556, "C", "T"); +const CFTR_A: (&str, i128, &str, &str) = ("chr7", 117_559_590, "ATCT", "A"); +const CFTR_B: (&str, i128, &str, &str) = ("chr7", 117_587_806, "G", "T"); +const OTC_A: (&str, i128, &str, &str) = ("chrX", 38_400_000, "C", "T"); + +/// One step 06 hit: Pathogenic with 2 stars, the FORMAT values given (GT +/// first), and `info` added to INFO. +fn hit( + site: (&str, i128, &str, &str), + gene: &str, + fmt: &str, + sample: &str, + info: &str, +) -> Vec { + let info = format!( + "GENEINFO={gene}:1;CLNSIG=Pathogenic;\ + CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts{info}" + ); + [ + site.0, + &site.1.to_string(), + ".", + site.2, + site.3, + ".", + "PASS", + &info, + fmt, + sample, + ] + .iter() + .map(|s| (*s).to_owned()) + .collect() +} + +/// A hit with good call quality (GQ 50, DP 30). +fn good(site: (&str, i128, &str, &str), gene: &str, gt: &str, ps: Option<&str>) -> Vec { + match ps { + Some(p) => hit(site, gene, "GT:GQ:DP:PS", &format!("{gt}:50:30:{p}"), ""), + None => hit(site, gene, "GT:GQ:DP", &format!("{gt}:50:30"), ""), + } +} + +fn no_deletions() -> DeletionInputs { + DeletionInputs { + annotsv: Ok(None), + step35: Ok(None), + } +} + +/// A class 5 MUTYH deletion, chr1:45335000-45337000, GT and PS as given. +fn mutyh_deletion(gt: &str, ps: Option<&str>) -> DeletionInputs { + DeletionInputs { + annotsv: Ok(Some(vec![SvRow { + sv: "chr1:45335000-45337000".into(), + sv_type: Some("DEL".into()), + gt: Some(gt.into()), + ps: ps.map(str::to_owned), + acmg_class: Some("5".into()), + genes: vec!["MUTYH".into()], + caller: Some("manta".into()), + support: None, + common: false, + }])), + step35: Ok(None), + } +} + +fn list(hits: Vec>, dels: &DeletionInputs) -> IndexMap { + let h: Result = Ok((Floor::default(), hits)); + obj(Carrier::read(ASSETS, &h, dels).unwrap().to_json()) +} + +fn obj(v: Value) -> IndexMap { + match v { + Value::Object(m) => m, + x => panic!("{x:?}"), + } +} + +fn rows<'a>(m: &'a IndexMap, k: &str) -> Vec<&'a IndexMap> { + let Some(Value::Array(a)) = m.get(k) else { + panic!("{k}: {m:?}") + }; + a.iter() + .map(|x| match x { + Value::Object(o) => o, + _ => panic!("{x:?}"), + }) + .collect() +} + +fn s<'a>(m: &'a IndexMap, k: &str) -> &'a str { + match m.get(k) { + Some(Value::Str(x)) => x, + x => panic!("{k}: {x:?} in {m:?}"), + } +} + +fn of<'a>(m: &'a IndexMap, k: &str, gene: &str) -> Vec<&'a IndexMap> { + rows(m, k) + .into_iter() + .filter(|r| s(r, "gene") == gene) + .collect() +} + +#[test] +fn a_weak_call_keeps_its_low_confidence_mark() { + let c = list( + vec![hit(MUTYH_A, "MUTYH", "GT:GQ:DP", "0/1:1:1", "")], + &no_deletions(), + ); + let r = of(&c, "carriers", "MUTYH"); + assert_eq!(r.len(), 1, "{c:?}"); + assert_eq!( + r[0].get("low_confidence"), + Some(&Value::Bool(true)), + "{r:?}" + ); + assert_eq!(r[0].get("gq"), Some(&Value::Int(1))); + assert_eq!(r[0].get("dp"), Some(&Value::Int(1))); + assert_eq!(s(r[0], "zygosity"), "het"); + + let c = list(vec![good(MUTYH_A, "MUTYH", "0/1", None)], &no_deletions()); + let r = of(&c, "carriers", "MUTYH"); + assert_eq!( + r[0].get("low_confidence"), + Some(&Value::Bool(false)), + "{r:?}" + ); +} + +#[test] +fn the_hits_file_floor_judges_the_carrier_rows() { + let dir = std::env::temp_dir().join(format!("og-i411-carrier-floor-{}", std::process::id())); + std::fs::create_dir_all(&dir).unwrap(); + let path = dir.join("S_clinvar_hits.vcf"); + let rec = hit(MUTYH_A, "MUTYH", "GT:GQ:DP", "0/1:35:20", "").join("\t"); + std::fs::write( + &path, + format!( + "##fileformat=VCFv4.2\n##PGP_CALL_FLOOR=GQ=40,DP=15\n\ + #CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\tFORMAT\tS\n{rec}\n" + ), + ) + .unwrap(); + let p = path.to_string_lossy().into_owned(); + let vcf = HitsVcf::read(p.clone(), p); + std::fs::remove_dir_all(&dir).unwrap(); + assert_eq!(vcf.read.as_ref().unwrap().0, Floor { gq: 40, dp: 15 }); + let c = obj(Carrier::read(ASSETS, &vcf.read, &no_deletions()) + .unwrap() + .to_json()); + let r = of(&c, "carriers", "MUTYH"); + assert_eq!(r.len(), 1, "{c:?}"); + assert_eq!( + r[0].get("low_confidence"), + Some(&Value::Bool(true)), + "GQ 35 is below the file's floor of GQ 40: {r:?}" + ); +} + +#[test] +fn a_homozygous_or_hemizygous_row_is_no_carrier() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "1/1", None), + good(OTC_A, "OTC", "1", None), + good(MUTYH_A, "MUTYH", "0/1", None), + ], + &no_deletions(), + ); + let carriers: Vec<&str> = rows(&c, "carriers").iter().map(|r| s(r, "gene")).collect(); + assert_eq!(carriers, ["MUTYH"], "{c:?}"); + let both: Vec<(&str, &str)> = rows(&c, "hom_or_hemizygous") + .iter() + .map(|r| (s(r, "gene"), s(r, "zygosity"))) + .collect(); + assert_eq!(both, [("CFTR", "hom"), ("OTC", "hemizygous")]); +} + +#[test] +fn a_homozygous_call_inside_a_deletion_is_listed_hemizygous_apart() { + let inside = ("chr1", 45_336_000, "G", "A"); + let c = list( + vec![good(inside, "MUTYH", "1/1", None)], + &mutyh_deletion("0/1", None), + ); + assert!(of(&c, "carriers", "MUTYH").is_empty(), "{c:?}"); + let r = of(&c, "hom_or_hemizygous", "MUTYH"); + assert_eq!(r.len(), 1, "{c:?}"); + assert_eq!(s(r[0], "genotype"), "hemizygous"); + assert_eq!(s(r[0], "zygosity"), "hemizygous"); +} + +#[test] +fn two_unphased_hets_in_one_recessive_gene_are_possible_two_hits() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + good(CFTR_B, "CFTR", "0/1", None), + ], + &no_deletions(), + ); + let r = of(&c, "carriers", "CFTR"); + assert_eq!(r.len(), 2, "{c:?}"); + for x in r { + assert_eq!(s(x, "pair"), "possible two hits", "{x:?}"); + assert!(s(x, "phase").starts_with("phase unknown"), "{x:?}"); + } +} + +#[test] +fn read_backed_phase_decides_two_hits_or_one_copy() { + let trans = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + good(CFTR_B, "CFTR", "1|0", Some("9")), + ], + &no_deletions(), + ); + for x in of(&trans, "carriers", "CFTR") { + assert_eq!(s(x, "pair"), "two hits", "{x:?}"); + assert!(s(x, "phase").contains("phase set 9"), "{x:?}"); + } + let cis = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + good(CFTR_B, "CFTR", "0|1", Some("9")), + ], + &no_deletions(), + ); + for x in of(&cis, "carriers", "CFTR") { + assert!(x.get("pair").is_none(), "a cis pair is one copy: {x:?}"); + assert!( + s(x, "phase").starts_with("two heterozygous variants in cis"), + "{x:?}" + ); + } + // A phased GT without a phase set says nothing about the other call. + let no_ps = list( + vec![ + good(CFTR_A, "CFTR", "0|1", None), + good(CFTR_B, "CFTR", "1|0", None), + ], + &no_deletions(), + ); + for x in of(&no_ps, "carriers", "CFTR") { + assert_eq!(s(x, "pair"), "possible two hits", "{x:?}"); + } +} + +#[test] +fn a_low_confidence_call_makes_two_hits_only_possible() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + hit(CFTR_B, "CFTR", "GT:GQ:DP:PS", "1|0:5:4:9", ""), + ], + &no_deletions(), + ); + for x in of(&c, "carriers", "CFTR") { + assert_eq!( + s(x, "pair"), + "possible two hits (low-confidence call)", + "{x:?}" + ); + } +} + +#[test] +fn a_combined_allele_and_its_part_are_one_allele() { + let joined = format!( + ";PGP_JOINED_FROM={}:{}:{}:{}|chr7:117559600:G:A", + CFTR_A.0, CFTR_A.1, CFTR_A.2, CFTR_A.3 + ); + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + hit(CFTR_B, "CFTR", "GT:GQ:DP", "0/1:50:30", &joined), + ], + &no_deletions(), + ); + for x in of(&c, "carriers", "CFTR") { + assert!(x.get("pair").is_none(), "{x:?}"); + assert!(x.get("phase").is_none(), "{x:?}"); + } +} + +fn two_hit_verdict(c: &IndexMap, gene: &str) -> String { + let Some(Value::Object(t)) = c.get("two_hits") else { + panic!("{c:?}") + }; + let g = rows(t, "genes"); + let g: Vec<_> = g.into_iter().filter(|r| s(r, "gene") == gene).collect(); + assert_eq!(g.len(), 1, "{t:?}"); + s(g[0], "verdict").to_owned() +} + +#[test] +fn a_deletion_plus_a_low_confidence_call_is_only_possibly_biallelic() { + let dels = mutyh_deletion("1|0", Some("5")); + let sure = list(vec![good(MUTYH_A, "MUTYH", "0|1", Some("5"))], &dels); + assert_eq!(two_hit_verdict(&sure, "MUTYH"), "biallelic"); + let weak = list( + vec![hit(MUTYH_A, "MUTYH", "GT:GQ:DP:PS", "0|1:12:6:5", "")], + &dels, + ); + assert_eq!( + two_hit_verdict(&weak, "MUTYH"), + "possibly biallelic (low-confidence call)" + ); +} diff --git a/tests/parity/golden/summary-collect/all-history/all-history.json b/tests/parity/golden/summary-collect/all-history/all-history.json index 6df9f687b..6dd6f2188 100644 --- a/tests/parity/golden/summary-collect/all-history/all-history.json +++ b/tests/parity/golden/summary-collect/all-history/all-history.json @@ -12795,8 +12795,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -12804,8 +12808,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -12813,8 +12821,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -12822,8 +12834,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -12832,37 +12848,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -12873,8 +12907,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/all-nf/all-nf.json b/tests/parity/golden/summary-collect/all-nf/all-nf.json index 700cb8ce2..b72d542d4 100644 --- a/tests/parity/golden/summary-collect/all-nf/all-nf.json +++ b/tests/parity/golden/summary-collect/all-nf/all-nf.json @@ -12604,8 +12604,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -12613,8 +12617,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -12622,8 +12630,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -12631,8 +12643,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -12641,37 +12657,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -12681,8 +12715,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -12693,8 +12731,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", diff --git a/tests/parity/golden/summary-collect/all/all.json b/tests/parity/golden/summary-collect/all/all.json index 467431b39..d3f14cfe2 100644 --- a/tests/parity/golden/summary-collect/all/all.json +++ b/tests/parity/golden/summary-collect/all/all.json @@ -12800,8 +12800,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -12809,8 +12813,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -12818,8 +12826,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -12827,8 +12839,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -12837,37 +12853,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -12878,8 +12912,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/cb-full/cb-full.json b/tests/parity/golden/summary-collect/cb-full/cb-full.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-full/cb-full.json +++ b/tests/parity/golden/summary-collect/cb-full/cb-full.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-nf/cb-nf.json b/tests/parity/golden/summary-collect/cb-nf/cb-nf.json index ea2911faa..5bbe94c9a 100644 --- a/tests/parity/golden/summary-collect/cb-nf/cb-nf.json +++ b/tests/parity/golden/summary-collect/cb-nf/cb-nf.json @@ -259,8 +259,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -268,8 +272,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -277,8 +285,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -286,8 +298,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -296,37 +312,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -336,8 +370,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -348,8 +386,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", diff --git a/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json b/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json index 76b421bcc..366a2d0d9 100644 --- a/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json +++ b/tests/parity/golden/summary-collect/cb-nfbad/cb-nfbad.json @@ -259,8 +259,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -268,8 +272,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -277,8 +285,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -286,8 +298,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -296,37 +312,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -336,8 +370,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json b/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json index c7668ea8a..2217746a0 100644 --- a/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json +++ b/tests/parity/golden/summary-collect/cb-notbi/cb-notbi.json @@ -259,8 +259,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -268,8 +272,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -277,8 +285,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -286,8 +298,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -296,37 +312,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hom", + "zygosity": "hom", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy" } @@ -336,8 +370,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", diff --git a/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json b/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json +++ b/tests/parity/golden/summary-collect/cb-quoted-dosage/cb-quoted-dosage.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json b/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json +++ b/tests/parity/golden/summary-collect/cb-quoted-interval/cb-quoted-interval.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json b/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json +++ b/tests/parity/golden/summary-collect/cb-quoted-smn/cb-quoted-smn.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json b/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json index 86fc5522d..bb8c3eff3 100644 --- a/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json +++ b/tests/parity/golden/summary-collect/cb-unicode-contig/cb-unicode-contig.json @@ -378,8 +378,12 @@ "gene": "MUTYH", "variant": "chr1:45331556 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 2, + "gq": 50, + "dp": 30, + "low_confidence": false, "inheritance": "AR", "condition": "MUTYH-related polyposis" }, @@ -387,8 +391,12 @@ "gene": "HFE", "variant": "chr6:26092913 G>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 99, + "dp": 40, + "low_confidence": false, "inheritance": "AR", "condition": "Symptomatic form of HFE-related hemochromatosis" }, @@ -396,8 +404,12 @@ "gene": "CFTR", "variant": "chr7:117559590 ATCT>A", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 4, + "gq": 15, + "dp": 30, + "low_confidence": true, "inheritance": "AR", "condition": "Cystic fibrosis" }, @@ -405,8 +417,12 @@ "gene": "GJB2", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", + "zygosity": "het", "significance": "Likely pathogenic", "stars": 1, + "gq": 40, + "dp": 5, + "low_confidence": true, "inheritance": "AR", "condition": "Nonsyndromic hearing loss, recessive (DFNB1A)", "combined_allele": "combined allele of chr13:20189473 C>T + chr13:20189475 G>A" @@ -415,37 +431,55 @@ "gene": "BRCA1", "variant": "chr17:43057100 C>T", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic", "stars": 3, + "gq": 60, + "dp": 35, + "low_confidence": false, "inheritance": "AR", "condition": "Fanconi anemia", "combined_allele": "part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes" }, + { + "gene": "HBA1", + "variant": "chr16:176700 G>A", + "genotype": "het", + "zygosity": "het", + "significance": "Pathogenic", + "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, + "inheritance": "AR", + "condition": "Alpha-thalassemia" + } + ], + "hom_or_hemizygous": [ { "gene": "GLA", "variant": "chrX:101398000 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 0, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "XL", "condition": "Fabry disease", "combined_allele": "possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record" }, - { - "gene": "HBA1", - "variant": "chr16:176700 G>A", - "genotype": "het", - "significance": "Pathogenic", - "stars": 2, - "inheritance": "AR", - "condition": "Alpha-thalassemia" - }, { "gene": "SMN1", "variant": "chr5:70951946 C>T", "genotype": "hemizygous", + "zygosity": "hemizygous", "significance": "Pathogenic", "stars": 2, + "gq": 45, + "dp": 31, + "low_confidence": false, "inheritance": "AR", "condition": "Spinal muscular atrophy", "hemizygous": "called homozygous inside one SMN1 copy (Parascopy, step 35)" @@ -456,8 +490,12 @@ "gene": "BTD", "variant": "chr3:15645186 G>C", "genotype": "het", + "zygosity": "het", "significance": "Pathogenic/Likely pathogenic", "stars": 1, + "gq": null, + "dp": null, + "low_confidence": false, "inheritance": "AR", "condition": "Biotinidase deficiency", "kind": "hypomorph", @@ -468,8 +506,8 @@ "genes": [ { "gene": "CFTR", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "CFTR_del deletion, 1 of 2 copies (read depth, step 35)", "variant": "chr7:117559590 ATCT>A", "genotype": "het", @@ -479,8 +517,8 @@ }, { "gene": "GJB2", - "verdict": "possibly biallelic", - "why": "a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", + "verdict": "possibly biallelic (low-confidence call)", + "why": "the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads", "deletion": "DEL chr13:20180000-20200000 (AnnotSV class 4, Manta)", "variant": "chr13:20189473 C>T", "genotype": "one copy, other copy not called ref (1/.)", diff --git a/tests/schema/summary.schema.json b/tests/schema/summary.schema.json index db8383557..04a17dd07 100644 --- a/tests/schema/summary.schema.json +++ b/tests/schema/summary.schema.json @@ -55,6 +55,99 @@ "type": "string" } } + }, + "carrier_row": { + "type": "object", + "required": [ + "gene", + "variant", + "genotype", + "zygosity", + "significance", + "stars", + "gq", + "dp", + "low_confidence", + "inheritance", + "condition" + ], + "properties": { + "gene": { + "type": "string" + }, + "variant": { + "type": "string" + }, + "genotype": { + "type": "string" + }, + "zygosity": { + "enum": [ + "het", + "hom", + "hemizygous", + "unknown" + ] + }, + "significance": { + "type": "string" + }, + "stars": { + "enum": [ + 0, + 1, + 2, + 3, + 4 + ] + }, + "gq": { + "type": [ + "integer", + "null" + ] + }, + "dp": { + "type": [ + "integer", + "null" + ] + }, + "low_confidence": { + "type": "boolean" + }, + "inheritance": { + "type": "string" + }, + "condition": { + "type": "string" + }, + "combined_allele": { + "type": "string" + }, + "kind": { + "type": [ + "string", + "null" + ] + }, + "name": { + "type": "string" + }, + "hemizygous": { + "type": "string" + }, + "pair": { + "enum": [ + "two hits", + "possible two hits", + "possible two hits (low-confidence call)" + ] + }, + "phase": { + "type": "string" + } + } } }, "type": "object", @@ -1408,6 +1501,90 @@ } ] }, + "carrier": { + "allOf": [ + { + "$ref": "#/definitions/section" + }, + { + "properties": { + "data": { + "type": "object", + "properties": { + "unavailable": { + "type": "string" + }, + "genes_on_list": { + "type": "integer", + "minimum": 0 + }, + "list": { + "type": "string" + }, + "carriers": { + "type": "array", + "items": { + "$ref": "#/definitions/carrier_row" + } + }, + "hom_or_hemizygous": { + "type": "array", + "items": { + "$ref": "#/definitions/carrier_row" + } + }, + "set_aside": { + "type": "array", + "items": { + "$ref": "#/definitions/carrier_row" + } + }, + "two_hits": { + "type": "object", + "properties": { + "genes": { + "type": "array", + "items": { + "type": "object", + "required": [ + "gene", + "verdict", + "why", + "deletion", + "variant", + "genotype" + ], + "properties": { + "verdict": { + "enum": [ + "biallelic", + "possibly biallelic", + "possibly biallelic (low-confidence call)" + ] + } + } + } + }, + "deletions_read": { + "type": "array", + "items": { + "type": "string" + } + }, + "deletions_not_read": { + "type": "array", + "items": { + "type": "string" + } + } + } + } + } + } + } + } + ] + }, "cpsr": { "allOf": [ { From f1d31c88fad8d9911dff0ef60c675a548dad8926 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 22:59:02 +0100 Subject: [PATCH 05/40] docs(carrier): say what each carrier row carries and when a row is no carrier Bead: clin-15 Bead: clin-19 --- CHANGELOG.md | 1 + docs/results/secondary-findings.md | 3 +++ 2 files changed, 4 insertions(+) diff --git a/CHANGELOG.md b/CHANGELOG.md index 893fff178..e4a0853bf 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,6 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`, and the report's carrier count leaves it out; the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 28ef4721d..ebfe7287d 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,6 +14,8 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`, the carrier count leaves it out, and the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show these fields yet. + **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; @@ -27,6 +29,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta - **biallelic** when the reads show the two hits on different copies. Either the hit is called homozygous inside the deletion, so it sits on the one copy left (the line and the carrier list call it hemizygous; if the deletion is a false call, the hit is homozygous and both copies still carry it), or both calls carry read-backed phase (a `|` genotype with the same phase set, PS) on different copies. A low-expression (hypomorph) allele called homozygous inside a deletion is only **possibly biallelic**: it causes disease with a null allele only if the deletion is real, so confirm the deletion (array or MLPA); - **possibly biallelic** otherwise: the phase is unknown. Most short-read calls carry no phase, so this is the usual line. Step 05's checked table keeps no genotype column yet, and step 35's counts have no phase, so in a pipeline run a deletion pairs as possibly biallelic unless the hit is called homozygous inside it. A parent's genome (step 38, [family analysis](../multi-sample.md#family-analysis-step-38-opt-in)) or long reads can settle it; +- **possibly biallelic (low-confidence call)** when the pair would count but the small variant's call is below step 6's call floor (its `low_confidence` mark): confirm the call first; - no line when read-backed phase puts both on the same copy (cis): the other copy is intact. Examples: an exon deletion of MUTYH plus a pathogenic MUTYH variant; three alpha-globin genes plus an HBA2 point variant; one SMN1 copy plus an SMN1 variant (short reads place few SMN1 variants reliably, so check with a targeted test); and the 1q21.1 deletion plus one of the two RBM8A low-expression alleles (c.-21G>A, rs139428292, or c.67+32G>C, rs201779890), the cause of TAR syndrome (thrombocytopenia with absent radius; Albers et al., Nat Genet 2012;44(4):435-439, PMID 22366785). On its own an RBM8A low-expression allele stays set aside. The [couple screen](../39-couple.md) (step 39) applies the same pairing between partners: a hypomorph allele of the list in one partner and a full loss of function in the same gene in the other (a ClinVar pathogenic variant, a Delly deletion) is a shared gene with its risk for a child; the allele in both partners, or in one alone, stays set aside. In the secondary-findings card a called deletion counts as one of the two variants a recessive gene needs, unless read-backed phase puts it on the variant's copy. The line under the carrier list names the deletion callers it read and the ones it could not read. A deletion AnnotSV ranks below class 4 is not counted. From 070d77906ea4dc16ebc8c5793917a7c8e8964785 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Fri, 20 Nov 2026 23:39:24 +0100 Subject: [PATCH 06/40] fix(chip): warn when the contamination estimate runs without gnomAD, or not at all FilterMutectCalls weighs each allele by its population frequency, which Mutect2 takes from gnomAD's germline resource. On public data (HG002 with HG005's reads mixed in) the estimate removed 31 of 35 PASS calls with gnomAD and none without it. The step now warns in that case, and main.nf warns on the console without --chip_common_sites and with it but without --chip_germline_resource, since a task's stderr is not shown. The docs say the estimate needs gnomAD too and give the measurement. Bead: trait-62 --- CHANGELOG.md | 2 +- docs/49-chip.md | 4 ++-- main.nf | 2 ++ scripts/49-chip.sh | 7 ++++++- tests/fake-docker/i411-chip-contamination.sh | 19 ++++++++++++++++++- 5 files changed, 29 insertions(+), 5 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 7a4a48b57..adaedb583 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its 59,295 sites across the genome and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls. The pileups do not stop at the CHIP exons, which hold only 8 of those sites, too few for an estimate. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. Without the VCF the log says there is no contamination estimate. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). +- Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its 59,295 sites across the genome and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls. The pileups do not stop at the CHIP exons, which hold only 8 of those sites, too few for an estimate. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. FilterMutectCalls weighs each allele by its gnomAD population frequency, so the estimate does its work only with `somatic/af-only-gnomad.hg38.vcf.gz` installed too. Without the common-sites VCF the log says there is no contamination estimate, and with it but without gnomAD the log warns that the estimate changes few calls. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/docs/49-chip.md b/docs/49-chip.md index 35ff6cf00..cbd547d2c 100644 --- a/docs/49-chip.md +++ b/docs/49-chip.md @@ -30,7 +30,7 @@ Pinned in `versions.env`; [Image versions](versions.md) lists the current tags. - the reference with its `.fai` and `.dict` - Ensembl's GRCh38 gene annotation, `reference/ensembl/Homo_sapiens.GRCh38..chr.gff3.gz` (`ENSEMBL_GFF_RELEASE` in `versions.env`, about 110 MB). Install it once with `./scripts/setup.sh --chip-data "${GENOME_DIR}"`; it is checked against `ENSEMBL_GFF_SHA256`. - Optional, and the same files as [step 29](29-mutect2-somatic.md): gnomAD's AF-only germline resource `somatic/af-only-gnomad.hg38.vcf.gz` and a panel of normals `somatic/1000g_pon.hg38.vcf.gz`, each with its `.tbi`. Without gnomAD, inherited variants are left out by their VAF only. -- Optional, and recommended: step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` with its `.tbi` ([step 29](29-mutect2-somatic.md) says how to download it). With it the step estimates how much of the sample is another person's DNA and FilterMutectCalls reads that estimate. Without it the log says there is no contamination estimate, and a contaminant's alleles can pass as a small clone. +- Optional, and recommended together with gnomAD: step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` with its `.tbi` ([step 29](29-mutect2-somatic.md) says how to download it). With it the step estimates how much of the sample is another person's DNA and FilterMutectCalls reads that estimate. Without it the log says there is no contamination estimate, and a contaminant's alleles can pass as a small clone. With it but without gnomAD the log warns that the estimate changes few calls (step 2 below says why). ## Command @@ -44,7 +44,7 @@ With `run-all.sh`: `TOOLS=...,chip`. It is opt-in, so a run lists step 49 only w ## How it decides 1. For each gene of `assets/chip_genes.tsv` the step takes the transcript Ensembl tags `MANE_Select`, and calls inside its coding exons, 10 bases wider on each side so the splice donor and acceptor sites are in. That is 162 exons and about 35 kb with Ensembl 116. -2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at every one of its 59,295 sites across the genome, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The pileups do not stop at the CHIP exons, as step 29's do at its intervals: the exons hold 8 of the 59,295 sites, too few for an estimate. Step 33's VerifyBamID2 gives a second, separate estimate (FREEMIX). +2. Mutect2 calls in tumour-only mode, with the read orientation model, and with gnomAD and the panel of normals when they are installed. With the common-sites VCF, GetPileupSummaries counts the reads at every one of its 59,295 sites across the genome, CalculateContamination estimates from them how much of the sample is another person's DNA, and FilterMutectCalls gets that estimate (`--contamination-table`). Another person's DNA adds its own alleles at a low VAF, the VAF of a small clone; with the estimate, FilterMutectCalls marks a call that contamination explains `contamination`, and the call reads `filtered`. The pileups do not stop at the CHIP exons, as step 29's do at its intervals: the exons hold 8 of the 59,295 sites, too few for an estimate. FilterMutectCalls weighs each allele by its population frequency, which Mutect2 takes from gnomAD, so the estimate does its work only with gnomAD installed too. On public data (GIAB's HG002 reads with HG005's reads mixed in, 19,365 of 209,006 reads, over DNMT3A, SF3B1 and IDH1 and 450 windows around common sites on chr2), CalculateContamination read 0.147 (error 0.023) for the mix and 0.006 for HG002 alone. With gnomAD, the mix had 35 PASS calls without the estimate and 4 with it, as many as HG002 alone; without gnomAD the estimate removed none of them. Step 33's VerifyBamID2 gives a second, separate estimate (FREEMIX). 3. Each call that changes the protein is put in the gene's class from the table: | Gene | Counted | Source (PMID) | diff --git a/main.nf b/main.nf index 14a300106..4f8b92b6c 100644 --- a/main.nf +++ b/main.nf @@ -1081,6 +1081,8 @@ workflow { def common = params.chip_common_sites // the contamination estimate FilterMutectCalls reads def chip_common = common ? file(common, checkIfExists: true) : [] def chip_common_index = common ? file("${common}.tbi", checkIfExists: true) : [] + if (!common) log.warn "chip: no --chip_common_sites, so FilterMutectCalls runs without a contamination estimate and another person's DNA in the sample can pass as a small clone (docs/49-chip.md)." + else if (!germ) log.warn "chip: --chip_common_sites without --chip_germline_resource: FilterMutectCalls has no population frequency to weigh the contamination estimate by, so it changes few calls (docs/49-chip.md)." ch_vcf .map { meta, _vcf, _idx -> [meta.id, meta] } .join(ch_bam.map { meta, _bam, _bai -> [meta.id, true] }, remainder: true) diff --git a/scripts/49-chip.sh b/scripts/49-chip.sh index b7f412ab1..c5c2950d9 100755 --- a/scripts/49-chip.sh +++ b/scripts/49-chip.sh @@ -94,7 +94,9 @@ FILTER=(gatk FilterMutectCalls -R "${REF_FASTA_C}" -V "$(cpath "${P}_unfiltered. # small clone. CalculateContamination estimates that share from the reads at # every site of the common-sites VCF, across the genome: the CHIP exons hold # only 8 of its 59,295 sites, too few for an estimate. FilterMutectCalls then -# marks the calls contamination explains. +# marks the calls contamination explains. It weighs each allele by its +# population frequency, which Mutect2 takes from gnomAD: without gnomAD the +# estimate changes few calls. rm -f "${P}_contamination.table" "${P}_segments.table" if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then echo " contamination estimate: common sites ${COMMON_VCF}" @@ -103,6 +105,9 @@ if [ -f "$COMMON_VCF" ] && [ -f "${COMMON_VCF}.tbi" ]; then run_in --cpus 2 --memory 4g "$GATK_IMAGE" gatk CalculateContamination -I "$(cpath "${P}_pileups.table")" \ --tumor-segmentation "$(cpath "${P}_segments.table")" -O "$(cpath "${P}_contamination.table")" FILTER+=(--contamination-table "$(cpath "${P}_contamination.table")" --tumor-segmentation "$(cpath "${P}_segments.table")") + if [ ! -f "$GNOMAD_VCF" ] || [ ! -f "${GNOMAD_VCF}.tbi" ]; then + echo " WARNING: the contamination estimate without gnomAD's germline resource: FilterMutectCalls has no population frequency to weigh it by, so it changes few calls (docs/49-chip.md)." + fi else echo " no common-sites VCF (${COMMON_VCF}): no contamination estimate, so another person's DNA in the sample can pass as a small clone (docs/49-chip.md says how to install it)." fi diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh index cbed00513..80d215f48 100755 --- a/tests/fake-docker/i411-chip-contamination.sh +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -4,7 +4,8 @@ # site of that VCF (not only inside the CHIP exons), CalculateContamination, then # FilterMutectCalls with --contamination-table and --tumor-segmentation. # Without the VCF, or without its .tbi, there is no estimate and the log says -# so. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run +# so; with it but without gnomAD's germline resource the log warns that the +# estimate changes few calls. The Nextflow CHIP_MUTECT2 runs the same commands: its script block, run # here with a fake gatk, passes the table when it gets --chip_common_sites and # not without it; main.nf hands it the file, and run-all.sh passes the VCF # under somatic/ to the pipeline only with its .tbi. @@ -61,6 +62,16 @@ awk '/ CalculateContamination / { c = NR } / FilterMutectCalls / { f = NR } END || fail "FilterMutectCalls ran before CalculateContamination" output_lacks chip-common 'no contamination estimate' output_has chip-common 'contamination estimate: common sites ' +output_has chip-common 'WARNING: the contamination estimate without gnomAD' +# With gnomAD's germline resource too: Mutect2 reads it and the warning goes. +printf 'placeholder\n' > "${G}/somatic/af-only-gnomad.hg38.vcf.gz" +printf 'placeholder\n' > "${G}/somatic/af-only-gnomad.hg38.vcf.gz.tbi" +: > "$FAKE_DOCKER_LOG" +run_expect 0 chip-common-gnomad "${SCRIPTS}/49-chip.sh" sample1 +docker_log_has '^run image=[^ ]*gatk.* Mutect2 .*--germline-resource /genome/somatic/af-only-gnomad\.hg38\.vcf\.gz' "Mutect2 did not get gnomAD" +docker_log_has "^run image=[^ ]*gatk.* FilterMutectCalls .*--contamination-table ${C}_contamination\\.table" "FilterMutectCalls with gnomAD did not get the contamination table" +output_lacks chip-common-gnomad 'without gnomAD' +rm -f "${G}/somatic/af-only-gnomad.hg38.vcf.gz" "${G}/somatic/af-only-gnomad.hg38.vcf.gz.tbi" # The VCF without its .tbi is not used. rm -f "${COMMON}.tbi" @@ -119,6 +130,12 @@ if grep -qE 'GetPileupSummaries|CalculateContamination|--contamination-table' "$ fail "CHIP_MUTECT2 estimated contamination without --chip_common_sites" fi grep -q 'no --chip_common_sites' "${NFW}/out.txt" || fail "CHIP_MUTECT2 without common sites does not say it has no estimate" +# main.nf warns on the console (a task's stderr stays in its work directory) +# without the common sites, and with them but without gnomAD. +grep -qF 'if (!common) log.warn "chip: no --chip_common_sites, so FilterMutectCalls runs without a contamination estimate' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not warn when chip runs without --chip_common_sites" +grep -qF 'else if (!germ) log.warn "chip: --chip_common_sites without --chip_germline_resource' "${REPO_ROOT}/main.nf" \ + || fail "main.nf does not warn when the contamination estimate runs without gnomAD" # main.nf hands the module the file and its index, in the order of its inputs. grep -qF 'def chip_common = common ? file(common, checkIfExists: true) : []' "${REPO_ROOT}/main.nf" \ || fail "main.nf does not read --chip_common_sites" From 0da2276e9e984c937062743bc269ef7c30e160bc Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 01:25:47 +0100 Subject: [PATCH 07/40] test(chip): verify the module input order for common sites Check the positional binding of the common-sites VCF and index. List the optional VCF in the Nextflow guide. Bead: trait-62 --- docs/nextflow.md | 6 +++--- tests/fake-docker/i411-chip-contamination.sh | 19 +++++++++++++++++++ 2 files changed, 22 insertions(+), 3 deletions(-) diff --git a/docs/nextflow.md b/docs/nextflow.md index a4538387e..cbaa93168 100644 --- a/docs/nextflow.md +++ b/docs/nextflow.md @@ -63,9 +63,9 @@ nextflow run main.nf \ # --tools '...,parascopy' + --parascopy_data (setup.sh --parascopy-data; docs/35-paralogs.md) # --tools '...,bloodtype' no data to install; RhD needs the BAM (docs/41-bloodtype.md) # --tools '...,lpa' no data to install; needs the BAM (docs/46-lpa.md) -# --tools '...,chip' + --chip_gff (setup.sh --chip-data), optional --chip_germline_resource -# and --chip_pon (each with its .tbi beside it); needs the BAM -# (docs/49-chip.md) +# --tools '...,chip' + --chip_gff (setup.sh --chip-data), optional --chip_germline_resource, +# --chip_pon, and --chip_common_sites (each with its .tbi beside it). +# Needs the BAM (docs/49-chip.md). # --tools '...,archaic' + --archaic_data (setup.sh --archaic), --archaic_pop, --hla_genes for the # genes of each segment (docs/43-archaic.md) # --tools '...,ancient' + --ancient_panel (setup.sh --ancient-panel); reads the gVCF, so a sample diff --git a/tests/fake-docker/i411-chip-contamination.sh b/tests/fake-docker/i411-chip-contamination.sh index 80d215f48..5edeb9e5b 100755 --- a/tests/fake-docker/i411-chip-contamination.sh +++ b/tests/fake-docker/i411-chip-contamination.sh @@ -141,6 +141,25 @@ grep -qF 'def chip_common = common ? file(common, checkIfExists: true) : [ || fail "main.nf does not read --chip_common_sites" grep -qF 'chip_pon, chip_pon_index, chip_common, chip_common_index)' "${REPO_ROOT}/main.nf" \ || fail "main.nf does not pass the common sites to CHIP_MUTECT2" +# The rendered script substitutes the VCF directly, so check the positional +# binding of the VCF and its index in the module's input declarations too. +awk ' + /^process CHIP_MUTECT2[[:space:]]*\{/ { in_process = 1 } + in_process && /^}/ { exit } + in_process && /^[[:space:]]*input:/ { in_input = 1; next } + in_input && /^[[:space:]]*output:/ { exit } + in_input { + sub(/[[:space:]]*\/\/.*/, "") + gsub(/^[[:space:]]+|[[:space:]]+$/, "") + if (two_back == "path(pon_index)" && previous == "path(common)" && $0 == "path(common_index)") { + found = 1 + exit + } + two_back = previous + previous = $0 + } + END { exit !found } +' "$MOD" || fail "CHIP_MUTECT2 does not take the common sites and their index after the panel of normals" # --- run-all.sh -------------------------------------------------------------------------- # TOOLS=chip passes the installed common-sites VCF to the pipeline, only with its .tbi. From 799d247ae3a8fe4d0f0c04a253eba4ae0807e432 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 11:22:10 +0100 Subject: [PATCH 08/40] fix(carrier): keep showing rows with no unchanged copy in both reports and on the live page Moving homozygous and hemizygous P/LP rows from `carriers` to `hom_or_hemizygous` left every consumer reading only `carriers`. The live page lost its act finding for such a row ("two changed copies", "the only copy changed"), and a gene left with a homozygous row fell to a plain ClinVar review finding. Both reports dropped the row from the carrier block. The live page (finding rows, the carrier panel and its headline) now reads both lists. Both report renderers (og-render and render_report.py, still step 24's) print each such row on its own line in the carrier block, "two changed copies" or "the only copy changed", "not the pattern of a carrier", and the block's first line counts it apart from the carriers. The report-render parity cases whose summary holds such rows get goldens for the new lines. The two CFTR pair tests now assert their row count, so they cannot pass with no row. Bead: clin-15 Bead: clin-19 --- CHANGELOG.md | 2 +- bin/live_results.py | 7 +- bin/owngenome_live.py | 2 +- bin/render_report.py | 7 + docs/results/secondary-findings.md | 2 +- rust/crates/og-render/src/sections/carrier.rs | 29 +- rust/crates/og-render/tests/clinical.rs | 36 +- .../tests/i411_carrier_confidence.rs | 2 + .../report-render/all-history/all-history.txt | 552 ++++++++++++++ .../golden/report-render/all-nf/all-nf.html | 710 ++++++++++++++++++ .../golden/report-render/all-nf/all-nf.txt | 371 +++++++++ tests/parity/golden/report-render/all/all.txt | 514 +++++++++++++ .../golden/report-render/cb-full/cb-full.html | 599 +++++++++++++++ .../golden/report-render/cb-full/cb-full.txt | 272 +++++++ .../golden/report-render/cb-nf/cb-nf.html | 545 ++++++++++++++ .../golden/report-render/cb-nf/cb-nf.txt | 230 ++++++ .../report-render/cb-nfbad/cb-nfbad.html | 477 ++++++++++++ .../report-render/cb-nfbad/cb-nfbad.txt | 143 ++++ .../report-render/cb-notbi/cb-notbi.html | 474 ++++++++++++ .../report-render/cb-notbi/cb-notbi.txt | 139 ++++ .../cb-quoted-dosage/cb-quoted-dosage.html | 599 +++++++++++++++ .../cb-quoted-dosage/cb-quoted-dosage.txt | 272 +++++++ .../cb-quoted-interval.html | 599 +++++++++++++++ .../cb-quoted-interval/cb-quoted-interval.txt | 272 +++++++ .../cb-quoted-smn/cb-quoted-smn.html | 599 +++++++++++++++ .../cb-quoted-smn/cb-quoted-smn.txt | 272 +++++++ .../cb-unicode-contig/cb-unicode-contig.html | 599 +++++++++++++++ .../cb-unicode-contig/cb-unicode-contig.txt | 272 +++++++ .../m-clinical-escape/m-clinical-escape.html | 599 +++++++++++++++ .../m-clinical-escape/m-clinical-escape.txt | 272 +++++++ .../m-clinical-stale/m-clinical-stale.html | 619 +++++++++++++++ .../m-clinical-stale/m-clinical-stale.txt | 285 +++++++ .../m-clinvar-freq-note.html | 599 +++++++++++++++ .../m-clinvar-freq-note.txt | 272 +++++++ .../m-clinvar-many/m-clinvar-many.html | 643 ++++++++++++++++ .../m-clinvar-many/m-clinvar-many.txt | 405 ++++++++++ .../m-clinvar-none/m-clinvar-none.html | 565 ++++++++++++++ .../m-clinvar-none/m-clinvar-none.txt | 229 ++++++ .../m-couple-empty/m-couple-empty.html | 608 +++++++++++++++ .../m-couple-empty/m-couple-empty.txt | 277 +++++++ .../report-render/m-couple/m-couple.html | 610 +++++++++++++++ .../report-render/m-couple/m-couple.txt | 279 +++++++ .../m-cpsr-none/m-cpsr-none.html | 584 ++++++++++++++ .../report-render/m-cpsr-none/m-cpsr-none.txt | 256 +++++++ .../m-cpsr-noown/m-cpsr-noown.html | 589 +++++++++++++++ .../m-cpsr-noown/m-cpsr-noown.txt | 262 +++++++ .../report-render/m-sf-notes/m-sf-notes.html | 600 +++++++++++++++ .../report-render/m-sf-notes/m-sf-notes.txt | 273 +++++++ .../m-since-clinical/m-since-clinical.html | 599 +++++++++++++++ .../m-since-clinical/m-since-clinical.txt | 275 +++++++ .../m-slivar-phase/m-slivar-phase.html | 575 ++++++++++++++ .../m-slivar-phase/m-slivar-phase.txt | 252 +++++++ .../m-slivar-unphased/m-slivar-unphased.html | 573 ++++++++++++++ .../m-slivar-unphased/m-slivar-unphased.txt | 250 ++++++ 54 files changed, 19938 insertions(+), 9 deletions(-) create mode 100644 tests/parity/golden/report-render/all-history/all-history.txt create mode 100644 tests/parity/golden/report-render/all-nf/all-nf.html create mode 100644 tests/parity/golden/report-render/all-nf/all-nf.txt create mode 100644 tests/parity/golden/report-render/all/all.txt create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.html create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.txt create mode 100644 tests/parity/golden/report-render/cb-nf/cb-nf.html create mode 100644 tests/parity/golden/report-render/cb-nf/cb-nf.txt create mode 100644 tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html create mode 100644 tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt create mode 100644 tests/parity/golden/report-render/cb-notbi/cb-notbi.html create mode 100644 tests/parity/golden/report-render/cb-notbi/cb-notbi.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.html create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt diff --git a/CHANGELOG.md b/CHANGELOG.md index e4a0853bf..392d1d3a3 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`, and the report's carrier count leaves it out; the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). diff --git a/bin/live_results.py b/bin/live_results.py index 975b8a6ff..ef7614200 100644 --- a/bin/live_results.py +++ b/bin/live_results.py @@ -374,7 +374,7 @@ def a_carrier(S, s): if d.get("unavailable"): return {"lines": rr.carrier_lines(d), "attention": True} rows = [[c.get("gene"), c.get("variant"), c.get("genotype"), c.get("significance"), c.get("stars"), - c.get("inheritance"), c.get("condition")] for c in d.get("carriers") or []] + c.get("inheritance"), c.get("condition")] for c in (d.get("carriers") or []) + (d.get("hom_or_hemizygous") or [])] two = (d.get("two_hits") or {}).get("genes") or [] return {"facts": [["Genes on the carrier list", d.get("genes_on_list")], ["Carrier findings", len(rows)], ["Genes with two hits", ", ".join(g if isinstance(g, str) else g.get("gene", ".") for g in two) @@ -833,7 +833,7 @@ def gene(x): return g if isinstance(g, str) else None sf_genes = {gene(x) for x in _items(sf.get("clinvar_hits")) if isinstance(x, dict)} car = _data(S, "carrier") - carrier_genes = {gene(c) for c in _items(car.get("carriers")) if isinstance(c, dict)} + carrier_genes = {gene(c) for c in _items(car.get("carriers")) + _items(car.get("hom_or_hemizygous")) if isinstance(c, dict)} th = car.get("two_hits") if isinstance(car.get("two_hits"), dict) else {} two_hit = {gene(g) for g in _items(th.get("genes"))} - {None} # 1. ACMG secondary findings: the gene's own reporting rule already said "report". The report's own @@ -943,7 +943,8 @@ def gene(x): "A ranking to bring to a clinical geneticist, not a diagnosis.", gene=x.get("gene"), evidence=[["Score", x.get("exomiser_score")], ["Inheritance", x.get("moi")]])) # 7. Carriers: one changed copy in a gene of the carrier list, and the couple screen. - for c in _items(car.get("carriers")): + # A row with no unchanged copy (hom_or_hemizygous) takes the branch below that says it is not a carrier. + for c in _items(car.get("carriers")) + _items(car.get("hom_or_hemizygous")): with _Row(out, "carrier-list", "act"): if c.get("gene") in two_hit: continue diff --git a/bin/owngenome_live.py b/bin/owngenome_live.py index c970ac660..d09815bd1 100755 --- a/bin/owngenome_live.py +++ b/bin/owngenome_live.py @@ -299,7 +299,7 @@ def _h_clinvar(d, summary): def _h_carrier(d, summary): lines = _rr().carrier_lines(d) - return lines[0], bool(d.get("carriers")) + return lines[0], bool(d.get("carriers") or d.get("hom_or_hemizygous")) def _h_couple(d, summary): diff --git a/bin/render_report.py b/bin/render_report.py index a339af688..26cf32ef9 100755 --- a/bin/render_report.py +++ b/bin/render_report.py @@ -2025,13 +2025,20 @@ def carrier_lines(c): """The sample's own carrier list (no partner), the same in both reports.""" if c.get("unavailable"): return [f"Carrier list: not made, {c['unavailable']}"] + both = c.get("hom_or_hemizygous") or [] # no unchanged copy: listed apart, not counted as carriers lines = [f"Carrier list ({c['genes_on_list']} genes): {len(c['carriers'])} finding(s)" + + (f", {len(both)} with no unchanged copy" if both else "") + (f", {len(c['set_aside'])} set aside" if c["set_aside"] else "")] def hemi(x): return f" ({x['hemizygous']})" if x.get("hemizygous") else "" for x in c["carriers"]: lines.append(f"{x['gene']} ({x['condition']}; {x['inheritance']}): {x['variant']} {x['genotype']}{hemi(x)}, " f"ClinVar {x['significance']}") + for x in both: + lines.append(f"{x['gene']} ({x['condition']}; {x['inheritance']}): {x['variant']} {x['genotype']}{hemi(x)}, " + f"ClinVar {x['significance']}: " + + ("two changed copies" if x["genotype"] == "hom" else "the only copy changed") + + ", not the pattern of a carrier") for x in c["set_aside"]: lines.append(f"Set aside: {x['gene']} {x['variant']} {x['genotype']}{hemi(x)}: {x['name']} is a {x['kind']} " "allele, not a carrier finding on its own") diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index ebfe7287d..419965724 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,7 +14,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`, the carrier count leaves it out, and the ClinVar table still shows it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show these fields yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: diff --git a/rust/crates/og-render/src/sections/carrier.rs b/rust/crates/og-render/src/sections/carrier.rs index ffaf982a4..d0dde8dc8 100644 --- a/rust/crates/og-render/src/sections/carrier.rs +++ b/rust/crates/og-render/src/sections/carrier.rs @@ -1,5 +1,6 @@ //! The sample's own carrier list (no partner): the ClinVar P/LP hits in -//! the genes of `assets/carrier_genes.tsv`, the hypomorph and +//! the genes of `assets/carrier_genes.tsv`, the rows with no unchanged copy +//! (`hom_or_hemizygous`, never counted as carriers), the hypomorph and //! pseudodeficiency alleles set aside, and the two-hit genes //! ([`super::two_hits`]). @@ -27,12 +28,21 @@ pub fn lines(c: &D<'_>) -> Result, Malformed> { )]); } let carriers = c.at("carriers")?.items()?; + // Homozygous or hemizygous: no unchanged copy, so listed apart and never + // counted as a carrier. A summary written before the list has none. + let both = match c.opt("hom_or_hemizygous")? { + Some(b) => b.items()?, + None => Vec::new(), + }; let set_aside = c.at("set_aside")?; let mut head = format!( "Carrier list ({} genes): {} finding(s)", c.s("genes_on_list")?, carriers.len() ); + if !both.is_empty() { + head += &format!(", {} with no unchanged copy", both.len()); + } if set_aside.truthy() { head += &format!(", {} set aside", set_aside.len()?); } @@ -49,6 +59,23 @@ pub fn lines(c: &D<'_>) -> Result, Malformed> { x.s("significance")? )); } + for x in &both { + let copies = if x.at("genotype")?.is("hom") { + "two changed copies" + } else { + "the only copy changed" + }; + out.push(format!( + "{} ({}; {}): {} {}{}, ClinVar {}: {copies}, not the pattern of a carrier", + x.s("gene")?, + x.s("condition")?, + x.s("inheritance")?, + x.s("variant")?, + x.s("genotype")?, + hemi(x)?, + x.s("significance")? + )); + } for x in set_aside.items()? { out.push(format!( "Set aside: {} {} {}{}: {} is a {} allele, not a carrier finding on its own", diff --git a/rust/crates/og-render/tests/clinical.rs b/rust/crates/og-render/tests/clinical.rs index a235a8eea..3c94eecaa 100644 --- a/rust/crates/og-render/tests/clinical.rs +++ b/rust/crates/og-render/tests/clinical.rs @@ -923,8 +923,18 @@ fn both_reports_print_the_two_hit_line_and_the_hemizygous_genotype() { let (txt, html) = reports(&collect(&d)); assert!(txt.contains("Biallelic: MUTYH")); assert!(html.contains("Biallelic: MUTYH")); - // The hit has no unchanged copy, so the summary lists it apart from the - // carriers (hom_or_hemizygous); the two-hit line still names it. + // The hit has no unchanged copy: the summary lists it apart from the + // carriers (hom_or_hemizygous), and both reports still print it in the + // carrier block, with the hemizygous note, and not as a carrier. + assert!(html.contains("hemizygous (called homozygous inside DEL")); + assert!(txt.contains("hemizygous (called homozygous inside DEL")); + for r in [&txt, &html] { + assert!(r.contains("1 finding(s), 1 with no unchanged copy"), "{r}"); + assert!( + r.contains("the only copy changed, not the pattern of a carrier"), + "{r}" + ); + } assert!( html.replace(">", ">") .contains("chr1:45336000 G>A hemizygous") @@ -934,6 +944,28 @@ fn both_reports_print_the_two_hit_line_and_the_hemizygous_genotype() { assert!(html.contains("biallelic with DEL chr1:45335000-45337000")); } +/// A homozygous P/LP row has no unchanged copy: the carrier block lists it +/// apart from the carriers and does not count it as one. +#[test] +fn a_homozygous_row_is_listed_apart_from_the_carriers() { + let t = Dir::new("hom-apart"); + let d = sample(&t, "hom", &[hit(SNV, "MUTYH", "1/1", None)], None); + let c = carrier_of(&d); + let lines = carrier::lines(&D::new(&c, "carrier")).unwrap(); + assert!( + lines[0].contains("0 finding(s), 1 with no unchanged copy"), + "{lines:?}" + ); + let line: Vec<&String> = lines.iter().filter(|x| x.starts_with("MUTYH (")).collect(); + assert_eq!(line.len(), 1, "{lines:?}"); + assert!(line[0].contains(" hom, ClinVar "), "{}", line[0]); + assert!( + line[0].ends_with(": two changed copies, not the pattern of a carrier"), + "{}", + line[0] + ); +} + /// test_cross_engine_biallelic.py check 10. #[test] fn two_hit_edges() { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 54c716aaf..45d2a84b6 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -281,6 +281,7 @@ fn a_low_confidence_call_makes_two_hits_only_possible() { ], &no_deletions(), ); + assert_eq!(of(&c, "carriers", "CFTR").len(), 2, "{c:?}"); for x in of(&c, "carriers", "CFTR") { assert_eq!( s(x, "pair"), @@ -303,6 +304,7 @@ fn a_combined_allele_and_its_part_are_one_allele() { ], &no_deletions(), ); + assert_eq!(of(&c, "carriers", "CFTR").len(), 2, "{c:?}"); for x in of(&c, "carriers", "CFTR") { assert!(x.get("pair").is_none(), "{x:?}"); assert!(x.get("phase").is_none(), "{x:?}"); diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt new file mode 100644 index 000000000..764ee1013 --- /dev/null +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -0,0 +1,552 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC + Database re-check: 2021-03-05 00:00:00 UTC: ClinVar newer-release +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + [New since 2021-01-01 00:00 UTC] + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + [New since 2021-01-01 00:00 UTC] + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + [New since 2021-01-01 00:00 UTC] + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2021-01-01 00:00 UTC] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2021-03-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [New since 2021-01-01 00:00 UTC] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [New since 2021-01-01 00:00 UTC] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of 2021-03-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2021-01-01 00:00 UTC] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + [New since 2021-01-01 00:00 UTC] + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [New since 2021-01-01 00:00 UTC] + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + [New since 2021-01-01 00:00 UTC] + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + [New since 2021-01-01 00:00 UTC] + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + [New since 2021-01-01 00:00 UTC] + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + [New since 2021-01-01 00:00 UTC] + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + [New since 2021-01-01 00:00 UTC] + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2021-01-01 00:00 UTC] + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [New since 2021-01-01 00:00 UTC] + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + [New since 2021-01-01 00:00 UTC] + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + [New since 2021-01-01 00:00 UTC] + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + [New since 2021-01-01 00:00 UTC] + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [New since 2021-01-01 00:00 UTC] + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + [New since 2021-01-01 00:00 UTC] + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + [New since 2021-01-01 00:00 UTC] + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [New since 2021-01-01 00:00 UTC] + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] +## Locityper Second Opinion at Hard Loci (step 53) +--- + [New since 2021-01-01 00:00 UTC] + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K's KIR pass (step 08, KIR=true) gave no call + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [New since 2021-01-01 00:00 UTC] + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + [New since 2021-01-01 00:00 UTC] + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [New since 2021-01-01 00:00 UTC] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + [New since 2021-01-01 00:00 UTC] + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + [New since 2021-01-01 00:00 UTC] + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [New since 2021-01-01 00:00 UTC] + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + [New since 2021-01-01 00:00 UTC] + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [New since 2021-01-01 00:00 UTC] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + [New since 2021-01-01 00:00 UTC] + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + [New since 2021-01-01 00:00 UTC] + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + [New since 2021-01-01 00:00 UTC] + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 1 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all-nf/all-nf.html b/tests/parity/golden/report-render/all-nf/all-nf.html new file mode 100644 index 000000000..992c7e6ee --- /dev/null +++ b/tests/parity/golden/report-render/all-nf/all-nf.html @@ -0,0 +1,710 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/all-nf/all-nf.txt b/tests/parity/golden/report-render/all-nf/all-nf.txt new file mode 100644 index 000000000..8e75283d2 --- /dev/null +++ b/tests/parity/golden/report-render/all-nf/all-nf.txt @@ -0,0 +1,371 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + Mean depth: nanx + Inferred sex: female + Declared sex: female + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 6 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (FINAL_CLASSIFICATION): + Pathogenic: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 0 + P/LP rows below the depth floor (DP below 8): 0 + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: . + No gene passed Exomiser's filters with a variant that fits a mode of inheritance. + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Mobile Element Insertions (step 50) +--- + Insertions called: 0 (none) + FKTN SVA (F; AR): callable (depth 30, seen) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: not assessed + . + VNtyper's coverage check: . + . + . + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + ClinVar and gnomAD: not annotated (mito/S_chrM_annotated.tsv is older than the chrM calls: rerun step 20) + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions: not looked for (no deletion table (mito/_chrM_deletions.tsv): step 20 ran before it looked for large deletions, eKLIPse wrote no table (see the step's log), or the Nextflow MITO_DELETIONS task failed (see the Nextflow log)) + mtDNA copy number: not counted (no copy-number table (mito/_mtdna_copies.tsv): step 20 ran before it counted mtDNA copies, or the Nextflow MITO_DELETIONS task failed (see the Nextflow log)) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats: too little depth + . + KIV-2 4925G>A null allele (rs1484919544): not assessed + LPA KIV-2 4925G>A: not assessed, step 46 wrote no S_lpa_kiv2_4925.tsv (a run from before this reader, or the check did not run). + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: . (not read) + Not determined: neither the KIV-2 count nor the two risk variants could be read. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + No CHIP call. + No CHIP gene has the depth to find a clone: no result either way. + Too shallow or not on the reference: DNMT3A. + 0 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Not assessed: too shallow + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: x (called) + SMN1 by both tools: Paraphase no call, Parascopy no row covers SMN1 exon 7: no comparison: one of them has no call + Variants on phased haplotypes: 0 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no row covers exon 7 + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no row covers exon 7 + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: SMN1 and SMN2 not assessed: no model: no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): not assessed: S_hba_copy_number.tsv has no status row + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: vcf/B.report.json (PharmCAT version unknown) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was not run in the run of 2020-01-01 00:00 UTC] + Genes with a non-normal phenotype: 0 More than one possible result: 0 Not called: 1 Called without a function phenotype (no drug guidance): 0 + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not called + pypgx *1/*2 + Cyrius *1/*2 (not usable: Filter LowQ) + pypgx and Cyrius agree: fewer than two usable calls + Probable (one caller: pypgx): *1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] +## Locityper Second Opinion at Hard Loci (step 53) +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC] + Loci called: 3 of 3; passing the authors' filter: 3 + HLA-DRB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: T1K (step 08) did not run + HLA-DQB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: T1K (step 08) did not run + CYP2D6 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ) + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Mitochondrial Haplogroup +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 12 was skipped in the run of 2020-01-01 00:00 UTC] + Haplogroup: U5a + Contamination (haplocheck): not checked (needs step 20's Mutect2 chrM calls) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/U5a + YFull MTree: https://www.yfull.com/mtree/U5a/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: insufficient markers (. markers, QC-score .) + +## Y Placement on the Current Public Tree +--- + Branch: no branch has a derived call (level ., .) + Path SNPs: . derived, . ancestral, . no call; . SNPs called at depth . or more + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Runs of Homozygosity +--- + Segments: 1 Total: 7.0 MB Largest: 7.0 MB + Autosomal ROH > 5MB: 1 + chr2:10000001-17000000 7.0MB + F_ROH: 0.0294 (7.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 0 No genotype at the position: 1 Other allele: 0 + Not read (no genotype in the gVCF): rs10455872 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + +## Polygenic Risk Scores +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 25 was failed (exit 2) in the run of 2020-01-01 00:00 UTC] + X (/ variants matched) PGS1 + Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 334 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 61,873; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: not assessed (no human depth) + No read on any of the 1 viral genomes. + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Steps Not Run +--- + - Mosaic loss of chromosome Y or X + - Variant calling + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Delly) + - Y-STR markers (HipSTR) + - Blood groups (predicted) + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt new file mode 100644 index 000000000..117f1c19f --- /dev/null +++ b/tests/parity/golden/report-render/all/all.txt @@ -0,0 +1,514 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2026-10-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: 20250901; step 6 used the ClinVar file of 2026-10-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K's KIR pass (step 08, KIR=true) gave no call + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 0 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.html b/tests/parity/golden/report-render/cb-nf/cb-nf.html new file mode 100644 index 000000000..508ad2473 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.html @@ -0,0 +1,545 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
chr2100AGhet...0gnomAD AF unknownchr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants6
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenicchr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 0

+

P/LP rows below the depth floor (DP below 8): 0

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not called; Parascopy's SMN1 count: not resolved

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
+
Readingno SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:07 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Stale · file date 2019-06-01 12:30 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was skipped in the run of 2020-01-01 00:00 UTC
+
StatusStale
+
Genes with a non-normal phenotype0
+
Genes with more than one possible result0
+
Genes not called1
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
CPIC drug-gene recommendations: STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was skipped in the run of 2020-01-01 00:00 UTC
+
PharmCAT (step 36's call)not called
+
pypgx*1/*2
+
Cyrius*1/*2 (not usable: Filter LowQ)
+
pypgx and Cyrius agreefewer than two usable calls
+
Probable (one caller: pypgx)*1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it
+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • SV consensus merge
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.txt b/tests/parity/golden/report-render/cb-nf/cb-nf.txt new file mode 100644 index 000000000..e3baa4d56 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.txt @@ -0,0 +1,230 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 6 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (FINAL_CLASSIFICATION): + Pathogenic: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 0 + P/LP rows below the depth floor (DP below 8): 0 + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not called; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: no SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: vcf/B.report.json (PharmCAT version unknown) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was skipped in the run of 2020-01-01 00:00 UTC] + Genes with a non-normal phenotype: 0 More than one possible result: 0 Not called: 1 Called without a function phenotype (no drug guidance): 0 + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not called + pypgx *1/*2 + Cyrius *1/*2 (not usable: Filter LowQ) + pypgx and Cyrius agree: fewer than two usable calls + Probable (one caller: pypgx): *1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - SV consensus merge + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html new file mode 100644 index 000000000..095c42ff2 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html @@ -0,0 +1,477 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
chr2100AGhet...0gnomAD AF unknownchr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Failed · link to this section

+
could not be read: S_clinical.vcf.gz: Compressed file ended before the end-of-stream marker was reached
+
StatusUnreadable
+
+
+
+
+

Cancer Predisposition

+

Step 17 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from no caller; not read: AnnotSV (step 05): no table; step 35's interval table: none; step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
+
Readingno SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading
+
HBA1 and HBA2 together (alpha-globin genes, from depth)not assessed: S_hba_copy_number.tsv has no status row
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
GenesCopies together (agCN)Reading
rhd4 (1 region(s), quality 40 or more, filter PASS).
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)not assessed (step 35's <id>_cn_intervals.tsv is not in this run's output)
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CYP2D6 Across Callers

+

Steps 32, 21 · Not run · link to this section

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)not run
+
pypgxnot run
+
Cyriusnot run
+
pypgx and Cyrius agreefewer than two usable calls
+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • PharmCAT
  • +
  • CPIC drug-gene recommendations
  • +
  • pypgx
  • +
  • Cyrius (CYP2D6)
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • SV consensus merge
  • +
  • Structural variants, class 4 and 5 (AnnotSV)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
  • Cancer predisposition (CPSR)
  • +
  • Variant prioritization (slivar)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt new file mode 100644 index 000000000..45a9a2042 --- /dev/null +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt @@ -0,0 +1,143 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [could not be read: S_clinical.vcf.gz: Compressed file ended before the end-of-stream marker was reached] +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from no caller; not read: AnnotSV (step 05): no table; step 35's interval table: none; step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: no SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): not assessed: S_hba_copy_number.tsv has no status row + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + rhd (agCN): 4 (1 region(s), quality 40 or more, filter PASS) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): not assessed (step 35's _cn_intervals.tsv is not in this run's output) + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - PharmCAT + - CPIC drug-gene recommendations + - pypgx + - Cyrius (CYP2D6) + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - SV consensus merge + - Structural variants, class 4 and 5 (AnnotSV) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + - Cancer predisposition (CPSR) + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html new file mode 100644 index 000000000..bd1e0f5a4 --- /dev/null +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html @@ -0,0 +1,474 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (vep/S_vep.vcf.gz has no .tbi index)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
chr2100AGhet...0gnomAD AF unknownchr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Cancer Predisposition

+

Step 17 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from step 35's HBA1/HBA2 count; not read: AnnotSV (step 05): no table; step 35's interval table: none; Parascopy's SMN1 count: not resolved

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copiesno SMN1 table (step 35 wrote no SMN copy-number table)
+
SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
+
Readingno SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading
+
HBA1 and HBA2 together (alpha-globin genes, from depth)0 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)not assessed (step 35's <id>_cn_intervals.tsv is not in this run's output)
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

CYP2D6 Across Callers

+

Steps 32, 21 · Not run · link to this section

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)not run
+
pypgxnot run
+
Cyriusnot run
+
pypgx and Cyrius agreefewer than two usable calls
+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • PharmCAT
  • +
  • CPIC drug-gene recommendations
  • +
  • pypgx
  • +
  • Cyrius (CYP2D6)
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • SV consensus merge
  • +
  • Structural variants, class 4 and 5 (AnnotSV)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
  • Cancer predisposition (CPSR)
  • +
  • Clinical variant filter
  • +
  • Variant prioritization (slivar)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt new file mode 100644 index 000000000..05cd3b868 --- /dev/null +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt @@ -0,0 +1,139 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + gnomAD AF: unknown for every hit (vep/S_vep.vcf.gz has no .tbi index) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF unknown + call: low-confidence call (GQ 15, DP 30): check the reads + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF unknown + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF unknown + call: low-confidence call (GQ 40, DP 5): check the reads + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Two hits across callers (a deletion plus a variant on the other copy): none found; deletions read from step 35's HBA1/HBA2 count; not read: AnnotSV (step 05): no table; step 35's interval table: none; Parascopy's SMN1 count: not resolved + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: no SMN1 table (step 35 wrote no SMN copy-number table) + SMN1 and SMN2 together (agCN) at exon 7: . (quality ., filter .) + Reading: no SMN1 table (step 35 wrote no SMN copy-number table): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): 0 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): not assessed (step 35's _cn_intervals.tsv is not in this run's output) + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - PharmCAT + - CPIC drug-gene recommendations + - pypgx + - Cyrius (CYP2D6) + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - SV consensus merge + - Structural variants, class 4 and 5 (AnnotSV) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html new file mode 100644 index 000000000..9b65c885e --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's dosage table has no row)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt new file mode 100644 index 000000000..c8c4cd456 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's dosage table has no row) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html new file mode 100644 index 000000000..2b8e65bf0 --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt new file mode 100644 index 000000000..c58e566d8 --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html new file mode 100644 index 000000000..ea96a3396 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetA<&>'"Pathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
<b>chr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (x <y> & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt new file mode 100644 index 000000000..4999e7724 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + A<&>'" chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (x & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html new file mode 100644 index 000000000..1b14657dc --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -0,0 +1,619 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
STALE: note of clinvar <&>
+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+
STALE: note of clinvar <&>
+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+
STALE: note of clinvar <&>
+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+
STALE: note of clinical <&>
+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+
STALE: note of clinical <&>
+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
STALE: note of cpsr <&>
+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
STALE: note of slivar <&>
+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+
STALE: note of carrier <&>
+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

Couple Carrier Screen

+

Step 39 · Stale · file date 2021-03-04 05:06 UTC · link to this section

+

A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

+
STALE: note of couple <&>
+

Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

+

Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

+

X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt new file mode 100644 index 000000000..4eb83c790 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -0,0 +1,285 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [STALE: note of clinvar <&>] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [STALE: note of clinical <&>] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [STALE: note of cpsr <&>] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [STALE: note of slivar <&>] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [STALE: note of carrier <&>] + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [STALE: note of couple <&>] + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html new file mode 100644 index 000000000..c3dd1efab --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below None or DP below None), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF: unknown for every hit (no VEP output)

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt new file mode 100644 index 000000000..1c3ca852d --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -0,0 +1,272 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below None or DP below None), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF: unknown for every hit (no VEP output) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html new file mode 100644 index 000000000..58196ec46 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -0,0 +1,643 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 50 of 60)

+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

Hit at a known lab-construct site past the first 50: MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)

+

Hit at a known lab-construct site past the first 50: SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped <x> (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

+

Hit at a known lab-construct site past the first 50: BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

+

Hit at a known lab-construct site past the first 50: . chr2:100 A>G het: known lab-construct site (lentiviral): not checked

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt new file mode 100644 index 000000000..00d39ed94 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -0,0 +1,405 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + Hits at a known lab-construct site past the first 50: + MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + . chr2:100 A>G het: known lab-construct site (lentiviral): not checked + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html new file mode 100644 index 000000000..3f4d1b994 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -0,0 +1,565 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches0
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Hits at a known lab-construct site (check the reads)1
+
ClinVar file dateunknown
+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

cDNA scan of every exon: not run: no BAM

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt new file mode 100644 index 000000000..e226fb54c --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -0,0 +1,229 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 0 + ClinVar file date: unknown + cDNA scan of every exon: not run: no BAM + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html new file mode 100644 index 000000000..724d393bf --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -0,0 +1,608 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

Couple Carrier Screen

+

Step 39 · Complete · link to this section

+

A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

+

Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt new file mode 100644 index 000000000..cf635f8f2 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -0,0 +1,277 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0 + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html new file mode 100644 index 000000000..9fdc8d823 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -0,0 +1,610 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

Couple Carrier Screen

+

Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

+

Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

+

Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

+

X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt new file mode 100644 index 000000000..28201efd1 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -0,0 +1,279 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html new file mode 100644 index 000000000..6ccc716bc --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -0,0 +1,584 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportNo HTML
+
+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt new file mode 100644 index 000000000..e4b96e531 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -0,0 +1,256 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html new file mode 100644 index 000000000..d14bf055a --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -0,0 +1,589 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown.

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+
+

Files of this step, beside this report: CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt new file mode 100644 index 000000000..76d23ae17 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -0,0 +1,262 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification table has no CLASSIFICATION column. + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown. + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html new file mode 100644 index 000000000..d7767564b --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -0,0 +1,600 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

carrier list <unreadable>

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt new file mode 100644 index 000000000..0bf737190 --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -0,0 +1,273 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, ? genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 2 weak call(s), 1 of unknown frequency), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + carrier list + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html new file mode 100644 index 000000000..49510cbee --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -0,0 +1,599 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown23 / 1 / 1
+ + + + + + + + + + + + + + + + + + + + + + +
GenePair in transReadsViewer
G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt new file mode 100644 index 000000000..1af75d23f --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -0,0 +1,275 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2026-01-01T00:00:00Z] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2026-01-01T00:00:00Z] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2026-01-01T00:00:00Z] + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html new file mode 100644 index 000000000..cdeb54184 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -0,0 +1,575 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
Pairs in trans / cis / unknown2.5 / 1 / 1
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt new file mode 100644 index 000000000..3d8614b73 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -0,0 +1,252 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 2.5 trans, 1 cis, 1 unknown of 26 pairs + ... 2.5 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html new file mode 100644 index 000000000..ea6d778ae --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -0,0 +1,573 @@ + + + + + + +OwnGenome Report + + + +
+ +
+
+

Genomic Analysis Report

+
+ Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
+
+ Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
+
+ +
+

Quality

+

Can I trust this data?

+
+
+
+

Quality Control

+

Steps 16b, 16, 33, 02 · Not run · link to this section

+

Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

+
Mean depthnot available
+
Inferred sex (indexcov)not available
+
Declared sexnot declared
+
Identity and contamination (step 33)Not run
+
+
+
+
+

Variant Calling

+

Step 03 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Clinical

+

Is there anything to take to a doctor?

+
+
+
+

ClinVar Screening

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

+
ClinVar matches8
+
Low-confidence calls (GQ below 20 or DP below 8), not counted2
+
By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
+
Loci with spliced reads (cDNA scan)1
+
Hits at a known lab-construct site (check the reads)1
+
Flagged by the cDNA read check1
+
ClinVar file dateunknown
+

gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

+
+
+

ClinVar Hits (best-reviewed first, 10 of 10)

+ + + + + + + + + + + + + +
ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+

Known Deep Intronic Sites and the cDNA Scan

+

Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

+

A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

+ + + +
GeneVariantPositionCallViewer
CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+

cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

+ + + +
LocusJunctionsReadsViewer
chr1:100-20025chr1:100-200
+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Clinical Variant Filter

+

Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Total interesting variants5
+
Genes3
+
. impact1
+
HIGH impact3
+
MODERATE impact1
+
Frequency unknown (not rare)1
+
Weak genotype calls2
+
+
+

Secondary-Findings Genes (ACMG SF v3.3)

+

A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

+ + + + + + + + + + +
GeneVariantGenotypeEvidenceViewer
MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
+

HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

+

HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

+

The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

+
+
+
+
+

Cancer Predisposition

+

Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

+
CPSR reportComplete
+
Pathogenic1
+
Likely_Pathogenic1
+
VUS1
+
Benign1
+
.1
+

ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

+

Final P/LP rows that CPSR's own rules class benign or likely benign: 1

+

Rows where ClinVar and CPSR's own class disagree on P/LP: 2

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

+

MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

+

P/LP rows below the depth floor (DP below 8): 1

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

+

cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

+

BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

+
+

Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

+
+
+
+

Variant Prioritization (slivar)

+

Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Prioritized variants2
+
Frequency unknown (not rare)1
+
Compound het candidates4 variants, 2 genes
+
+
+
+
+

Repeat Expansions

+

Step 09 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Mitochondrial Analysis

+

Step 20 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Carrier

+

What could I pass on to a child?

+
+
+
+

Carrier List (this sample)

+

Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

+

Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

+

MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

+

HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

+

CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

+

GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

+

BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

+

HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

+

GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

+

Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

+

Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

+

Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

+

Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

+

Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

+

Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

+
+
+
+
+

SMN1/SMN2 Copy Number (Parascopy)

+

Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

+

Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

+
StatusComplete
+
SMN1 copies1 (quality 30, filter PASS)
+
SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
+
SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
+
SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
+
SMN2 copies3 (quality 30, filter PASS)
+
SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
+
Readingone SMN1 copy: the pattern of an SMA carrier
+
HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
+
CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
+
Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
+
Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
+
RegionRowPlaceCopiesChange
CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
xDUP1chr1:2-1003 of 2duplication
xGJB6chr13:x-21 of 2deletion
+
+
+
+
+
+

Medicines

+

How might I respond to medicines?

+
+
+
+

Pharmacogenomics

+

Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

+
PharmCAT reportComplete
+
PharmCAT version3.4.0
+
PharmCAT vs pypgx conflicts1
+
+

Files of this step, beside this report: PharmCAT HTML report

+
+
+
+

CPIC Drug Recommendations

+

Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+

CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

+
StatusComplete
+
Genes with a non-normal phenotype1
+
Genes with more than one possible result1
+
Genes not called0
+
Genes called without a function phenotype (no drug guidance)0
+
TipRecommendations per gene: cpic/S_cpic_recommendations.txt
+
+
+

Genes With a Non-Normal or Unresolved Phenotype (CPIC)

+ + + + +
GeneDiplotypePhenotype
CYP2D6*1/*4Intermediate Metabolizer
CYP2C19*1/*17Rapid
+
WARNING: CYP2C19 has two possible phenotypes
+
WARNING: last
+

Drugs for each gene: cpic/S_cpic_recommendations.txt

+
+

Files of this step, beside this report: CPIC recommendations per gene (text)

+
+
+
+

pypgx Pharmacogenomics

+

Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

+
Genes called3/6
+
CYP2D6 diplotype*1/*2
+

Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

+

Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

+

Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

+

CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

+
+
+

PGx Copy Number

+
CYP2D6Normal (pypgx, read depth)
+
CYP2A6not called: pypgx failed (pypgx, read depth)
+
CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
+
SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
+
+
+

CYP2D6 Across Callers

+

CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

+
PharmCAT (step 36's call)*1/*4
+
pypgx*1/*2
+
Cyrius*2/*1
+
pypgx and Cyrius agreeyes
+
Step 36*1/*2
+

Passed to PharmCAT: pypgx and Cyrius agree

+
+
+
+
+

HLA Typing

+

Step 08 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Ancestry

+

Where do my ancestors come from?

+
+
+
+

Mitochondrial Haplogroup

+

Step 12 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Runs of Homozygosity

+

Step 11 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

Traits and scores

+

What do studies say about my traits and risk scores?

+
+
+
+

Traits

+

Step 42 · Not run · link to this section

+
StatusNot run
+
+
+
+
+

Telomere content (relative)

+

Step 10 · Not run · link to this section

+
StatusNot run
+
+
+
+
+
+

What this report leaves out

+

Which steps did not run, and what does no step look at?

+
+
+
+

Steps Not Run

+
    +
  • Coverage (mosdepth)
  • +
  • Gene callability (mosdepth)
  • +
  • Sex check (indexcov)
  • +
  • Sample identity and contamination (somalier, VerifyBamID2)
  • +
  • Mosaic loss of chromosome Y or X
  • +
  • Variant calling
  • +
  • Paralog genes (Paraphase, PacBio HiFi)
  • +
  • HLA typing (T1K)
  • +
  • Polygenic risk scores
  • +
  • Fine-grained ancestry (ADMIXTURE, RFMix)
  • +
  • Structural variants (Manta)
  • +
  • Structural variants (Delly)
  • +
  • Copy number (CNVpytor)
  • +
  • Repeat expansions (ExpansionHunter)
  • +
  • Telomere content (TelomereHunter)
  • +
  • Runs of homozygosity
  • +
  • Mitochondrial haplogroup
  • +
  • Y-chromosome haplogroup (Yleaf)
  • +
  • Y placement on the current public tree
  • +
  • Y-STR markers (HipSTR)
  • +
  • Raw-data export (23andMe v5 layout)
  • +
  • Blood groups (predicted)
  • +
  • Lp(a): LPA KIV-2 repeat count
  • +
  • MUC1 VNTR frameshifts (VNtyper)
  • +
  • Locityper second opinion at hard loci
  • +
  • Mitochondrial variants
  • +
  • Traits panel
  • +
  • Archaic ancestry (IBDmix)
  • +
  • Ancient populations (AADR PCA)
  • +
  • Viral DNA in the unmapped reads
  • +
  • Symptom-driven ranking (Exomiser)
  • +
  • Clonal haematopoiesis (CHIP)
  • +
  • Mobile element insertions (MEGAnE)
  • +
  • Mosaic chromosomal alterations (MoChA)
  • +
+
+
+
+
+

Not Assessed by This Pipeline

+
    +
  • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
  • +
  • Methylation and imprinting
  • +
  • Repeat expansions outside the ExpansionHunter catalog
  • +
  • Phase: two variants in one gene are compound-het candidates, not confirmed
  • +
  • Variants of uncertain significance (not interpreted)
  • +
  • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
  • +
  • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
  • +
  • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
  • +
  • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
  • +
+
+
+
+
+
+ Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
+ + +
+
+ + diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt new file mode 100644 index 000000000..14371953d --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -0,0 +1,250 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-11-21 10:08 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + (Candidates only: unphased single-sample data. See docs/31-slivar.md) + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ From e2737d8240440249e9ec3218b5db8478d0e78dd6 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 11:59:37 +0100 Subject: [PATCH 09/40] test(personal-data): allow the synthetic LPA genotypes of the all report goldens The report-render goldens of the all and all-history cases print the LPA section of the synthetic corpus summary, whose two risk-allele lines read as an rsID with a genotype. They are invented test data: allow those two lines in those goldens only. Bead: clin-15 --- scripts/ci/check-personal-data.sh | 2 ++ 1 file changed, 2 insertions(+) diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index a51191031..152153072 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -156,6 +156,8 @@ tests/smoke/commands.tsv HTT at 19/45 repeats tests/smoke/commands.tsv ATXN3 at 22/24 repeats rust/crates/og-facts/tests/facts.rs "rs2231142 G/G" rust/crates/og-facts/tests/facts.rs "rs9923231 C/C" +tests/parity/golden/report-render/all*/all*.txt rs10455872: A/G (1 risk allele) +tests/parity/golden/report-render/all*/all*.txt rs3798220: T|C (1 risk allele) ' # Whole files that are not scanned (glob), with the reason. Keep this list From f631b3c8fe27732b4d333d004808793e39c4277a Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 13:41:26 +0100 Subject: [PATCH 10/40] test(parity): fix the time of the report corpus, so its goldens hold on every run A collected summary carries the minute og summary collect ran (generated_utc), and both reports print it. The report-render goldens of the cases with a row in hom_or_hemizygous therefore failed on the next day's run. report-corpus.sh now writes one fixed time into every collected summary (sed on that one line, so a summary that holds NaN or Infinity on purpose stays as it is), and the goldens are written again from og run inside the checkout, as CI runs it: the all and all-nf summaries now read their repeat tables, as on CI. The pinned oracle matches the old og on every other output (299 of 301; the other 2 are the committed viral golden), and no new golden is stale. The all and all-history text goldens also print the corpus's invented repeat sizes: allow those two lines too. Bead: clin-15 --- scripts/ci/check-personal-data.sh | 2 + tests/parity/gen/report-corpus.sh | 7 ++ .../report-render/all-history/all-history.txt | 72 +++++++++++++++++-- .../golden/report-render/all-nf/all-nf.html | 51 ++++++++++--- .../golden/report-render/all-nf/all-nf.txt | 55 ++++++++++++-- tests/parity/golden/report-render/all/all.txt | 72 +++++++++++++++++-- .../golden/report-render/cb-full/cb-full.html | 2 +- .../golden/report-render/cb-full/cb-full.txt | 2 +- .../golden/report-render/cb-nf/cb-nf.html | 2 +- .../golden/report-render/cb-nf/cb-nf.txt | 2 +- .../report-render/cb-nfbad/cb-nfbad.html | 2 +- .../report-render/cb-nfbad/cb-nfbad.txt | 2 +- .../report-render/cb-notbi/cb-notbi.html | 2 +- .../report-render/cb-notbi/cb-notbi.txt | 2 +- .../cb-quoted-dosage/cb-quoted-dosage.html | 2 +- .../cb-quoted-dosage/cb-quoted-dosage.txt | 2 +- .../cb-quoted-interval.html | 2 +- .../cb-quoted-interval/cb-quoted-interval.txt | 2 +- .../cb-quoted-smn/cb-quoted-smn.html | 2 +- .../cb-quoted-smn/cb-quoted-smn.txt | 2 +- .../cb-unicode-contig/cb-unicode-contig.html | 2 +- .../cb-unicode-contig/cb-unicode-contig.txt | 2 +- .../m-clinical-escape/m-clinical-escape.html | 2 +- .../m-clinical-escape/m-clinical-escape.txt | 2 +- .../m-clinical-stale/m-clinical-stale.html | 2 +- .../m-clinical-stale/m-clinical-stale.txt | 2 +- .../m-clinvar-freq-note.html | 2 +- .../m-clinvar-freq-note.txt | 2 +- .../m-clinvar-many/m-clinvar-many.html | 2 +- .../m-clinvar-many/m-clinvar-many.txt | 2 +- .../m-clinvar-none/m-clinvar-none.html | 2 +- .../m-clinvar-none/m-clinvar-none.txt | 2 +- .../m-couple-empty/m-couple-empty.html | 2 +- .../m-couple-empty/m-couple-empty.txt | 2 +- .../report-render/m-couple/m-couple.html | 2 +- .../report-render/m-couple/m-couple.txt | 2 +- .../m-cpsr-none/m-cpsr-none.html | 2 +- .../report-render/m-cpsr-none/m-cpsr-none.txt | 2 +- .../m-cpsr-noown/m-cpsr-noown.html | 2 +- .../m-cpsr-noown/m-cpsr-noown.txt | 2 +- .../report-render/m-sf-notes/m-sf-notes.html | 2 +- .../report-render/m-sf-notes/m-sf-notes.txt | 2 +- .../m-since-clinical/m-since-clinical.html | 2 +- .../m-since-clinical/m-since-clinical.txt | 2 +- .../m-slivar-phase/m-slivar-phase.html | 2 +- .../m-slivar-phase/m-slivar-phase.txt | 2 +- .../m-slivar-unphased/m-slivar-unphased.html | 2 +- .../m-slivar-unphased/m-slivar-unphased.txt | 2 +- 48 files changed, 276 insertions(+), 67 deletions(-) diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index 152153072..e62535b1f 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -158,6 +158,8 @@ rust/crates/og-facts/tests/facts.rs "rs2231142 G/G" rust/crates/og-facts/tests/facts.rs "rs9923231 C/C" tests/parity/golden/report-render/all*/all*.txt rs10455872: A/G (1 risk allele) tests/parity/golden/report-render/all*/all*.txt rs3798220: T|C (1 risk allele) +tests/parity/golden/report-render/all*/all*.txt HTT 17/20 normal,normal +tests/parity/golden/report-render/all*/all*.txt ATXN1 30/37 not sized ' # Whole files that are not scanned (glob), with the reason. Keep this list diff --git a/tests/parity/gen/report-corpus.sh b/tests/parity/gen/report-corpus.sh index cc4519b69..059db202d 100644 --- a/tests/parity/gen/report-corpus.sh +++ b/tests/parity/gen/report-corpus.sh @@ -67,6 +67,13 @@ while IFS=$'\t' read -r case inputs args; do done (cd "$dir" && "$og" summary collect "${keep[@]}" --out "../../${case}.json" > /dev/null 2>&1) \ || rm -f "${case}.json" + # The time of writing, fixed, so a report-render golden of a collected + # summary (or of a change of one) stays true on every run. + if [ -s "${case}.json" ]; then + # sed, not jq: a summary may hold NaN or Infinity on purpose. + sed -E 's/^( *"generated_utc": )"[^"]*"/\1"2026-01-02 03:04 UTC"/' "${case}.json" > "${case}.json.t" + mv "${case}.json.t" "${case}.json" + fi done < folders/cases.tsv rm -rf folders diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index 764ee1013..3198ce5c2 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC Database re-check: 2021-03-05 00:00:00 UTC: ClinVar newer-release ================================================================================ @@ -183,7 +183,36 @@ ## Repeat Expansions (ExpansionHunter) --- [New since 2021-01-01 00:00 UTC] - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + ## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) --- [New since 2021-01-01 00:00 UTC] @@ -369,15 +398,48 @@ ## HLA Typing (T1K) --- [New since 2021-01-01 00:00 UTC] - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + ## Locityper Second Opinion at Hard Loci (step 53) --- [New since 2021-01-01 00:00 UTC] Loci called: 4 of 5; passing the authors' filter: 3 HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K's KIR pass (step 08, KIR=true) gave no call + primary: T1K KIR pass (step 08): 1 genes typed CYP2D6 Locityper: not called: low depth primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) diff --git a/tests/parity/golden/report-render/all-nf/all-nf.html b/tests/parity/golden/report-render/all-nf/all-nf.html index 992c7e6ee..5905f7e3a 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.html +++ b/tests/parity/golden/report-render/all-nf/all-nf.html @@ -122,7 +122,7 @@

Contents

  • Variant prioritization
  • Symptom-driven ranking
  • Mobile element insertions
  • -
  • Repeat expansions
  • +
  • Repeat expansions
  • MUC1 repeat (ADTKD)
  • Mitochondrial variants
  • Lp(a)
  • @@ -141,7 +141,7 @@

    Contents

  • PharmCAT
  • CPIC recommendations
  • pypgx, Cyrius and CYP2D6
  • -
  • HLA typing
  • +
  • HLA typing
  • Locityper second opinion
  • @@ -176,7 +176,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown @@ -349,9 +349,17 @@

    Mobile Element Insertions

    Repeat Expansions

    -

    Step 09 · Failed · link to this section

    -
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'
    -
    StatusUnreadable
    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)older than ExpansionHunter's result: rerun step 9b
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG12-5T/TG12-5T
    +

    5T: 2 copys with the 5T poly-T tract, TG12 on the 5T copies. 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. R117H was not read (no step 42 traits row for rs78655421 was called), so whether it sits on the 5T copy is not known. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*28/TA9
    +

    *28/TA9 (TA7/TA9, 8/10 TA units as ExpansionHunter counts them): a TA length outside TA5 to TA8 is not a named allele here, so its function is not read and it is not compared with PharmCAT (step 7). (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +
    LocusRepeat CountStrangerNotes
    HTTnot in output
    FMR1not in output
    C9ORF72not in output
    ATXN1not in output
    DMPKnot in output
    CFTR_T5/5
    CFTR_TG12/12
    UGT1A18/10
    @@ -531,9 +539,32 @@

    CYP2D6 Across Callers

    HLA Typing

    -

    Step 08 · Failed · link to this section

    -
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'
    -
    StatusUnreadable
    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-DQA1DQA1*03:01 (quality 0) / DQA1*01:01 (quality 30); low confidence (T1K quality 0 or below)
    +
    HLA-DQB1DQB1*02:01 (quality 40)
    +
    HLA-DRB1DRB1*04:01 (quality 40) / DRB1*07:01 (quality 40)
    +

    Coeliac DQ: not determined (HLA-DQA1 low confidence)

    +

    DQB1*02 copies: 2

    +

    DRB1*04:01 present: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    A*31:01 not determined (HLA-A not typed): carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +

    C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet)

    +
    HLA databaseunknown
    +
    OptiType checknot compared: OptiType did not run: no class I reads
    +

    too few KIR reads

    @@ -543,7 +574,7 @@

    Locityper Second Opinion at Hard Loci

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC
    Loci called3 of 3 (3 pass the filter)
    -
    LocusLocityperFilterPrimary caller
    HLA-DRB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    HLA-DQB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    CYP2D6h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passpypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08): DRB1*04:01/DRB1*07:01
    HLA-DQB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08): DQB1*02:01
    CYP2D6h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passpypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ)
    diff --git a/tests/parity/golden/report-render/all-nf/all-nf.txt b/tests/parity/golden/report-render/all-nf/all-nf.txt index 8e75283d2..41062aeaf 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.txt +++ b/tests/parity/golden/report-render/all-nf/all-nf.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ @@ -130,7 +130,25 @@ ## Repeat Expansions (ExpansionHunter) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] + Loci in output: 3 + Stranger's result is older than ExpansionHunter's: rerun step 9b. No locus is marked as normal or expanded. + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG12-5T/TG12-5T + 5T: 2 copys with the 5T poly-T tract, TG12 on the 5T copies. 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. R117H was not read (no step 42 traits row for rs78655421 was called), so whether it sits on the 5T copy is not known. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *28/TA9 + *28/TA9 (TA7/TA9, 8/10 TA units as ExpansionHunter counts them): a TA length outside TA5 to TA8 is not a named allele here, so its function is not read and it is not compared with PharmCAT (step 7). (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Every locus (key loci first): repeat count, Stranger status, notes + HTT not in output - + FMR1 not in output - + C9ORF72 not in output - + ATXN1 not in output - + DMPK not in output - + CFTR_T 5/5 - + CFTR_TG 12/12 - + UGT1A1 8/10 - + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + ## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) --- Result: not assessed @@ -264,15 +282,42 @@ ## HLA Typing (T1K) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] + HLA-DQA1 DQA1*03:01 (quality 0) / DQA1*01:01 (quality 30); low confidence (T1K quality 0 or below) + HLA-DQB1 DQB1*02:01 (quality 40) + HLA-DRB1 DRB1*04:01 (quality 40) / DRB1*07:01 (quality 40) + Coeliac DQ: not determined (HLA-DQA1 low confidence) + DQB1*02 copies: 2 + DRB1*04:01 present: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + A*31:01 not determined (HLA-A not typed): carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + not compared: OptiType did not run: no class I reads + KIR genes (T1K, KIR=true): + too few KIR reads + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + ## Locityper Second Opinion at Hard Loci (step 53) --- [STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC] Loci called: 3 of 3; passing the authors' filter: 3 HLA-DRB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DRB1*04:01/DRB1*07:01 HLA-DQB1 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DQB1*02:01 CYP2D6 Locityper: h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass) primary: pypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ) A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index 117f1c19f..15cb06ab0 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ @@ -173,7 +173,36 @@ ## Repeat Expansions (ExpansionHunter) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'] + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + ## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) --- Result: negative @@ -345,14 +374,47 @@ ## HLA Typing (T1K) --- - [could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'] + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: IPD-IMGT/HLA 3.60 extra + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + ## Locityper Second Opinion at Hard Loci (step 53) --- Loci called: 4 of 5; passing the authors' filter: 3 HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K (step 08) did not run + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) - primary: T1K's KIR pass (step 08, KIR=true) gave no call + primary: T1K KIR pass (step 08): 1 genes typed CYP2D6 Locityper: not called: low depth primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.html b/tests/parity/golden/report-render/cb-nf/cb-nf.html index 508ad2473..8ce72db92 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.html +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.txt b/tests/parity/golden/report-render/cb-nf/cb-nf.txt index e3baa4d56..ac7d9b88a 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.txt +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html index 095c42ff2..7c8f6da4b 100644 --- a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt index 45a9a2042..957ddacbc 100644 --- a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC ================================================================================ ################################################################################ diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html index bd1e0f5a4..e3365b996 100644 --- a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt index 05cd3b868..7e2fb7d86 100644 --- a/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC ================================================================================ ################################################################################ diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index 9b65c885e..152e83fc3 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index c8c4cd456..0786439a6 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index 2b8e65bf0..ff5a242ab 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index c58e566d8..af8d4a1ba 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index ea96a3396..9a5a4da4b 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index 4999e7724..89954e3ab 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index 1b14657dc..5b67b1e82 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -162,7 +162,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index 4eb83c790..620915c00 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index c3dd1efab..3f5ba65f4 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index 1c3ca852d..508a4358d 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index 58196ec46..a0751b532 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 00d39ed94..4eb79e3bb 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index 3f4d1b994..daa7ea1e7 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index e226fb54c..532a16449 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index 724d393bf..6d2304010 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -162,7 +162,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index cf635f8f2..5706ec222 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index 9fdc8d823..84b4d55f4 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -162,7 +162,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index 28201efd1..c64a44a24 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index 6ccc716bc..7a8558199 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index e4b96e531..9711220ee 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index d14bf055a..f4f6722cb 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 76d23ae17..4d5a6fddf 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index d7767564b..850ef691a 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index 0bf737190..e4986aedf 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index 49510cbee..c91ecc749 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 1af75d23f..59ab75868 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index cdeb54184..f827bbc4f 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index 3d8614b73..5eccfc04b 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index ea6d778ae..07a81c6e0 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -161,7 +161,7 @@

    Contents

    Genomic Analysis Report

    - Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC
    Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index 14371953d..06eb71fe4 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -1,7 +1,7 @@ ================================================================================ GENOMICS ANALYSIS REPORT Sample: S - Generated: 2026-11-21 10:08 UTC + Generated: 2026-01-02 03:04 UTC Latest run-all.sh run: 2020-01-01 00:00 UTC ================================================================================ From 6059508132ae43190bf3a066592f788f3798ef28 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 16:53:57 +0100 Subject: [PATCH 11/40] fix(sf): cap a secondary-findings pair that rests on a low-confidence call The SF card called two_hits(), so a class 4/5 deletion plus a P/LP call below step 06's call floor read 'biallelic' there, while the carrier list of the same report read it as possibly biallelic (low-confidence call). Two phased hets of which one is a low-confidence call also read 'biallelic' with no mark. Each counted allele now carries its low_confidence mark. The deletion rule goes through two_hits_with, and a pair whose proof needs a low-confidence call reads 'possibly biallelic (low-confidence call)'. A confident homozygous call or a confident pair stays 'biallelic'. Bead: clin-19 --- rust/crates/og-summary/src/collect/acmg.rs | 65 +- .../tests/i411_carrier_confidence.rs | 95 +- .../report-render/all-history/all-history.txt | 55 + .../golden/report-render/all-nf/all-nf.html | 1464 +++++++++++++++++ .../golden/report-render/all-nf/all-nf.txt | 29 + tests/parity/golden/report-render/all/all.txt | 48 + .../golden/report-render/cb-full/cb-full.html | 99 ++ .../golden/report-render/cb-full/cb-full.txt | 21 + .../golden/report-render/cb-nf/cb-nf.html | 81 + .../golden/report-render/cb-nf/cb-nf.txt | 4 + .../report-render/cb-nfbad/cb-nfbad.html | 47 + .../report-render/cb-notbi/cb-notbi.html | 47 + .../cb-quoted-dosage/cb-quoted-dosage.html | 99 ++ .../cb-quoted-dosage/cb-quoted-dosage.txt | 21 + .../cb-quoted-interval.html | 99 ++ .../cb-quoted-interval/cb-quoted-interval.txt | 21 + .../cb-quoted-smn/cb-quoted-smn.html | 99 ++ .../cb-quoted-smn/cb-quoted-smn.txt | 21 + .../cb-unicode-contig/cb-unicode-contig.html | 99 ++ .../cb-unicode-contig/cb-unicode-contig.txt | 21 + .../m-clinical-escape/m-clinical-escape.html | 100 ++ .../m-clinical-escape/m-clinical-escape.txt | 21 + .../m-clinical-stale/m-clinical-stale.html | 100 ++ .../m-clinical-stale/m-clinical-stale.txt | 21 + .../m-clinvar-freq-note.html | 99 ++ .../m-clinvar-freq-note.txt | 21 + .../m-clinvar-many/m-clinvar-many.html | 99 ++ .../m-clinvar-many/m-clinvar-many.txt | 21 + .../m-clinvar-none/m-clinvar-none.html | 94 ++ .../m-clinvar-none/m-clinvar-none.txt | 21 + .../m-couple-empty/m-couple-empty.html | 99 ++ .../m-couple-empty/m-couple-empty.txt | 21 + .../report-render/m-couple/m-couple.html | 100 ++ .../report-render/m-couple/m-couple.txt | 21 + .../m-cpsr-none/m-cpsr-none.html | 97 ++ .../report-render/m-cpsr-none/m-cpsr-none.txt | 21 + .../m-cpsr-noown/m-cpsr-noown.html | 99 ++ .../m-cpsr-noown/m-cpsr-noown.txt | 21 + .../report-render/m-sf-notes/m-sf-notes.html | 99 ++ .../report-render/m-sf-notes/m-sf-notes.txt | 21 + .../m-since-clinical/m-since-clinical.html | 99 ++ .../m-since-clinical/m-since-clinical.txt | 21 + .../m-slivar-phase/m-slivar-phase.html | 79 + .../m-slivar-phase/m-slivar-phase.txt | 21 + .../m-slivar-unphased/m-slivar-unphased.html | 99 ++ .../m-slivar-unphased/m-slivar-unphased.txt | 21 + 46 files changed, 4058 insertions(+), 13 deletions(-) diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index c2f58b970..01f50c511 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -29,7 +29,7 @@ use super::clinvar::{ }; use super::text::{self, digits, format_map, gt_field, info_map}; use super::two_hits::{ - DeletionInputs, Entry, Spans, Variant, Verdict, gene_deletions, phase_haps, two_hits, + DeletionInputs, Entry, Spans, Variant, Verdict, gene_deletions, phase_haps, two_hits_with, }; use indexmap::IndexMap; use pycompat::json::Value; @@ -439,8 +439,9 @@ struct Cand { } /// One distinct variant of a gene as the verdict counts it: its alt -/// copies, ploidy, GT and phase set, and whether it stands for a combined -/// allele and its parts. +/// copies, ploidy, GT and phase set, whether it stands for a combined +/// allele and its parts, and whether a call of it is below step 06's call +/// floor (low confidence). #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -448,6 +449,7 @@ struct Allele { gt: String, ps: Option, combined: bool, + low: bool, } impl Allele { @@ -458,6 +460,7 @@ impl Allele { gt: String::new(), ps: None, combined: false, + low: false, } } @@ -618,15 +621,39 @@ fn sf_verdicts( }; out.insert(k.clone(), why); } + // The count again without the low-confidence calls: a pair that needs + // one of them is only possible until the call is confirmed. + let firm: IndexMap = kept + .iter() + .filter(|(_, a)| !a.low) + .map(|(k, a)| (k.clone(), a.clone())) + .collect(); + let (n_firm, proof_firm, _) = copies_hit(&firm); + let low = |why: String| { + ( + Verdict::LowConfidence.word(), + format!( + "a call it rests on is below the call floor (low confidence), so confirm it \ + first; {why}" + ), + ) + }; let pair = (counted && n >= 2).then(|| match (proof, deletion) { - (Some(p), _) => ("biallelic", p), + (Some(p), _) => match proof_firm { + Some(f) => ("biallelic", f), + None => low(p), + }, (None, Some(e)) => (e.verdict.word(), format!("with {}: {}", e.deletion, e.why)), - (None, None) => ( - Verdict::PossiblyBiallelic.word(), - "phase unknown: no read-backed phase links the variants, so they may sit on the \ - same copy (cis)" - .to_owned(), - ), + (None, None) => { + let why = "phase unknown: no read-backed phase links the variants, so they may sit \ + on the same copy (cis)" + .to_owned(); + if n_firm >= 2 { + (Verdict::PossiblyBiallelic.word(), why) + } else { + low(why) + } + } }); let hypo: Vec<&str> = out .iter() @@ -950,9 +977,11 @@ fn tier(i: &Inputs) -> Result, String> { // allele's own call stands for its parts. let (own, folded): (Vec<&Cand>, Vec<&Cand>) = small.iter().copied().partition(|x| unit(x) == x.key); + // A step 06 hit below its call floor (the ClinVar row's low_confidence). + let is_low = |x: &Cand| matches!(x.fields.get("low_confidence"), Some(Value::Bool(true))); for x in &own { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; - alleles + let a = alleles .entry(x.gene.clone()) .or_default() .entry(x.key.clone()) @@ -961,6 +990,7 @@ fn tier(i: &Inputs) -> Result, String> { ps: x.ps.clone(), ..Allele::of(x.copies, p) }); + a.low |= is_low(x); } for x in &folded { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; @@ -975,6 +1005,7 @@ fn tier(i: &Inputs) -> Result, String> { }); a.copies = a.copies.max(x.copies); a.combined = true; + a.low |= is_low(x); } for x in &svs { alleles @@ -1021,7 +1052,17 @@ fn tier(i: &Inputs) -> Result, String> { }); } } - let found = two_hits(&variants, &dels); + let low: HashSet<(String, Key)> = own + .iter() + .filter(|x| is_low(x)) + .filter_map(|x| match &x.key { + AKey::Small(k) => Some((x.gene.clone(), k.clone())), + _ => None, + }) + .collect(); + let found = two_hits_with(&variants, &dels, |v| { + low.contains(&(v.gene.clone(), v.key.clone())) + }); let mut two: HashMap<(String, Key), String> = HashMap::new(); for g in found.entries.keys() { if matches!(rules[g].report_if.as_str(), "biallelic" | "hemizygous") { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 45d2a84b6..4676e850a 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -8,9 +8,12 @@ //! heterozygous hits of one recessive gene as two plain carrier rows, and a //! deletion plus a low-confidence call as a confident two-hit gene. These //! cases run the list on synthetic hits with the shipped -//! `assets/carrier_genes.tsv`. +//! `assets/carrier_genes.tsv`. The last cases run the ACMG SF card on the +//! same hits (`assets/acmg_sf.tsv`): a pair that rests on a low-confidence +//! call reads the same there. use indexmap::IndexMap; +use og_summary::collect::acmg::{Inputs, acmg_sf}; use og_summary::collect::carrier::Carrier; use og_summary::collect::clinvar::{Floor, HitRecords, HitsVcf}; use og_summary::collect::two_hits::{DeletionInputs, SvRow}; @@ -21,6 +24,7 @@ const ASSETS: &str = concat!(env!("CARGO_MANIFEST_DIR"), "/../../../assets"); // MUTYH and CFTR spans in assets/carrier_genes.tsv: chr1:45329163-45340893 // and chr7:117287120-117715971. MUTYH is on the ACMG SF list, CFTR is not. const MUTYH_A: (&str, i128, &str, &str) = ("chr1", 45_331_556, "C", "T"); +const MUTYH_B: (&str, i128, &str, &str) = ("chr1", 45_332_803, "T", "C"); const CFTR_A: (&str, i128, &str, &str) = ("chr7", 117_559_590, "ATCT", "A"); const CFTR_B: (&str, i128, &str, &str) = ("chr7", 117_587_806, "G", "T"); const OTC_A: (&str, i128, &str, &str) = ("chrX", 38_400_000, "C", "T"); @@ -335,3 +339,92 @@ fn a_deletion_plus_a_low_confidence_call_is_only_possibly_biallelic() { "possibly biallelic (low-confidence call)" ); } + +/// The ACMG SF card on step 06's hits alone (no clinical VCF). +fn sf(hits: Vec>, dels: &DeletionInputs) -> IndexMap { + let h: Result = Ok((Floor::default(), hits)); + obj(acmg_sf(&Inputs { + assets: ASSETS, + hits: Some(&h), + clinical: None, + deletions: dels, + }) + .unwrap()) +} + +/// The `pair` word of each reported ClinVar row of `gene` on the SF card. +fn sf_pairs(c: &IndexMap, gene: &str) -> Vec { + let r = of(c, "clinvar_hits", gene); + assert!(!r.is_empty(), "{c:?}"); + r.iter().map(|x| s(x, "pair").to_owned()).collect() +} + +#[test] +fn the_sf_card_caps_a_deletion_pair_on_a_low_confidence_call() { + let dels = mutyh_deletion("1|0", Some("9")); + let weak = sf( + vec![hit(MUTYH_A, "MUTYH", "GT:GQ:DP:PS", "0|1:5:4:9", "")], + &dels, + ); + assert_eq!( + sf_pairs(&weak, "MUTYH"), + ["possibly biallelic (low-confidence call)"] + ); + let sure = sf(vec![good(MUTYH_A, "MUTYH", "0|1", Some("9"))], &dels); + assert_eq!(sf_pairs(&sure, "MUTYH"), ["biallelic"]); +} + +#[test] +fn the_sf_card_caps_a_phased_pair_on_a_low_confidence_call() { + let weak = sf( + vec![ + good(MUTYH_A, "MUTYH", "0|1", Some("9")), + hit(MUTYH_B, "MUTYH", "GT:GQ:DP:PS", "1|0:5:4:9", ""), + ], + &no_deletions(), + ); + let low = "possibly biallelic (low-confidence call)"; + assert_eq!(sf_pairs(&weak, "MUTYH"), [low, low]); + for x in of(&weak, "clinvar_hits", "MUTYH") { + assert!(s(x, "phase").contains("low confidence"), "{x:?}"); + } + // Unphased, one of them weak: the same mark. + let unphased = sf( + vec![ + good(MUTYH_A, "MUTYH", "0/1", None), + hit(MUTYH_B, "MUTYH", "GT:GQ:DP", "0/1:5:4", ""), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&unphased, "MUTYH"), [low, low]); + // Both confident: biallelic, and possibly biallelic unphased. + let sure = sf( + vec![ + good(MUTYH_A, "MUTYH", "0|1", Some("9")), + good(MUTYH_B, "MUTYH", "1|0", Some("9")), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&sure, "MUTYH"), ["biallelic", "biallelic"]); + let open = sf( + vec![ + good(MUTYH_A, "MUTYH", "0/1", None), + good(MUTYH_B, "MUTYH", "0/1", None), + ], + &no_deletions(), + ); + assert_eq!( + sf_pairs(&open, "MUTYH"), + ["possibly biallelic", "possibly biallelic"] + ); + // A confident homozygous call proves both copies on its own; a weak + // second variant does not weaken that. + let hom = sf( + vec![ + good(MUTYH_A, "MUTYH", "1/1", None), + hit(MUTYH_B, "MUTYH", "GT:GQ:DP", "0/1:5:4", ""), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&hom, "MUTYH"), ["biallelic", "biallelic"]); +} diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index 3198ce5c2..84e4a5c3e 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -173,6 +173,45 @@ chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt +## Structural Variants (Manta) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + [New since 2021-01-01 00:00 UTC] + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [New since 2021-01-01 00:00 UTC] + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + [New since 2021-01-01 00:00 UTC] + Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) + DEL 9:1-100 class 4 G9 support: single caller (tiddit) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ## Mobile Element Insertions (step 50) --- Insertions called: 3 (ALU 2, L1 1) @@ -272,6 +311,13 @@ 1 other protein changes listed, not counted: chip/S_chip.tsv. Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. +## Mosaic loss of chromosome Y or X +--- + [New since 2021-01-01 00:00 UTC] + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + ## Mosaic Chromosomal Alterations (MoChA, step 51) --- [New since 2021-01-01 00:00 UTC] @@ -595,6 +641,15 @@ HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. +## Raw-Data Export (23andMe v5 layout) +--- + [New since 2021-01-01 00:00 UTC] + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + ## Steps Not Run --- All major steps completed. diff --git a/tests/parity/golden/report-render/all-nf/all-nf.html b/tests/parity/golden/report-render/all-nf/all-nf.html index 5905f7e3a..56196d55f 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.html +++ b/tests/parity/golden/report-render/all-nf/all-nf.html @@ -121,12 +121,14 @@

    Contents

  • Cancer predisposition
  • Variant prioritization
  • Symptom-driven ranking
  • +
  • Structural variants
  • Mobile element insertions
  • Repeat expansions
  • MUC1 repeat (ADTKD)
  • Mitochondrial variants
  • Lp(a)
  • Clonal haematopoiesis
  • +
  • Mosaic loss of chromosome Y or X
  • Mosaic chromosomal alterations
  • @@ -162,6 +164,7 @@

    Contents

  • Other and exports
    1. Viral DNA
    2. +
    3. Raw-data export
  • What this report leaves out @@ -170,6 +173,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -229,6 +233,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -337,6 +342,27 @@

    Symptom-Driven Ranking (Exomiser)

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Copy number (CNVpytor): STALE: from an earlier run (2019-06-01 12:30 UTC); step 18 was skipped (opt-in) in the run of 2020-01-01 00:00 UTC
    +
    SV consensus merge: STALE: from an earlier run (2019-06-01 12:30 UTC); step 22 was failed (exit 1) in the run of 2020-01-01 00:00 UTC
    +
    Manta SVs (total / PASS)0 / 0
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVs2
    +
    CNVpytor significant (e-val < 0.01)2
    +
    CNVpytor significant after filters1 (left out: 1 on chrY of a declared female)
    +
    Consensus SVs (2+ callers)1
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +
    StatusComplete
    +

    Class 4-5 SVs: 0

    +
    +

    Mobile Element Insertions

    @@ -380,6 +406,7 @@

    MUC1 VNTR Frameshifts (VNtyper)

    Mitochondrial Analysis

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4
    chrM variants (PASS)1
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    Length heteroplasmy in the D-loop poly-C tracts0
    @@ -417,6 +444,13 @@

    Clonal Haematopoiesis (CHIP)

    0 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    @@ -620,6 +654,7 @@

    Runs of Homozygosity

    Step 11 · Complete · file date 2019-06-01 12:30 UTC · link to this section

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000CFTR chr7:117559590 ATCT>A: Pathogenic, 4 stars, het, low-confidence callBRCA1,NBR2 chr17:43057100 C>T: Pathogenic, 3 stars, hetHFE chr6:26092913 G>A: Pathogenic, 3 stars, hetMUTYH chr1:45331556 C>T: Pathogenic, 2 stars, hetHBA1 chr16:176700 G>A: Pathogenic, 2 stars, hetSMN1 chr5:70951946 C>T: Pathogenic, 2 stars, homGJB2 chr13:20189473 C>T: Likely pathogenic, 1 star, one copy, other copy not called ref (1/.), low-confidence callBTD chr3:15645186 G>C: Pathogenic/Likely pathogenic, 1 star, het. chr2:100 A>G: ., 0 stars, hetGLA chrX:101398000 C>T: Pathogenic, 0 stars, 1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar call
    StatusComplete
    ROH total7.0 MB
    ROH largest segment7.0 MB
    @@ -684,6 +719,16 @@

    Viral DNA in the Unmapped Reads

    No read on any viral genome.

    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 10 of 10 (100.0%); '--' at 0

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/. and consumer_export/.

    +
    +
    @@ -723,6 +768,1425 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/all-nf/all-nf.txt b/tests/parity/golden/report-render/all-nf/all-nf.txt index 41062aeaf..7bf9c546c 100644 --- a/tests/parity/golden/report-render/all-nf/all-nf.txt +++ b/tests/parity/golden/report-render/all-nf/all-nf.txt @@ -122,6 +122,28 @@ No gene passed Exomiser's filters with a variant that fits a mode of inheritance. A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt +## Structural Variants (Manta) +--- + Total SVs: 0 PASS: 0 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Copy Number Variants (CNVpytor) +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 18 was skipped (opt-in) in the run of 2020-01-01 00:00 UTC] + Total CNVs: 2 (2 deletions, 0 duplications) + Significant (e-val < 0.01): 2 + Significant after filters: 1 (left out: 1 on chrY of a declared female) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [STALE: from an earlier run (2019-06-01 12:30 UTC); step 22 was failed (exit 1) in the run of 2020-01-01 00:00 UTC] + Consensus SVs (2+ callers): 1 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 0 + ## Mobile Element Insertions (step 50) --- Insertions called: 0 (none) @@ -387,6 +409,13 @@ No read on any of the 1 viral genomes. From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 10 of 10 (100.0%); '--' at 0 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/. and consumer_export/. + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + ## Steps Not Run --- - Mosaic loss of chromosome Y or X diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index 15cb06ab0..9e0859df8 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -164,6 +164,40 @@ chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) + DEL 9:1-100 class 4 G9 support: single caller (tiddit) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ## Mobile Element Insertions (step 50) --- Insertions called: 3 (ALU 2, L1 1) @@ -258,6 +292,12 @@ 1 other protein changes listed, not counted: chip/S_chip.tsv. Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. +## Mosaic loss of chromosome Y or X +--- + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + ## Mosaic Chromosomal Alterations (MoChA, step 51) --- Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) @@ -557,6 +597,14 @@ HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + ## Steps Not Run --- All major steps completed. diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index ff5a242ab..588864b73 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index af8d4a1ba..ab3502a3c 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.html b/tests/parity/golden/report-render/cb-nf/cb-nf.html index 8ce72db92..b2cce9090 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.html +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -298,6 +302,23 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)N/A
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +
    StatusComplete
    +

    Class 4-5 SVs: 0

    +
    +

    Repeat Expansions

    @@ -312,6 +333,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -527,6 +555,59 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-nf/cb-nf.txt b/tests/parity/golden/report-render/cb-nf/cb-nf.txt index ac7d9b88a..0f027956a 100644 --- a/tests/parity/golden/report-render/cb-nf/cb-nf.txt +++ b/tests/parity/golden/report-render/cb-nf/cb-nf.txt @@ -96,6 +96,10 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 0 + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html index 7c8f6da4b..2af4f1ca0 100644 --- a/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html +++ b/tests/parity/golden/report-render/cb-nfbad/cb-nfbad.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -248,6 +252,18 @@

    Variant Prioritization (slivar)

    StatusNot run
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Not run · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)N/A
    +
    +

    Repeat Expansions

    @@ -262,6 +278,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -459,6 +482,30 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html index e3365b996..13029d9b6 100644 --- a/tests/parity/golden/report-render/cb-notbi/cb-notbi.html +++ b/tests/parity/golden/report-render/cb-notbi/cb-notbi.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -247,6 +251,18 @@

    Variant Prioritization (slivar)

    StatusNot run
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Not run · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)N/A
    +
    +

    Repeat Expansions

    @@ -261,6 +277,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -456,6 +479,30 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index 152e83fc3..ea9891284 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index 0786439a6..e4af1140f 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index ff5a242ab..588864b73 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index af8d4a1ba..ab3502a3c 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index ff5a242ab..588864b73 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index af8d4a1ba..ab3502a3c 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index ff5a242ab..4730e2e56 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHsingle caller (Manta)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index af8d4a1ba..9c2957b3a 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: single caller (Manta) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index 9a5a4da4b..d0d716b1f 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,72 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index 89954e3ab..9cfb76642 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index 5b67b1e82..afd02899a 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -156,6 +158,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -202,6 +205,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    STALE: note of clinvar <&>
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    @@ -343,6 +347,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -357,6 +384,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -601,6 +635,72 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index 620915c00..549dba951 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -132,6 +132,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index 3f5ba65f4..71cb39891 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below None or DP below None: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below None or DP below None), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index 508a4358d..14a79ff24 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index a0751b532..ece70cbb1 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A and more3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T and more2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T and more0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -379,6 +383,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -393,6 +420,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -625,6 +659,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 4eb79e3bb..351fd3e65 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -261,6 +261,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index daa7ea1e7..fed6ce1e6 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars3 stars22 stars: 3 hits with 2 review stars2 stars31 star: 1 hit with 1 review star1 star10 stars: 2 hits with 0 review stars0 stars2
    ClinVar matches0
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    Hits at a known lab-construct site (check the reads)1
    @@ -301,6 +305,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -315,6 +342,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -547,6 +581,66 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index 532a16449..2775a2396 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -85,6 +85,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index 6d2304010..d514f6db5 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -156,6 +158,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -202,6 +205,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -336,6 +340,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -350,6 +377,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -590,6 +624,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index 5706ec222..1a6242848 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index 84b4d55f4..27436ddd2 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -156,6 +158,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -202,6 +205,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -336,6 +340,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -350,6 +377,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -592,6 +626,72 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index c64a44a24..3dde7aea9 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -128,6 +128,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index 7a8558199..e2d8c5fcf 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -320,6 +324,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -334,6 +361,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -566,6 +600,69 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index 9711220ee..c73177061 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -112,6 +112,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index f4f6722cb..d7820497d 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -325,6 +329,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -339,6 +366,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -571,6 +605,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 4d5a6fddf..5e016d16b 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -118,6 +118,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index 850ef691a..70e52e743 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -336,6 +340,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -350,6 +377,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -582,6 +616,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index e4986aedf..fd8beca52 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -129,6 +129,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index c91ecc749..f49fdfd65 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -335,6 +339,29 @@

    Variant Prioritization (slivar)

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -349,6 +376,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -581,6 +615,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 59ab75868..4f105b67d 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -130,6 +130,27 @@ ... 3 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index f827bbc4f..d0f1fb5bb 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -311,6 +315,29 @@

    Variant Prioritization (slivar)

    Pairs in trans / cis / unknown2.5 / 1 / 1
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -325,6 +352,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -557,6 +591,51 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index 5eccfc04b..b17cbd9a6 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -108,6 +108,27 @@ ... 2.5 more in the pairs table (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index 07a81c6e0..511f859c6 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -119,8 +119,10 @@

    Contents

  • Clinical filter and secondary findings
  • Cancer predisposition
  • Variant prioritization
  • +
  • Structural variants
  • Repeat expansions
  • Mitochondrial variants
  • +
  • Mosaic loss of chromosome Y or X
  • Carrier @@ -155,6 +157,7 @@

    Contents

  • Not assessed
  • +
  • Genes and rsIDs in these results
  • @@ -201,6 +204,7 @@

    Clinical

    ClinVar Screening

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    ClinVar matches8
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    @@ -309,6 +313,29 @@

    Variant Prioritization (slivar)

    Compound het candidates4 variants, 2 genes
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +

    Repeat Expansions

    @@ -323,6 +350,13 @@

    Mitochondrial Analysis

    StatusNot run
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    @@ -555,6 +589,71 @@

    Not Assessed by This Pipeline

    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    Disclaimer: This report is for educational and research purposes only. It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index 06eb71fe4..e96760679 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -106,6 +106,27 @@ Compound het candidates: 4 variants across 2 genes (Candidates only: unphased single-sample data. See docs/31-slivar.md) +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) + DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + ################################################################################ # 3. CARRIER: What could I pass on to a child? ################################################################################ From fa5f6e622da5a0394aa60a1ff4da6d5d14460725 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 16:53:57 +0100 Subject: [PATCH 12/40] fix(live): flag the carrier headline of og live serve for hom or hemizygous rows The Python server flags a sample whose carrier list holds only homozygous or hemizygous rows (a man with only a GLA row). og live serve read only 'carriers', so it gave such a sample no attention flag. Bead: clin-15 --- rust/crates/og-live/src/state.rs | 38 +++++++++++++++++++++++++++++++- 1 file changed, 37 insertions(+), 1 deletion(-) diff --git a/rust/crates/og-live/src/state.rs b/rust/crates/og-live/src/state.rs index ac2f54208..b9d0d187b 100644 --- a/rust/crates/og-live/src/state.rs +++ b/rust/crates/og-live/src/state.rs @@ -375,7 +375,10 @@ fn line_of(key: &str, sm: &Summary) -> Result, bool)>, Ma positive(&n)?, ) } - "carrier" => (Some(first(sec::carrier::lines(&d)?)?), flag("carriers")), + "carrier" => ( + Some(first(sec::carrier::lines(&d)?)?), + flag("carriers") || flag("hom_or_hemizygous"), + ), "couple" => ( with_note(&sec::couple::lines(&d)?, COUPLE_NOTE), flag("shared") || flag("x_linked"), @@ -1143,6 +1146,39 @@ mod tests { assert_eq!(utc_seconds(""), None); } + /// The carrier headline of a summary whose carrier section is `data`. + fn carrier_headline(data: &str) -> (String, &'static str) { + let sec = format!(r#"{{"state": "ok", "title": "Carrier list", "data": {data}}}"#); + let summary = og_render::model::Summary::parse(&format!( + r#"{{"databases": {{}}, "sections": {{"carrier": {sec}}}}}"# + )) + .unwrap(); + let raw = pycompat::json::loads(&sec).unwrap(); + headline("carrier", Some(&raw), &summary).unwrap() + } + + #[test] + fn a_carrier_list_of_only_hom_or_hemizygous_rows_asks_for_attention() { + // A man with only a hemizygous GLA row: no carrier, but no unchanged + // copy either, so the headline asks for attention as the Python + // server's does (bin/owngenome_live.py, _h_carrier). + let gla = r#"{"gene": "GLA", "condition": "Fabry disease", "inheritance": "XL", + "variant": "chrX:101398000 C>T", "genotype": "hemizygous", "zygosity": "hemizygous", + "significance": "Pathogenic", "gq": 50, "dp": 30, "low_confidence": false}"#; + let only = carrier_headline(&format!( + r#"{{"genes_on_list": 3, "carriers": [], "hom_or_hemizygous": [{gla}], "set_aside": []}}"# + )); + assert_eq!(only.1, "attention", "{}", only.0); + assert!(only.0.contains("1 with no unchanged copy"), "{}", only.0); + let none = carrier_headline( + r#"{"genes_on_list": 3, "carriers": [], "hom_or_hemizygous": [], "set_aside": []}"#, + ); + assert_eq!(none.1, "info", "{}", none.0); + // A summary written before the list existed reads as before. + let old = carrier_headline(r#"{"genes_on_list": 3, "carriers": [], "set_aside": []}"#); + assert_eq!(old.1, "info", "{}", old.0); + } + #[test] fn a_note_joined_as_two_sentences() { let l = |a: &[&str]| a.iter().map(|x| (*x).to_owned()).collect::>(); From 4df2db0b9ef7078c0bce056a634dc3f238d5a83e Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 16:53:57 +0100 Subject: [PATCH 13/40] test(parity): whole-report goldens for the carrier cases The report-render cases now compare whole reports. The 24 cases whose summary holds a homozygous or hemizygous carrier row get whole-report goldens; each differs from the oracle only in the carrier block. The docs and the changelog say what the SF card now does with a pair on a low-confidence call. Bead: clin-15, clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 ++-- 2 files changed, 3 insertions(+), 3 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index dac5c8073..49d46fa12 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. The secondary-findings card applies the same cap: its `pair` for a gene whose pair needs a low-confidence call (a deletion plus that call, or two heterozygous variants, phased or not) is `possibly biallelic (low-confidence call)`, and so is the card's two-hit line for that deletion. A confident homozygous call or a confident pair stays `biallelic`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 419965724..4f5d52a17 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`, as the secondary-findings card caps the same pair at `possibly biallelic (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, or a confident pair, keeps `biallelic` even when another variant of the gene is a low-confidence call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; From 9a27ad7a83ea0214ec86986af00f0fe8b37eff41 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:05:27 +0100 Subject: [PATCH 14/40] fix(nextflow): stop the clinical filter crashing on REVEL and AlphaMissense scores written as text Bead: nf-vcfanno-ops --- CHANGELOG.md | 2 + modules/local/vcfanno/main.nf | 9 +- scripts/ci/e2e-case-paths.tsv | 1 + scripts/ci/e2e-case-times.tsv | 1 + .../e2e/i411-nf-vcfanno-ops-1-score-tiers.sh | 139 ++++++++++++++++++ tests/test_vcfanno_toml.sh | 38 +++++ 6 files changed, 186 insertions(+), 4 deletions(-) create mode 100755 tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh create mode 100755 tests/test_vcfanno_toml.sh diff --git a/CHANGELOG.md b/CHANGELOG.md index 4ac2445c2..68e5bece4 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -503,6 +503,8 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n - `og` runs natively on a Mac that hosts the live site, so the genome map works there too. `scripts/setup.sh --og` and each release now also make `og-darwin-arm64` and `og-darwin-x86_64`, and `bin/og` runs them on macOS. They are built without the new cargo feature `bam` (on by default, so the Linux builds are unchanged): the BAM tools say so and exit 2 there. `rust/og.sh check` refuses a stale macOS binary, and a release's `SHA256SUMS` lists all four. +- Nextflow vcfanno now writes CADD, REVEL and AlphaMissense scores as floating-point INFO fields, matching step 30. The clinical filter can compare them with its numeric thresholds. + ## Releases - 1.0.0 (not released yet): [docs/releases/v1.0.0.md](docs/releases/v1.0.0.md) diff --git a/modules/local/vcfanno/main.nf b/modules/local/vcfanno/main.nf index 18a433a3e..f43dce628 100644 --- a/modules/local/vcfanno/main.nf +++ b/modules/local/vcfanno/main.nf @@ -49,6 +49,7 @@ process VCFANNO { task.ext.when == null || task.ext.when script: + // Match step 30. The max op writes TSV scores as Float for numeric filters. def toml = "" if (cadd_snv) { toml += """ @@ -56,7 +57,7 @@ process VCFANNO { file="${cadd_snv}" columns=[6] names=["CADD_PHRED"] -ops=["self"] +ops=["max"] """ } if (cadd_indel) { @@ -65,7 +66,7 @@ ops=["self"] file="${cadd_indel}" columns=[6] names=["CADD_PHRED_indel"] -ops=["self"] +ops=["max"] """ } if (spliceai_snv) { @@ -92,7 +93,7 @@ ops=["self"] file="${revel}" columns=[5] names=["REVEL"] -ops=["self"] +ops=["max"] """ } if (alphamissense) { @@ -101,7 +102,7 @@ ops=["self"] file="${alphamissense}" columns=[9,10] names=["AM_pathogenicity","AM_class"] -ops=["self","self"] +ops=["max","self"] """ } if (!toml) { diff --git a/scripts/ci/e2e-case-paths.tsv b/scripts/ci/e2e-case-paths.tsv index 1241a5e03..a4808c80d 100644 --- a/scripts/ci/e2e-case-paths.tsv +++ b/scripts/ci/e2e-case-paths.tsv @@ -110,6 +110,7 @@ hba-short-read-accuracy-1-nf-report assets/acmg_sf.tsv assets/callability_genes. hla-second-caller-1-bash assets/pgx_genes.tsv assets/stub/db/hla.dat assets/stub/db/kir.dat bin/cn_loci.tsv bin/og bin/render_report.py scripts/08-hla-typing.sh scripts/24-html-report.sh scripts/32-pypgx.sh scripts/36-pgx-consensus.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh hla-second-caller-2-nextflow assets/acmg_sf.tsv assets/callability_genes.tsv assets/carrier_genes.tsv assets/mito_confirmed.tsv assets/pgx_genes.tsv assets/stub/db/hla.dat assets/stub/db/kir.dat assets/stub/sample.vcf.gz bin/cn_loci.tsv bin/collect_summary.py bin/og bin/render_report.py bin/results_index.py modules/local/hla_typing/* modules/local/html_report/* modules/local/pgx_consensus/* modules/local/pharmcat/* modules/local/t1k_build/* modules/local/vcf_precheck/* scripts/07-pharmacogenomics.sh scripts/08-hla-typing.sh scripts/21-cyrius.sh scripts/24-html-report.sh scripts/32-pypgx.sh scripts/36-pgx-consensus.sh scripts/ci/fake-docker/lib.sh scripts/cyrius-constraints.txt scripts/setup.sh scripts/validate-setup.sh i411-callability-overlap-1-mates modules/local/mosdepth/* scripts/16b-mosdepth.sh scripts/lib/common.sh +i411-nf-vcfanno-ops-1-score-tiers bin/og modules/local/clinical_filter/* modules/local/vcfanno/* scripts/30-vcfanno.sh ibd-segments-1 assets/families.example.tsv assets/par_grch38.bed assets/pedigree.example.tsv assets/stub/pedigree.tsv bin/og rust/crates/og-dev/src/fixture.rs scripts/38-family.sh scripts/ci/fake-docker/lib.sh scripts/setup.sh live-server-1-weblog assets/live/* assets/viewer/index.html bin/live_results.py bin/og bin/owngenome_live.py bin/owngenome_live_results.py bin/render_report.py bin/run_state.py modules/local/roh/* modules/local/vcf_precheck/* rust/crates/og-dev/src/fixture.rs scripts/11-roh-analysis.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh lpa-1 assets/acmg_sf.tsv assets/callability_genes.tsv assets/carrier_genes.tsv assets/mito_confirmed.tsv assets/par_grch38.bed assets/stub/sample.vcf.gz bin/cn_loci.tsv bin/collect_summary.py bin/og bin/render_report.py bin/results_index.py modules/local/deepvariant/* modules/local/html_report/* modules/local/lpa/* modules/local/vcf_precheck/* scripts/24-html-report.sh scripts/46-lpa.sh scripts/ci/fake-docker/lib.sh scripts/validate-setup.sh diff --git a/scripts/ci/e2e-case-times.tsv b/scripts/ci/e2e-case-times.tsv index ab5d048e2..4bf109c17 100644 --- a/scripts/ci/e2e-case-times.tsv +++ b/scripts/ci/e2e-case-times.tsv @@ -106,6 +106,7 @@ hba-short-read-accuracy-1-nf-report shard 111 - hla-second-caller-1-bash shard 482 - hla-second-caller-2-nextflow shard 188 hla-second-caller-1-bash i411-callability-overlap-1-mates shard 40 - +i411-nf-vcfanno-ops-1-score-tiers shard 37 - ibd-segments-1 shard 239 - live-server-1-weblog shard 18 - lpa-1 shard 42 - diff --git a/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh new file mode 100755 index 000000000..2b9be6bb2 --- /dev/null +++ b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh @@ -0,0 +1,139 @@ +#!/usr/bin/env bash +# Run all six synthetic score tracks through both annotation paths and feed +# the Nextflow output into CLINICAL_FILTER. Only the high scores select hits. +# shellcheck source=lib.sh +. "$(dirname "$0")/lib.sh" + +command -v nextflow >/dev/null || { fail "nextflow is not on PATH"; finish; } +WORK=$(mktemp -d "${CASE_TMP}/run.XXXXXX") || { fail "cannot create the case directory"; finish; } +GENOME_DIR="${WORK}/genome" +S=VCFANNO_TEST +P="${WORK}/project" +VEP="${S}/vep/${S}_vep.vcf" +ANNOT="${GENOME_DIR}/annotations" + +( + set -e + mkdir -p "${GENOME_DIR}/${S}/vep" "$ANNOT" "$P/bin/.og" + cp "${REPO}/bin/og" "$P/bin/" + cp "${REPO}"/bin/.og/og-linux-* "$P/bin/.og/" + + # Use synthetic CSQ entries with LOW impact so that an impact tier cannot + # pick any record by itself. + { + cat <<'VCF' +##fileformat=VCFv4.2 +##contig= +##INFO= +##FORMAT= +VCF + printf '#CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\tFORMAT\t%s\n' "$S" + printf 'chr1\t%s\t%s\tA\t%s\t.\tPASS\tCSQ=%s|%s|LOW|TESTGENE|TX1|0.001\tGT\t0/1\n' \ + 101 cadd_snv C C synonymous_variant \ + 202 cadd_indel AT T intron_variant \ + 303 revel G G missense_variant \ + 404 alphamissense T T missense_variant \ + 505 cadd_below AAG AG intron_variant \ + 550 missense_below G G missense_variant \ + 606 spliceai_snv C C intron_variant \ + 707 spliceai_indel AT T intron_variant + } > "${GENOME_DIR}/${VEP}" + + printf '#Chrom\tPos\tRef\tAlt\tRawScore\tPHRED\n1\t101\tA\tC\t3.1\t25\n' \ + > "$ANNOT/whole_genome_SNVs.tsv" + printf '#Chrom\tPos\tRef\tAlt\tRawScore\tPHRED\n1\t202\tA\tAT\t3.2\t26\n1\t505\tA\tAAG\t1.1\t10\n' \ + > "$ANNOT/gnomad.genomes.r4.0.indel.tsv" + printf '%s\n' \ + $'#chr\tpos\tref\talt\tREVEL' \ + $'chr1\t303\tA\tG\t0.9' \ + $'chr1\t404\tA\tT\t0.1' \ + $'chr1\t550\tA\tG\t0.2' > "$ANNOT/revel_grch38.tsv" + printf '%s\n' \ + $'#CHROM\tPOS\tREF\tALT\tgenome\tuniprot_id\ttranscript_id\tprotein_variant\tam_pathogenicity\tam_class' \ + $'chr1\t303\tA\tG\thg38\tPTEST\tTX1\tA1G\t0.1\tlikely_benign' \ + $'chr1\t404\tA\tT\thg38\tPTEST\tTX1\tA2T\t0.9\tlikely_pathogenic' \ + $'chr1\t550\tA\tG\thg38\tPTEST\tTX1\tA3G\t0.2\tlikely_benign' > "$ANNOT/AlphaMissense_hg38.tsv" + + splice_track() { + printf '##fileformat=VCFv4.2\n##contig=\n' + printf '##INFO=\n' + printf '#CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\n' + printf '1\t%s\t.\tA\t%s\t.\tPASS\tSpliceAI=%s|TESTGENE|0.3|0|0|0|1|0|0|0\n' "$1" "$2" "$2" + } + splice_track 606 C > "$ANNOT/spliceai_scores.masked.snv.hg38.vcf" + splice_track 707 AT > "$ANNOT/spliceai_scores.masked.indel.hg38.vcf" + + docker run --rm --user "$(id -u):$(id -g)" --network none \ + -v "${GENOME_DIR}:/genome" -w /genome "$GATK_IMAGE" bash -ec ' + for file in annotations/*.tsv; do + bgzip -c "$file" > "$file.gz" + tabix -s 1 -b 2 -e 2 "$file.gz" + done + for file in annotations/*.vcf "$1"; do + bgzip -c "$file" > "$file.gz" + tabix -p vcf "$file.gz" + done + ' bash "$VEP" +) +setup_rc=$? + +[ "$setup_rc" -eq 0 ] || { fail "could not prepare the synthetic VCF and score tables"; finish; } + +cat > "$P/main.nf" < file("${ANNOT}/\$name") } + VCFANNO(channel.of([[id: '${S}'], input, file("\${input}.tbi")]), + tracks[0], file("\${tracks[0]}.tbi"), tracks[1], file("\${tracks[1]}.tbi"), + tracks[2], file("\${tracks[2]}.tbi"), tracks[3], file("\${tracks[3]}.tbi"), + tracks[4], file("\${tracks[4]}.tbi"), tracks[5], file("\${tracks[5]}.tbi")) + VCFANNO_INDEX(VCFANNO.out.vcf) + CLINICAL_FILTER(VCFANNO_INDEX.out.vcf.join(VCFANNO_INDEX.out.vcf_index)) +} +NF +cat > "$P/nextflow.config" <&1 | tee "$STEP_LOG" +NF_RC=${PIPESTATUS[0]} +check_eq "VCFANNO, VCFANNO_INDEX and CLINICAL_FILTER exit 0" "$NF_RC" 0 +[ "$NF_RC" -eq 0 ] || finish + +clinical="nextflow/${S}/clinical/${S}" +check_eq "CLINICAL_FILTER selects the six high-score records and excludes the two low-score records" \ + "$(bcf query -f '%ID\n' "${clinical}_clinical.vcf.gz" | paste -sd, -)" \ + cadd_snv,cadd_indel,revel,alphamissense,spliceai_snv,spliceai_indel +check_eq "CLINICAL_FILTER reports one row per high-score hit" \ + "$(awk 'END {print NR - 1}' "${GENOME_DIR}/${clinical}_clinical_summary.tsv")" 6 + +run_step 30-vcfanno.sh "$S" +check_step_exit 30-vcfanno.sh + +info_types() { + bcf view -h "$1" | sed -nE 's/^##INFO= "$TMP/bash.toml" +extract_annotations "${2:-$ROOT/modules/local/vcfanno/main.nf}" > "$TMP/nextflow.toml" +diff -u "$TMP/bash.toml" "$TMP/nextflow.toml" +echo "Step 30 and Nextflow configure the same vcfanno tracks and operations." From 12341ab9c2c9f634d040e26f95035973759dd189 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:14:45 +0100 Subject: [PATCH 15/40] fix(carrier): give the carrier list and the SF card one answer beside a weak call The two cards capped different pairs when a gene held a low-confidence call. The carrier list capped a pair whenever any of its hets was weak, so a confident phased pair beside a weak third het read "possible two hits (low-confidence call)". The secondary-findings card capped only a pair whose proof needed the weak call. Commit 60595081 also said a confident pair stays biallelic beside a low-confidence call. That was false for a confident deletion pair: the card gave it the low-confidence word, while the same row's two-hit line said biallelic. And a combined allele lost its confidence when any one of its calls was weak. Both cards now count a gene's hits twice, with every call and with the confident calls alone: - A pair the confident calls prove is "two hits" on the list and "biallelic" on the card, whatever weak call sits beside it. - On the card, a confident deletion pair that is biallelic or possibly biallelic is used before the low-confidence cap. - A pair that only a weak call proves gets the low-confidence word. - Hits of unknown phase are "possible two hits" and "possibly biallelic" when two of them are confident. Two confident unphased hets plus a weak homozygous call now read "possibly biallelic" on the card, as the carrier list already said. - An allele counts the copies its confident calls give (a count, not a flag), so a combined allele that one confident call proves stays firm. The carrier list counts a combined allele the same way. No reported or not-reported decision moves; only `pair` and `phase` change. A new test runs MUTYH, which is on both lists, through both cards over 25 shapes of hits and requires the same answer from both. Bead: clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 +- rust/crates/og-summary/src/collect/acmg.rs | 70 ++- rust/crates/og-summary/src/collect/carrier.rs | 160 ++++--- .../tests/i411_carrier_confidence.rs | 416 +++++++++++++++++- 5 files changed, 560 insertions(+), 92 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 49d46fa12..20770e5b6 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. A pair that rests on a low-confidence call is at most `possible two hits (low-confidence call)`, and a deletion plus a low-confidence call in one gene reads `possibly biallelic (low-confidence call)` under `two_hits`. The secondary-findings card applies the same cap: its `pair` for a gene whose pair needs a low-confidence call (a deletion plus that call, or two heterozygous variants, phased or not) is `possibly biallelic (low-confidence call)`, and so is the card's two-hit line for that deletion. A confident homozygous call or a confident pair stays `biallelic`. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. Hits of unknown phase are `possible two hits` and `possibly biallelic` when two of them are confident, and the low-confidence word otherwise. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is. So a gene on both lists gets the same answer on both. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 4f5d52a17..5c075e3f3 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. When one of the two is a low-confidence call, the pair is at most `possible two hits (low-confidence call)`, as the secondary-findings card caps the same pair at `possibly biallelic (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)`. Hits of unknown phase are `possible two hits` when two of them are confident, and the low-confidence word otherwise. A combined allele counts as confident when any call of it is. The secondary-findings card below counts the same way, so a gene on both lists gets the same answer: its `biallelic` is `two hits` here, and its `possibly biallelic (low-confidence call)` is `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, or a confident pair, keeps `biallelic` even when another variant of the gene is a low-confidence call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`. A combined allele counts as confident when any call of it is. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 01f50c511..760784756 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -440,8 +440,8 @@ struct Cand { /// One distinct variant of a gene as the verdict counts it: its alt /// copies, ploidy, GT and phase set, whether it stands for a combined -/// allele and its parts, and whether a call of it is below step 06's call -/// floor (low confidence). +/// allele and its parts, and the alt copies its confident calls give (`firm`: +/// 0 when every call of it is below step 06's call floor, low confidence). #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -449,7 +449,7 @@ struct Allele { gt: String, ps: Option, combined: bool, - low: bool, + firm: usize, } impl Allele { @@ -460,7 +460,7 @@ impl Allele { gt: String::new(), ps: None, combined: false, - low: false, + firm: 0, } } @@ -621,12 +621,23 @@ fn sf_verdicts( }; out.insert(k.clone(), why); } - // The count again without the low-confidence calls: a pair that needs - // one of them is only possible until the call is confirmed. + // The count again with only the copies confident calls give: a pair + // that needs a low-confidence call is only possible until the call is + // confirmed. A small allele no confident call gives drops out; one whose + // confident calls give fewer copies than it counts loses its phase too, + // as that came from the low call. A deletion counts as it is: its pair + // is judged by `two_hits_with`. let firm: IndexMap = kept .iter() - .filter(|(_, a)| !a.low) - .map(|(k, a)| (k.clone(), a.clone())) + .filter(|(k, a)| !matches!(k, AKey::Small(_)) || a.firm > 0) + .map(|(k, a)| { + let mut f = a.clone(); + if matches!(k, AKey::Small(_)) && a.firm < a.copies { + f.copies = a.firm; + f.ps = None; + } + (k.clone(), f) + }) .collect(); let (n_firm, proof_firm, _) = copies_hit(&firm); let low = |why: String| { @@ -638,21 +649,28 @@ fn sf_verdicts( ), ) }; - let pair = (counted && n >= 2).then(|| match (proof, deletion) { - (Some(p), _) => match proof_firm { - Some(f) => ("biallelic", f), - None => low(p), - }, - (None, Some(e)) => (e.verdict.word(), format!("with {}: {}", e.deletion, e.why)), - (None, None) => { - let why = "phase unknown: no read-backed phase links the variants, so they may sit \ - on the same copy (cis)" - .to_owned(); - if n_firm >= 2 { - (Verdict::PossiblyBiallelic.word(), why) - } else { - low(why) + let unknown = || { + "phase unknown: no read-backed phase links the variants, so they may sit on the same \ + copy (cis)" + .to_owned() + }; + // The best the evidence gives: a confident proof, then the deletion pair + // when it is at least possibly biallelic (`two_hits_with` already lowers + // a pair on a low call), then a proof that needs a low call, then the + // copies counted with phase unknown. + let pair = (counted && n >= 2).then(|| { + let del = deletion.map(|e| (e.verdict, format!("with {}: {}", e.deletion, e.why))); + match (proof_firm, proof, del) { + (Some(f), _, _) => ("biallelic", f), + (None, _, Some((v @ (Verdict::Biallelic | Verdict::PossiblyBiallelic), why))) => { + (v.word(), why) } + (None, Some(p), Some(_)) => low(p), + (None, Some(_), None) if n_firm >= 2 => (Verdict::PossiblyBiallelic.word(), unknown()), + (None, Some(p), None) => low(p), + (None, None, Some((v, why))) => (v.word(), why), + (None, None, None) if n_firm >= 2 => (Verdict::PossiblyBiallelic.word(), unknown()), + (None, None, None) => low(unknown()), } }); let hypo: Vec<&str> = out @@ -990,7 +1008,9 @@ fn tier(i: &Inputs) -> Result, String> { ps: x.ps.clone(), ..Allele::of(x.copies, p) }); - a.low |= is_low(x); + if !is_low(x) { + a.firm = a.firm.max(x.copies); + } } for x in &folded { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; @@ -1005,7 +1025,9 @@ fn tier(i: &Inputs) -> Result, String> { }); a.copies = a.copies.max(x.copies); a.combined = true; - a.low |= is_low(x); + if !is_low(x) { + a.firm = a.firm.max(x.copies); + } } for x in &svs { alleles diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index bafa8a8cd..e77b26c36 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -14,7 +14,9 @@ //! heterozygous hits in one recessive gene are counted as copies, the way //! the secondary-findings card counts them: read-backed phase on different //! copies is two hits, phase unknown is possible two hits, both on one copy -//! is one hit. +//! is one hit. A pair that needs a low-confidence call is possible two hits +//! (low-confidence call); a pair the confident calls prove alone keeps its +//! word, whatever weak call sits beside it. use super::assets::carrier_genes; use super::clinvar::{ @@ -82,7 +84,11 @@ fn joined_keys(r: &[String]) -> Vec { /// How two or more different heterozygous hits of one gene pair up: the /// pair word (`two hits`, `possible two hits`, none when they sit on one /// copy) and why. `None` when fewer than two distinct alleles are left -/// once a combined allele and its parts count once. +/// once a combined allele and its parts count once. The hets are counted +/// twice, all of them and the confident ones alone: two hits when the +/// confident ones prove it, the low-confidence word when only all of them +/// do, and with phase unknown, possible two hits when the confident ones +/// still count two copies. fn het_pair(hets: &[Het]) -> Option<(Option, String)> { // A combined allele and its parts count once, under the combined // allele, when its call is phased or at most one part is here; an @@ -102,79 +108,105 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { if kept.len() < 2 { return None; } - let mut n = 0; - let mut sets: IndexMap<&str, (BTreeSet, usize)> = IndexMap::new(); - let mut halves: IndexMap<(&str, i128), (BTreeSet, usize)> = IndexMap::new(); - for h in &kept { - if let Some((ps, hs)) = h.phased() { - let s = sets.entry(ps).or_default(); - s.0.extend(hs); - s.1 += 1; - } else if let Some(i) = h.half() { - let s = halves.entry((h.key.0.as_str(), h.key.1)).or_default(); - s.0.insert(i); - s.1 += 1; - } else { - n += 1; - } - } - let mut proof: Option = None; - let mut cis: Option<&str> = None; - for (ps, (h, count)) in &sets { - n += h.len(); - if h.len() >= 2 { - proof.get_or_insert_with(|| { - format!( - "in trans: read-backed phase puts them on different copies (phase set {ps})" - ) - }); - } else if *count >= 2 { - cis.get_or_insert(ps); + // A kept allele is firm when a call of it is confident: its own, or a + // call folded into it (a part under its combined allele, or an unphased + // combined allele under its first part), as the secondary-findings card + // counts it. + let mut firm: HashSet<&VarKey> = kept.iter().filter(|h| !h.low).map(|h| &h.key).collect(); + for h in hets.iter().filter(|h| !h.joined.is_empty()) { + if gone.contains(&h.key) { + if !h.low { + firm.extend(h.joined.iter().find(|k| present.contains(k))); + } + } else if hets.iter().any(|p| !p.low && h.joined.contains(&p.key)) { + firm.insert(&h.key); } } - for ((chrom, pos), (h, count)) in &halves { - if h.len() >= 2 { - n += 2 + count - h.len(); - proof.get_or_insert_with(|| { - format!("in trans: the two alt alleles of one call at {chrom}:{pos}") - }); - } else { - n += count; + // The copies a set of hets hits: the count, the proof of two copies if a + // call gives one, and the first phase set holding two or more of them on + // one copy (cis). + let count = |hs: &[&Het]| -> (usize, Option, Option) { + let mut n = 0; + let mut sets: IndexMap<&str, (BTreeSet, usize)> = IndexMap::new(); + let mut halves: IndexMap<(&str, i128), (BTreeSet, usize)> = IndexMap::new(); + for h in hs { + if let Some((ps, s)) = h.phased() { + let e = sets.entry(ps).or_default(); + e.0.extend(s); + e.1 += 1; + } else if let Some(i) = h.half() { + let e = halves.entry((h.key.0.as_str(), h.key.1)).or_default(); + e.0.insert(i); + e.1 += 1; + } else { + n += 1; + } } - } - let (word, why) = match (proof, cis) { - (Some(p), _) => ("two hits", p), - (None, _) if n >= 2 => ( - "possible two hits", - "phase unknown: no read-backed phase links the variants, so they may sit on the same \ - copy (cis)" - .to_owned(), - ), - (None, Some(ps)) => { - return Some(( - None, - format!( - "two heterozygous variants in cis: read-backed phase puts them on the same \ - copy (phase set {ps}), so one copy is hit" - ), - )); + let mut proof: Option = None; + let mut cis: Option = None; + for (ps, (h, count)) in &sets { + n += h.len(); + if h.len() >= 2 { + proof.get_or_insert_with(|| { + format!( + "in trans: read-backed phase puts them on different copies (phase set {ps})" + ) + }); + } else if *count >= 2 { + cis.get_or_insert_with(|| (*ps).to_owned()); + } } - (None, None) => { - return Some(( - None, - "the variants sit on one copy, so one copy is hit".to_owned(), - )); + for ((chrom, pos), (h, count)) in &halves { + if h.len() >= 2 { + n += 2 + count - h.len(); + proof.get_or_insert_with(|| { + format!("in trans: the two alt alleles of one call at {chrom}:{pos}") + }); + } else { + n += count; + } } + (n, proof, cis) }; - if kept.iter().any(|h| h.low) { - return Some(( + let (n, proof, cis) = count(&kept); + let sure: Vec<&Het> = kept + .iter() + .copied() + .filter(|h| firm.contains(&h.key)) + .collect(); + let (n_firm, proof_firm, _) = count(&sure); + // A pair that needs a low-confidence call is only possible until the + // call is confirmed. + let low = |why: String| { + Some(( Some("possible two hits (low-confidence call)".to_owned()), format!( "a call below the call floor (low confidence) is one of them, so confirm it first; {why}" ), - )); + )) + }; + let unknown = "phase unknown: no read-backed phase links the variants, so they may sit on the \ + same copy (cis)" + .to_owned(); + match (proof_firm, proof, cis) { + (Some(f), _, _) => Some((Some("two hits".to_owned()), f)), + (None, Some(p), _) => low(p), + (None, None, _) if n >= 2 && n_firm >= 2 => { + Some((Some("possible two hits".to_owned()), unknown)) + } + (None, None, _) if n >= 2 => low(unknown), + (None, None, Some(ps)) => Some(( + None, + format!( + "two heterozygous variants in cis: read-backed phase puts them on the same copy \ + (phase set {ps}), so one copy is hit" + ), + )), + (None, None, None) => Some(( + None, + "the variants sit on one copy, so one copy is hit".to_owned(), + )), } - Some((Some(word.to_owned()), why)) } impl Carrier { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 4676e850a..e050bca86 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -10,7 +10,9 @@ //! cases run the list on synthetic hits with the shipped //! `assets/carrier_genes.tsv`. The last cases run the ACMG SF card on the //! same hits (`assets/acmg_sf.tsv`): a pair that rests on a low-confidence -//! call reads the same there. +//! call reads the same there, a low-confidence call beside a confident pair +//! leaves it as it is, and MUTYH, on both lists, gets the same answer from +//! both cards over each shape of hits. use indexmap::IndexMap; use og_summary::collect::acmg::{Inputs, acmg_sf}; @@ -28,6 +30,9 @@ const MUTYH_B: (&str, i128, &str, &str) = ("chr1", 45_332_803, "T", "C"); const CFTR_A: (&str, i128, &str, &str) = ("chr7", 117_559_590, "ATCT", "A"); const CFTR_B: (&str, i128, &str, &str) = ("chr7", 117_587_806, "G", "T"); const OTC_A: (&str, i128, &str, &str) = ("chrX", 38_400_000, "C", "T"); +// A third MUTYH and CFTR site, outside the test deletion. +const MUTYH_C: (&str, i128, &str, &str) = ("chr1", 45_334_000, "G", "A"); +const CFTR_C: (&str, i128, &str, &str) = ("chr7", 117_600_000, "C", "T"); /// One step 06 hit: Pathogenic with 2 stars, the FORMAT values given (GT /// first), and `info` added to INFO. @@ -295,6 +300,88 @@ fn a_low_confidence_call_makes_two_hits_only_possible() { } } +/// A hit below the default call floor (GQ 5, DP 4), PS added when given. +fn weak(site: (&str, i128, &str, &str), gene: &str, gt: &str, ps: Option<&str>) -> Vec { + match ps { + Some(p) => hit(site, gene, "GT:GQ:DP:PS", &format!("{gt}:5:4:{p}"), ""), + None => hit(site, gene, "GT:GQ:DP", &format!("{gt}:5:4"), ""), + } +} + +/// The `pair` word of the carrier rows of `gene`, one per row. +fn carrier_pairs(c: &IndexMap, gene: &str) -> Vec> { + of(c, "carriers", gene) + .iter() + .map(|x| match x.get("pair") { + Some(Value::Str(p)) => Some(p.clone()), + _ => None, + }) + .collect() +} + +#[test] +fn a_weak_third_het_leaves_a_confident_phased_pair_two_hits() { + // Unphased, in the pair's phase set, or on the other copy: the + // confident pair proves two copies by itself. + for third in [ + weak(CFTR_C, "CFTR", "0/1", None), + weak(CFTR_C, "CFTR", "0|1", Some("9")), + weak(CFTR_C, "CFTR", "1|0", Some("9")), + ] { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0|1", Some("9")), + good(CFTR_B, "CFTR", "1|0", Some("9")), + third, + ], + &no_deletions(), + ); + let p = carrier_pairs(&c, "CFTR"); + assert_eq!(p.len(), 3, "{c:?}"); + for x in &p { + assert_eq!(x.as_deref(), Some("two hits"), "{c:?}"); + } + for x in of(&c, "carriers", "CFTR") { + assert!(s(x, "phase").starts_with("in trans"), "{x:?}"); + } + } +} + +#[test] +fn a_weak_third_het_leaves_two_confident_unphased_hets_possible_two_hits() { + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + good(CFTR_B, "CFTR", "0/1", None), + weak(CFTR_C, "CFTR", "0/1", None), + ], + &no_deletions(), + ); + let p = carrier_pairs(&c, "CFTR"); + assert_eq!(p.len(), 3, "{c:?}"); + for x in &p { + assert_eq!(x.as_deref(), Some("possible two hits"), "no low cap: {c:?}"); + } + // One confident het and two weak ones: any pair rests on a weak call, + // so the cap stays (the two-het case is + // a_low_confidence_call_makes_two_hits_only_possible). + let c = list( + vec![ + good(CFTR_A, "CFTR", "0/1", None), + weak(CFTR_B, "CFTR", "0/1", None), + weak(CFTR_C, "CFTR", "0/1", None), + ], + &no_deletions(), + ); + for x in carrier_pairs(&c, "CFTR") { + assert_eq!( + x.as_deref(), + Some("possible two hits (low-confidence call)"), + "{c:?}" + ); + } +} + #[test] fn a_combined_allele_and_its_part_are_one_allele() { let joined = format!( @@ -428,3 +515,330 @@ fn the_sf_card_caps_a_phased_pair_on_a_low_confidence_call() { ); assert_eq!(sf_pairs(&hom, "MUTYH"), ["biallelic", "biallelic"]); } + +/// The rank of a pair word, strongest first, on either card. +fn rank(word: &str) -> Option { + match word { + "biallelic" | "two hits" => Some(0), + "possibly biallelic" | "possible two hits" => Some(1), + "possibly biallelic (low-confidence call)" | "possible two hits (low-confidence call)" => { + Some(2) + } + _ => None, + } +} + +const WORDS: [&str; 3] = [ + "biallelic", + "possibly biallelic", + "possibly biallelic (low-confidence call)", +]; + +/// The reported rows of `gene` whose pair is weaker than the pair their own +/// `two_hit` line names. None should be: the gene's pair is the best of its +/// pairs. +fn rows_weaker_than_their_two_hit(c: &IndexMap, gene: &str) -> Vec { + let mut bad = Vec::new(); + for x in of(c, "clinvar_hits", gene) { + let (Some(Value::Str(t)), Some(Value::Str(p))) = (x.get("two_hit"), x.get("pair")) else { + continue; + }; + if let Some(own) = WORDS.iter().rev().find(|w| t.starts_with(*w)) + && rank(p) > rank(own) + { + bad.push(format!("pair {p} is weaker than its own two_hit {t}")); + } + } + bad +} + +fn assert_rows_agree(c: &IndexMap, gene: &str) { + let bad = rows_weaker_than_their_two_hit(c, gene); + assert!(bad.is_empty(), "{bad:?}: {c:?}"); +} + +#[test] +fn a_weak_call_beside_a_confident_deletion_pair_leaves_it_biallelic() { + let dels = mutyh_deletion("1|0", Some("9")); + // E6a: a weak homozygous call; E6b: the weak call on the deletion's + // copy, in the same phase set. + for weak_call in [ + weak(MUTYH_B, "MUTYH", "1/1", None), + weak(MUTYH_B, "MUTYH", "1|0", Some("9")), + ] { + let c = sf( + vec![good(MUTYH_A, "MUTYH", "0|1", Some("9")), weak_call], + &dels, + ); + assert_eq!(sf_pairs(&c, "MUTYH"), ["biallelic", "biallelic"], "{c:?}"); + let sure = &of(&c, "clinvar_hits", "MUTYH")[0]; + assert!( + s(sure, "two_hit").starts_with("biallelic with DEL"), + "{sure:?}" + ); + assert_rows_agree(&c, "MUTYH"); + } +} + +#[test] +fn a_combined_allele_a_confident_call_proves_is_firm() { + // A combined allele phased on one copy, its part on the same copy, and a + // third het on the other copy. One of the combined call and its part is + // weak; the other is confident, so the pair is proven. + let joined = format!( + ";PGP_JOINED_FROM={}:{}:{}:{}|chr1:45331560:G:A", + MUTYH_A.0, MUTYH_A.1, MUTYH_A.2, MUTYH_A.3 + ); + let combined = |gq: u32, dp: u32| { + hit( + MUTYH_B, + "MUTYH", + "GT:GQ:DP:PS", + &format!("0|1:{gq}:{dp}:9"), + &joined, + ) + }; + // E4a: the combined call confident, its part weak. + let e4a = sf( + vec![ + combined(50, 30), + weak(MUTYH_A, "MUTYH", "0|1", Some("9")), + good(MUTYH_C, "MUTYH", "1|0", Some("9")), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&e4a, "MUTYH"), ["biallelic"; 3], "{e4a:?}"); + // E4b: the combined call weak, its part confident. + let e4b = sf( + vec![ + combined(5, 4), + good(MUTYH_A, "MUTYH", "0|1", Some("9")), + good(MUTYH_C, "MUTYH", "1|0", Some("9")), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&e4b, "MUTYH"), ["biallelic"; 3], "{e4b:?}"); +} + +#[test] +fn a_weak_hom_beside_two_confident_unphased_hets_is_possibly_biallelic() { + // E3c: the confident pair alone is possibly biallelic, as the carrier + // list says for the same hets; the weak homozygous call does not lower + // it to the low-confidence word. + let c = sf( + vec![ + good(MUTYH_A, "MUTYH", "0/1", None), + good(MUTYH_C, "MUTYH", "0/1", None), + weak(MUTYH_B, "MUTYH", "1/1", None), + ], + &no_deletions(), + ); + assert_eq!(sf_pairs(&c, "MUTYH"), ["possibly biallelic"; 3], "{c:?}"); +} + +/// The carrier list's answer for a gene, in the SF card's words: the best of +/// its het pair, its deletion pair and its homozygous or hemizygous rows (a +/// low-confidence one only possibly so). `None` when none of them says two +/// copies may be hit. +fn carrier_answer(c: &IndexMap, gene: &str) -> Option<&'static str> { + let mut best: Option = None; + let mut take = |r: Option| { + if let Some(r) = r { + best = Some(best.map_or(r, |b| b.min(r))); + } + }; + for x in of(c, "carriers", gene) { + if let Some(Value::Str(p)) = x.get("pair") { + take(Some(rank(p).unwrap_or_else(|| panic!("{p}")))); + } + } + for x in of(c, "hom_or_hemizygous", gene) { + let low = x.get("low_confidence") == Some(&Value::Bool(true)); + take(Some(if low { 2 } else { 0 })); + } + let Some(Value::Object(t)) = c.get("two_hits") else { + panic!("{c:?}") + }; + for x in rows(t, "genes") + .into_iter() + .filter(|r| s(r, "gene") == gene) + { + take(rank(s(x, "verdict"))); + } + best.map(|b| WORDS[b]) +} + +/// The SF card's answer for a gene: the one pair word of its reported rows. +fn sf_answer(c: &IndexMap, gene: &str) -> Option<&'static str> { + let words: std::collections::BTreeSet = of(c, "clinvar_hits", gene) + .iter() + .filter_map(|x| match x.get("pair") { + Some(Value::Str(p)) => Some(p.clone()), + _ => None, + }) + .collect(); + assert!(words.len() <= 1, "one pair per gene: {c:?}"); + let w = words.into_iter().next()?; + rank(&w).map(|r| WORDS[r]) +} + +#[test] +fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { + let (a, b, cc) = (MUTYH_A, MUTYH_B, MUTYH_C); + let g = |site, gt, ps| good(site, "MUTYH", gt, ps); + let w = |site, gt, ps| weak(site, "MUTYH", gt, ps); + let joined = format!( + ";PGP_JOINED_FROM={}:{}:{}:{}|chr1:45331560:G:A", + a.0, a.1, a.2, a.3 + ); + let combined = |q: &str| hit(b, "MUTYH", "GT:GQ:DP:PS", &format!("0|1:{q}:9"), &joined); + let del = || mutyh_deletion("1|0", Some("9")); + let none = no_deletions; + let p9 = Some("9"); + let bi = Some("biallelic"); + let maybe = Some("possibly biallelic"); + let low = Some("possibly biallelic (low-confidence call)"); + #[allow(clippy::type_complexity)] + let shapes: Vec<(&str, Vec>, DeletionInputs, Option<&str>)> = vec![ + ("confident hom", vec![g(a, "1/1", None)], none(), bi), + ("weak hom", vec![w(a, "1/1", None)], none(), low), + ( + "confident phased pair", + vec![g(a, "0|1", p9), g(b, "1|0", p9)], + none(), + bi, + ), + ( + "confident unphased pair", + vec![g(a, "0/1", None), g(b, "0/1", None)], + none(), + maybe, + ), + ( + "confident cis pair", + vec![g(a, "0|1", p9), g(b, "0|1", p9)], + none(), + None, + ), + ("weak het alone", vec![w(a, "0/1", None)], none(), None), + ( + "E1 confident hom + weak het", + vec![g(a, "1/1", None), w(b, "0/1", None)], + none(), + bi, + ), + ( + "E2a confident phased pair + weak unphased third", + vec![g(a, "0|1", p9), g(b, "1|0", p9), w(cc, "0/1", None)], + none(), + bi, + ), + ( + "E2b confident phased pair + weak third in the phase set", + vec![g(a, "0|1", p9), g(b, "1|0", p9), w(cc, "0|1", p9)], + none(), + bi, + ), + ( + "E2c confident phased pair + weak hom", + vec![g(a, "0|1", p9), g(b, "1|0", p9), w(cc, "1/1", None)], + none(), + bi, + ), + ( + "E3a confident + weak phased pair", + vec![g(a, "0|1", p9), w(b, "1|0", p9)], + none(), + low, + ), + ( + "E3b confident + weak unphased hets", + vec![g(a, "0/1", None), w(b, "0/1", None)], + none(), + low, + ), + ( + "E3c two confident unphased hets + weak hom", + vec![g(a, "0/1", None), g(cc, "0/1", None), w(b, "1/1", None)], + none(), + maybe, + ), + ( + "E3d two confident unphased hets + weak het", + vec![g(a, "0/1", None), g(cc, "0/1", None), w(b, "0/1", None)], + none(), + maybe, + ), + ( + "E3e two weak hets", + vec![w(a, "0/1", None), w(b, "0/1", None)], + none(), + low, + ), + ( + "E3f confident het + weak hom", + vec![g(a, "0/1", None), w(b, "1/1", None)], + none(), + low, + ), + ( + "E4a combined confident, part weak, third in trans", + vec![combined("50:30"), w(a, "0|1", p9), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "E4b combined weak, part confident, third in trans", + vec![combined("5:4"), g(a, "0|1", p9), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "E5a deletion + confident het in trans", + vec![g(a, "0|1", p9)], + del(), + bi, + ), + ( + "E5b deletion + weak het in trans", + vec![w(a, "0|1", p9)], + del(), + low, + ), + ( + "E6a deletion + confident het + weak hom", + vec![g(a, "0|1", p9), w(b, "1/1", None)], + del(), + bi, + ), + ( + "E6b deletion + confident het + weak het in cis with it", + vec![g(a, "0|1", p9), w(b, "1|0", p9)], + del(), + bi, + ), + ( + "E6c unphased deletion + confident het + weak hom", + vec![g(a, "0/1", None), w(b, "1/1", None)], + mutyh_deletion("0/1", None), + maybe, + ), + ("deletion alone", vec![], del(), None), + ("nothing", vec![], none(), None), + ]; + let mut wrong = Vec::new(); + for (label, hits, dels, want) in shapes { + let carrier = list(hits.clone(), &dels); + let card = sf(hits, &dels); + // The whole output of both cards, for a before/after diff. + eprintln!("DUMP {label}\tSF {card:?}\tCARRIER {carrier:?}"); + let (x, y) = (sf_answer(&card, "MUTYH"), carrier_answer(&carrier, "MUTYH")); + if x != want || y != want { + wrong.push(format!("{label}: want {want:?}, SF {x:?}, carrier {y:?}")); + } + for b in rows_weaker_than_their_two_hit(&card, "MUTYH") { + wrong.push(format!("{label}: {b}")); + } + } + assert!(wrong.is_empty(), "{}", wrong.join("\n")); +} From a857c8c2074734ddfd8f8a8421445039a476cbef Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:22:48 +0100 Subject: [PATCH 16/40] test(report): check the reason the reports give for an unknown SV support With step 22's consensus set and an SV whose support is null, both reports must say the consensus cannot tell, never that it did not run, in the AnnotSV rows and in the secondary-findings SV rows, and the AnnotSV count line must count the unknown rows. Without the consensus the old text stays. Red on the code before the fix: the header lacks "not known: 1" and the row says "no step 22 consensus". Bead: sv-01 --- .../og-render/tests/i411_sv_support_text.rs | 192 ++++++++++++++++++ 1 file changed, 192 insertions(+) create mode 100644 rust/crates/og-render/tests/i411_sv_support_text.rs diff --git a/rust/crates/og-render/tests/i411_sv_support_text.rs b/rust/crates/og-render/tests/i411_sv_support_text.rs new file mode 100644 index 000000000..f7809f035 --- /dev/null +++ b/rust/crates/og-render/tests/i411_sv_support_text.rs @@ -0,0 +1,192 @@ +//! The reports give the right reason when an SV's caller support is not +//! known (#411 sv-01). +//! +//! `og summary collect` writes an SV's `support` as `null` in two cases: +//! step 22's consensus did not run, or it ran and cannot tell (an `SV_VCF` +//! run's `sv_vcf` rows, a row with no record ID, an ID in two events, a +//! vote with no readable ID). The reports gave both the reason "no step 22 +//! consensus", so a user whose step 22 did run read that it did not. The +//! AnnotSV header counted only single-caller rows, so with the consensus +//! set and every row unknown it read "single caller: 0". +//! +//! Now the AnnotSV section's `consensus` field picks the reason, in the +//! AnnotSV block and in the secondary-findings rows, and the header counts +//! the unknown rows when the consensus ran. Without the consensus the old +//! text stays. + +use og_render::escape::e; +use og_render::model::Summary; +use og_render::sections::{acmg_sf, annotsv}; +use og_render::{html, text}; + +const CANNOT_TELL: &str = "not known (step 22's consensus cannot tell)"; +const NO_CONSENSUS: &str = "not known (no step 22 consensus)"; + +/// A summary with an AnnotSV section of two class 4-5 SVs (one seen by one +/// caller, one whose support is `second`) and an SF tier with one +/// structural row whose support is null. `consensus` is the AnnotSV +/// section's `consensus` field, as JSON. +fn summary(consensus: &str, second: &str) -> Summary { + Summary::parse(&summary_json(consensus, second, true)).expect("a summary") +} + +/// The summary's JSON; without `with_annotsv` it has no AnnotSV section. +fn summary_json(consensus: &str, second: &str, with_annotsv: bool) -> String { + let annotsv = format!( + r#""annotsv": {{"title": "Structural Variants, Class 4 and 5 (AnnotSV)", "state": "ok", "step": "05", + "source": "annotsv/S1_sv_class4_5_checked.tsv", "file_date": "2026-11-21 11:00:00", "note": null, + "data": {{"count": 2, "consensus": {consensus}, "consensus_note": null, "single_caller": 1, + "exon_edge": 0, "exon_edge_checked": true, "common": 0, "downgraded": [], "rows": [ + {{"type": "DEL", "sv": "chr1:1000-5000", "acmg_class": "5", "genes": ["G1"], "caller": "manta", + "support": 1, "support_callers": ["manta"], "exon_edge": "no", "population_af": null}}, + {{"type": "DUP", "sv": "chr2:2000-9000", "acmg_class": "4", "genes": ["G2"], "caller": "sv_vcf", + "support": {second}, "support_callers": ["manta", "delly"], "exon_edge": "no", "population_af": null}}]}}}},"# + ); + let annotsv = if with_annotsv { annotsv.as_str() } else { "" }; + format!( + r#"{{ + "schema_version": 2, "sample": "S1", "generated_utc": "2026-11-21 12:00 UTC", + "run": {{"started_utc": "2026-11-21 10:00 UTC", "declared_sex": "female"}}, + "databases": {{"clinvar_release": "2026-10-01", "cpsr_clinvar_release": null, "hla_database": null}}, + "manifest": [], + "sections": {{ + {annotsv} + "clinical": {{"title": "Clinical Variant Filter", "state": "ok", "step": "23", + "source": "clinical/S1_clinical.tsv", "file_date": "2026-11-21 11:00:00", "note": null, + "data": {{"variants": 3, "acmg_sf": {{"version": "SF v3.3", "genes_on_list": 84, "clinvar_hits": [], + "high_impact": [], "structural_checked": true, "structural": [ + {{"gene": "G1", "variant": "DEL chr1:1000-5000", "acmg_class": "5", "caller": "sv_vcf", "support": null}}]}}}}}} + }}, + "cyp2d6": null, "not_run": [], "not_assessed": [] +}}"# + ) +} + +/// The block of section `sid` in the HTML report. +fn frame<'a>(page: &'a str, sid: &str) -> &'a str { + page.split_once(&format!("id=\"{sid}\">")) + .map_or("", |(_, rest)| { + rest.split("").next().unwrap_or("") + }) +} + +/// Both reports, text and HTML. +fn reports(s: &Summary) -> (String, String) { + ( + text::report(s).expect("the text report"), + html::report(s).expect("the HTML report"), + ) +} + +/// The consensus ran: a null support is one it cannot tell, in the AnnotSV +/// rows, the header and the SF row; "no step 22 consensus" is gone. +#[test] +fn a_consensus_that_cannot_tell_says_so() { + let s = summary(r#""sv_merged/S1_sv_consensus.vcf.gz""#, "null"); + let (txt, page) = reports(&s); + + let head = " Class 4-5 SVs: 2 (single caller: 1, not known: 1; deletions on exon edges: 0; common: 0)"; + assert!(txt.lines().any(|l| l == head), "{txt}"); + assert!( + txt.lines().any( + |l| l.starts_with(" DUP chr2:2000-9000 class 4 G2 support: ") + && l.ends_with(CANNOT_TELL) + ), + "{txt}" + ); + assert!( + txt.contains("G1 DEL chr1:1000-5000 . AnnotSV class 5, caller support not known (step 22's consensus cannot tell)"), + "{txt}" + ); + // The consensus ran, so its "did not run" note is not there either. + assert!(!txt.contains("did not run"), "{txt}"); + + let sv = frame(&page, "structural-variants"); + assert!(sv.contains(&format!("{}", e(CANNOT_TELL))), "{sv}"); + assert!( + sv.contains(&*e( + "single caller: 1, not known: 1; deletions on exon edges: 0" + )), + "{sv}" + ); + let clinical = frame(&page, "clinical-filter"); + assert!( + clinical.contains(&*e( + "AnnotSV class 5, caller support not known (step 22's consensus cannot tell)" + )), + "{clinical}" + ); + for (name, report) in [("text", txt.as_str()), ("HTML", page.as_str())] { + assert!( + !report.contains("no step 22 consensus"), + "the {name} report still says the consensus did not run:\n{report}" + ); + } +} + +/// The consensus ran and saw every row: the header has no unknown count. +#[test] +fn a_consensus_that_saw_every_row_adds_no_unknown_count() { + let s = summary(r#""sv_merged/S1_sv_consensus.vcf.gz""#, "2"); + let lines = + annotsv::lines(&og_render::sections::clinvar::D::of(&s.section("annotsv"))).unwrap(); + assert_eq!( + lines[0], + "Class 4-5 SVs: 2 (single caller: 1; deletions on exon edges: 0; common: 0)" + ); + let (txt, _) = reports(&s); + assert!(txt.contains("support: 2 callers (manta, delly)"), "{txt}"); +} + +/// No consensus: the old reason stays everywhere, with the note that says +/// step 22 did not run, and the header reads "not known" as before. +#[test] +fn without_the_consensus_the_old_reason_stays() { + let s = summary("null", "null"); + let (txt, page) = reports(&s); + + let head = + " Class 4-5 SVs: 2 (single caller: not known; deletions on exon edges: 0; common: 0)"; + assert!(txt.lines().any(|l| l == head), "{txt}"); + assert!( + txt.lines().any( + |l| l.starts_with(" DUP chr2:2000-9000 class 4 G2 support: ") + && l.ends_with(NO_CONSENSUS) + ), + "{txt}" + ); + assert!( + txt.contains("G1 DEL chr1:1000-5000 . AnnotSV class 5, caller support not known (no step 22 consensus)"), + "{txt}" + ); + assert!(txt.contains("step 22's consensus did not run"), "{txt}"); + let sv = frame(&page, "structural-variants"); + assert!( + sv.contains(&format!("{}", e(NO_CONSENSUS))), + "{sv}" + ); + for (name, report) in [("text", txt.as_str()), ("HTML", page.as_str())] { + assert!( + !report.contains("cannot tell"), + "the {name} report gives the consensus's reason without a consensus:\n{report}" + ); + } +} + +/// The SF rows read the AnnotSV section's flag: with no AnnotSV section at +/// all, the old reason stays. +#[test] +fn sf_rows_without_an_annotsv_section_keep_the_old_reason() { + let s = Summary::parse(&summary_json( + r#""sv_merged/S1_sv_consensus.vcf.gz""#, + "null", + false, + )) + .expect("a summary"); + let txt = acmg_sf::text(&s).unwrap().join("\n"); + assert!( + txt.contains("AnnotSV class 5, caller support not known (no step 22 consensus)"), + "{txt}" + ); + assert!(!txt.contains("cannot tell"), "{txt}"); +} From f91075bd714b2166839ad9002e9ad492aaf70588 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:22:48 +0100 Subject: [PATCH 17/40] fix(report): give the right reason when step 22's consensus cannot tell an SV's support og summary collect writes an SV's support as null when step 22's consensus ran but cannot tell (an SV_VCF run's rows, a row with no ID, an ID in two events, a vote with no readable ID). Both renderers still said "not known (no step 22 consensus)" for every null, and the AnnotSV count line read "single caller: 0". The AnnotSV section's consensus flag now picks the reason in the AnnotSV rows and the secondary-findings SV rows, and the count line adds ", not known: M" when the consensus ran. bin/render_report.py and bin/live_results.py change the same lines for the live site. The pinned Python oracle prints the old reason, so the 50 report-render cases that show it get whole-report goldens. report-corpus.sh pins each collected summary's generated_utc so those goldens stay stable (the same hunk as the carrier-confidence lane). Bead: sv-01 --- CHANGELOG.md | 1 + bin/live_results.py | 4 +- bin/render_report.py | 18 +- docs/05-annotsv.md | 2 +- rust/crates/og-render/src/sections/acmg_sf.rs | 27 +- rust/crates/og-render/src/sections/annotsv.rs | 42 +- tests/parity/gen/report-corpus.sh | 7 + .../report-render/a-escape/a-escape.html | 920 +++++++++++++++++ .../report-render/a-escape/a-escape.txt | 439 +++++++++ .../report-render/a-failed/a-failed.html | 860 ++++++++++++++++ .../report-render/a-failed/a-failed.txt | 405 ++++++++ .../golden/report-render/a-full/a-full.html | 922 +++++++++++++++++ .../golden/report-render/a-full/a-full.txt | 441 +++++++++ .../report-render/a-missing/a-missing.html | 813 +++++++++++++++ .../report-render/a-missing/a-missing.txt | 373 +++++++ .../a-no-painting/a-no-painting.html | 919 +++++++++++++++++ .../a-no-painting/a-no-painting.txt | 440 +++++++++ .../report-render/a-numbers/a-numbers.txt | 441 +++++++++ .../report-render/a-painting/a-painting.html | 923 +++++++++++++++++ .../report-render/a-painting/a-painting.txt | 442 +++++++++ .../report-render/a-partial/a-partial.html | 884 +++++++++++++++++ .../report-render/a-partial/a-partial.txt | 389 ++++++++ .../report-render/a-prs-raw/a-prs-raw.html | 921 +++++++++++++++++ .../report-render/a-prs-raw/a-prs-raw.txt | 441 +++++++++ .../report-render/a-prs-sex/a-prs-sex.html | 923 +++++++++++++++++ .../report-render/a-prs-sex/a-prs-sex.txt | 442 +++++++++ .../golden/report-render/a-since/a-since.html | 922 +++++++++++++++++ .../golden/report-render/a-since/a-since.txt | 444 +++++++++ .../golden/report-render/a-stale/a-stale.html | 930 ++++++++++++++++++ .../golden/report-render/a-stale/a-stale.txt | 449 +++++++++ .../a-unreadable/a-unreadable.html | 860 ++++++++++++++++ .../a-unreadable/a-unreadable.txt | 397 ++++++++ .../report-render/a-y-calls/a-y-calls.html | 909 +++++++++++++++++ .../report-render/a-y-calls/a-y-calls.txt | 424 ++++++++ .../report-render/all-history/all-history.txt | 669 +++++++++++++ tests/parity/golden/report-render/all/all.txt | 624 ++++++++++++ .../c-float--inf/c-float--inf.txt | 411 ++++++++ .../report-render/c-float-inf/c-float-inf.txt | 418 ++++++++ .../report-render/c-float-nan/c-float-nan.txt | 407 ++++++++ .../golden/report-render/c-full/c-full.txt | 442 +++++++++ .../golden/report-render/cb-full/cb-full.html | 698 +++++++++++++ .../golden/report-render/cb-full/cb-full.txt | 293 ++++++ .../cb-no-assets/cb-no-assets.html | 672 +++++++++++++ .../cb-no-assets/cb-no-assets.txt | 266 +++++ .../cb-quoted-dosage/cb-quoted-dosage.html | 698 +++++++++++++ .../cb-quoted-dosage/cb-quoted-dosage.txt | 293 ++++++ .../cb-quoted-interval.html | 698 +++++++++++++ .../cb-quoted-interval/cb-quoted-interval.txt | 293 ++++++ .../cb-quoted-smn/cb-quoted-smn.html | 698 +++++++++++++ .../cb-quoted-smn/cb-quoted-smn.txt | 293 ++++++ .../cb-unicode-contig/cb-unicode-contig.html | 698 +++++++++++++ .../cb-unicode-contig/cb-unicode-contig.txt | 293 ++++++ .../m-clinical-escape/m-clinical-escape.html | 699 +++++++++++++ .../m-clinical-escape/m-clinical-escape.txt | 293 ++++++ .../m-clinical-failed/m-clinical-failed.html | 564 +++++++++++ .../m-clinical-failed/m-clinical-failed.txt | 186 ++++ .../m-clinical-stale/m-clinical-stale.html | 719 ++++++++++++++ .../m-clinical-stale/m-clinical-stale.txt | 306 ++++++ .../m-clinical-unreadable.html | 564 +++++++++++ .../m-clinical-unreadable.txt | 179 ++++ .../m-clinvar-freq-note.html | 698 +++++++++++++ .../m-clinvar-freq-note.txt | 293 ++++++ .../m-clinvar-many/m-clinvar-many.html | 742 ++++++++++++++ .../m-clinvar-many/m-clinvar-many.txt | 426 ++++++++ .../m-clinvar-none/m-clinvar-none.html | 659 +++++++++++++ .../m-clinvar-none/m-clinvar-none.txt | 250 +++++ .../m-couple-empty/m-couple-empty.html | 707 +++++++++++++ .../m-couple-empty/m-couple-empty.txt | 298 ++++++ .../report-render/m-couple/m-couple.html | 710 +++++++++++++ .../report-render/m-couple/m-couple.txt | 300 ++++++ .../m-cpsr-none/m-cpsr-none.html | 681 +++++++++++++ .../report-render/m-cpsr-none/m-cpsr-none.txt | 277 ++++++ .../m-cpsr-noown/m-cpsr-noown.html | 688 +++++++++++++ .../m-cpsr-noown/m-cpsr-noown.txt | 283 ++++++ .../report-render/m-sf-notes/m-sf-notes.html | 699 +++++++++++++ .../report-render/m-sf-notes/m-sf-notes.txt | 294 ++++++ .../m-since-clinical/m-since-clinical.html | 698 +++++++++++++ .../m-since-clinical/m-since-clinical.txt | 296 ++++++ .../m-slivar-phase/m-slivar-phase.html | 654 ++++++++++++ .../m-slivar-phase/m-slivar-phase.txt | 273 +++++ .../m-slivar-unphased/m-slivar-unphased.html | 672 +++++++++++++ .../m-slivar-unphased/m-slivar-unphased.txt | 271 +++++ .../s-consumer-reasons.html | 922 +++++++++++++++++ .../s-consumer-reasons/s-consumer-reasons.txt | 441 +++++++++ .../s-consumer-stale/s-consumer-stale.html | 922 +++++++++++++++++ .../s-consumer-stale/s-consumer-stale.txt | 441 +++++++++ .../s-sexloss-chrx/s-sexloss-chrx.html | 925 +++++++++++++++++ .../s-sexloss-chrx/s-sexloss-chrx.txt | 447 +++++++++ .../s-sexloss-detected.html | 925 +++++++++++++++++ .../s-sexloss-detected/s-sexloss-detected.txt | 447 +++++++++ .../s-sexloss-failed/s-sexloss-failed.html | 923 +++++++++++++++++ .../s-sexloss-failed/s-sexloss-failed.txt | 445 +++++++++ .../s-sexloss-gain-stale.html | 925 +++++++++++++++++ .../s-sexloss-gain-stale.txt | 447 +++++++++ .../s-sexloss-not-estimated.html | 924 +++++++++++++++++ .../s-sexloss-not-estimated.txt | 446 +++++++++ .../s-sexloss-odd/s-sexloss-odd.html | 925 +++++++++++++++++ .../s-sexloss-odd/s-sexloss-odd.txt | 447 +++++++++ .../report-render/s-sv-stale/s-sv-stale.html | 926 +++++++++++++++++ .../report-render/s-sv-stale/s-sv-stale.txt | 445 +++++++++ 100 files changed, 53314 insertions(+), 26 deletions(-) create mode 100644 tests/parity/golden/report-render/a-escape/a-escape.html create mode 100644 tests/parity/golden/report-render/a-escape/a-escape.txt create mode 100644 tests/parity/golden/report-render/a-failed/a-failed.html create mode 100644 tests/parity/golden/report-render/a-failed/a-failed.txt create mode 100644 tests/parity/golden/report-render/a-full/a-full.html create mode 100644 tests/parity/golden/report-render/a-full/a-full.txt create mode 100644 tests/parity/golden/report-render/a-missing/a-missing.html create mode 100644 tests/parity/golden/report-render/a-missing/a-missing.txt create mode 100644 tests/parity/golden/report-render/a-no-painting/a-no-painting.html create mode 100644 tests/parity/golden/report-render/a-no-painting/a-no-painting.txt create mode 100644 tests/parity/golden/report-render/a-numbers/a-numbers.txt create mode 100644 tests/parity/golden/report-render/a-painting/a-painting.html create mode 100644 tests/parity/golden/report-render/a-painting/a-painting.txt create mode 100644 tests/parity/golden/report-render/a-partial/a-partial.html create mode 100644 tests/parity/golden/report-render/a-partial/a-partial.txt create mode 100644 tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html create mode 100644 tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt create mode 100644 tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html create mode 100644 tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt create mode 100644 tests/parity/golden/report-render/a-since/a-since.html create mode 100644 tests/parity/golden/report-render/a-since/a-since.txt create mode 100644 tests/parity/golden/report-render/a-stale/a-stale.html create mode 100644 tests/parity/golden/report-render/a-stale/a-stale.txt create mode 100644 tests/parity/golden/report-render/a-unreadable/a-unreadable.html create mode 100644 tests/parity/golden/report-render/a-unreadable/a-unreadable.txt create mode 100644 tests/parity/golden/report-render/a-y-calls/a-y-calls.html create mode 100644 tests/parity/golden/report-render/a-y-calls/a-y-calls.txt create mode 100644 tests/parity/golden/report-render/all-history/all-history.txt create mode 100644 tests/parity/golden/report-render/all/all.txt create mode 100644 tests/parity/golden/report-render/c-float--inf/c-float--inf.txt create mode 100644 tests/parity/golden/report-render/c-float-inf/c-float-inf.txt create mode 100644 tests/parity/golden/report-render/c-float-nan/c-float-nan.txt create mode 100644 tests/parity/golden/report-render/c-full/c-full.txt create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.html create mode 100644 tests/parity/golden/report-render/cb-full/cb-full.txt create mode 100644 tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html create mode 100644 tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html create mode 100644 tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html create mode 100644 tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html create mode 100644 tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html create mode 100644 tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html create mode 100644 tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt create mode 100644 tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html create mode 100644 tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html create mode 100644 tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt create mode 100644 tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html create mode 100644 tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html create mode 100644 tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html create mode 100644 tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html create mode 100644 tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html create mode 100644 tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.html create mode 100644 tests/parity/golden/report-render/m-couple/m-couple.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html create mode 100644 tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html create mode 100644 tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html create mode 100644 tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html create mode 100644 tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html create mode 100644 tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html create mode 100644 tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt create mode 100644 tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html create mode 100644 tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt create mode 100644 tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html create mode 100644 tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html create mode 100644 tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html create mode 100644 tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html create mode 100644 tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html create mode 100644 tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html create mode 100644 tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt create mode 100644 tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html create mode 100644 tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt create mode 100644 tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html create mode 100644 tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt diff --git a/CHANGELOG.md b/CHANGELOG.md index 66ce46e0e..e676a7222 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -25,6 +25,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). - Step 22's SV consensus no longer counts a record a caller did not call as a second caller. Before, every PASS record went to SURVIVOR, so a PASS Delly record genotyped `0/0`, a Delly call whose sample filter (`FT`) says `LowQual`, or a CNVpytor segment no quality rule had read sat beside a Manta-only call and made it read "2 callers". A new verb, `og sv survivor-prep --caller NAME IN OUT`, now writes each caller's input for both the script and the Nextflow `SURVIVOR_PREP`, in place of the bcftools and awk they each carried. A record votes when its FILTER and its sample `FT` are `PASS` or `.` and its genotype is not reference only (`0/0`, `0|0`, haploid `0`, `0/.`); a no-call (`./.`) and a sites-only record still vote. A CNVpytor call votes when its e-value is below 0.01 and its share of MAPQ 0 reads below 0.5, the rule step 05 already applies when it adds CNVpytor's calls; the VCF step 22 makes from CNVpytor's table now carries the table's e-value, `q0` and `pN` as `pytorP1`, `pytorQ0` and `pytorPN`, so the rule reads both inputs. A header without `GT` or without these tags no longer matters. Step 18's closing hint and `docs/18-cnvpytor.md` gave e-value below 0.05 and size over 1 kb; they now give the same rule. What changes in the output: `sv_merged/inputs/.vcf` holds only the records that vote, and the consensus can hold fewer records. No file, column or option is renamed or removed. Part of #411 (sv-05, sv-06, sv-09, sv-10, sv-11, sv-40). - A class 4 or 5 SV gets support from more than one caller only from the step 22 consensus event that lists its own record: same contig and SV type, its caller voting in `SUPP_VEC`, and its original record ID in that caller's `FORMAT/ID`. Before, the nearest consensus record within 1,000 bp lent its callers, whatever its type or filter, so a filtered call, a call of the other type or an unrelated call nearby made a Manta-only call read "2 callers". A row that no event lists shows as single caller, when the consensus names every vote of its caller. When the consensus cannot tell, the support is now "not known": `Support` and `Support_callers` are empty in `_sv_class4_5_checked.tsv`, and `support` is `null` in `summary.json`. That happens when the row has no record ID, its caller is not a consensus column (`sv_vcf` rows of an `SV_VCF` run), its ID is in two events, or a vote of its caller has no readable ID (CNVpytor calls when step 22 made CNVpytor's VCF from its table). `og sv add-callers` now keeps Delly's `RDCN` on each Delly call it adds (`FORMAT GT:RDCN` and the `##FORMAT=` header line), so `Depth_support` reads the depth that step checked: `yes` for a call over 1,000 bp it kept. A Delly call over 1,000 bp with no `RDCN`, from a VCF not written by Delly 2.x, now reads `unknown` instead of `yes` and keeps its class; step 05's log line counts it apart from `not checked`. No column, option or file name changes. Part of #411 (sv-01, sv-08, sv-03) and follow-up to #542. +- The reports no longer say step 22 did not run when it did. Step 22's consensus leaves an SV's caller support "not known" when it cannot tell: an `SV_VCF` run's `sv_vcf` rows, a row with no record ID, an ID in two events, or a vote with no readable ID. Both reports still gave those SVs the reason "not known (no step 22 consensus)", and the AnnotSV count line read "single caller: 0", as if every SV had two callers. When the AnnotSV section's `consensus` is set, the AnnotSV rows and the secondary-findings SV rows now say "not known (step 22's consensus cannot tell)", and the count line adds the unknown ones, as in `single caller: 0, not known: 3`. Without the consensus the old text stays. The Python live site (`bin/render_report.py`, `bin/live_results.py`) writes the same text. No file, key or option changes; only the report text does. The pinned Python oracle still prints the old reason, so the 50 report-render parity cases that show it now have goldens. Part of #411 (sv-01), follow-up to #566. - The callability section of `summary.json` now says, for each gene a step of its own calls, whether that step ran. A gene such as SMN1, CYP2D6, HBA1, LPA or RHD that step 16b did not read is listed under `not_read_owned` with its owner, and it read as handed to that step even when the step never ran for the sample, so its coverage stood alone as the answer. Each entry gains two fields: `owner_step` (`35`, `32`, `46` or `41`) and `owner_status` (`ran`; `not run` when that step wrote no file of its own for the gene in the sample folder, a Parascopy gene being judged by its own table in `assets/paralog_loci.tsv`; or `from an earlier run` when that file is older than the last run and the step was not `ok` in it, the rule that makes a section stale). Fields are only added; none is renamed or removed, and the reports do not show them yet. The share keeps its four decimals (0.8988 stays 0.8988). Part of #411 (clin-25). - Step 10 (telomere content) always reads the GRCh38 chromosome bands now. When `reference/cytoBand.hg38.txt` was missing, `scripts/10-telomere-hunter.sh` warned and ran TelomereHunter without `-b`, so it sorted reads by its own hg19 band ends on GRCh38 positions; the Nextflow module did the same whenever `--cytoband` was not set, which is the default. The script now installs the copy the repository ships (`assets/reference/cytoBand.hg38.txt`) before it runs, and the pipeline passes that copy when `--cytoband` is not set. The step also moves from TelomereHunter 1.1.0, Python 2.7 code, to its maintained successor TelomereHunter2 1.0.12 (`TELOMEREHUNTER_IMAGE`, `quay.io/biocontainers/telomerehunter2`). On the image test's input both give the same `tel_content` (5347.255643 with 1,100 planted telomeric reads, 5337.585253 with 1,098), so earlier values stay comparable. THREADS now sets its worker count (`-c`), and the container gets a higher open-file limit, which it needs on a BAM with many contigs. Output change: `telomere///_summary.tsv` keeps its name, but its columns follow TelomereHunter2 (`tel_content` third, `intratelomeric_reads`, `tel_read_count`, `read_lengths`, plus three read-class counts). `summary.json` and the reports read both layouts by name and do not change. The docs no longer describe the value as an age measure: `tests/test_telomere_wording.sh` fails when a file that describes step 10 does. Part of #411 (trait-46, trait-47, trait-48, trait-49). - Step 25 and the Nextflow `PRS_SUMMARY` withhold a score's percentile when the genotypes pgsc_calc scored list variants only. Every site such a VCF leaves out adds nothing to the sum, so the sum leans away from the panel's sums, which come from complete genotypes, and the percentile was not comparable. Each score keeps its raw sum. Its `Percentile` is `NA`, its `Effect` is empty, and a new column before `Input`, `Percentile_Note`, says `percentile withheld: the input lists variants only`. The decision reads the genotypes, not the kind of input: at least one genotyped position in five must be a reference call (0/0), the rule step 26b applies to the panel's sites. Genotypes from a gVCF and chip VCFs from `scripts/chip-to-vcf.sh`, which list their reference calls, keep their percentiles. `og prs table` takes the genotypes with a new option, `--target VCF`, and prints the NOTE that step 25 printed before; the NOTE now follows the genotypes too, so a gVCF without reference blocks at the score positions gets it. `og summary collect` passes the note on as `percentile_note`. When every percentile was withheld, both reports say "Percentile withheld: the input lists variants only" and why, and the summary's `not_assessed` list says the percentiles were withheld, in place of the lines for a run without the panel, which told the user to install a panel the run had used. The output gains one column; no column, option or file name changes. diff --git a/bin/live_results.py b/bin/live_results.py index 975b8a6ff..3f235d411 100644 --- a/bin/live_results.py +++ b/bin/live_results.py @@ -250,7 +250,7 @@ def a_structural(S, s): ["Consensus SVs (2+ callers)", sv.get("consensus", ".")], ["AnnotSV class 4 and 5", av.get("count", ".")]] rows = [[x.get("type"), x.get("sv"), x.get("gt"), x.get("length"), x.get("acmg_class"), - rr.annotsv_genes_text(x) if x.get("genes") is not None else ".", rr.annotsv_support_text(x), + rr.annotsv_genes_text(x) if x.get("genes") is not None else ".", rr.annotsv_support_text(x, av.get("consensus")), "; ".join(rr.annotsv_flags(x)) if "exon_edge" in x else "."] for x in av.get("rows") or []] return {"facts": facts, "table": table(["Type", "Where", "Genotype", "Length", "Class", "Genes", "Support", @@ -889,7 +889,7 @@ def gene(x): f"A {x.get('type') or 'structural change'} of {abs(int(num(x.get('length')) or 0)):,} bases that " f"AnnotSV ranks class {x.get('acmg_class')}. Short reads can misplace large changes: confirm it.", gene=(x.get("genes") or [None])[0], detail=x.get("sv"), - evidence=[["Class", x.get("acmg_class")], ["Callers", rr.annotsv_support_text(x)], + evidence=[["Class", x.get("acmg_class")], ["Callers", rr.annotsv_support_text(x, _data(S, "annotsv").get("consensus"))], ["Genotype", x.get("gt")]], viewer=str(x.get("sv") or "").replace(" ", "") or None)) # 6. Repeat expansions outside Stranger's "normal", or in an intermediate zone. for l in _items(_data(S, "expansions").get("loci")): diff --git a/bin/render_report.py b/bin/render_report.py index fa3496b4f..d13fedd1b 100755 --- a/bin/render_report.py +++ b/bin/render_report.py @@ -836,9 +836,9 @@ def comphet_phase_html(d): "those calls are listed apart with the reason and are not counted here.") -def annotsv_support_text(x): +def annotsv_support_text(x, consensus=None): if x["support"] is None: - return "not known (no step 22 consensus)" + return "not known (step 22's consensus cannot tell)" if consensus else "not known (no step 22 consensus)" if x["support"] == 1: return f"single caller ({x['caller']})" return f"{x['support']} callers ({', '.join(x['support_callers'])})" @@ -874,7 +874,7 @@ def annotsv_lines(d): """Step 05's class 4-5 lines, the same in both reports.""" head = f"Class 4-5 SVs: {d['count']}" if d["count"]: - head += (f" (single caller: {d['single_caller'] if d['consensus'] else 'not known'}; deletions on exon edges: " + head += (f" (single caller: {str(d['single_caller']) + (f', not known: {m}' if (m := sum(x['support'] is None for x in d.get('rows') or [])) else '') if d['consensus'] else 'not known'}; deletions on exon edges: " f"{d['exon_edge'] if d['exon_edge_checked'] else 'not checked'}; common: {d['common']})") lines = [head] if d.get("downgraded"): @@ -1343,7 +1343,7 @@ def head(key, title=None): w(f" {line}") for x in d["rows"]: w(f" {x['type']:<4} {x['sv']} class {x['acmg_class']} {annotsv_genes_text(x)} " - f"support: {annotsv_support_text(x)}") + f"support: {annotsv_support_text(x, d['consensus'])}") for f in annotsv_flags(x): w(f" {f}") if d.get("downgraded"): @@ -1553,7 +1553,7 @@ def head(key, title=None): f"{len(sf['clinvar_hits'])} ClinVar P/LP, {high_rare(sf)} rare HIGH impact" + high_apart(sf) + (f", {len(sf['structural'])} class 4/5 SV(s)" if sf.get("structural_checked") else "") + (f", {len(sf['not_reported'])} not reported by the gene's rule" if sf.get("not_reported") else "")) - for g, v, z, ev in sf_rows(sf): + for g, v, z, ev in sf_rows(sf, (S.get("annotsv", MISSING).get("data") or {}).get("consensus")): w(f" {g:<8} {v} {z} {ev}") for line in sf_apart_lines(sf): w(f" {line}") @@ -1991,7 +1991,7 @@ def paralogs_unchecked(S): "change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.") -def sf_rows(sf): +def sf_rows(sf, consensus=None): """The secondary findings as (gene, variant, genotype, evidence) rows, the same in both reports: ClinVar hits, rare HIGH-impact records, then class 4 and 5 SVs.""" @@ -2004,7 +2004,7 @@ def extra(x): for x in sf["high_impact"]] def support(x): if x["support"] is None: - return "caller support not known (no step 22 consensus)" + return "caller support not known (step 22's consensus cannot tell)" if consensus else "caller support not known (no step 22 consensus)" return f"single caller ({x['caller']})" if x["support"] == 1 else f"{x['support']} callers" rows += [(x["gene"], x["variant"], ".", f"AnnotSV class {x['acmg_class']}, {support(x)}" + (f"; through {x['via']}" if x.get("via") else "") + extra(x)) for x in sf.get("structural", [])] @@ -2843,7 +2843,7 @@ def a(key, lines): if av.get("rows"): body.append(f" {VIEWER_TH}" + "".join(f"" - f"" + f"" f"{viewer_td_of(x['sv'])}" for x in av["rows"]) + "
    SVClassGenesCallersChecks
    {E(x['type'] + ' ' + x['sv'])}{E(x['acmg_class'])}{E(annotsv_genes_text(x))}{E(annotsv_support_text(x))}{E(annotsv_genes_text(x))}{E(annotsv_support_text(x, av['consensus']))}{E('; '.join(annotsv_flags(x)) or 'none')}
    ") @@ -3062,7 +3062,7 @@ def a(key, lines): if sf and (sf["clinvar_hits"] or sf["high_impact"] or sf.get("structural") or sf.get("not_reported") or sf.get("unavailable")): rows = "".join(f"{E(g)}{E(v)}{E(z)}{E(ev)}{viewer_td_of(v)}\n" - for g, v, z, ev in sf_rows(sf)) + for g, v, z, ev in sf_rows(sf, (S.get("annotsv", MISSING).get("data") or {}).get("consensus"))) a("clinical", card(S["clinical"], f"Secondary-Findings Genes ({sf['version']})", [" ", f" {VIEWER_TH}", rows.rstrip("\n"), "
    GeneVariantGenotypeEvidence
    "] diff --git a/docs/05-annotsv.md b/docs/05-annotsv.md index fc4be32a3..df211c79d 100644 --- a/docs/05-annotsv.md +++ b/docs/05-annotsv.md @@ -135,7 +135,7 @@ The reports (`og summary collect`) read each SV's support from step 22's consens - its ID is a member of two events; - or the consensus holds a vote of its caller without a readable ID. This covers the CNVpytor calls when step 22 made CNVpytor's VCF from its table, which writes no record IDs. It also covers a consensus without `FORMAT/ID`; SURVIVOR 1.0.7 always writes it, so only a file made another way lacks it. -Without the consensus file the support is "not known" too. `og sv postfilter --consensus` adds the same `Support` and `Support_callers` columns to the table, both empty when the support is not known. +Without the consensus file the support is "not known" too. `og sv postfilter --consensus` adds the same `Support` and `Support_callers` columns to the table, both empty when the support is not known. The reports give the reason: "not known (step 22's consensus cannot tell)" when the consensus ran, "not known (no step 22 consensus)" when it did not. When the consensus ran, the section's count line adds how many SVs it could not tell, as in `single caller: 2, not known: 3`. Both reports list every class 4 and 5 SV in a section of their own, with its support, the exon-edge flag and the frequency. The bash report (`scripts/24-html-report.sh`, which `run-all.sh` runs) reads the table from the sample folder. The Nextflow `HTML_REPORT` gets the table from `ANNOTSV` and, with `survivor_merge` in `--tools`, the consensus, so a report written by `nextflow run` alone has the same section. A report of a run without AnnotSV lists it under the steps not run. diff --git a/rust/crates/og-render/src/sections/acmg_sf.rs b/rust/crates/og-render/src/sections/acmg_sf.rs index 800535851..7128de9a3 100644 --- a/rust/crates/og-render/src/sections/acmg_sf.rs +++ b/rust/crates/og-render/src/sections/acmg_sf.rs @@ -9,6 +9,7 @@ use pycompat::fmt::ljust; use crate::model::{Card, Cell, HtmlPart, Inline, Layout, Line, Malformed, Summary, Table}; use crate::notes::ACMG_NOTE; +use crate::sections::annotsv::unknown_reason; use crate::sections::clinvar::{D, viewer_of}; use crate::{html, text}; @@ -73,9 +74,21 @@ fn extra(x: &D<'_>) -> Result { Ok(out) } +/// Whether step 22's consensus ran, as the AnnotSV section says: then an +/// SV whose support is not known is one the consensus cannot tell. +pub fn consensus_ran(s: &Summary) -> Result { + let sec = s.section("annotsv"); + let d = D::of(&sec); + if d.is_none() { + return Ok(false); + } + d.flag("consensus") +} + /// The secondary findings as rows, the same in both reports: ClinVar hits, -/// rare HIGH-impact records, then class 4 and 5 SVs. -pub fn rows(sf: &D<'_>) -> Result, Malformed> { +/// rare HIGH-impact records, then class 4 and 5 SVs. `consensus` is +/// [`consensus_ran`]. +pub fn rows(sf: &D<'_>, consensus: bool) -> Result, Malformed> { let mut out = Vec::new(); for x in sf.at("clinvar_hits")?.items()? { let low = if x.flag("low_confidence")? { @@ -111,7 +124,7 @@ pub fn rows(sf: &D<'_>) -> Result, Malformed> { for x in sv.items()? { let support = x.at("support")?; let support = if support.is_none() { - "caller support not known (no step 22 consensus)".to_owned() + format!("caller support not known ({})", unknown_reason(consensus)) } else if support.is_num(1) { format!("single caller ({})", x.s("caller")?) } else { @@ -223,7 +236,7 @@ pub fn text(s: &Summary) -> Result, Malformed> { line += &format!(", {} not reported by the gene's rule", nr.len()?); } w.push(line); - for (g, v, z, ev) in rows(&sf)? { + for (g, v, z, ev) in rows(&sf, consensus_ran(s)?)? { w.push(format!(" {} {v} {z} {ev}", ljust(&g, 8))); } for line in apart_lines(&sf)? { @@ -270,7 +283,7 @@ fn counts_card(d: &D<'_>) -> Result { } /// The SF card, when the tier lists anything or says why it could not. -fn sf_card(sf: &D<'_>) -> Result, Malformed> { +fn sf_card(sf: &D<'_>, consensus: bool) -> Result, Malformed> { let shown = sf.at("clinvar_hits")?.truthy() || sf.at("high_impact")?.truthy() || sf.flag("structural")? @@ -280,7 +293,7 @@ fn sf_card(sf: &D<'_>) -> Result, Malformed> { return Ok(None); } let mut cells = Vec::new(); - for (g, v, z, ev) in rows(sf)? { + for (g, v, z, ev) in rows(sf, consensus)? { let at = viewer_of(&v)?; cells.push(vec![ Cell::Text(g), @@ -318,7 +331,7 @@ pub fn html(s: &Summary) -> Result { let d = D::of(&sec); let mut cards = vec![html::card(&sec, counts_card(&d)?)?]; if let Some(sf) = d.opt("acmg_sf")? - && let Some(card) = sf_card(&sf)? + && let Some(card) = sf_card(&sf, consensus_ran(s)?)? { cards.push(html::card(&sec, card)?); } diff --git a/rust/crates/og-render/src/sections/annotsv.rs b/rust/crates/og-render/src/sections/annotsv.rs index 37caf236a..b3594cdf9 100644 --- a/rust/crates/og-render/src/sections/annotsv.rs +++ b/rust/crates/og-render/src/sections/annotsv.rs @@ -17,11 +17,21 @@ use crate::{html, text}; const TITLE: &str = "Structural Variants, Class 4 and 5 (AnnotSV)"; -/// How many callers saw the SV. -pub fn support_text(x: &D<'_>) -> Result { +/// Why an SV's caller support is not known: step 22's consensus ran +/// (`consensus`, the section's flag) and cannot tell, or it did not run. +pub fn unknown_reason(consensus: bool) -> &'static str { + if consensus { + "step 22's consensus cannot tell" + } else { + "no step 22 consensus" + } +} + +/// How many callers saw the SV; `consensus` is the section's flag. +pub fn support_text(x: &D<'_>, consensus: bool) -> Result { let s = x.at("support")?; if s.is_none() { - return Ok("not known (no step 22 consensus)".to_owned()); + return Ok(format!("not known ({})", unknown_reason(consensus))); } if s.is_num(1) { return Ok(format!("single caller ({})", x.s("caller")?)); @@ -115,7 +125,23 @@ pub fn lines(d: &D<'_>) -> Result, Malformed> { if count.truthy() { let consensus = d.at("consensus")?.truthy(); let single = if consensus { - d.s("single_caller")? + // The consensus ran, but a row it cannot tell has no support: + // count those apart, so "single caller: 0" never reads as + // "every SV had two callers". + let mut unknown = 0; + if let Some(rows) = d.opt("rows")? { + for x in rows.items()? { + if x.at("support")?.is_none() { + unknown += 1; + } + } + } + let single = d.s("single_caller")?; + if unknown > 0 { + format!("{single}, not known: {unknown}") + } else { + single + } } else { "not known".to_owned() }; @@ -158,6 +184,7 @@ pub fn text(s: &Summary) -> Result, Malformed> { } let d = D::of(&s.section("annotsv")); w.extend(lines(&d)?.iter().map(|l| format!(" {l}"))); + let consensus = d.at("consensus")?.truthy(); for x in d.at("rows")?.items()? { w.push(format!( " {} {} class {} {} support: {}", @@ -165,7 +192,7 @@ pub fn text(s: &Summary) -> Result, Malformed> { x.s("sv")?, x.s("acmg_class")?, genes_text(&x)?, - support_text(&x)? + support_text(&x, consensus)? )); for f in flags(&x)? { w.push(format!(" {f}")); @@ -215,6 +242,7 @@ pub fn html(s: &Summary) -> Result { } let rows = d.opt("rows")?; if let Some(rows) = &rows { + let consensus = d.at("consensus")?.truthy(); let mut cells = Vec::new(); for x in rows.items()? { let checks = flags(&x)?.join("; "); @@ -222,7 +250,7 @@ pub fn html(s: &Summary) -> Result { Cell::Text(sv_cell(&x)?), Cell::Text(x.s("acmg_class")?), Cell::Text(genes_text(&x)?), - Cell::Text(support_text(&x)?), + Cell::Text(support_text(&x, consensus)?), Cell::Text(if checks.is_empty() { "none".to_owned() } else { @@ -338,7 +366,7 @@ mod tests { DEL chr1:1000-50005A<B, C&D, G1 and 1 more\ 2 callers (manta, delly)on exon edges: exon 2; benign-set AF 0.001 (gnomAD); \ rule R1: loss <of> function & more{}\ - INS chr3:74no genenot known (no step 22 consensus)\ + INS chr3:74no genenot known (step 22's consensus cannot tell)\ none{}", viewer("chr1:1000-5000"), viewer("chr3:7") diff --git a/tests/parity/gen/report-corpus.sh b/tests/parity/gen/report-corpus.sh index 29ca21a4e..48577cd07 100644 --- a/tests/parity/gen/report-corpus.sh +++ b/tests/parity/gen/report-corpus.sh @@ -70,6 +70,13 @@ while IFS=$'\t' read -r case inputs args; do done (cd "$dir" && "$og" summary collect "${keep[@]}" --out "../../${case}.json" > /dev/null 2>&1) \ || rm -f "${case}.json" + # The time of writing, fixed, so a report-render golden of a collected + # summary (or of a change of one) stays true on every run. + if [ -s "${case}.json" ]; then + # sed, not jq: a summary may hold NaN or Infinity on purpose. + sed -E 's/^( *"generated_utc": )"[^"]*"/\1"2026-01-02 03:04 UTC"/' "${case}.json" > "${case}.json.t" + mv "${case}.json.t" "${case}.json" + fi done < folders/cases.tsv rm -rf folders diff --git a/tests/parity/golden/report-render/a-escape/a-escape.html b/tests/parity/golden/report-render/a-escape/a-escape.html new file mode 100644 index 000000000..d817fa0f8 --- /dev/null +++ b/tests/parity/golden/report-render/a-escape/a-escape.html @@ -0,0 +1,920 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West <Eurasia>95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ <b>W</b> ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest <Eurasia>: Continental groups: 95% (bootstrap range 93% to 97%)West <Eurasia>95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH<b>&"x'
    +
    Contamination (haplocheck)YES, two mtDNA haplogroups in the reads (another person's DNA?) (level 0.4<)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/"><script>alert(1)</script> (opens a website; the address carries the haplogroup)
    +
    <i>YFull</i> & cohttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/"x"&y/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1<R>1M1&M2
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS<393>13high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    chr1:1-2 <GENE>

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_<BA>2000 BCESpainA & B10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    C<A>D & "x"PGS0000180.5100/12075 (EUR)HR <1.5>
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100C<A>D & "x" (PGS000018): 75 (EUR)C<A>D & "x" (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-escape/a-escape.txt b/tests/parity/golden/report-render/a-escape/a-escape.txt new file mode 100644 index 000000000..f26fcffa2 --- /dev/null +++ b/tests/parity/golden/report-render/a-escape/a-escape.txt @@ -0,0 +1,439 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H&"x' + Contamination (haplocheck): YES, two mtDNA haplogroups in the reads (another person's DNA?) (level 0.4<) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/"> + YFull & co: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/"x"&y/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS<393> 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + chr1:1-2 + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_ (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CD & "x" 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR <1.5> + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-failed/a-failed.html b/tests/parity/golden/report-render/a-failed/a-failed.html new file mode 100644 index 000000000..c27e3035e --- /dev/null +++ b/tests/parity/golden/report-render/a-failed/a-failed.html @@ -0,0 +1,860 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +

    Y Placement on the Current Public Tree

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +

    Y-STR Markers (HipSTR)

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: why: <b>&'"
    +
    StatusFailed
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-failed/a-failed.txt b/tests/parity/golden/report-render/a-failed/a-failed.txt new file mode 100644 index 000000000..2f9cfb1e9 --- /dev/null +++ b/tests/parity/golden/report-render/a-failed/a-failed.txt @@ -0,0 +1,405 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [FAILED: why: &'"] + +## Mitochondrial Haplogroup +--- + [FAILED: why: &'"] + +## Y-Chromosome Haplogroup (Yleaf) +--- + [FAILED: why: &'"] + +## Y Placement on the Current Public Tree +--- + [FAILED: why: &'"] + +## Y-STR Markers (HipSTR) +--- + [FAILED: why: &'"] + +## Archaic Ancestry (IBDmix, step 43) +--- + [FAILED: why: &'"] + +## Ancient Populations (AADR PCA, step 44) +--- + [FAILED: why: &'"] + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [FAILED: why: &'"] + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-full/a-full.html b/tests/parity/golden/report-render/a-full/a-full.html new file mode 100644 index 000000000..09bcbdeff --- /dev/null +++ b/tests/parity/golden/report-render/a-full/a-full.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-full/a-full.txt b/tests/parity/golden/report-render/a-full/a-full.txt new file mode 100644 index 000000000..cec992442 --- /dev/null +++ b/tests/parity/golden/report-render/a-full/a-full.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-missing/a-missing.html b/tests/parity/golden/report-render/a-missing/a-missing.html new file mode 100644 index 000000000..45dc102e4 --- /dev/null +++ b/tests/parity/golden/report-render/a-missing/a-missing.html @@ -0,0 +1,813 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-missing/a-missing.txt b/tests/parity/golden/report-render/a-missing/a-missing.txt new file mode 100644 index 000000000..05acd591c --- /dev/null +++ b/tests/parity/golden/report-render/a-missing/a-missing.txt @@ -0,0 +1,373 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-no-painting/a-no-painting.html b/tests/parity/golden/report-render/a-no-painting/a-no-painting.html new file mode 100644 index 000000000..1696f1a8b --- /dev/null +++ b/tests/parity/golden/report-render/a-no-painting/a-no-painting.html @@ -0,0 +1,919 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-no-painting/a-no-painting.txt b/tests/parity/golden/report-render/a-no-painting/a-no-painting.txt new file mode 100644 index 000000000..2c6e0aff7 --- /dev/null +++ b/tests/parity/golden/report-render/a-no-painting/a-no-painting.txt @@ -0,0 +1,440 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Chromosome painting: none (no chromosome long enough) + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-numbers/a-numbers.txt b/tests/parity/golden/report-render/a-numbers/a-numbers.txt new file mode 100644 index 000000000..27583c4bc --- /dev/null +++ b/tests/parity/golden/report-render/a-numbers/a-numbers.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 100% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R 2.0D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + 1 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (51.2 Mb in 120 segments) + Denisovan: 0.01% (0.0 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5.5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + 7 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.25 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-painting/a-painting.html b/tests/parity/golden/report-render/a-painting/a-painting.html new file mode 100644 index 000000000..68deafaeb --- /dev/null +++ b/tests/parity/golden/report-render/a-painting/a-painting.html @@ -0,0 +1,923 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-painting/a-painting.txt b/tests/parity/golden/report-render/a-painting/a-painting.txt new file mode 100644 index 000000000..dae609fbd --- /dev/null +++ b/tests/parity/golden/report-render/a-painting/a-painting.txt @@ -0,0 +1,442 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Wide 0% (0% to 6%) + Left out of the model: Oceania (continental and regional group), Papua (regional group), Odd (name) (x group), Plain. The panel has fewer than 12 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting, share of the painted genome: Africa 30%, West Eurasia 70% + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-partial/a-partial.html b/tests/parity/golden/report-render/a-partial/a-partial.html new file mode 100644 index 000000000..781b98035 --- /dev/null +++ b/tests/parity/golden/report-render/a-partial/a-partial.html @@ -0,0 +1,884 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-partial/a-partial.txt b/tests/parity/golden/report-render/a-partial/a-partial.txt new file mode 100644 index 000000000..f89aa2bcf --- /dev/null +++ b/tests/parity/golden/report-render/a-partial/a-partial.txt @@ -0,0 +1,389 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- +## Mitochondrial Haplogroup +--- +## Y-Chromosome Haplogroup (Yleaf) +--- +## Y Placement on the Current Public Tree +--- +## Y-STR Markers (HipSTR) +--- +## Archaic Ancestry (IBDmix, step 43) +--- +## Ancient Populations (AADR PCA, step 44) +--- +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html new file mode 100644 index 000000000..b11b722a4 --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.html @@ -0,0 +1,921 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt new file mode 100644 index 000000000..0d6b1b11b --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-raw/a-prs-raw.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 + T2D 0.1 (10/20 variants matched) PGS000014 + Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html new file mode 100644 index 000000000..5d440c4d2 --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.html @@ -0,0 +1,923 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt new file mode 100644 index 000000000..d8bda9460 --- /dev/null +++ b/tests/parity/golden/report-render/a-prs-sex/a-prs-sex.txt @@ -0,0 +1,442 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + Prostate 1 (5/6 variants matched) PGS2 not applicable to the declared sex (male-specific score) + Breast 2 (7/9 variants matched) PGS3 percentile 40 (AFR) no published OR or HR for AFR + Height 3 (1/2 variants matched) PGS4 percentile 60 (AFR) no published OR or HR for AFR; evaluated in EUR, AFR + Percentile: where the score falls among the AFR samples of the reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. Rows on chrX were left out, because the sample's sex was not given: PGS3 (3). Give the sex to score them (docs/25-prs.md). No sex was declared, so these sex-specific scores are shown for any sex: PGS3 (female). Give the sex to mark a score of the other sex not applicable (docs/25-prs.md). + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-since/a-since.html b/tests/parity/golden/report-render/a-since/a-since.html new file mode 100644 index 000000000..30277ba22 --- /dev/null +++ b/tests/parity/golden/report-render/a-since/a-since.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-since/a-since.txt b/tests/parity/golden/report-render/a-since/a-since.txt new file mode 100644 index 000000000..470d96bc1 --- /dev/null +++ b/tests/parity/golden/report-render/a-since/a-since.txt @@ -0,0 +1,444 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [New since 2026-01-01T00:00:00Z] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [New since 2026-01-01T00:00:00Z] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [New since 2026-01-01T00:00:00Z] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-stale/a-stale.html b/tests/parity/golden/report-render/a-stale/a-stale.html new file mode 100644 index 000000000..82b0ab21e --- /dev/null +++ b/tests/parity/golden/report-render/a-stale/a-stale.html @@ -0,0 +1,930 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/a-stale/a-stale.txt b/tests/parity/golden/report-render/a-stale/a-stale.txt new file mode 100644 index 000000000..b7889214f --- /dev/null +++ b/tests/parity/golden/report-render/a-stale/a-stale.txt @@ -0,0 +1,449 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [STALE: why: &'"] + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [STALE: why: &'"] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + [STALE: why: &'"] + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + [STALE: why: &'"] + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [STALE: why: &'"] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + [STALE: why: &'"] + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + [STALE: why: &'"] + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [STALE: why: &'"] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-unreadable/a-unreadable.html b/tests/parity/golden/report-render/a-unreadable/a-unreadable.html new file mode 100644 index 000000000..48103d733 --- /dev/null +++ b/tests/parity/golden/report-render/a-unreadable/a-unreadable.html @@ -0,0 +1,860 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +

    Y Placement on the Current Public Tree

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +

    Y-STR Markers (HipSTR)

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: why: <b>&'"
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-unreadable/a-unreadable.txt b/tests/parity/golden/report-render/a-unreadable/a-unreadable.txt new file mode 100644 index 000000000..58e5b48cb --- /dev/null +++ b/tests/parity/golden/report-render/a-unreadable/a-unreadable.txt @@ -0,0 +1,397 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [could not be read: why: &'"] +## Mitochondrial Haplogroup +--- + [could not be read: why: &'"] +## Y-Chromosome Haplogroup (Yleaf) +--- + [could not be read: why: &'"] +## Y Placement on the Current Public Tree +--- + [could not be read: why: &'"] +## Y-STR Markers (HipSTR) +--- + [could not be read: why: &'"] +## Archaic Ancestry (IBDmix, step 43) +--- + [could not be read: why: &'"] +## Ancient Populations (AADR PCA, step 44) +--- + [could not be read: why: &'"] +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [could not be read: why: &'"] +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/a-y-calls/a-y-calls.html b/tests/parity/golden/report-render/a-y-calls/a-y-calls.html new file mode 100644 index 000000000..f1b84a346 --- /dev/null +++ b/tests/parity/golden/report-render/a-y-calls/a-y-calls.html @@ -0,0 +1,909 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)not checked (needs step 20's Mutect2 chrM calls)
    +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +

    Ancestral inside the terminal branch: M1,M2

    +

    Ancestral on the path, outvoted by the SNPs below it: None

    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + +
    #Ancient groupDatesCountryPlacePeople
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/a-y-calls/a-y-calls.txt b/tests/parity/golden/report-render/a-y-calls/a-y-calls.txt new file mode 100644 index 000000000..734f14e56 --- /dev/null +++ b/tests/parity/golden/report-render/a-y-calls/a-y-calls.txt @@ -0,0 +1,424 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): not checked (needs step 20's Mutect2 chrM calls) + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + Ancestral inside the terminal branch: M1,M2 + Ancestral on the path, outvoted by the SNPs below it: None + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt new file mode 100644 index 000000000..ef251f96e --- /dev/null +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -0,0 +1,669 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC + Database re-check: 2021-03-05 00:00:00 UTC: ClinVar newer-release +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + [New since 2021-01-01 00:00 UTC] + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + [New since 2021-01-01 00:00 UTC] + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + [New since 2021-01-01 00:00 UTC] + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2021-01-01 00:00 UTC] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2021-03-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [New since 2021-01-01 00:00 UTC] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [New since 2021-01-01 00:00 UTC] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of 2021-03-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2021-01-01 00:00 UTC] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + [New since 2021-01-01 00:00 UTC] + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + [New since 2021-01-01 00:00 UTC] + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + [New since 2021-01-01 00:00 UTC] + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [New since 2021-01-01 00:00 UTC] + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + [New since 2021-01-01 00:00 UTC] + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + [New since 2021-01-01 00:00 UTC] + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + [New since 2021-01-01 00:00 UTC] + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + [New since 2021-01-01 00:00 UTC] + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + [New since 2021-01-01 00:00 UTC] + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + [New since 2021-01-01 00:00 UTC] + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + [New since 2021-01-01 00:00 UTC] + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + [New since 2021-01-01 00:00 UTC] + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2021-01-01 00:00 UTC] + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [New since 2021-01-01 00:00 UTC] + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + [New since 2021-01-01 00:00 UTC] + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + [New since 2021-01-01 00:00 UTC] + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + [New since 2021-01-01 00:00 UTC] + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + [New since 2021-01-01 00:00 UTC] + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + [New since 2021-01-01 00:00 UTC] + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + [New since 2021-01-01 00:00 UTC] + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + [New since 2021-01-01 00:00 UTC] + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + [New since 2021-01-01 00:00 UTC] + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + [New since 2021-01-01 00:00 UTC] + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + [New since 2021-01-01 00:00 UTC] + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + [New since 2021-01-01 00:00 UTC] + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + [New since 2021-01-01 00:00 UTC] + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + [New since 2021-01-01 00:00 UTC] + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + [New since 2021-01-01 00:00 UTC] + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [New since 2021-01-01 00:00 UTC] + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + [New since 2021-01-01 00:00 UTC] + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + [New since 2021-01-01 00:00 UTC] + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + [New since 2021-01-01 00:00 UTC] + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + [New since 2021-01-01 00:00 UTC] + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + [New since 2021-01-01 00:00 UTC] + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + [New since 2021-01-01 00:00 UTC] + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 1 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt new file mode 100644 index 000000000..e2600a51d --- /dev/null +++ b/tests/parity/golden/report-render/all/all.txt @@ -0,0 +1,624 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Quality control +--- + Mean depth: 31.2x + Alignment: 1000 reads in, 1000 primary records in the BAM + Inferred sex: male + Declared sex: male + Sex from the reads (somalier): male (declared and measured sex agree) + Contamination (VerifyBamID2 FREEMIX): 0.0010 (warning above ) + Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error. + +## Genes This Genome Could Not Read Reliably +--- + 217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more. + Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference) + Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx + A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section. + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: 2026-10-01 + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 0 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: 20250901; step 6 used the ClinVar file of 2026-10-01 + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band) + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY or chrX: not detected above 10% (None) + From depth: estimated share of the cells that lost one X 2.0% (95% range -1.0% to 5.0%); None to autosome depth ratio 0.980, 1.0 expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) not run + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: IPD-IMGT/HLA 3.60 extra + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32): *1/*2; Cyrius (step 21): *2/*1 + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + All major steps completed. + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +Run manifest: run_manifest.tsv (pipeline commit unknown, 0 images) +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-float--inf/c-float--inf.txt b/tests/parity/golden/report-render/c-float--inf/c-float--inf.txt new file mode 100644 index 000000000..16d839961 --- /dev/null +++ b/tests/parity/golden/report-render/c-float--inf/c-float--inf.txt @@ -0,0 +1,411 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 1 (1 deletions, 0 duplications) + Significant (e-val < 0.01): 1 + Significant after filters: 1; no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 0 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF -inf filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level -inf% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + No CHIP gene has the depth to find a clone: no result either way. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality -inf, filter PASS), not resolved: no comparison: one of them has no call + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality -inf, filter PASS), not resolved + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality *, filter PASS), not resolved + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality -inf, filter PASS) + Reading: SMN1 not resolved (quality under 20 or filter not PASS): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality -inf, filter PASS); chr7:5980001-5990000 3 (quality -inf, filter LowQual): no region with a whole copy number, filter PASS and quality 20 or more + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01 (quality -inf) / A*01:01 (quality -inf); low confidence (T1K quality 0 or below), not passed to PharmCAT + Coeliac DQ: not determined (HLA-DQA1 not typed; HLA-DQB1 not typed) + DQB1*02 copies: not determined + A*31:01 not determined (HLA-A low confidence): carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 not determined (HLA-DQB1 not typed): narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 not determined (HLA-DRB1 not typed): multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [could not be read: S_roh.txt has a run of length -inf] +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-float-inf/c-float-inf.txt b/tests/parity/golden/report-render/c-float-inf/c-float-inf.txt new file mode 100644 index 000000000..2a49c2e2c --- /dev/null +++ b/tests/parity/golden/report-render/c-float-inf/c-float-inf.txt @@ -0,0 +1,418 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 1 (1 deletions, 0 duplications) + Significant (e-val < 0.01): 0 + Significant after filters: 0; no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 0 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF inf filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level inf% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level inf% + m.301_399del (99 bp) level inf% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + No CHIP gene has the depth to find a clone: no result either way. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality inf, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality inf, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality *, filter PASS), not resolved + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality inf, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality inf, filter PASS); chr7:5980001-5990000 3 (quality inf, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01 (quality inf) / A*01:01 (quality inf) + Coeliac DQ: not determined (HLA-DQA1 not typed; HLA-DQB1 not typed) + DQB1*02 copies: not determined + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 not determined (HLA-DQB1 not typed): narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 not determined (HLA-DRB1 not typed): multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia inf% (inf% to inf%) + Africa inf% (inf% to inf%) + Regional groups (fraction, bootstrap range): + Iberia inf% (inf% to inf%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [could not be read: S_roh.txt has a run of length inf] +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-float-nan/c-float-nan.txt b/tests/parity/golden/report-render/c-float-nan/c-float-nan.txt new file mode 100644 index 000000000..0a44d80db --- /dev/null +++ b/tests/parity/golden/report-render/c-float-nan/c-float-nan.txt @@ -0,0 +1,407 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 1 (1 deletions, 0 duplications) + Significant (e-val < 0.01): 1 + Significant after filters: 1; no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 1 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 0 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 0 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 1 + m.3243A>G (MT-TL1) AF nan filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level nan% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + [could not be read: ValueError: cannot convert float NaN to integer] +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality nan, filter PASS), not resolved: no comparison: one of them has no call + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality nan, filter PASS), not resolved + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality *, filter PASS), not resolved + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality nan, filter PASS) + Reading: SMN1 not resolved (quality under 20 or filter not PASS): no carrier reading + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality nan, filter PASS); chr7:5980001-5990000 3 (quality nan, filter LowQual): no region with a whole copy number, filter PASS and quality 20 or more + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01 (quality nan) / A*01:01 (quality nan) + Coeliac DQ: not determined (HLA-DQA1 not typed; HLA-DQB1 not typed) + DQB1*02 copies: not determined + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + B*15:02 not determined (HLA-B not typed): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B not typed): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B not typed): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B not typed): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + C*06:02 not determined (HLA-C not typed): psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 not determined (HLA-DQB1 not typed): narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 not determined (HLA-DRB1 not typed): multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 not determined (HLA-DRB1 not typed): rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08) did not run + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + [could not be read: S_roh.txt has a run of length nan] +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40; depth unknown (no total_reads or read_lengths in the summary): not checked + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/c-full/c-full.txt b/tests/parity/golden/report-render/c-full/c-full.txt new file mode 100644 index 000000000..613ed2877 --- /dev/null +++ b/tests/parity/golden/report-render/c-full/c-full.txt @@ -0,0 +1,442 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Short not available (not available/not available variants matched) PGS1 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html new file mode 100644 index 000000000..6872ae388 --- /dev/null +++ b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.html @@ -0,0 +1,672 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + +
    GeneVariantGenotypeEvidenceViewer
    +

    Secondary findings: not assessed, acmg_sf.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets)

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list: not made, carrier_genes.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt new file mode 100644 index 000000000..c8e940efc --- /dev/null +++ b/tests/parity/golden/report-render/cb-no-assets/cb-no-assets.txt @@ -0,0 +1,266 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary findings: not assessed, acmg_sf.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets) + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list: not made, carrier_genes.tsv is not in nowhere: the report needs the repository's assets/ folder (render_report.py --assets) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html new file mode 100644 index 000000000..e9a5fbb73 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's dosage table has no row)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt new file mode 100644 index 000000000..2d4f39b53 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's dosage table has no row) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html new file mode 100644 index 000000000..7d6bb92a9 --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt new file mode 100644 index 000000000..94b2ba22f --- /dev/null +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html new file mode 100644 index 000000000..8faaf8ce0 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -0,0 +1,699 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetA<&>'"Pathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    <b>chr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (x <y> & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt new file mode 100644 index 000000000..c4237beb3 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + A<&>'" chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (x & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html new file mode 100644 index 000000000..f71d180af --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.html @@ -0,0 +1,564 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Genes This Genome Could Not Read Reliably

    +

    Step 16b · Failed · link to this section

    +
    FAILED: note of callability <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of clinvar <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of clinical <&>
    +
    StatusFailed
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +
    FAILED: note of clinical <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of cpsr <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of slivar <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of carrier <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: note of couple <&>
    +
    StatusFailed
    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt new file mode 100644 index 000000000..5d4901536 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-failed/m-clinical-failed.txt @@ -0,0 +1,186 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Genes This Genome Could Not Read Reliably +--- + [FAILED: note of callability <&>] + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [FAILED: note of clinvar <&>] + +## Clinical Variant Filter +--- + [FAILED: note of clinical <&>] + +## Cancer Predisposition Screening (CPSR) +--- + [FAILED: note of cpsr <&>] + +## Variant Prioritization (slivar) +--- + [FAILED: note of slivar <&>] + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [FAILED: note of carrier <&>] + +## Couple Carrier Screen (step 39) +--- + [FAILED: note of couple <&>] + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html new file mode 100644 index 000000000..f7824baab --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -0,0 +1,719 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    STALE: note of clinvar <&>
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    +
    STALE: note of clinvar <&>
    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    +
    STALE: note of clinvar <&>
    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +
    STALE: note of clinical <&>
    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    +
    STALE: note of clinical <&>
    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    STALE: note of cpsr <&>
    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    STALE: note of slivar <&>
    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +
    STALE: note of carrier <&>
    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +
    STALE: note of couple <&>
    +

    Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt new file mode 100644 index 000000000..e34bf5c21 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -0,0 +1,306 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [STALE: note of clinvar <&>] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + [STALE: note of clinical <&>] + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + [STALE: note of cpsr <&>] + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [STALE: note of slivar <&>] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [STALE: note of carrier <&>] + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + [STALE: note of couple <&>] + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html new file mode 100644 index 000000000..5460283e0 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.html @@ -0,0 +1,564 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Genes This Genome Could Not Read Reliably

    +

    Step 16b · Failed · link to this section

    +
    could not be read: note of callability <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of clinvar <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of clinical <&>
    +
    StatusUnreadable
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +
    could not be read: note of clinical <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of cpsr <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of slivar <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of carrier <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    could not be read: note of couple <&>
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt new file mode 100644 index 000000000..44596563f --- /dev/null +++ b/tests/parity/golden/report-render/m-clinical-unreadable/m-clinical-unreadable.txt @@ -0,0 +1,179 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Genes This Genome Could Not Read Reliably +--- + [could not be read: note of callability <&>] +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [could not be read: note of clinvar <&>] +## Clinical Variant Filter +--- + [could not be read: note of clinical <&>] +## Cancer Predisposition Screening (CPSR) +--- + [could not be read: note of cpsr <&>] +## Variant Prioritization (slivar) +--- + [could not be read: note of slivar <&>] +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [could not be read: note of carrier <&>] +## Couple Carrier Screen (step 39) +--- + [could not be read: note of couple <&>] +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html new file mode 100644 index 000000000..fe45fe133 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below None or DP below None: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below None or DP below None), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF: unknown for every hit (no VEP output)

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt new file mode 100644 index 000000000..ded5b0175 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -0,0 +1,293 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below None or DP below None), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF: unknown for every hit (no VEP output) + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html new file mode 100644 index 000000000..77f14856c --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -0,0 +1,742 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A, BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A and more3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T, MUTYH chr1:45331556 C>T and more2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C, BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T, . chr2:100 A>G, GLA chrX:101398000 C>T and more0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 50 of 60)

    + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    Hit at a known lab-construct site past the first 50: MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)

    +

    Hit at a known lab-construct site past the first 50: SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped <x> (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

    +

    Hit at a known lab-construct site past the first 50: BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge)

    +

    Hit at a known lab-construct site past the first 50: . chr2:100 A>G het: known lab-construct site (lentiviral): not checked

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt new file mode 100644 index 000000000..6c35ceac1 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -0,0 +1,426 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 12 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + Hits at a known lab-construct site past the first 50: + MUTYH chr1:45331556 C>T het: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + SMN1 chr5:70951946 C>T hom: known lab-construct site (pcDNA3): clipped (3 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + BTD chr3:15645186 G>C het: known lab-construct site (EGFP): clear (0 of 4 alt reads and 0 of 10 ref reads clipped at an exon edge) + . chr2:100 A>G het: known lab-construct site (lentiviral): not checked + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html new file mode 100644 index 000000000..d635a5050 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -0,0 +1,659 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars3 stars22 stars: 3 hits with 2 review stars2 stars31 star: 1 hit with 1 review star1 star10 stars: 2 hits with 0 review stars0 stars2
    +
    ClinVar matches0
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Hits at a known lab-construct site (check the reads)1
    +
    ClinVar file dateunknown
    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    cDNA scan of every exon: not run: no BAM

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt new file mode 100644 index 000000000..c7056e920 --- /dev/null +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -0,0 +1,250 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 0 + ClinVar file date: unknown + cDNA scan of every exon: not run: no BAM + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html new file mode 100644 index 000000000..3b396cf6f --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -0,0 +1,707 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt new file mode 100644 index 000000000..901ce6cc7 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -0,0 +1,298 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: the partner. Genes where both carry a change: 0; X-linked findings: 0; genes where only one partner carries a change: 0 + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html new file mode 100644 index 000000000..d866af2b6 --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -0,0 +1,710 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: .

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt new file mode 100644 index 000000000..dfd48d62c --- /dev/null +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -0,0 +1,300 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## Couple Carrier Screen (step 39) +--- + Partner: P<2>. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P<2>: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P<2>: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html new file mode 100644 index 000000000..88a023be6 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -0,0 +1,681 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportNo HTML
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt new file mode 100644 index 000000000..438e209b2 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -0,0 +1,277 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html new file mode 100644 index 000000000..158a4f7c6 --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -0,0 +1,688 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown.

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +
    +

    Files of this step, beside this report: CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt new file mode 100644 index 000000000..9e9ae40ff --- /dev/null +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -0,0 +1,283 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification table has no CLASSIFICATION column. + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + The classification table has no CPSR_CLASSIFICATION column, so no disagreement can be shown. + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html new file mode 100644 index 000000000..25128ef05 --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -0,0 +1,699 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    carrier list <unreadable>

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt new file mode 100644 index 000000000..2ed7ebc29 --- /dev/null +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -0,0 +1,294 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, ? genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 2 weak call(s), 1 of unknown frequency), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + carrier list + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html new file mode 100644 index 000000000..f3204a08b --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -0,0 +1,698 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt new file mode 100644 index 000000000..760948d7d --- /dev/null +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -0,0 +1,296 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + [New since 2026-01-01T00:00:00Z] + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + [New since 2026-01-01T00:00:00Z] + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 23 trans, 1 cis, 1 unknown of 26 pairs + G1 chr1:10 A>G + chr1:15 C>T in trans on 1 of 2 reads or read pairs + G2 chr1:20 A>G + chr1:25 C>T in trans on 2 of 3 reads or read pairs + G3 chr1:30 A>G + chr1:35 C>T in trans on 3 of 4 reads or read pairs + G4 chr1:40 A>G + chr1:45 C>T in trans on 4 of 5 reads or read pairs + G5 chr1:50 A>G + chr1:55 C>T in trans on 5 of 6 reads or read pairs + G6 chr1:60 A>G + chr1:65 C>T in trans on 6 of 7 reads or read pairs + G7 chr1:70 A>G + chr1:75 C>T in trans on 7 of 8 reads or read pairs + G8 chr1:80 A>G + chr1:85 C>T in trans on 8 of 9 reads or read pairs + G9 chr1:90 A>G + chr1:95 C>T in trans on 9 of 10 reads or read pairs + G10 chr1:100 A>G + chr1:105 C>T in trans on 10 of 11 reads or read pairs + G11 chr1:110 A>G + chr1:115 C>T in trans on 11 of 12 reads or read pairs + G12 chr1:120 A>G + chr1:125 C>T in trans on 12 of 13 reads or read pairs + G13 chr1:130 A>G + chr1:135 C>T in trans on 13 of 14 reads or read pairs + G14 chr1:140 A>G + chr1:145 C>T in trans on 14 of 15 reads or read pairs + G15 chr1:150 A>G + chr1:155 C>T in trans on 15 of 16 reads or read pairs + G16 chr1:160 A>G + chr1:165 C>T in trans on 16 of 17 reads or read pairs + G17 chr1:170 A>G + chr1:175 C>T in trans on 17 of 18 reads or read pairs + G18 chr1:180 A>G + chr1:185 C>T in trans on 18 of 19 reads or read pairs + G19 chr1:190 A>G + chr1:195 C>T in trans on 19 of 20 reads or read pairs + G20 chr1:200 A>G + chr1:205 C>T in trans on 20 of 21 reads or read pairs + ... 3 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + [New since 2026-01-01T00:00:00Z] + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html new file mode 100644 index 000000000..3fec4ad98 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -0,0 +1,654 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown2.5 / 1 / 1
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt new file mode 100644 index 000000000..2e036d5f3 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -0,0 +1,273 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + Phase from the reads: 2.5 trans, 1 cis, 1 unknown of 26 pairs + ... 2.5 more in the pairs table + (A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/_compound_het_pairs.tsv) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html new file mode 100644 index 000000000..475f4c332 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -0,0 +1,672 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt new file mode 100644 index 000000000..39e44dd84 --- /dev/null +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -0,0 +1,271 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC + Latest run-all.sh run: 2020-01-01 00:00 UTC +================================================================================ + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## ClinVar Pathogenic Screen +--- + Pathogenic/Likely Pathogenic hits: 8 + Low-confidence calls (GQ below 20 or DP below 8), listed but not counted above: 2 + ClinVar file date: unknown + By review status: 4 stars 0, 3 stars 2, 2 stars 3, 1 star 1, 0 stars 2 + cDNA read check (alt reads clipped at exon edges): 1 flagged + gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1% + + Hits (best-reviewed first, up to 50): gene, position, genotype, significance [review status] stars + CFTR chr7:117559590 ATCT>A het Pathogenic [practice guideline] 4* + frequency: gnomAD AF 0.008 + call: low-confidence call (GQ 15, DP 30): check the reads + reads: not checked: not in the read-check table + BRCA1,NBR2 chr17:43057100 C>T het Pathogenic [reviewed by expert panel] 3* (part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypes) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + HFE chr6:26092913 G>A het Pathogenic [reviewed by expert panel] 3* + frequency: gnomAD AF 0.06; common: unlikely to be a high-penetrance finding + reads: not checked + MUTYH chr1:45331556 C>T het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF 0.002 + reads: known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge) + HBA1 chr16:176700 G>A het Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + SMN1 chr5:70951946 C>T hom Pathogenic [criteria provided, multiple submitters, no conflicts] 2* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GJB2 chr13:20189473 C>T one copy, other copy not called ref (1/.) Likely pathogenic [criteria provided, single submitter] 1* (combined allele of chr13:20189473 C>T + chr13:20189475 G>A) + frequency: gnomAD AF 0.03; common: unlikely to be a high-penetrance finding + call: low-confidence call (GQ 40, DP 5): check the reads + reads: not checked: not in the read-check table + BTD chr3:15645186 G>C het Pathogenic/Likely pathogenic [criteria provided, conflicting classifications] 1* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + . chr2:100 A>G het . [.] 0* + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + GLA chrX:101398000 C>T 1 Pathogenic [no assertion criteria provided] 0* (possibly one allele with chrX:101398004 G>A: check ClinVar for a combined record) + frequency: gnomAD AF unknown + reads: not checked: not in the read-check table + cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads) + chr1:100-200: 2 junctions, 5 reads + A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there. + Known deep intronic sites (always reported): gene, variant, call + CFTR c.3718-2477C>T chr7:117639961 C>T no call + Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way. + Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked. + +## Clinical Variant Filter +--- + Clinical variants: 5 in 3 genes + By impact: . 1, HIGH 3, MODERATE 1 + Frequency unknown (not counted as rare): 1 + Weak genotype calls (check the reads): 2 + Secondary-findings genes (ACMG SF v3.3, 84 genes): 3 ClinVar P/LP, 2 rare HIGH impact (listed apart: 1 weak call(s)), 2 class 4/5 SV(s), 3 not reported by the gene's rule + MUTYH chr1:45331556 C>T het ClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000) + BRCA1 chr17:43057100 C>T het ClinVar Pathogenic + GLA chrX:101398000 C>T 1 ClinVar Pathogenic + MUTYH chr1:45332000 G>A het stop_gained + MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant + MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (step 22's consensus cannot tell) + HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) + HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only + A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification. + +## Cancer Predisposition Screening (CPSR) +--- + HTML report in cpsr/ (open in a browser) + Classification breakdown (CLASSIFICATION): + Pathogenic: 1 + Likely_Pathogenic: 1 + VUS: 1 + Benign: 1 + .: 1 + ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown + Final P/LP rows that CPSR's own rules class benign or likely benign: 1 + Rows where ClinVar and CPSR's own class disagree on P/LP: 2 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1) + MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP + P/LP rows below the depth floor (DP below 8): 1 + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads + cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged + BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge) + CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen. + +## Variant Prioritization (slivar) +--- + Prioritized variants: 2 + Frequency unknown (prioritized, not counted as rare): 1 + Compound het candidates: 4 variants across 2 genes + (Candidates only: unphased single-sample data. See docs/31-slivar.md) + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:45338000-45340000 class 5 MUTYH support: not known (step 22's consensus cannot tell) + on exon edges: + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (step 22's consensus cannot tell) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (step 22's consensus cannot tell) + benign-set AF 0.001 (gnomAD) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (step 22's consensus cannot tell) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (step 22's consensus cannot tell) + DEL 3:15600000-15700000 class 5 BTD support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Carrier List (this sample) +--- + Carrier list (3292 genes): 8 finding(s), 1 set aside + MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic + HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic + CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic + GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic + BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic + HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own + Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) + Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) + Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way + Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35) + Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 30, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not assessed + SMN1 marker reading: SMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run). + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 30, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 40, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): 3 (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): not assessed (step 35's _cyp21a2_psv.tsv is not in this run's output) + Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1): not assessed (step 35's _cn_dosage.tsv is not in this run's output) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 3 rows (3 called); 3 with a deletion or a duplication + Deletion: CFTR region (CFTR_del, chr7:117500001-117600000), 1 of 2 copies + Duplication: x (DUP1, chr1:2-100), 3 of 2 copies + Deletion: x (GJB6, chr13:x-2), 1 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## Pharmacogenomics (PharmCAT) +--- + Report: pharmcat/S.report.json (PharmCAT 3.4.0) + HTML report beside it (open in a browser for full details) + PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone. + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 1 Not called: 0 Called without a function phenotype (no drug guidance): 0 + CYP2D6 *1/*4 Intermediate Metabolizer + CYP2C19 *1/*17 Rapid + WARNING: CYP2C19 has two possible phenotypes + WARNING: last + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## pypgx Pharmacogenomics +--- + Genes called: 3/6 + CYP2D6 diplotype: *1/*2 + PharmCAT vs pypgx conflicts: 1 + Scope differences (only one tool called): 2 + Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md) + Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads + Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads + CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95 + +## PGx copy number +--- + CYP2D6 Normal (pypgx, read depth) + CYP2A6 not called: pypgx failed (pypgx, read depth) + CYP2B6 not called: the CYP2D6 depth check failed (pypgx, read depth) + SLCO1B1 not called: pypgx gave no copy-number call (pypgx, read depth) + +## CYP2D6 across callers +--- + PharmCAT (step 36's call) *1/*4 + pypgx *1/*2 + Cyrius *2/*1 + pypgx and Cyrius agree: yes + Step 36: *1/*2, passed to PharmCAT (pypgx and Cyrius agree) + CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - Variant calling + - Paralog genes (Paraphase, PacBio HiFi) + - HLA typing (T1K) + - Polygenic risk scores + - Fine-grained ancestry (ADMIXTURE, RFMix) + - Structural variants (Manta) + - Structural variants (Delly) + - Copy number (CNVpytor) + - Repeat expansions (ExpansionHunter) + - Telomere content (TelomereHunter) + - Runs of homozygosity + - Mitochondrial haplogroup + - Y-chromosome haplogroup (Yleaf) + - Y placement on the current public tree + - Y-STR markers (HipSTR) + - Raw-data export (23andMe v5 layout) + - Blood groups (predicted) + - Lp(a): LPA KIV-2 repeat count + - MUC1 VNTR frameshifts (VNtyper) + - Locityper second opinion at hard loci + - Mitochondrial variants + - Traits panel + - Archaic ancestry (IBDmix) + - Ancient populations (AADR PCA) + - Viral DNA in the unmapped reads + - Symptom-driven ranking (Exomiser) + - Clonal haematopoiesis (CHIP) + - Mobile element insertions (MEGAnE) + - Mosaic chromosomal alterations (MoChA) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + - Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums + - Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in) + - MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them + - Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html new file mode 100644 index 000000000..234b3b3d1 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 1234

    +

    Files: consumer_export/S_23andme.txt and consumer_export/S_ancestry.txt

    +

    '--' because: low <depth> 9; zeta 5; alpha 5; one 1

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + + diff --git a/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt new file mode 100644 index 000000000..e1d9a0da8 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-reasons/s-consumer-reasons.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 1234 + Files: consumer_export/S_23andme.txt and consumer_export/S_ancestry.txt + '--' because: low 9; zeta 5; alpha 5; one 1 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html new file mode 100644 index 000000000..2390dc042 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.html @@ -0,0 +1,922 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt new file mode 100644 index 000000000..0768ecf09 --- /dev/null +++ b/tests/parity/golden/report-render/s-consumer-stale/s-consumer-stale.txt @@ -0,0 +1,441 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + [STALE: older export] + Sites with a genotype: 590000 of 0; '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html new file mode 100644 index 000000000..8dfd4400b --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt new file mode 100644 index 000000000..33e86cf31 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-chrx/s-sexloss-chrx.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrX: detected (allele fraction & depth) + From chrX allele fractions at 40 heterozygous sites: 12.5% (95% range 10.0% to ?) + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html new file mode 100644 index 000000000..32486a829 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt new file mode 100644 index 000000000..dc23c55e8 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-detected/s-sexloss-detected.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY: detected (depth below the floor) + From depth: estimated share of the cells that lost the Y 28.8% (95% range 25.0% to 33.0%); chrY to autosome depth ratio 0.712, None expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html new file mode 100644 index 000000000..584a23f25 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.html @@ -0,0 +1,923 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt new file mode 100644 index 000000000..f2d16991d --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-failed/s-sexloss-failed.txt @@ -0,0 +1,445 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + [FAILED: step 33 failed] + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html new file mode 100644 index 000000000..fdbc32688 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt new file mode 100644 index 000000000..b6b834a71 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-gain-stale/s-sexloss-gain-stale.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + [STALE: from an older run ] + chrY: an extra copy, not a loss (depth above 1) + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html new file mode 100644 index 000000000..8f53ca88d --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.html @@ -0,0 +1,924 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt new file mode 100644 index 000000000..1c67f391b --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-not-estimated/s-sexloss-not-estimated.txt @@ -0,0 +1,446 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY: not estimated (too few reads on chrY) + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html new file mode 100644 index 000000000..5ef547d91 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.html @@ -0,0 +1,925 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt new file mode 100644 index 000000000..4b3646409 --- /dev/null +++ b/tests/parity/golden/report-render/s-sexloss-odd/s-sexloss-odd.txt @@ -0,0 +1,447 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic loss of chromosome Y or X +--- + chrY or chrX: maybe (None) + From depth: estimated share of the cells that lost one X 5.0% (95% range ? to ?); to autosome depth ratio ?, None expected + Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md). + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ diff --git a/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html new file mode 100644 index 000000000..4c449b1c8 --- /dev/null +++ b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.html @@ -0,0 +1,926 @@ + + + + + + +OwnGenome Report + + + + + + diff --git a/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt new file mode 100644 index 000000000..98dc7c892 --- /dev/null +++ b/tests/parity/golden/report-render/s-sv-stale/s-sv-stale.txt @@ -0,0 +1,445 @@ +================================================================================ + GENOMICS ANALYSIS REPORT + Sample: S + Generated: 2026-01-02 03:04 UTC +================================================================================ + +################################################################################ +# 1. QUALITY: Can I trust this data? +################################################################################ + +## Variant Calling (DeepVariant) +--- + Total variants: 1 + PASS variants: 1 + SNPs: 0 Indels: 1 + Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own. + +################################################################################ +# 2. CLINICAL: Is there anything to take to a doctor? +################################################################################ + +## Symptom-Driven Ranking (Exomiser, step 48) +--- + Symptoms searched: Seizure (HP:0001250), HP:0000001 + 1. GENE1 (AD) score 0.9 (symptom match 0.8) + chr1-1-A-G 0/1 missense p.X ACMG LP; D1 + chr1-2-A-G 0/1 stop p.Y ACMG P; D1 + 2. GENE2 (AR) score 0.5 (symptom match 0.4) + chr2-1-A-G 1/1 splice c.1 ACMG VUS; D2 + A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md). In words: exomiser/S_exomiser.txt + +## Structural Variants (Manta) +--- + [STALE: why: &'"] + Total SVs: 3 PASS: 1 + Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease. + +## Structural Variants (Delly) +--- + [STALE: why: &'"] + Total SVs: 1 PASS: 1 + +## Copy Number Variants (CNVpytor) +--- + Total CNVs: 8 (5 deletions, 3 duplications) + Significant (e-val < 0.01): 7 + Significant after filters: 4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept + Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female. + +## SV Consensus Merge +--- + [STALE: why: &'"] + Consensus SVs (2+ callers): 3 + +## Structural Variants, Class 4 and 5 (AnnotSV) +--- + [STALE: why: &'"] + Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1) + Moved to class 3 by step 05's rules, not counted above: 1 + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (step 22's consensus cannot tell) + on exon edges: exon 2 + benign-set AF 0.001 (gnomAD) + DUP 2:150-880 class 4 GENE3 support: not known (step 22's consensus cannot tell) + DEL 9:1-100 class 4 G9 support: not known (step 22's consensus cannot tell) + benign-set AF 0.2 (gnomAD), common + Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): + INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) + A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here. + +## Mobile Element Insertions (step 50) +--- + Insertions called: 3 (ALU 2, L1 1) + FKTN SVA (Fukuyama; AR): callable (depth 30, not seen) + TAF1 SVA (XDP; XL): not callable (depth 2) + Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/_mei.tsv. + +## Repeat Expansions (ExpansionHunter) +--- + Loci in output: 9 + Outside the normal range (Stranger): 2 + FMR1 58 premutation + FMR1 motif count: interrupted: AGG + RFC1 >=400/>=500 full_mutation + RFC1 motif count: pathogenic: AAGGG dominant + Not graded (no thresholds in the catalog): 1 (EXTRA1: no published range) + Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md). + CFTR intron 9 (legacy IVS8) TG and poly-T tract: TG11/TG12 5T/7T + 5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922) + UGT1A1 promoter TA repeat: *1/*28 + *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955) + SLC6A4 5-HTTLPR promoter length polymorphism: not tested + not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427) + Loci without a Stranger status (not in its catalog): 3 + Not sized from short reads, so not counted as normal: 5 (FMR1, C9ORF72, ATXN1, EXTRA1, RFC1) + Every locus (key loci first): repeat count, Stranger status, notes + DMPK not in output - + HTT 17/20 normal,normal normal max 26 + FMR1 58 premutation low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG + C9ORF72 . - no call + ATXN1 30/37 not sized size not determined (flanking reads only), interval 30-30/35-40; normal max 35 + CFTR_T 5/7 - + CFTR_TG 11/12 - + EXTRA1 8/9 not graded low confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range) + RFC1 >=400/>=500 full_mutation longer than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800 + UGT1A1 7/8 normal + RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion. + Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md. + +## MUC1 VNTR Frameshifts (ADTKD-MUC1, VNtyper) +--- + Result: negative + . + VNtyper's coverage check: . + . + none + The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it. + +## Mitochondrial Variants (Mutect2) +--- + PASS variants: 7 + Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts): 1 + Length heteroplasmy in the D-loop poly-C tracts (m.303-315, m.16184-16193; common, usually technical): 2 + chrM:302 A>AC,ACC AF 0.3 + chrM:16189 T>C AF 0.5 + Annotation (mito/S_chrM_annotated.tsv): ClinVar 2026-10-01; gnomAD not annotated: no file + ClinVar pathogenic or likely pathogenic: 1 + Heteroplasmic, or in ClinVar with a class other than benign: + chrM:3243 A>G AF 0.40 ClinVar Pathogenic (criteria; MELAS) gnomAD AF hom 0, het 0 + chrM:302 A>AC AF 0.3 not in ClinVar not in gnomAD poly-C tract + chrM:500 C>T AF 0.99 ClinVar Uncertain_significance (.; .) not in gnomAD + Confirmed disease variants (assets/mito_confirmed.tsv): 3 + m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine. + m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues. + m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision. + Large deletions (eKLIPse): 3, of them 1 named in assets/mito_confirmed.tsv; listed: named ones and any at 1.0% or more + m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382 + m.101_199del (None bp) level 2.5% + A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md). + mtDNA copy number: not assessed (unknown) + Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy. + ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests. + +## Lp(a): LPA KIV-2 Repeat Count and Risk Variants +--- + KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low + ok + KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it + . + A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure. + rs10455872: A/G (1 risk allele) + rs3798220: T|C (1 risk allele) + Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood. + . + The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people. + +## Clonal Haematopoiesis (CHIP, step 49) +--- + DNMT3A R882H: VAF 0.05 (3 of 60 reads), . + Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out. + Too shallow or not on the reference: ASXL1, SRSF2. + 1 other protein changes listed, not counted: chip/S_chip.tsv. + Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it. + +## Mosaic Chromosomal Alterations (MoChA, step 51) +--- + Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .) + Loss on q, chr20:1-2 (10 Mb): about 0.1 of the cells + Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/_mocha.tsv. + +################################################################################ +# 3. CARRIER: What could I pass on to a child? +################################################################################ + +## Couple Carrier Screen (step 39) +--- + Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2 + Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP) + X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: . + A screen, not a diagnosis: the couple report (couple__.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md). + +## Paralog Genes (Paraphase, PacBio HiFi) +--- + SMN1: 2 (called); ok + SMN2: 2 (called) + HBA1: 1 (called) + HBA2: 2 (called) + PMS2: 2 (called) + SMN1 by both tools: Paraphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either + Other Paraphase regions: 2 (1 with a call) + Variants on phased haplotypes: 3 + Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory. + +## SMN1/SMN2 Copy Number (Parascopy, short reads) +--- + SMN1 copies: 1 (quality 31, filter PASS) + SMN1 g.27134T>G silent-carrier marker (rs143838139): not seen, 0 of 31 reads carry it, about 0 copies + SMN1 marker reading: no read carries the G + SMN1 marker caveat: The marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it. + SMN2 copies: 3 (quality 25, filter PASS) + SMN1 and SMN2 together (agCN) at exon 7: 4 (quality 45.5, filter PASS) + Reading: one SMN1 copy: the pattern of an SMA carrier + HBA1 and HBA2 together (alpha-globin genes, from depth): . (.; estimate .) + CYP21A2 (RCCX module, from depth and six PSV sites): . CYP21A2 copies, module total 4 of ., finding none + HP (haptoglobin) copies (from depth): 2 (estimate 2.1). Reading: usual + LCE3B/LCE3C copies (from depth): 1 (estimate 1.0). Reading: one deleted + CCL3L1/CCL3L3 copies (from depth): not assessed (low depth) + GBA1, GBAP1 (agCN): 4 (2 region(s), quality 35.25 or more, filter PASS). Reading: agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy + STRC, STRCP1 (agCN): unreadable: S_strc_copy_number.tsv lacks the copy-number columns + mytable (agCN): not assessed: no read over the locus + pms2 (agCN): chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual) + Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth): 4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication + Deletion: AZFc (AZFc, chrY:23000001-26000000), 0 of 1 copies + Duplication: dup (X1, chr1:2-2), 3 of 2 copies + Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia). + +################################################################################ +# 4. MEDICINES: How might I respond to medicines? +################################################################################ + +## CPIC Drug-Gene Recommendations +--- + Genes with a non-normal phenotype: 1 More than one possible result: 0 Not called: 0 Called without a function phenotype (no drug guidance): 0 + UGT1A1 *1/*28 Intermediate + Drugs per gene: cpic/S_cpic_recommendations.txt + CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response. + +## HLA Typing (T1K) +--- + HLA-A A*02:01:01 (quality 60) / A*01:01:01 (quality 50) + HLA-B B*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT + HLA-C C*07:01:01 (quality 40) + HLA-DQA1 DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30) + HLA-DQB1 DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30) + HLA-DRB1 DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan) + HFE HFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)] + Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent + DQB1*02 copies: 2 + A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med) + C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet) + DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet) + DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet) + DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum) + B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature) + B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet) + B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A) + B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med) + Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased. + HLA database: unknown + HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36). + OptiType check (HLA_QC=true, two fields): + HLA-A agree: T1K A*02:01, OptiType A*02:01 + HLA-B agree: T1K B*57:01, OptiType B*57:01 (ok) + KIR genes (T1K, KIR=true): + KIR2DL1 KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20) + No allele called (absent, or too few reads): KIR3DL3 + KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance. + +## Locityper Second Opinion at Hard Loci (step 53) +--- + Loci called: 4 of 5; passing the authors' filter: 3 + HLA-DRB1 Locityper: h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K (step 08): DRB1*03:01:01/DRB1*07:01:01 + KIR Locityper: k1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass) + primary: T1K KIR pass (step 08): 1 genes typed + CYP2D6 Locityper: not called: low depth + primary: pypgx (step 32) and Cyrius (step 21) did not run + FCGR Locityper: f + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q) + primary: no other step calls FCGR + ZZZ Locityper: z + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass) + primary: no other step calls this locus + A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/_locityper.tsv. + +################################################################################ +# 5. ANCESTRY: Where do my ancestors come from? +################################################################################ + +## Fine-Grained Ancestry (ADMIXTURE, RFMix) +--- + Continental groups (fraction, bootstrap range): + West Eurasia 95% (93% to 97%) + Africa 5% + Regional groups (fraction, bootstrap range): + Iberia 60% (50% to 70%) + Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown. + Chromosome painting: none; not painted: RFMix failed on chr21 + Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md. + +## Mitochondrial Haplogroup +--- + Haplogroup: H5a1 + Contamination (haplocheck): no (level .) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/mtdna/H5a1 + YFull MTree: https://www.yfull.com/mtree/H5a1/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/12-mito-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y-Chromosome Haplogroup (Yleaf) +--- + Haplogroup: R1b1a1b1a1a2*(xR-L21) (40 markers, QC-score 0.98) + FamilyTreeDNA Discover (free, no upload): https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 + YFull YTree: https://www.yfull.com/tree/R1b1a1b1a1a2/ + More routes, and the files to share: https://github.com/GeiserX/OwnGenome/blob/main/docs/37-y-haplogroup.md#explore-your-branch-further + Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares. + +## Y Placement on the Current Public Tree +--- + Branch: R-Z2105 (level 12, ISOGG 2026) + Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more + 1 A0-T 1D A N + 2 R D A N + A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works. + +## Y-STR Markers (HipSTR) +--- + Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads + Y-12 DYS393 13 (high) + Y-12 DYS390 24 (low) + Y-25 DYS464 . (not callable) + Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/_y_str.tsv; y_str/_y_str.csv is the same list for a spreadsheet. + +## Archaic Ancestry (IBDmix, step 43) +--- + Neanderthal: 2.00% (50.0 Mb in 120 segments) + Denisovan: 0.01% (0.2 Mb in 3 segments) + Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU + Longest segments: + a + b + j + An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/_archaic_segments.tsv; docs/43-archaic.md says where the numbers end. +## Ancient Populations (AADR PCA, step 44) +--- + AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected. + Nearest ancient groups: + 1. Spain_BA (2000 BCE, Spain; 10 people) + 2. France_N (, France; 5 people) + Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot. Plot: ancient/S_ancient_pca.svg + +## Runs of Homozygosity +--- + Segments: 3 Total: 37.5 MB Largest: 27.0 MB + Autosomal ROH > 5MB: 2 + chr2:10000001-17000000 7.0MB + chr15:23000001-50000000 27.0MB + F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs) + ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) ** + Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419) + Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md). + F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more. + Left out in centromere and heterochromatin bands: 46.5 MB + Segments on chrX/chrY, not counted: 1 + Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal. + +################################################################################ +# 6. TRAITS AND SCORES: What do studies say about my traits and risk scores? +################################################################################ + +## Traits Panel (step 42) +--- + Read: 3 No genotype at the position: 1 Other allele: 1 + Lp(a) (LPA rs10455872): A/G. one copy (PMID 1) + Lp(a) (LPA rs3798220): T|C. one copy (PMID 1) + R117H (CFTR rs78655421): G/A. one copy (PMID 1) + x (X rs2): C/C. other (PMID 1) + x (X rs3): C/T. A low-quality call at this position (genotype quality 5, below 20): not read; check the reads. (PMID 1) + Not read (no genotype in the gVCF): rs1 + Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how. Notes per row: traits/S_traits.tsv + Genotype rules (several sites read together; traits/S_genotype_rules.tsv): + bitter (TAS2R38 rs1): PAV/AVI (not phased). taster (PMID 1) + kidney (APOL1 rs73885319, rs60910145): G0/G1. one G1 (PMID 20647424) + With G2 (rs71785313): G1/G2. G2 (rs71785313): 1 copy of the deletion called. Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis. + APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. + APOE (rs429358): T/C. e3/e4 + +## Polygenic Risk Scores +--- + CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) + T2D 0.1 (10/20 variants matched) PGS000014 + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + +## Blood Groups (predicted from the genome) +--- + ABO A A1/O1 (high) + RhD RhD positive . (medium) + Kell . K-/k+ (.) + Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/_bloodtype_evidence.tsv. + +## Telomere content (relative, TelomereHunter) +--- + Telomere content: 1.5 intratelomeric reads per million reads with 48-52% GC + Intratelomeric reads: 40 (floor 2,000 at 30.0x) + WARNING: too few telomeric reads for a stable estimate; do not compare this value. + Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md). + +################################################################################ +# 7. OTHER AND EXPORTS: What else did the run find or write? +################################################################################ + +## Viral DNA in the Unmapped Reads (step 47) +--- + HHV-6: inherited integrated HHV-6B likely + phiX: spike-in (500 reads, 100% of the genome) + HHV-6B: inherited integrated HHV-6 likely (2000 reads, 99% of the genome, 1.0 copies per cell) + From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/_viral.tsv. + +## Raw-Data Export (23andMe v5 layout) +--- + Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000 + Homozygous reference from the gVCF's reference blocks: 0 + Files: consumer_export/S_23andme.txt and consumer_export/. + '--' because: low depth 9000; filtered 1000 + These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first. + +## Steps Not Run +--- + - Coverage (mosdepth) + - Gene callability (mosdepth) + - Sex check (indexcov) + - Sample identity and contamination (somalier, VerifyBamID2) + - Mosaic loss of chromosome Y or X + - ClinVar screen + - PharmCAT + - pypgx + - Cyrius (CYP2D6) + - Cancer predisposition (CPSR) + - Clinical variant filter + - Variant prioritization (slivar) + +## Not Assessed by This Pipeline +--- + - Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes) + - Methylation and imprinting + - Repeat expansions outside the ExpansionHunter catalog + - Phase: two variants in one gene are compound-het candidates, not confirmed + - Variants of uncertain significance (not interpreted) + +================================================================================ + DISCLAIMER: This is NOT a clinical report. Discuss findings with a + qualified healthcare professional before making medical decisions. +================================================================================ From 44d3398bb1a6a43847dad652f93ef24cae52721b Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 18:23:52 +0100 Subject: [PATCH 18/40] ci(personal-data): allow the corpus's made-up genotypes in report-render goldens The whole-report goldens of the c-full, all and a-/s- report-render cases print the made-up lipoprotein(a) genotypes and repeat sizes of the summary-collect corpus. The scan read them as personal data. Allow those four lines under tests/parity/golden/report-render only. Bead: sv-01 --- scripts/ci/check-personal-data.sh | 4 ++++ 1 file changed, 4 insertions(+) diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index a51191031..828d86e18 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -146,6 +146,10 @@ CONTRIBUTING.md /mnt/user\|internal-host\|/home/ CONTRIBUTING.md (`/mnt/user/`, `/home/username/`, etc.) modules/local/cyrius/main.nf ${prefix}\\t*1/*1\\tPASS tests/fake-docker/reports-stale-step.sh sample1\t*1/*1\tPASS +tests/parity/golden/report-render/*/* rs10455872: A/G (1 risk allele) +tests/parity/golden/report-render/*/* rs3798220: T|C (1 risk allele) +tests/parity/golden/report-render/*/* HTT 17/20 normal,normal +tests/parity/golden/report-render/*/* ATXN1 30/37 not sized tests/test_collect_summary.py S\t*1/*4\tPASS tests/test_collect_summary.py strec("HTT", "17/30" tests/test_collect_summary.py strec("C9ORF72", "2/8" From 966083d43b5553b1a72eed42e83cc905b5449aeb Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 19:13:54 +0100 Subject: [PATCH 19/40] test(e2e): compress the score-tier tables with the bcftools image, not the 9 GB GATK one GATK_IMAGE is pulled lazily, so the shard that ran this case pulled about 9 GB to bgzip five small tables. The bcftools image is cached and ships bgzip and tabix. --- tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh index 2b9be6bb2..da9e86244 100755 --- a/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh +++ b/tests/e2e/i411-nf-vcfanno-ops-1-score-tiers.sh @@ -64,7 +64,7 @@ VCF splice_track 707 AT > "$ANNOT/spliceai_scores.masked.indel.hg38.vcf" docker run --rm --user "$(id -u):$(id -g)" --network none \ - -v "${GENOME_DIR}:/genome" -w /genome "$GATK_IMAGE" bash -ec ' + -v "${GENOME_DIR}:/genome" -w /genome "${BCFTOOLS_HTTPS_IMAGE:?}" bash -ec ' for file in annotations/*.tsv; do bgzip -c "$file" > "$file.gz" tabix -s 1 -b 2 -e 2 "$file.gz" From f059dc31578059b5041d68ae1b507491877bb7aa Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 19:20:26 +0100 Subject: [PATCH 20/40] fix(report): count an SV row without a support key as not known The new count line read each row's support with d["support"] (Python) and at("support") (og-render). A live-site summary whose rows have no support key then raised, and the live site dropped the structural card: tests/test_owngenome_live_family.py counted 0 flagged cards where it expects 1. Both now count a missing key as not known, the same as null. Bead: sv-01 --- bin/render_report.py | 2 +- rust/crates/og-render/src/sections/annotsv.rs | 4 ++-- .../og-render/tests/i411_sv_support_text.rs | 18 ++++++++++++++++++ 3 files changed, 21 insertions(+), 3 deletions(-) diff --git a/bin/render_report.py b/bin/render_report.py index d13fedd1b..625de561c 100755 --- a/bin/render_report.py +++ b/bin/render_report.py @@ -874,7 +874,7 @@ def annotsv_lines(d): """Step 05's class 4-5 lines, the same in both reports.""" head = f"Class 4-5 SVs: {d['count']}" if d["count"]: - head += (f" (single caller: {str(d['single_caller']) + (f', not known: {m}' if (m := sum(x['support'] is None for x in d.get('rows') or [])) else '') if d['consensus'] else 'not known'}; deletions on exon edges: " + head += (f" (single caller: {str(d['single_caller']) + (f', not known: {m}' if (m := sum(x.get('support') is None for x in d.get('rows') or [])) else '') if d['consensus'] else 'not known'}; deletions on exon edges: " f"{d['exon_edge'] if d['exon_edge_checked'] else 'not checked'}; common: {d['common']})") lines = [head] if d.get("downgraded"): diff --git a/rust/crates/og-render/src/sections/annotsv.rs b/rust/crates/og-render/src/sections/annotsv.rs index b3594cdf9..88b1948e0 100644 --- a/rust/crates/og-render/src/sections/annotsv.rs +++ b/rust/crates/og-render/src/sections/annotsv.rs @@ -127,11 +127,11 @@ pub fn lines(d: &D<'_>) -> Result, Malformed> { let single = if consensus { // The consensus ran, but a row it cannot tell has no support: // count those apart, so "single caller: 0" never reads as - // "every SV had two callers". + // "every SV had two callers". A row without the key counts too. let mut unknown = 0; if let Some(rows) = d.opt("rows")? { for x in rows.items()? { - if x.at("support")?.is_none() { + if x.get("support")?.is_none_or(|v| v.is_none()) { unknown += 1; } } diff --git a/rust/crates/og-render/tests/i411_sv_support_text.rs b/rust/crates/og-render/tests/i411_sv_support_text.rs index f7809f035..2bdc4f3fa 100644 --- a/rust/crates/og-render/tests/i411_sv_support_text.rs +++ b/rust/crates/og-render/tests/i411_sv_support_text.rs @@ -190,3 +190,21 @@ fn sf_rows_without_an_annotsv_section_keep_the_old_reason() { ); assert!(!txt.contains("cannot tell"), "{txt}"); } + +/// A row with no `support` key (a summary written by hand, or an older +/// one) counts as not known: the count line still comes out. +#[test] +fn a_row_without_a_support_key_counts_as_not_known() { + let s = Summary::parse( + r#"{"sections": {"annotsv": {"state": "ok", "data": {"count": 1, "consensus": 1, + "single_caller": 0, "exon_edge_checked": false, "exon_edge": 0, "common": 0, + "rows": [{"sv": "chr17:1-2", "type": "DEL", "acmg_class": 5, "genes": ["G"]}]}}}}"#, + ) + .expect("a summary"); + let lines = + annotsv::lines(&og_render::sections::clinvar::D::of(&s.section("annotsv"))).unwrap(); + assert_eq!( + lines[0], + "Class 4-5 SVs: 1 (single caller: 0, not known: 1; deletions on exon edges: not checked; common: 0)" + ); +} From 87f194a8ebe3452e12653675679dd007a28d99c4 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 20:15:57 +0100 Subject: [PATCH 21/40] fix(carrier): let only confident calls give the phase of a two-copy pair Two confident hets of unknown phase beside a weak het in trans with one of them read "possible two hits (low-confidence call)" on the carrier list but "possibly biallelic" on the secondary-findings card. The card checked two confident copies of unknown phase before the low cap; the list capped first. The list now takes the same step in the same order. A combined allele that is confident only through a folded part kept the GT and phase set of its own weak call, so both cards could call a pair biallelic that the confident calls do not prove. Each allele is now counted with the GT and phase set of the confident call that makes it confident, on both cards. On the card's deletion path a weak combined allele with a confident part is no longer marked low when the confident calls give its copies, and it pairs with the deletion by that confident call's phase. New shapes in the agreement test: R1, R1b, R1c (the list now says possible two hits), R2 and R3d (the card now says possibly biallelic, with its two-hit line), R3 (both now say possibly), and R6 and R7, which keep the low word on both cards. Bead: clin-19 --- rust/crates/og-summary/src/collect/acmg.rs | 63 ++++++++++++++----- rust/crates/og-summary/src/collect/carrier.rs | 42 ++++++++----- .../tests/i411_carrier_confidence.rs | 52 +++++++++++++++ 3 files changed, 129 insertions(+), 28 deletions(-) diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 760784756..5547f8533 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -441,7 +441,8 @@ struct Cand { /// One distinct variant of a gene as the verdict counts it: its alt /// copies, ploidy, GT and phase set, whether it stands for a combined /// allele and its parts, and the alt copies its confident calls give (`firm`: -/// 0 when every call of it is below step 06's call floor, low confidence). +/// 0 when every call of it is below step 06's call floor, low confidence), +/// with the GT and phase set of the confident call that gives them. #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -450,6 +451,8 @@ struct Allele { ps: Option, combined: bool, firm: usize, + firm_gt: String, + firm_ps: Option, } impl Allele { @@ -461,6 +464,18 @@ impl Allele { ps: None, combined: false, firm: 0, + firm_gt: String::new(), + firm_ps: None, + } + } + + /// Count a confident call of this allele: the most copies one gives, + /// with that call's GT and phase set. + fn confirm(&mut self, copies: usize, gt: &str, ps: &Option) { + if copies > self.firm { + self.firm = copies; + self.firm_gt = gt.to_owned(); + self.firm_ps = ps.clone(); } } @@ -625,16 +640,23 @@ fn sf_verdicts( // that needs a low-confidence call is only possible until the call is // confirmed. A small allele no confident call gives drops out; one whose // confident calls give fewer copies than it counts loses its phase too, - // as that came from the low call. A deletion counts as it is: its pair - // is judged by `two_hits_with`. + // as that came from the low call; any other takes the GT and phase set + // of the confident call, so a phase only a low call gives proves + // nothing. A deletion counts as it is: its pair is judged by + // `two_hits_with`. let firm: IndexMap = kept .iter() .filter(|(k, a)| !matches!(k, AKey::Small(_)) || a.firm > 0) .map(|(k, a)| { let mut f = a.clone(); - if matches!(k, AKey::Small(_)) && a.firm < a.copies { - f.copies = a.firm; - f.ps = None; + if matches!(k, AKey::Small(_)) { + if a.firm < a.copies { + f.copies = a.firm; + f.ps = None; + } else { + f.gt = a.firm_gt.clone(); + f.ps = a.firm_ps.clone(); + } } (k.clone(), f) }) @@ -654,10 +676,11 @@ fn sf_verdicts( copy (cis)" .to_owned() }; - // The best the evidence gives: a confident proof, then the deletion pair + // The best the evidence gives: a confident proof; then the deletion pair // when it is at least possibly biallelic (`two_hits_with` already lowers - // a pair on a low call), then a proof that needs a low call, then the - // copies counted with phase unknown. + // a pair on a low call); then, with no deletion pair, two confident + // copies of unknown phase; then the low word for a pair that needs a + // low call. let pair = (counted && n >= 2).then(|| { let del = deletion.map(|e| (e.verdict, format!("with {}: {}", e.deletion, e.why))); match (proof_firm, proof, del) { @@ -1009,7 +1032,7 @@ fn tier(i: &Inputs) -> Result, String> { ..Allele::of(x.copies, p) }); if !is_low(x) { - a.firm = a.firm.max(x.copies); + a.confirm(x.copies, &x.gt, &x.ps); } } for x in &folded { @@ -1026,7 +1049,7 @@ fn tier(i: &Inputs) -> Result, String> { a.copies = a.copies.max(x.copies); a.combined = true; if !is_low(x) { - a.firm = a.firm.max(x.copies); + a.confirm(x.copies, &x.gt, &x.ps); } } for x in &svs { @@ -1047,12 +1070,24 @@ fn tier(i: &Inputs) -> Result, String> { ), }; let (dels, _, _) = gene_deletions(i.deletions, &spans); + // The confident call of a small allele whose own call is low, when it + // gives as many copies: a combined allele counts as confident when any + // call of it is, and its pair with a deletion then rests on that call's + // GT and phase set, not on the low call's. + let confirmed = |x: &Cand| { + alleles + .get(&x.gene) + .and_then(|a| a.get(&x.key)) + .filter(|a| is_low(x) && a.firm >= x.copies) + .map(|a| (a.firm_gt.clone(), a.firm_ps.clone())) + }; let mut seen = HashSet::new(); let mut variants = Vec::new(); for x in &own { let AKey::Small(k) = &x.key else { continue }; let pseudo = rules[&x.gene].severity_kind(k) == Some("pseudodeficiency"); if !pseudo && seen.insert((x.gene.clone(), k.clone())) { + let (gt, ps) = confirmed(x).unwrap_or_else(|| (x.gt.clone(), x.ps.clone())); variants.push(Variant { gene: x.gene.clone(), key: k.clone(), @@ -1068,15 +1103,15 @@ fn tier(i: &Inputs) -> Result, String> { }, copies: x.copies, ploidy: if x.ploidy == 0 { 2 } else { x.ploidy }, - gt: x.gt.clone(), - ps: x.ps.clone(), + gt, + ps, allele: None, }); } } let low: HashSet<(String, Key)> = own .iter() - .filter(|x| is_low(x)) + .filter(|x| is_low(x) && confirmed(x).is_none()) .filter_map(|x| match &x.key { AKey::Small(k) => Some((x.gene.clone(), k.clone())), _ => None, diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index e77b26c36..98a411a12 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -26,7 +26,7 @@ use super::text::{self, gt_field}; use super::two_hits::{DeletionInputs, Spans, Variant, gene_deletions, phase_haps, two_hits_with}; use indexmap::IndexMap; use pycompat::json::Value; -use std::collections::{BTreeSet, HashSet}; +use std::collections::{BTreeSet, HashMap, HashSet}; /// The section's data: the list, or why it could not be made. #[derive(Debug, Clone, PartialEq)] @@ -86,9 +86,10 @@ fn joined_keys(r: &[String]) -> Vec { /// copy) and why. `None` when fewer than two distinct alleles are left /// once a combined allele and its parts count once. The hets are counted /// twice, all of them and the confident ones alone: two hits when the -/// confident ones prove it, the low-confidence word when only all of them -/// do, and with phase unknown, possible two hits when the confident ones -/// still count two copies. +/// confident ones prove it; else possible two hits when the confident ones +/// still count two copies of unknown phase, whatever a low-confidence call +/// adds; else the low-confidence word when a pair needs a low-confidence +/// call. fn het_pair(hets: &[Het]) -> Option<(Option, String)> { // A combined allele and its parts count once, under the combined // allele, when its call is phased or at most one part is here; an @@ -111,15 +112,22 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { // A kept allele is firm when a call of it is confident: its own, or a // call folded into it (a part under its combined allele, or an unphased // combined allele under its first part), as the secondary-findings card - // counts it. - let mut firm: HashSet<&VarKey> = kept.iter().filter(|h| !h.low).map(|h| &h.key).collect(); + // counts it. The confident count takes that call's GT and phase set: a + // phase only a low-confidence call gives proves nothing. + let mut firm: HashMap<&VarKey, &Het> = kept + .iter() + .filter(|h| !h.low) + .map(|h| (&h.key, *h)) + .collect(); for h in hets.iter().filter(|h| !h.joined.is_empty()) { if gone.contains(&h.key) { - if !h.low { - firm.extend(h.joined.iter().find(|k| present.contains(k))); + if !h.low + && let Some(k) = h.joined.iter().find(|k| present.contains(k)) + { + firm.entry(k).or_insert(h); } - } else if hets.iter().any(|p| !p.low && h.joined.contains(&p.key)) { - firm.insert(&h.key); + } else if let Some(p) = hets.iter().find(|p| !p.low && h.joined.contains(&p.key)) { + firm.entry(&h.key).or_insert(p); } } // The copies a set of hets hits: the count, the proof of two copies if a @@ -169,12 +177,17 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { (n, proof, cis) }; let (n, proof, cis) = count(&kept); - let sure: Vec<&Het> = kept + let sure: Vec = kept .iter() - .copied() - .filter(|h| firm.contains(&h.key)) + .filter_map(|h| { + firm.get(&h.key).map(|c| Het { + gt: c.gt.clone(), + ps: c.ps.clone(), + ..(*h).clone() + }) + }) .collect(); - let (n_firm, proof_firm, _) = count(&sure); + let (n_firm, proof_firm, _) = count(&sure.iter().collect::>()); // A pair that needs a low-confidence call is only possible until the // call is confirmed. let low = |why: String| { @@ -190,6 +203,7 @@ fn het_pair(hets: &[Het]) -> Option<(Option, String)> { .to_owned(); match (proof_firm, proof, cis) { (Some(f), _, _) => Some((Some("two hits".to_owned()), f)), + (None, Some(_), _) if n_firm >= 2 => Some((Some("possible two hits".to_owned()), unknown)), (None, Some(p), _) => low(p), (None, None, _) if n >= 2 && n_firm >= 2 => { Some((Some("possible two hits".to_owned()), unknown)) diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index e050bca86..2ee6f9575 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -692,6 +692,10 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { a.0, a.1, a.2, a.3 ); let combined = |q: &str| hit(b, "MUTYH", "GT:GQ:DP:PS", &format!("0|1:{q}:9"), &joined); + // The same combined allele, unphased and weak. + let combined_open = || hit(b, "MUTYH", "GT:GQ:DP", "0/1:5:4", &joined); + // A second alt allele at MUTYH_A's position, for a split call there. + let a2 = (a.0, a.1, a.2, "G"); let del = || mutyh_deletion("1|0", Some("9")); let none = no_deletions; let p9 = Some("9"); @@ -823,6 +827,54 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { mutyh_deletion("0/1", None), maybe, ), + ( + "R1 confident het + weak het in trans with it + confident unphased het", + vec![g(a, "0|1", p9), w(b, "1|0", p9), g(cc, "0/1", None)], + none(), + maybe, + ), + ( + "R1b confident het + weak het in trans with it + confident het in another phase set", + vec![g(a, "0|1", p9), w(b, "1|0", p9), g(cc, "1|0", Some("7"))], + none(), + maybe, + ), + ( + "R1c confident half call + weak half call at one position + confident het", + vec![g(a, "1/.", None), w(a2, "./1", None), g(cc, "0/1", None)], + none(), + maybe, + ), + ( + "R2 weak unphased combined, confident part + unphased deletion", + vec![combined_open(), g(a, "0/1", None)], + mutyh_deletion("0/1", None), + maybe, + ), + ( + "R3 weak phased combined, confident unphased part, third in trans by the weak phase", + vec![combined("5:4"), g(a, "0/1", None), g(cc, "1|0", p9)], + none(), + maybe, + ), + ( + "R3d weak phased combined, confident unphased part, deletion in trans by the weak phase", + vec![combined("5:4"), g(a, "0/1", None)], + del(), + maybe, + ), + ( + "R6 confident cis pair + weak het in trans", + vec![g(a, "0|1", p9), g(b, "0|1", p9), w(cc, "1|0", p9)], + none(), + low, + ), + ( + "R7 deletion in cis with a confident het + weak het in trans", + vec![g(a, "1|0", p9), w(b, "0|1", p9)], + del(), + low, + ), ("deletion alone", vec![], del(), None), ("nothing", vec![], none(), None), ]; From 6ec4394f5ea15ab9c80e51f73cd7fa3698d04e41 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 20:15:57 +0100 Subject: [PATCH 22/40] docs(carrier): say where the carrier list and the SF card agree The docs and the changelog said a gene on both lists gets the same answer. That holds for a recessive gene the SF card counts by two copies, and only at the gene level: on the carrier list the answer is the best of `pair`, the `two_hits` verdict and the homozygous rows, and `pair` counts heterozygous hits only. Say so, and name the new rule for two confident copies of unknown phase. Bead: clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 ++-- 2 files changed, 3 insertions(+), 3 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 20770e5b6..fccca7cc2 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. Hits of unknown phase are `possible two hits` and `possibly biallelic` when two of them are confident, and the low-confidence word otherwise. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is. So a gene on both lists gets the same answer on both. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 5c075e3f3..17ae9a6c0 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. A pair that only a low-confidence call proves is `possible two hits (low-confidence call)`. Hits of unknown phase are `possible two hits` when two of them are confident, and the low-confidence word otherwise. A combined allele counts as confident when any call of it is. The secondary-findings card below counts the same way, so a gene on both lists gets the same answer: its `biallelic` is `two hits` here, and its `possibly biallelic (low-confidence call)` is `possible two hits (low-confidence call)`. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`. A combined allele counts as confident when any call of it is. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; From 327a7c34578151b6017c5f0eca7b2bbbffba0e1d Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 20:36:22 +0100 Subject: [PATCH 23/40] fix(live): give the live site's secondary-findings rows the consensus reason too bin/live_results.py called sf_rows without the AnnotSV consensus in the clinical-filter table and in the findings list, so those rows still said "no step 22 consensus" after step 22 ran, next to AnnotSV rows that said it cannot tell. Both now pass the consensus, as the AnnotSV rows do. The parity README names the new golden cases and the generated_utc pin, and the two repeat-size allow lines cover only the text goldens. Bead: sv-01 --- bin/live_results.py | 4 ++-- scripts/ci/check-personal-data.sh | 4 ++-- tests/parity/README.md | 2 +- 3 files changed, 5 insertions(+), 5 deletions(-) diff --git a/bin/live_results.py b/bin/live_results.py index 3f235d411..78c59d1bc 100644 --- a/bin/live_results.py +++ b/bin/live_results.py @@ -202,7 +202,7 @@ def a_clinical_filter(S, s): if sf.get("unavailable"): # Not assessed is never zero findings: the report's sentence instead of the counts. return {"facts": facts, "lines": rr.sf_apart_lines(sf), "attention": True} - rows = [[r[0], r[1], r[2], r[3]] for r in rr.sf_rows(sf)] if sf else [] + rows = [[r[0], r[1], r[2], r[3]] for r in rr.sf_rows(sf, _data(S, "annotsv").get("consensus"))] if sf else [] high = f"{rr.high_rare(sf)}{rr.high_apart(sf)}" if sf.get("high_impact_checked") else "not checked" facts += [[f"{sf.get('version') or 'ACMG SF'}: ClinVar P/LP in its genes", len(sf.get("clinvar_hits") or [])], ["High-impact rare variants in its genes", high]] @@ -840,7 +840,7 @@ def gene(x): # rows (rr.sf_rows): one it cannot read costs this rule, never the rest. sf_list = [] with _Row(out, "clinical-filter", "act"): - sf_list = rr.sf_rows(sf) if sf and not sf.get("unavailable") else [] + sf_list = rr.sf_rows(sf, _data(S, "annotsv").get("consensus")) if sf and not sf.get("unavailable") else [] for r in sf_list: with _Row(out, "clinical-filter", "act"): out.append(_f("act", "clinical-filter", ("sf", r[0], r[1]), f"Secondary finding in {r[0]}", diff --git a/scripts/ci/check-personal-data.sh b/scripts/ci/check-personal-data.sh index 828d86e18..78ebe099e 100755 --- a/scripts/ci/check-personal-data.sh +++ b/scripts/ci/check-personal-data.sh @@ -148,8 +148,8 @@ modules/local/cyrius/main.nf ${prefix}\\t*1/*1\\tPASS tests/fake-docker/reports-stale-step.sh sample1\t*1/*1\tPASS tests/parity/golden/report-render/*/* rs10455872: A/G (1 risk allele) tests/parity/golden/report-render/*/* rs3798220: T|C (1 risk allele) -tests/parity/golden/report-render/*/* HTT 17/20 normal,normal -tests/parity/golden/report-render/*/* ATXN1 30/37 not sized +tests/parity/golden/report-render/*/*.txt HTT 17/20 normal,normal +tests/parity/golden/report-render/*/*.txt ATXN1 30/37 not sized tests/test_collect_summary.py S\t*1/*4\tPASS tests/test_collect_summary.py strec("HTT", "17/30" tests/test_collect_summary.py strec("C9ORF72", "2/8" diff --git a/tests/parity/README.md b/tests/parity/README.md index 60e49dea2..78ed842a3 100644 --- a/tests/parity/README.md +++ b/tests/parity/README.md @@ -49,4 +49,4 @@ duplicate records, TAS2R38 phase blocks, phase-site VCFs and catalog refusals. The oracle adapter maps the three Rust verbs to the old flags. The Python report keeps only the metadata and table reader listed in `remnants.tsv`. -The `report-render` cases render the summaries that `gen/report-corpus.sh` writes: each summary-collect folder collected whole by `og summary collect`, and changes of a few of those summaries made with `jq`. Both reports are compared whole, byte for byte, against `bin/render_report.py`'s: every section, the charts and the closing gene list. The generator's `oracle.sh` reads a null PRS count as og's "not available", and its copy of `results_index.py` leaves out the `acmg_sf` section as og's index does. Six summaries whose PRS scores the Python's HTML report cannot render run as text-only cases. One case, `m-optin-viral-na`, is compared with its committed goldens instead: og's viral line differs from the Python's on purpose there. The Python still runs, so a golden it matches fails as stale. +The `report-render` cases render the summaries that `gen/report-corpus.sh` writes: each summary-collect folder collected whole by `og summary collect`, and changes of a few of those summaries made with `jq`. Both reports are compared whole, byte for byte, against `bin/render_report.py`'s: every section, the charts and the closing gene list. The generator's `oracle.sh` reads a null PRS count as og's "not available", and its copy of `results_index.py` leaves out the `acmg_sf` section as og's index does. Six summaries whose PRS scores the Python's HTML report cannot render run as text-only cases. Cases where og's report differs from the Python's on purpose are compared with their committed goldens instead: `m-optin-viral-na` for its viral line, and the cases that show the SV support reason of a consensus that cannot tell. `report-corpus.sh` fixes each summary's `generated_utc`, so those goldens stay stable. The Python still runs, so a golden it matches fails as stale. From ff501c3c7cf8f1305c49a70590500574dbb9a52a Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 21:54:02 +0100 Subject: [PATCH 24/40] fix(carrier): let no weak call make an allele firm or give it a phase A HIGH-impact record of the clinical VCF for the same variant made a weak call count as confident on the secondary-findings card, because the card read only step 06's low_confidence mark. With the record's phase set it proved a pair biallelic from a weak phase alone, and beside a deletion it cleared the low-confidence word. The card now also treats a call whose HIGH-impact record has weak_call as low confidence. The carrier list paired a weak combined allele with a deletion by the weak row's own GT and phase set, while the card used its confident part. The list now pairs it the same way: by the first confident row of the same allele with as many copies. The card dropped the phase of a combined allele whose confident call gives fewer copies than the weak one, although that phase came from the confident call. Every small allele now counts with the copies, GT and phase set of its confident call. The agreement test gains eight shapes (H1, H2, H3p, H5, X4, X4b, X9b, X10); each fails on the previous head. Part of #411 (clin-19). --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 6 +- rust/crates/og-summary/src/collect/acmg.rs | 39 +++--- rust/crates/og-summary/src/collect/carrier.rs | 30 +++- .../tests/i411_carrier_confidence.rs | 131 +++++++++++++++++- 5 files changed, 178 insertions(+), 30 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index fccca7cc2..99f1521ce 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer when the hits file and the clinical VCF state the same call floor, apart from one rare deletion shape where the card is more cautious: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 17ae9a6c0..79dd76dd5 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So when the hits file and the clinical VCF state different call floors, a call can be low confidence on the list and confident on the card. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a call below step 6's call floor (its `low_confidence` mark) is `possibly biallelic (low-confidence call)`: confirm that call first. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a low-confidence call is `possibly biallelic (low-confidence call)`: confirm that call first. A low-confidence call is one below step 6's call floor (its `low_confidence` mark), or a weak HIGH-impact call (a HIGH-impact record's `weak_call` mark: below the clinical call floor, or an allele balance out of range). A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is. Then it counts with the copies, GT and phase set of that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; @@ -29,7 +29,7 @@ Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, - **biallelic** when the reads show the two hits on different copies. Either the hit is called homozygous inside the deletion, so it sits on the one copy left (the line and the carrier list call it hemizygous; if the deletion is a false call, the hit is homozygous and both copies still carry it), or both calls carry read-backed phase (a `|` genotype with the same phase set, PS) on different copies. A low-expression (hypomorph) allele called homozygous inside a deletion is only **possibly biallelic**: it causes disease with a null allele only if the deletion is real, so confirm the deletion (array or MLPA); - **possibly biallelic** otherwise: the phase is unknown. Most short-read calls carry no phase, so this is the usual line. Step 05's checked table keeps no genotype column yet, and step 35's counts have no phase, so in a pipeline run a deletion pairs as possibly biallelic unless the hit is called homozygous inside it. A parent's genome (step 38, [family analysis](../multi-sample.md#family-analysis-step-38-opt-in)) or long reads can settle it; -- **possibly biallelic (low-confidence call)** when the pair would count but the small variant's call is below step 6's call floor (its `low_confidence` mark): confirm the call first; +- **possibly biallelic (low-confidence call)** when the pair would count but the small variant's call is low confidence: below step 6's call floor (its `low_confidence` mark), or on the card also a weak HIGH-impact call. Confirm the call first. A low-confidence call of a combined allele pairs by a confident call of the same allele (the combined call or a part of it) when that call gives as many copies, with that call's GT and phase set; - no line when read-backed phase puts both on the same copy (cis): the other copy is intact. Examples: an exon deletion of MUTYH plus a pathogenic MUTYH variant; three alpha-globin genes plus an HBA2 point variant; one SMN1 copy plus an SMN1 variant (short reads place few SMN1 variants reliably, so check with a targeted test); and the 1q21.1 deletion plus one of the two RBM8A low-expression alleles (c.-21G>A, rs139428292, or c.67+32G>C, rs201779890), the cause of TAR syndrome (thrombocytopenia with absent radius; Albers et al., Nat Genet 2012;44(4):435-439, PMID 22366785). On its own an RBM8A low-expression allele stays set aside. The [couple screen](../39-couple.md) (step 39) applies the same pairing between partners: a hypomorph allele of the list in one partner and a full loss of function in the same gene in the other (a ClinVar pathogenic variant, a Delly deletion) is a shared gene with its risk for a child; the allele in both partners, or in one alone, stays set aside. In the secondary-findings card a called deletion counts as one of the two variants a recessive gene needs, unless read-backed phase puts it on the variant's copy. The line under the carrier list names the deletion callers it read and the ones it could not read. A deletion AnnotSV ranks below class 4 is not counted. diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 5547f8533..831b6270c 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -441,8 +441,9 @@ struct Cand { /// One distinct variant of a gene as the verdict counts it: its alt /// copies, ploidy, GT and phase set, whether it stands for a combined /// allele and its parts, and the alt copies its confident calls give (`firm`: -/// 0 when every call of it is below step 06's call floor, low confidence), -/// with the GT and phase set of the confident call that gives them. +/// 0 when every call of it is low confidence: below step 06's call floor, or +/// a weak HIGH-impact call), with the GT and phase set of the confident call +/// that gives them. #[derive(Debug, Clone, PartialEq)] struct Allele { copies: usize, @@ -638,25 +639,19 @@ fn sf_verdicts( } // The count again with only the copies confident calls give: a pair // that needs a low-confidence call is only possible until the call is - // confirmed. A small allele no confident call gives drops out; one whose - // confident calls give fewer copies than it counts loses its phase too, - // as that came from the low call; any other takes the GT and phase set - // of the confident call, so a phase only a low call gives proves - // nothing. A deletion counts as it is: its pair is judged by - // `two_hits_with`. + // confirmed. A small allele no confident call gives drops out; any other + // takes the copies, GT and phase set of the confident call that gives + // them, so a phase only a low call gives proves nothing. A deletion + // counts as it is: its pair is judged by `two_hits_with`. let firm: IndexMap = kept .iter() .filter(|(k, a)| !matches!(k, AKey::Small(_)) || a.firm > 0) .map(|(k, a)| { let mut f = a.clone(); if matches!(k, AKey::Small(_)) { - if a.firm < a.copies { - f.copies = a.firm; - f.ps = None; - } else { - f.gt = a.firm_gt.clone(); - f.ps = a.firm_ps.clone(); - } + f.copies = a.firm; + f.gt = a.firm_gt.clone(); + f.ps = a.firm_ps.clone(); } (k.clone(), f) }) @@ -666,8 +661,8 @@ fn sf_verdicts( ( Verdict::LowConfidence.word(), format!( - "a call it rests on is below the call floor (low confidence), so confirm it \ - first; {why}" + "a call it rests on is low confidence (below the call floor, or a weak \ + HIGH-impact call), so confirm it first; {why}" ), ) }; @@ -1018,8 +1013,14 @@ fn tier(i: &Inputs) -> Result, String> { // allele's own call stands for its parts. let (own, folded): (Vec<&Cand>, Vec<&Cand>) = small.iter().copied().partition(|x| unit(x) == x.key); - // A step 06 hit below its call floor (the ClinVar row's low_confidence). - let is_low = |x: &Cand| matches!(x.fields.get("low_confidence"), Some(Value::Bool(true))); + // A low-confidence call: a step 06 hit below its call floor (the + // ClinVar row's low_confidence), or a weak HIGH-impact call (its + // weak_call: the clinical call floor or allele balance). Neither makes + // its allele firm. + let is_low = |x: &Cand| { + matches!(x.fields.get("low_confidence"), Some(Value::Bool(true))) + || matches!(x.fields.get("weak_call"), Some(Value::Bool(true))) + }; for x in &own { let p = if x.ploidy == 0 { 2 } else { x.ploidy }; let a = alleles diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index 98a411a12..ce1184778 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -246,6 +246,8 @@ impl Carrier { // Which list each item is on: carriers (false) or set aside (true). let mut aside: Vec = Vec::new(); let mut variants: Vec<(Variant, usize)> = Vec::new(); + // The parts of each variant's combined allele, by the same index. + let mut vjoined: Vec> = Vec::new(); let mut low: HashSet<(String, VarKey)> = HashSet::new(); // The heterozygous carrier hits of each recessive gene, with the // items they are. @@ -325,6 +327,7 @@ impl Carrier { }, items.len() - 1, )); + vjoined.push(joined_keys(r)); } } } @@ -352,9 +355,32 @@ impl Carrier { .map(|(g, x)| (g.clone(), x.span.clone())) .collect(); let (dels, read, unread) = gene_deletions(deletions, &spans); - let vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); + // A low-confidence row pairs with a deletion by a confident call of + // its combined allele, as the secondary-findings card counts it: the + // first confident row of the gene, with as many copies, that is a + // part of it or that it is a part of. That row's GT and phase set + // stand for it, and the pair no longer needs a low-confidence call. + let mut vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); + let mut low_pair = low.clone(); + let is_low = |v: &Variant| low.contains(&(v.gene.clone(), v.key.clone())); + for (i, (v, _)) in variants.iter().enumerate() { + if !is_low(v) { + continue; + } + let sure = variants.iter().enumerate().find(|(j, (c, _))| { + c.gene == v.gene + && !is_low(c) + && c.copies >= v.copies + && (vjoined[i].contains(&c.key) || vjoined[*j].contains(&v.key)) + }); + if let Some((_, (c, _))) = sure { + vs[i].gt = c.gt.clone(); + vs[i].ps = c.ps.clone(); + low_pair.remove(&(v.gene.clone(), v.key.clone())); + } + } let found = two_hits_with(&vs, &dels, |v| { - low.contains(&(v.gene.clone(), v.key.clone())) + low_pair.contains(&(v.gene.clone(), v.key.clone())) }); for (v, at) in &variants { if let Some(t) = found.hemi.get(&(v.gene.clone(), v.key.clone())) { diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index 2ee6f9575..eb40fc17b 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -12,10 +12,11 @@ //! same hits (`assets/acmg_sf.tsv`): a pair that rests on a low-confidence //! call reads the same there, a low-confidence call beside a confident pair //! leaves it as it is, and MUTYH, on both lists, gets the same answer from -//! both cards over each shape of hits. +//! both cards over each shape of hits, some with a HIGH-impact record of +//! the clinical VCF beside the hit on the card. use indexmap::IndexMap; -use og_summary::collect::acmg::{Inputs, acmg_sf}; +use og_summary::collect::acmg::{ClinicalVcf, HighRecord, Inputs, acmg_sf}; use og_summary::collect::carrier::Carrier; use og_summary::collect::clinvar::{Floor, HitRecords, HitsVcf}; use og_summary::collect::two_hits::{DeletionInputs, SvRow}; @@ -429,16 +430,65 @@ fn a_deletion_plus_a_low_confidence_call_is_only_possibly_biallelic() { /// The ACMG SF card on step 06's hits alone (no clinical VCF). fn sf(hits: Vec>, dels: &DeletionInputs) -> IndexMap { + sf_with_high(hits, Vec::new(), dels) +} + +/// The ACMG SF card on step 06's hits plus a clinical VCF whose only +/// HIGH-impact records are `high` (none: no clinical VCF). +fn sf_with_high( + hits: Vec>, + high: Vec<(Site, HighRecord)>, + dels: &DeletionInputs, +) -> IndexMap { let h: Result = Ok((Floor::default(), hits)); + let clinical: Option> = (!high.is_empty()).then(|| { + Ok(ClinicalVcf { + records: high.len(), + high: Ok(high + .into_iter() + .map(|(s, r)| ((s.0.to_owned(), s.1, s.2.to_owned(), s.3.to_owned()), r)) + .collect()), + }) + }); obj(acmg_sf(&Inputs { assets: ASSETS, hits: Some(&h), - clinical: None, + clinical: clinical.as_ref(), deletions: dels, }) .unwrap()) } +type Site = (&'static str, i128, &'static str, &'static str); + +/// A HIGH-impact MUTYH stop-gain record of the clinical VCF for the hit at +/// `site`, with the hit's own GT and phase set, as a real run gives it, +/// called weak (GQ 5, DP 4) or confident (GQ 50, DP 30). +fn high(site: Site, gt: &str, ps: Option<&str>, weak: bool) -> (Site, HighRecord) { + let (gq, dp) = if weak { (5, 4) } else { (50, 30) }; + ( + site, + HighRecord { + genotype: gt.to_owned(), + ps: ps.map(str::to_owned), + genes: [("MUTYH".to_owned(), "stop_gained".to_owned())] + .into_iter() + .collect(), + transcript: "MANE", + frequency: "rare", + weak, + why: if weak { + vec!["GQ 5 < 30".to_owned(), "DP 4 < 10".to_owned()] + } else { + Vec::new() + }, + gq: Some(gq), + dp: Some(dp), + ad: None, + }, + ) +} + /// The `pair` word of each reported ClinVar row of `gene` on the SF card. fn sf_pairs(c: &IndexMap, gene: &str) -> Vec { let r = of(c, "clinvar_hits", gene); @@ -694,6 +744,8 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { let combined = |q: &str| hit(b, "MUTYH", "GT:GQ:DP:PS", &format!("0|1:{q}:9"), &joined); // The same combined allele, unphased and weak. let combined_open = || hit(b, "MUTYH", "GT:GQ:DP", "0/1:5:4", &joined); + // The same combined allele, called homozygous and weak. + let combined_hom = || hit(b, "MUTYH", "GT:GQ:DP", "1/1:5:4", &joined); // A second alt allele at MUTYH_A's position, for a split call there. let a2 = (a.0, a.1, a.2, "G"); let del = || mutyh_deletion("1|0", Some("9")); @@ -877,11 +929,80 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { ), ("deletion alone", vec![], del(), None), ("nothing", vec![], none(), None), + ( + "X4 weak hom combined, confident part, third in trans with the part", + vec![combined_hom(), g(a, "0|1", p9), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "X4b confident combined, weak hom part, third in trans with the combined", + vec![combined("50:30"), w(a, "1/1", None), g(cc, "1|0", p9)], + none(), + bi, + ), + ( + "X9b weak unphased combined, confident part in cis with the deletion", + vec![combined_open(), g(a, "0|1", p9)], + mutyh_deletion("0|1", p9), + None, + ), + ( + "X10 weak phased combined, confident part in cis with the deletion", + vec![combined("5:4"), g(a, "1|0", p9)], + del(), + None, + ), ]; + // The same weak calls with a HIGH-impact record of the variant on the + // card, weak too (its GT and phase set the call's own): the record is + // no confident call of it. + let hw = |site, gt, ps| high(site, gt, ps, true); + #[allow(clippy::type_complexity)] + let with_high: Vec<( + &str, + Vec>, + Vec<(Site, HighRecord)>, + DeletionInputs, + Option<&str>, + )> = vec![ + ( + "H1 weak het with a weak HIGH record + confident unphased het", + vec![w(a, "0/1", None), g(cc, "0/1", None)], + vec![hw(a, "0/1", None)], + none(), + low, + ), + ( + "H2 weak het with a weak HIGH record + unphased deletion", + vec![w(a, "0/1", None)], + vec![hw(a, "0/1", None)], + mutyh_deletion("0/1", None), + low, + ), + ( + "H3p weak het with a weak HIGH record, in trans with a confident het by its own phase", + vec![w(a, "0|1", p9), g(b, "1|0", p9)], + vec![hw(a, "0|1", p9)], + none(), + low, + ), + ( + "H5 two weak hets with weak HIGH records", + vec![w(a, "0/1", None), w(b, "0/1", None)], + vec![hw(a, "0/1", None), hw(b, "0/1", None)], + none(), + low, + ), + ]; + let all = shapes + .into_iter() + .map(|(l, h, d, w)| (l, h, Vec::new(), d, w)) + .chain(with_high); let mut wrong = Vec::new(); - for (label, hits, dels, want) in shapes { + for (label, hits, records, dels, want) in all { let carrier = list(hits.clone(), &dels); - let card = sf(hits, &dels); + let card = sf_with_high(hits, records, &dels); // The whole output of both cards, for a before/after diff. eprintln!("DUMP {label}\tSF {card:?}\tCARRIER {carrier:?}"); let (x, y) = (sf_answer(&card, "MUTYH"), carrier_answer(&carrier, "MUTYH")); From ae476dbe1fb6c93cbae472246204d8ab04c908f4 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 22:00:48 +0100 Subject: [PATCH 25/40] docs(carrier): name the weak HIGH-impact call where the two lists differ A HIGH-impact record is weak on a skewed allele balance too, not only below the clinical call floor. Such a call is now low confidence on the secondary-findings card and confident on the carrier list, even when both files state the same floor. The changelog and the results page said the two lists agree whenever the floors match; they now name this case. Part of #411 (clin-19). --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 2 +- 2 files changed, 2 insertions(+), 2 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 99f1521ce..43cde4eae 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer when the hits file and the clinical VCF state the same call floor, apart from one rare deletion shape where the card is more cautious: on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (another call floor in the clinical VCF, or an allele balance out of range): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 79dd76dd5..4a6128366 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,7 +14,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So when the hits file and the clinical VCF state different call floors, a call can be low confidence on the list and confident on the card. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So a call can be low confidence on one list and confident on the other: when the hits file and the clinical VCF state different call floors, or when the allele balance of a HIGH-impact call is out of range (then it is low confidence on the card only). The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: From 4299bb37ed317b7cf9bf65a4f9dc0ad8058ccd69 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 23:10:59 +0100 Subject: [PATCH 26/40] docs(carrier): name the real split between the two lists, not allele balance The docs said a HIGH-impact call weak on allele balance is low confidence on the card only. It never lowers a hit whose ClinVar row is confident, so that split does not exist. The real one is the HIGH-impact call of a part of a combined allele, which makes the allele confident on the card while the list marks it low confidence. Bead: clin-19 --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 4 ++-- 2 files changed, 3 insertions(+), 3 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index 43cde4eae..dbf8af6e9 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -4,7 +4,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (another call floor in the clinical VCF, or an allele balance out of range): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - The reads drawing on a live finding page now says what it is before it is shown. It is the same nine bars on every finding, but its label read "The reads at " above it and only a caption after it said it was a sketch, so it looked like the person's own reads. The label now reads "Where to look at the reads: . An illustration, not your reads.", and the link to the real reads in the genome viewer stays. In the public demo, which has no reads, every offer of reads said so only after the click: the finding page's link, a card's "See the reads at" link, a chart mark's link and a search hit's "reads at " link opened a page saying the demo has none, and the map's card button and reads pill opened a panel saying so. They now read "Reads: not in the demo": the links are plain text, and the map's buttons still open the panel that says why. On any site, the map's reads panel, which opens under the map and often below the screen, now scrolls into view when it opens. The browser check `rust/crates/og-browser/tests/rv_live_reads_sketch_label.rs` builds the demo and checks all of it. No option, output or file name changes. - `og live serve` serves the live site from the one static `og` binary, in Rust: the home, run and family pages, `state.json` and its headlines, the event stream, the run files, the map, `/metrics` and the search, charts, ops and re-check plugins, with the same policy on every answer. It has no login yet, so it serves loopback only and refuses the password, TLS and proxy options with exit 2; `scripts/owngenome-live.sh` still starts the Python server ([Watch a Run Live](docs/live-site.md)). `bin/owngenome_recheck.py`, the shim that ran `og recheck`, is gone: call `bin/og recheck`. The Python checks of the site that `og live serve` now answers moved to `cargo test -p og-live`. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 4a6128366..742dabaa3 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,12 +14,12 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So a call can be low confidence on one list and confident on the other: when the hits file and the clinical VCF state different call floors, or when the allele balance of a HIGH-impact call is out of range (then it is low confidence on the card only). The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So the card can count a call the list does not have: a HIGH-impact variant that is no ClinVar hit, or the HIGH-impact call of a part of a combined allele, which makes that allele confident on the card while the list marks it low confidence. When the clinical VCF states a lower call floor than the hits file, a call can also be low confidence on the list and confident on the card. A HIGH-impact call that is weak on allele balance alone never lowers a hit whose ClinVar row is confident. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: - a dominant gene (BRCA1, LDLR, MYH7 and most others): one pathogenic or likely pathogenic variant is reported; -- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a low-confidence call is `possibly biallelic (low-confidence call)`: confirm that call first. A low-confidence call is one below step 6's call floor (its `low_confidence` mark), or a weak HIGH-impact call (a HIGH-impact record's `weak_call` mark: below the clinical call floor, or an allele balance out of range). A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is. Then it counts with the copies, GT and phase set of that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; +- a recessive gene (MUTYH, ATP7B, BTD, CYP27A1, GAA, RPE65, CASQ2, TRDN): both copies of the gene must be hit. A homozygote, or two variants that read-backed phase puts on different copies (a `|` genotype with the same phase set, PS), are biallelic. Two different variants of unknown phase are still reported, as possibly biallelic: most short-read calls carry no phase, and they may sit on one copy. In `summary.json` each such finding has a `pair` field (`biallelic` or `possibly biallelic`) and a `phase` field that says why. The card counts the variants twice, with every call and with the confident calls alone. A pair that needs a low-confidence call is `possibly biallelic (low-confidence call)`: confirm that call first. A low-confidence call is one below step 6's call floor (its `low_confidence` mark), or a weak HIGH-impact call (a HIGH-impact record's `weak_call` mark: below the clinical call floor, or an allele balance out of range). A variant counts as confident when any call of it is: its ClinVar row or its HIGH-impact record. A confident homozygous call, a confident pair or a confident deletion pair keeps `biallelic` even when another variant of the gene is a low-confidence call, and two confident variants of unknown phase stay `possibly biallelic`, even when a low-confidence call would prove the pair. A combined allele counts as confident when any call of it is. Then it counts with the copies, GT and phase set of that confident call. Two variants that read-backed phase puts on the same copy (cis) hit one copy only, so they are listed apart with the phase set. A `|` genotype with no phase set, or a half call such as `1|.`, counts as phase unknown. The two alt alleles of one split call (`1/.` and `./1` at one position) sit on different copies. A combined allele of step 6 counts once with its parts, unless it is unphased and two of its parts are hits on their own. A record with no alt copy called counts nothing. One heterozygous MUTYH variant is listed apart as not reported, with the reason; - HFE: only homozygous p.Cys282Tyr. A heterozygous p.Cys282Tyr or a homozygous p.His63Asp is not reported; - X-linked: GLA (Fabry disease) and OTC are reported in a hemizygous male and a heterozygous female alike. ABCD1 (X-linked adrenoleukodystrophy) is reported hemizygous, homozygous or with two heterozygous variants, never for one heterozygous variant; - BTD with p.Asp444His: reported as partial, not profound, biotinidase deficiency; From 366365f3c799da69469395c245a3b76a4533b67f Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 23:10:59 +0100 Subject: [PATCH 27/40] fix(carrier): let a phased combined allele lend no phase to its weak part The carrier list rescued a weak part by its confident combined allele in every case. The card counts a part through its combined allele only when that allele is unphased and the part is its first part present, so a phased combined allele inside a deletion made its weak part just outside it read biallelic on the list. The SF card's deletion pair on a weak HIGH-impact call also blamed the call floor; it now names both kinds of low-confidence call. Bead: clin-19 --- rust/crates/og-summary/src/collect/acmg.rs | 14 ++++- rust/crates/og-summary/src/collect/carrier.rs | 22 ++++++- .../tests/i411_carrier_confidence.rs | 58 +++++++++++++++++++ 3 files changed, 90 insertions(+), 4 deletions(-) diff --git a/rust/crates/og-summary/src/collect/acmg.rs b/rust/crates/og-summary/src/collect/acmg.rs index 831b6270c..7a4e6d4a9 100644 --- a/rust/crates/og-summary/src/collect/acmg.rs +++ b/rust/crates/og-summary/src/collect/acmg.rs @@ -1118,9 +1118,21 @@ fn tier(i: &Inputs) -> Result, String> { _ => None, }) .collect(); - let found = two_hits_with(&variants, &dels, |v| { + let mut found = two_hits_with(&variants, &dels, |v| { low.contains(&(v.gene.clone(), v.key.clone())) }); + // The card's low calls include a weak HIGH-impact call, so its pairs + // name both kinds, as its own low-confidence word does. + let (floor, either) = ( + "the variant's call is below the call floor (low confidence)", + "the variant's call is low confidence (below the call floor, or a weak HIGH-impact call)", + ); + for e in found.entries.values_mut() { + e.why = e.why.replacen(floor, either, 1); + } + for t in found.pairs.values_mut() { + *t = t.replacen(floor, either, 1); + } let mut two: HashMap<(String, Key), String> = HashMap::new(); for g in found.entries.keys() { if matches!(rules[g].report_if.as_str(), "biallelic" | "hemizygous") { diff --git a/rust/crates/og-summary/src/collect/carrier.rs b/rust/crates/og-summary/src/collect/carrier.rs index ce1184778..59c87a738 100644 --- a/rust/crates/og-summary/src/collect/carrier.rs +++ b/rust/crates/og-summary/src/collect/carrier.rs @@ -358,11 +358,26 @@ impl Carrier { // A low-confidence row pairs with a deletion by a confident call of // its combined allele, as the secondary-findings card counts it: the // first confident row of the gene, with as many copies, that is a - // part of it or that it is a part of. That row's GT and phase set - // stand for it, and the pair no longer needs a low-confidence call. + // part of it, or an unphased combined allele whose first part present + // it is (the card counts such an allele under that part). A phased + // combined allele stands for its parts, so it never lends them its + // phase. That row's GT and phase set stand for it, and the pair no + // longer needs a low-confidence call. let mut vs: Vec = variants.iter().map(|(v, _)| v.clone()).collect(); let mut low_pair = low.clone(); let is_low = |v: &Variant| low.contains(&(v.gene.clone(), v.key.clone())); + let phased = |v: &Variant| { + v.ps.as_deref().is_some_and(|p| !p.is_empty()) + && phase_haps(Some(&v.gt)).is_some_and(|h| !h.is_empty()) + }; + // The first part of combined row `j` present among the gene's + // variants, in `PGP_JOINED_FROM` order. + let first_part = |j: usize| { + let g = &variants[j].0.gene; + vjoined[j] + .iter() + .find(|k| variants.iter().any(|(x, _)| &x.gene == g && &x.key == *k)) + }; for (i, (v, _)) in variants.iter().enumerate() { if !is_low(v) { continue; @@ -371,7 +386,8 @@ impl Carrier { c.gene == v.gene && !is_low(c) && c.copies >= v.copies - && (vjoined[i].contains(&c.key) || vjoined[*j].contains(&v.key)) + && (vjoined[i].contains(&c.key) + || (!phased(c) && first_part(*j) == Some(&v.key))) }); if let Some((_, (c, _))) = sure { vs[i].gt = c.gt.clone(); diff --git a/rust/crates/og-summary/tests/i411_carrier_confidence.rs b/rust/crates/og-summary/tests/i411_carrier_confidence.rs index eb40fc17b..a81913c93 100644 --- a/rust/crates/og-summary/tests/i411_carrier_confidence.rs +++ b/rust/crates/og-summary/tests/i411_carrier_confidence.rs @@ -489,6 +489,16 @@ fn high(site: Site, gt: &str, ps: Option<&str>, weak: bool) -> (Site, HighRecord ) } +/// The same HIGH-impact record with good GQ and DP, weak on its allele +/// balance alone (5 alt reads of 30 on a heterozygote). +fn high_ab(site: Site, gt: &str, ps: Option<&str>) -> (Site, HighRecord) { + let (s, mut r) = high(site, gt, ps, false); + r.weak = true; + r.why = vec!["alt reads 0.17 of the depth on a heterozygote".to_owned()]; + r.ad = Some("25,5".to_owned()); + (s, r) +} + /// The `pair` word of each reported ClinVar row of `gene` on the SF card. fn sf_pairs(c: &IndexMap, gene: &str) -> Vec { let r = of(c, "clinvar_hits", gene); @@ -511,6 +521,29 @@ fn the_sf_card_caps_a_deletion_pair_on_a_low_confidence_call() { assert_eq!(sf_pairs(&sure, "MUTYH"), ["biallelic"]); } +/// A HIGH-impact call weak on its allele balance alone is low confidence on +/// the card, and its deletion pair says so without blaming the call floor. +#[test] +fn the_sf_card_names_a_weak_high_impact_call_in_its_deletion_pair() { + let card = sf_with_high( + Vec::new(), + vec![high_ab(MUTYH_A, "0/1", None)], + &mutyh_deletion("0/1", None), + ); + let r = of(&card, "high_impact", "MUTYH"); + assert_eq!(r.len(), 1, "{card:?}"); + assert_eq!(s(r[0], "pair"), "possibly biallelic (low-confidence call)"); + let either = "low confidence (below the call floor, or a weak HIGH-impact call)"; + for k in ["phase", "two_hit"] { + let t = s(r[0], k); + assert!(t.contains(either), "{k}: {t}"); + assert!( + !t.contains("below the call floor (low confidence)"), + "{k}: {t}" + ); + } +} + #[test] fn the_sf_card_caps_a_phased_pair_on_a_low_confidence_call() { let weak = sf( @@ -748,6 +781,18 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { let combined_hom = || hit(b, "MUTYH", "GT:GQ:DP", "1/1:5:4", &joined); // A second alt allele at MUTYH_A's position, for a split call there. let a2 = (a.0, a.1, a.2, "G"); + // A confident phased combined allele at chr1:45336998, inside the test + // deletion, whose second part sits at chr1:45337002, just past its end. + let edge = ("chr1", 45_337_002, "C", "T"); + let straddle = || { + hit( + ("chr1", 45_336_998, "ATGCC", "GTGCT"), + "MUTYH", + "GT:GQ:DP:PS", + "0|1:50:30:9", + ";PGP_JOINED_FROM=chr1:45336998:A:G|chr1:45337002:C:T", + ) + }; let del = || mutyh_deletion("1|0", Some("9")); let none = no_deletions; let p9 = Some("9"); @@ -953,6 +998,12 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { del(), None, ), + ( + "N13 confident phased combined inside the deletion, weak part just outside it, deletion in trans", + vec![straddle(), w(edge, "0/1", None)], + del(), + maybe, + ), ]; // The same weak calls with a HIGH-impact record of the variant on the // card, weak too (its GT and phase set the call's own): the record is @@ -994,6 +1045,13 @@ fn the_carrier_list_and_the_sf_card_agree_on_a_gene_on_both_lists() { none(), low, ), + ( + "N1 confident het with a HIGH record weak on allele balance alone + confident unphased het", + vec![g(a, "0/1", None), g(cc, "0/1", None)], + vec![high_ab(a, "0/1", None)], + none(), + maybe, + ), ]; let all = shapes .into_iter() From a1b27b3df8851da4b637b3947b06c43988de656b Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sat, 21 Nov 2026 23:17:35 +0100 Subject: [PATCH 28/40] test(parity): regenerate 38 report-render goldens on main's SV support text Main now prints the SV caller support as main's code words it ("caller support not known (no step 22 consensus)" and the like), so the 38 report goldens this PR adds no longer matched og. Each file is og's own output from the merged tree; oracle-diff summary-collect report-render agrees on all 1097 items, and no summary-collect golden moved. Bead: clin-19 --- .../report-render/all-history/all-history.txt | 10 +++++----- tests/parity/golden/report-render/all/all.txt | 10 +++++----- .../golden/report-render/cb-full/cb-full.html | 8 ++++---- .../golden/report-render/cb-full/cb-full.txt | 18 +++++++++--------- .../cb-quoted-dosage/cb-quoted-dosage.html | 8 ++++---- .../cb-quoted-dosage/cb-quoted-dosage.txt | 18 +++++++++--------- .../cb-quoted-interval/cb-quoted-interval.html | 8 ++++---- .../cb-quoted-interval/cb-quoted-interval.txt | 18 +++++++++--------- .../cb-quoted-smn/cb-quoted-smn.html | 8 ++++---- .../cb-quoted-smn/cb-quoted-smn.txt | 18 +++++++++--------- .../cb-unicode-contig/cb-unicode-contig.html | 8 ++++---- .../cb-unicode-contig/cb-unicode-contig.txt | 18 +++++++++--------- .../m-clinical-escape/m-clinical-escape.html | 8 ++++---- .../m-clinical-escape/m-clinical-escape.txt | 18 +++++++++--------- .../m-clinical-stale/m-clinical-stale.html | 8 ++++---- .../m-clinical-stale/m-clinical-stale.txt | 18 +++++++++--------- .../m-clinvar-freq-note.html | 8 ++++---- .../m-clinvar-freq-note.txt | 18 +++++++++--------- .../m-clinvar-many/m-clinvar-many.html | 8 ++++---- .../m-clinvar-many/m-clinvar-many.txt | 18 +++++++++--------- .../m-clinvar-none/m-clinvar-none.html | 8 ++++---- .../m-clinvar-none/m-clinvar-none.txt | 18 +++++++++--------- .../m-couple-empty/m-couple-empty.html | 8 ++++---- .../m-couple-empty/m-couple-empty.txt | 18 +++++++++--------- .../report-render/m-couple/m-couple.html | 8 ++++---- .../golden/report-render/m-couple/m-couple.txt | 18 +++++++++--------- .../report-render/m-cpsr-none/m-cpsr-none.html | 8 ++++---- .../report-render/m-cpsr-none/m-cpsr-none.txt | 18 +++++++++--------- .../m-cpsr-noown/m-cpsr-noown.html | 8 ++++---- .../m-cpsr-noown/m-cpsr-noown.txt | 18 +++++++++--------- .../report-render/m-sf-notes/m-sf-notes.html | 8 ++++---- .../report-render/m-sf-notes/m-sf-notes.txt | 18 +++++++++--------- .../m-since-clinical/m-since-clinical.html | 8 ++++---- .../m-since-clinical/m-since-clinical.txt | 18 +++++++++--------- .../m-slivar-phase/m-slivar-phase.html | 8 ++++---- .../m-slivar-phase/m-slivar-phase.txt | 18 +++++++++--------- .../m-slivar-unphased/m-slivar-unphased.html | 8 ++++---- .../m-slivar-unphased/m-slivar-unphased.txt | 18 +++++++++--------- 38 files changed, 244 insertions(+), 244 deletions(-) diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index 84e4a5c3e..d6f60827b 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -200,13 +200,13 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- [New since 2021-01-01 00:00 UTC] - Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 3 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (no step 22 consensus) on exon edges: exon 2 benign-set AF 0.001 (gnomAD) - DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) - DEL 9:1-100 class 4 G9 support: single caller (tiddit) + DUP 2:150-880 class 4 GENE3 support: not known (no step 22 consensus) + DEL 9:1-100 class 4 G9 support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) @@ -611,7 +611,7 @@ CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) T2D 0.1 (10/20 variants matched) PGS000014 Short not available (not available/not available variants matched) PGS1 - Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. ## Blood Groups (predicted from the genome) --- diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index 9e0859df8..03c715856 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -186,13 +186,13 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 3 (single caller: 1; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 3 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:1100-5100 class 5 GENE1, GENE2 support: 2 callers (manta, delly) + DEL 1:1100-5100 class 5 GENE1, GENE2 support: not known (no step 22 consensus) on exon edges: exon 2 benign-set AF 0.001 (gnomAD) - DUP 2:150-880 class 4 GENE3 support: 3 callers (manta, delly, tiddit, caller 4) - DEL 9:1-100 class 4 G9 support: single caller (tiddit) + DUP 2:150-880 class 4 GENE3 support: not known (no step 22 consensus) + DEL 9:1-100 class 4 G9 support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): INV 7:1-100 no gene AnnotSV class 4 -> 3 (mhc: the MHC) @@ -570,7 +570,7 @@ CAD 0.5 (100/120 variants matched) PGS000018 percentile 75 (EUR) effect HR 1.5 (EUR) T2D 0.1 (10/20 variants matched) PGS000014 Short not available (not available/not available variants matched) PGS1 - Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. + Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. ## Blood Groups (predicted from the genome) --- diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index 588864b73..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gained
    chr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index ab3502a3c..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index ea9891284..50c6f17ac 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index e4af1140f..4dd70693e 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index 588864b73..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index ab3502a3c..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index 588864b73..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index ab3502a3c..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index 4730e2e56..da5f01318 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHsingle caller (Manta)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index 9c2957b3a..2f2125230 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 6; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: single caller (Manta) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index d0d716b1f..98d967d9f 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index 9cfb76642..a02bc03a9 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index afd02899a..81656e7a8 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -278,8 +278,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -362,9 +362,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index 549dba951..f5910ef77 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -74,8 +74,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -138,16 +138,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index 71cb39891..4c7f69b36 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index 14a79ff24..7be47c40d 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index ece70cbb1..14fb3370b 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -316,8 +316,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -398,9 +398,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 351fd3e65..06b41f0b8 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -205,8 +205,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -267,16 +267,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index fed6ce1e6..3001a07f3 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -238,8 +238,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -320,9 +320,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index 2775a2396..680f40fdb 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -29,8 +29,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -91,16 +91,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index d514f6db5..d42c0df81 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -273,8 +273,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -355,9 +355,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index 1a6242848..201e3c3f5 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index 27436ddd2..0e4f04cec 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -273,8 +273,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -355,9 +355,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index 3dde7aea9..68ba48448 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -134,16 +134,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index e2d8c5fcf..b88e3b02f 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -339,9 +339,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index c73177061..41b647e7b 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -118,16 +118,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index d7820497d..563d5b2c4 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -344,9 +344,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 5e016d16b..c560033c8 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -124,16 +124,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index 70e52e743..70a31868e 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -355,9 +355,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index fd8beca52..732c94735 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -135,16 +135,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index f49fdfd65..0b2e84ba7 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -354,9 +354,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 4f105b67d..a28702b2e 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -73,8 +73,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -136,16 +136,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index d0f1fb5bb..eb10ee6a1 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -330,9 +330,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index b17cbd9a6..58d139a78 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -114,16 +114,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index 511f859c6..47607470f 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -272,8 +272,8 @@

    Secondary-Findings Genes (ACMG SF v3.3)

    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000 MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000 MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000 -MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 -BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000 +MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000 +BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (no step 22 consensus)chr17:43000000-43100000

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    @@ -328,9 +328,9 @@

    Structural Variants

    Structural Variants, Class 4 and 5 (AnnotSV)

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    StatusComplete
    -

    Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1)

    +

    Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1)

    Moved to class 3 by step 05's rules, not counted above: 1

    -
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYH2 callers (manta, delly)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMsingle caller (Delly)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2single caller (CNVpytor)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEsingle caller (Manta)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1single caller (Manta)none13:20180000-20200000
    DEL 3:15600000-157000005BTDsingle caller (Manta)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (no step 22 consensus)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (no step 22 consensus)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (no step 22 consensus)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (no step 22 consensus)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (no step 22 consensus)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (no step 22 consensus)benign-set AF 0.2 (gnomAD), common3:15600000-15700000

    Moved to class 3 by step 05's rules

    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index e96760679..dcdbe1688 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -72,8 +72,8 @@ MUTYH chr1:45332000 G>A het stop_gained MYBPC3 chr11:47332000 G>A het splice_donor_variant,intron_variant MSH2 chr2:47414000 A>AT het frameshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. - BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, single caller (CNVpytor) + MSH2 DEL chr2:47386000-47388000 . AnnotSV class 4, caller support not known (no step 22 consensus); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding. + BRCA1 DUP chr17:43000000-43100000 . AnnotSV class 4, caller support not known (no step 22 consensus) HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants) HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only @@ -112,16 +112,16 @@ ## Structural Variants, Class 4 and 5 (AnnotSV) --- - Class 4-5 SVs: 6 (single caller: 5; deletions on exon edges: 1; common: 1) + Class 4-5 SVs: 6 (single caller: 0; deletions on exon edges: 1; common: 1) Moved to class 3 by step 05's rules, not counted above: 1 - DEL 1:45338000-45340000 class 5 MUTYH support: 2 callers (manta, delly) + DEL 1:45338000-45340000 class 5 MUTYH support: not known (no step 22 consensus) on exon edges: - DEL chr2:47386000-47388000 class 4 EPCAM support: single caller (Delly) - DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: single caller (CNVpytor) + DEL chr2:47386000-47388000 class 4 EPCAM support: not known (no step 22 consensus) + DUP 17:43000000-43100000 class 4 BRCA1, NBR2 support: not known (no step 22 consensus) benign-set AF 0.001 (gnomAD) - DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: single caller (Manta) - DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: single caller (Manta) - DEL 3:15600000-15700000 class 5 BTD support: single caller (Manta) + DEL 13:20180000-20200000 class 5 GJB2, NOTAGENE support: not known (no step 22 consensus) + DEL 13:20180000-20200000 class 4 GJB2, XYZ1 support: not known (no step 22 consensus) + DEL 3:15600000-15700000 class 5 BTD support: not known (no step 22 consensus) benign-set AF 0.2 (gnomAD), common Moved to class 3 by step 05's rules (from AnnotSV's class, with the reason): DEL 3:15600000-15700000 BTD AnnotSV class 5 -> 3 (rule not named: no detail) From 7a6a81d6590198d5154812778e160ffcc2a99081 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:04:07 +0100 Subject: [PATCH 29/40] ci(e2e): weigh prs-3-panel-measure at 2900 s only on a run that is not traced A traced run skips the panel measure (measure_on in its file, #572), so its shard should not be planned around 2900 seconds of work that never runs. --- .github/workflows/e2e.yml | 13 +++++++------ docs/testing.md | 2 +- 2 files changed, 8 insertions(+), 7 deletions(-) diff --git a/.github/workflows/e2e.yml b/.github/workflows/e2e.yml index 7f1af299c..028f13ce9 100644 --- a/.github/workflows/e2e.yml +++ b/.github/workflows/e2e.yml @@ -119,12 +119,13 @@ env: E2E_SHARDS: 6 # Times that replace scripts/ci/e2e-case-times.tsv's for this run # (scripts/ci/e2e-shards.sh). prs-3-panel-measure measures the 1000 Genomes - # panel only on a run dispatched on a branch other than main (measure_on in - # its file), where it took 2684 to 3452 s (median 2900, runs 44488552622, - # 44616213787 and 44790003535 on the geiresx fork); elsewhere it takes 0 s, - # as the table says. Without this its shard got a full share of other cases - # on top and finished last. Set here, so every job of a run splits alike. - E2E_SECONDS: ${{ github.event_name == 'workflow_dispatch' && github.ref != 'refs/heads/main' && 'prs-3-panel-measure=2900' || '' }} + # panel only on a run dispatched on a branch other than main and not traced + # (measure_on in its file), where it took 2684 to 3452 s (median 2900, runs + # 44488552622, 44616213787 and 44790003535 on the geiresx fork); elsewhere it + # takes 0 s, as the table says. Without this its shard got a full share of + # other cases on top and finished last. Set here, so every job of a run + # splits alike. + E2E_SECONDS: ${{ github.event_name == 'workflow_dispatch' && github.ref != 'refs/heads/main' && !inputs.trace && 'prs-3-panel-measure=2900' || '' }} concurrency: group: ${{ github.workflow }}-${{ github.event_name }}-${{ github.ref }} diff --git a/docs/testing.md b/docs/testing.md index f5d53322f..71fcec1ff 100644 --- a/docs/testing.md +++ b/docs/testing.md @@ -77,7 +77,7 @@ You can build it yourself on Linux with Docker, `bgzip`, `tabix` and about 10 GB In CI the cases run in parallel legs, each case at most once: a pull request runs only the cases it can affect ([Which cases a pull request runs](#which-cases-a-pull-request-runs)), main and the monthly run run them all. On 2026-11-02 the 130 cases took 230 minutes one after another on one runner (run 41390434697), against a 300-minute job limit. Now: - `e2e-plan` splits the cases with [`scripts/ci/e2e-shards.sh`](https://github.com/GeiserX/OwnGenome/blob/main/scripts/ci/e2e-shards.sh). The leg `e2e base` runs the cases of stage `base` in [`scripts/ci/e2e-case-times.tsv`](https://github.com/GeiserX/OwnGenome/blob/main/scripts/ci/e2e-case-times.tsv) (every numbered case: the fixture check, setup validation, alignment, DeepVariant, GATK, the single steps on HG002, the reports and the Nextflow run; and `bash-step-08-hla`), because most other cases read what those wrote. Every other picked case goes to one of the shard legs (`e2e shard 1`, `e2e shard 2`, ...). A full run uses all `E2E_SHARDS` (6) legs. For picked cases, `e2e-shards.sh count` sets how many: the cases' total seconds divided by the heaviest group's seconds (the critical path, since a group is never split) or by 900 seconds when that is larger, rounded down, plus one more leg when the rest is 900 seconds or more, and never more than `E2E_SHARDS` (6). A shard leg spends 18 to 20 minutes on top of its cases (pulling images, fetching and unpacking the base outputs, the parity checks and the uploads; run 41847167444), so a leg with less than 15 minutes of cases costs more runner time than it saves in wall time. With every case that rule gives 4 or 5 legs, and that is why a full run does not use it: the runner's disk, not time, is what a leg runs out of. With 5 legs, shards of 30 and 37 cases filled one runner's disk until the runner itself died (run 41995851301, shard 3), while 6 legs passed on the same main (run 41995719742). -- The table holds each case's median time on the passing runs of nine e2e runs of 2026-11-04 (41766267038, 41767270253, 41773233871, 41774860458, 41779067613, 41790595358, 41799741941, 41807346887 and 41821518376), and its `needs`: the non-base cases whose outputs it reads. The needs were written from what each case says it reads (its header and its checks) and from the cases that failed in a split run without them (run 41455829120). A case and every case it needs, followed through, form a group that stays in one shard, in name order. Groups go to the least loaded shard, heaviest first. Every case needs a row: `e2e-shards.sh check`, which `tests/test_e2e_shards.sh` runs on the real table in the unit tests, fails and names each case without one. The split itself still runs a case with no row, as a 300-second case that needs nothing, so add the row with the case's measured seconds from its first passing run. A case whose cost depends on the run gets its time for that run from `E2E_SECONDS` (`CASE=SECONDS ...`), which `e2e.yml` sets for every job of the run, so they all split alike: `prs-3-panel-measure` measures the 1000 Genomes panel only on a run dispatched on a branch other than main, where it took 2684 to 3452 seconds (median 2900), and takes 0 seconds elsewhere, as its row says. Before, a dispatched run gave its shard a full share of other cases on top of those 48 minutes, and that shard finished last in 12 of 18 runs. `e2e-shards.sh seconds` prints the time each case is weighed by, and the plan job's summary names any time `E2E_SECONDS` replaced. +- The table holds each case's median time on the passing runs of nine e2e runs of 2026-11-04 (41766267038, 41767270253, 41773233871, 41774860458, 41779067613, 41790595358, 41799741941, 41807346887 and 41821518376), and its `needs`: the non-base cases whose outputs it reads. The needs were written from what each case says it reads (its header and its checks) and from the cases that failed in a split run without them (run 41455829120). A case and every case it needs, followed through, form a group that stays in one shard, in name order. Groups go to the least loaded shard, heaviest first. Every case needs a row: `e2e-shards.sh check`, which `tests/test_e2e_shards.sh` runs on the real table in the unit tests, fails and names each case without one. The split itself still runs a case with no row, as a 300-second case that needs nothing, so add the row with the case's measured seconds from its first passing run. A case whose cost depends on the run gets its time for that run from `E2E_SECONDS` (`CASE=SECONDS ...`), which `e2e.yml` sets for every job of the run, so they all split alike: `prs-3-panel-measure` measures the 1000 Genomes panel only on a run dispatched on a branch other than main and not traced, where it took 2684 to 3452 seconds (median 2900), and takes 0 seconds elsewhere, as its row says. Before, a dispatched run gave its shard a full share of other cases on top of those 48 minutes, and that shard finished last in 12 of 18 runs. `e2e-shards.sh seconds` prints the time each case is weighed by, and the plan job's summary names any time `E2E_SECONDS` replaced. - The job `og` builds `og` once, for the runners only (`OG_ARCHES=x86_64`, no macOS binaries; see `rust/og.sh`), and hands it to every leg as the artifact `og-e2e`. Guard's `rust` job and the Rust workflow's `images` job still build all four binaries. The base leg does not wait for `og` to start: it mounts the spare disk, frees disk, sets up Docker, Java and Nextflow, restores the image cache and pulls the images while `og` builds, and only then waits for `og-e2e` (step "Wait for og"). A shard leg finds the artifact at once. When the job `og` ends without it, the leg stops. - The base leg runs first. It packs every file its cases wrote or changed (at its absolute path, with owners, modes and times) and uploads it as the artifact `e2e-base`, kept for 3 days so that "Re-run failed jobs" the next day still finds it. The shard legs start only after it passed (`needs:`), so a shard never holds a runner while it waits: when many runs share the account's runners, shards that started early and waited took the runners the base legs needed (run 41506673662 had three shards running and its base leg still queued). Each shard fetches the artifact, tried up to five times, takes the base leg's work area, unpacks the archive there, deletes it (about 4 GB the cases need) and runs its cases. When the base leg fails, the shards are skipped and `e2e` is red. - The shard that holds `nextflow-from-fastq-2-nextflow` and the one that holds `nextflow-hardening-2-nf` run the parity checks; the plan fails when either case runs and the case before it in its pair is in a different shard. From 8befa62284e7180cd3316fc62d6c180eea943c3b Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:04:07 +0100 Subject: [PATCH 30/40] docs(prs): say the panel measure adds 35 to 80 minutes, as its case says --- docs/25-prs.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/25-prs.md b/docs/25-prs.md index c7c437ff7..b6ffd767c 100644 --- a/docs/25-prs.md +++ b/docs/25-prs.md @@ -179,7 +179,7 @@ The panel is pgsc_calc's 1000 Genomes database, `pgsc_1000G_v1.tar.zst` (`PGSC_P | Memory | 7.3 to 7.6 GB at the peak for the whole machine; the largest task, 6.9 to 7.1 GB (plink2 scoring the panel's own samples, and the panel's variant filter) | | Time | 20 to 30 minutes for the run, on 4 CPUs | -That run scored PGS000018 alone and fits a 16 GB machine; the default scores need more ([Memory](#memory)). It does not fit the 14 GB of disk a GitHub-hosted runner guarantees, and its download takes 13 to 31 minutes on a runner, so the panel stays opt-in (`setup.sh --ancestry-panel`), and the tests on every pull request project the fixture sample onto the PGS Catalog's 268 MB synthetic panel instead (`tests/e2e/prs-2-ancestry.sh`). The 1000 Genomes run above repeats on an E2E run dispatched on a branch other than main and not traced (or with `PGSC_MEASURE=1`): it adds about 40 minutes, which a dispatched run of main keeps for its other cases. +That run scored PGS000018 alone and fits a 16 GB machine; the default scores need more ([Memory](#memory)). It does not fit the 14 GB of disk a GitHub-hosted runner guarantees, and its download takes 13 to 31 minutes on a runner, so the panel stays opt-in (`setup.sh --ancestry-panel`), and the tests on every pull request project the fixture sample onto the PGS Catalog's 268 MB synthetic panel instead (`tests/e2e/prs-2-ancestry.sh`). The 1000 Genomes run above repeats on an E2E run dispatched on a branch other than main and not traced (or with `PGSC_MEASURE=1`): it adds 35 to 80 minutes, which a dispatched run of main keeps for its other cases. ## Interpreting Results From f6578120f55d6ecf451d564fa889f00c1430ab78 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:13:53 +0100 Subject: [PATCH 31/40] test(parity): regenerate report-render goldens for #559 with #571 #559 (carrier confidence) and #571 (SV support reason) each added the same 38 report-render goldens, each written by its own og. On the merged tree og prints both changes, so the 38 files are og's output on this tip: every line of each comes from one of the two sides, and oracle-diff now agrees on all 1097 summary-collect and report-render items (38 differed before). --- .../golden/report-render/all-history/all-history.txt | 6 +++--- tests/parity/golden/report-render/all/all.txt | 6 +++--- tests/parity/golden/report-render/cb-full/cb-full.html | 10 +++++----- tests/parity/golden/report-render/cb-full/cb-full.txt | 10 +++++----- .../cb-quoted-dosage/cb-quoted-dosage.html | 10 +++++----- .../cb-quoted-dosage/cb-quoted-dosage.txt | 10 +++++----- .../cb-quoted-interval/cb-quoted-interval.html | 10 +++++----- .../cb-quoted-interval/cb-quoted-interval.txt | 10 +++++----- .../report-render/cb-quoted-smn/cb-quoted-smn.html | 10 +++++----- .../report-render/cb-quoted-smn/cb-quoted-smn.txt | 10 +++++----- .../cb-unicode-contig/cb-unicode-contig.html | 10 +++++----- .../cb-unicode-contig/cb-unicode-contig.txt | 10 +++++----- .../m-clinical-escape/m-clinical-escape.html | 10 +++++----- .../m-clinical-escape/m-clinical-escape.txt | 10 +++++----- .../m-clinical-stale/m-clinical-stale.html | 10 +++++----- .../m-clinical-stale/m-clinical-stale.txt | 10 +++++----- .../m-clinvar-freq-note/m-clinvar-freq-note.html | 10 +++++----- .../m-clinvar-freq-note/m-clinvar-freq-note.txt | 10 +++++----- .../report-render/m-clinvar-many/m-clinvar-many.html | 10 +++++----- .../report-render/m-clinvar-many/m-clinvar-many.txt | 10 +++++----- .../report-render/m-clinvar-none/m-clinvar-none.html | 10 +++++----- .../report-render/m-clinvar-none/m-clinvar-none.txt | 10 +++++----- .../report-render/m-couple-empty/m-couple-empty.html | 10 +++++----- .../report-render/m-couple-empty/m-couple-empty.txt | 10 +++++----- .../parity/golden/report-render/m-couple/m-couple.html | 10 +++++----- .../parity/golden/report-render/m-couple/m-couple.txt | 10 +++++----- .../golden/report-render/m-cpsr-none/m-cpsr-none.html | 10 +++++----- .../golden/report-render/m-cpsr-none/m-cpsr-none.txt | 10 +++++----- .../report-render/m-cpsr-noown/m-cpsr-noown.html | 10 +++++----- .../golden/report-render/m-cpsr-noown/m-cpsr-noown.txt | 10 +++++----- .../golden/report-render/m-sf-notes/m-sf-notes.html | 10 +++++----- .../golden/report-render/m-sf-notes/m-sf-notes.txt | 10 +++++----- .../m-since-clinical/m-since-clinical.html | 10 +++++----- .../m-since-clinical/m-since-clinical.txt | 10 +++++----- .../report-render/m-slivar-phase/m-slivar-phase.html | 10 +++++----- .../report-render/m-slivar-phase/m-slivar-phase.txt | 10 +++++----- .../m-slivar-unphased/m-slivar-unphased.html | 10 +++++----- .../m-slivar-unphased/m-slivar-unphased.txt | 10 +++++----- 38 files changed, 186 insertions(+), 186 deletions(-) diff --git a/tests/parity/golden/report-render/all-history/all-history.txt b/tests/parity/golden/report-render/all-history/all-history.txt index ef251f96e..5f802f3b4 100644 --- a/tests/parity/golden/report-render/all-history/all-history.txt +++ b/tests/parity/golden/report-render/all-history/all-history.txt @@ -332,15 +332,15 @@ ## Carrier List (this sample) --- [New since 2021-01-01 00:00 UTC] - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called diff --git a/tests/parity/golden/report-render/all/all.txt b/tests/parity/golden/report-render/all/all.txt index e2600a51d..9eb954616 100644 --- a/tests/parity/golden/report-render/all/all.txt +++ b/tests/parity/golden/report-render/all/all.txt @@ -310,15 +310,15 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); Parascopy's SMN1 count (step 35); not read: step 35's HBA1/HBA2 count: not called diff --git a/tests/parity/golden/report-render/cb-full/cb-full.html b/tests/parity/golden/report-render/cb-full/cb-full.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.html +++ b/tests/parity/golden/report-render/cb-full/cb-full.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-full/cb-full.txt b/tests/parity/golden/report-render/cb-full/cb-full.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-full/cb-full.txt +++ b/tests/parity/golden/report-render/cb-full/cb-full.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html index e9a5fbb73..788cb4191 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt index 2d4f39b53..3f5176dea 100644 --- a/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt +++ b/tests/parity/golden/report-render/cb-quoted-dosage/cb-quoted-dosage.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt +++ b/tests/parity/golden/report-render/cb-quoted-interval/cb-quoted-interval.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt +++ b/tests/parity/golden/report-render/cb-quoted-smn/cb-quoted-smn.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html index 7d6bb92a9..452a35b3b 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt index 94b2ba22f..06a377aea 100644 --- a/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt +++ b/tests/parity/golden/report-render/cb-unicode-contig/cb-unicode-contig.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html index 8faaf8ce0..a922e0a52 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (x <y> & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt index c4237beb3..a4ece0c48 100644 --- a/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt +++ b/tests/parity/golden/report-render/m-clinical-escape/m-clinical-escape.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (x & z; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html index f7824baab..3cac70c83 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.html @@ -403,18 +403,18 @@

    Carrier List (this sample)

    Step 06 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    STALE: note of carrier <&>
    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt index e34bf5c21..82d31461c 100644 --- a/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt +++ b/tests/parity/golden/report-render/m-clinical-stale/m-clinical-stale.txt @@ -160,18 +160,18 @@ ## Carrier List (this sample) --- [STALE: note of carrier <&>] - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html index fe45fe133..4f5be96f6 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt index ded5b0175..4be3275d9 100644 --- a/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt +++ b/tests/parity/golden/report-render/m-clinvar-freq-note/m-clinvar-freq-note.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html index 77f14856c..065ab269f 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.html @@ -438,18 +438,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt index 6c35ceac1..77cc1df16 100644 --- a/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt +++ b/tests/parity/golden/report-render/m-clinvar-many/m-clinvar-many.txt @@ -288,18 +288,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html index d635a5050..dc636873b 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.html @@ -360,18 +360,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt index c7056e920..d72ad6faa 100644 --- a/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt +++ b/tests/parity/golden/report-render/m-clinvar-none/m-clinvar-none.txt @@ -112,18 +112,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html index 3b396cf6f..20e2e619b 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.html @@ -395,18 +395,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt index 901ce6cc7..a08eaea38 100644 --- a/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt +++ b/tests/parity/golden/report-render/m-couple-empty/m-couple-empty.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-couple/m-couple.html b/tests/parity/golden/report-render/m-couple/m-couple.html index d866af2b6..f35955562 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.html +++ b/tests/parity/golden/report-render/m-couple/m-couple.html @@ -395,18 +395,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-couple/m-couple.txt b/tests/parity/golden/report-render/m-couple/m-couple.txt index dfd48d62c..13230ddce 100644 --- a/tests/parity/golden/report-render/m-couple/m-couple.txt +++ b/tests/parity/golden/report-render/m-couple/m-couple.txt @@ -155,18 +155,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html index 88a023be6..70e8f7f78 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.html @@ -379,18 +379,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt index 438e209b2..ff0b41d4c 100644 --- a/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt +++ b/tests/parity/golden/report-render/m-cpsr-none/m-cpsr-none.txt @@ -139,18 +139,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html index 158a4f7c6..7159d4e8f 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.html @@ -384,18 +384,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt index 9e9ae40ff..d0e48bfc5 100644 --- a/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt +++ b/tests/parity/golden/report-render/m-cpsr-noown/m-cpsr-noown.txt @@ -145,18 +145,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html index 25128ef05..7c9a9dd25 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.html @@ -395,18 +395,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt index 2ed7ebc29..8ece36f9b 100644 --- a/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt +++ b/tests/parity/golden/report-render/m-sf-notes/m-sf-notes.txt @@ -156,18 +156,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html index f3204a08b..b6856ca65 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.html @@ -394,18 +394,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt index 760948d7d..0ee19e856 100644 --- a/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt +++ b/tests/parity/golden/report-render/m-since-clinical/m-since-clinical.txt @@ -158,18 +158,18 @@ ## Carrier List (this sample) --- [New since 2026-01-01T00:00:00Z] - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html index 3fec4ad98..34f4965b7 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.html @@ -370,18 +370,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt index 2e036d5f3..c801d0115 100644 --- a/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt +++ b/tests/parity/golden/report-render/m-slivar-phase/m-slivar-phase.txt @@ -135,18 +135,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html index 475f4c332..4bddb1ce6 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.html @@ -368,18 +368,18 @@

    Carrier

    Carrier List (this sample)

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    -

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    -

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    -

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    -

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    -

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    diff --git a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt index 39e44dd84..f70473f5a 100644 --- a/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt +++ b/tests/parity/golden/report-render/m-slivar-unphased/m-slivar-unphased.txt @@ -133,18 +133,18 @@ ## Carrier List (this sample) --- - Carrier list (3292 genes): 8 finding(s), 1 set aside + Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic - GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic - SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic + GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier + SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own - Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads - Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads + Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls) Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000) Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way From cc4b811fd2470afc1d0913cb677196f60e78f144 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:50:56 +0100 Subject: [PATCH 32/40] docs(carrier): name the deletion-straddle shape where the SF card is more cautious --- CHANGELOG.md | 2 +- docs/results/secondary-findings.md | 2 +- 2 files changed, 2 insertions(+), 2 deletions(-) diff --git a/CHANGELOG.md b/CHANGELOG.md index c1071d80f..b4d7fcd81 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -5,7 +5,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n ## Unreleased - The E2E run dispatched on a batch of pull requests finishes sooner, with every case and check it ran before. The shard split now weighs `prs-3-panel-measure` at its measured 2900 seconds on a run dispatched on a branch (`E2E_SECONDS`), where it measures the 1000 Genomes panel, so its shard no longer gets a full share of other cases on top. The base leg sets up while `og` builds, and the job `og` builds only the Linux x86_64 binary the legs run (`OG_ARCHES`, `OG_DARWIN_ARCHES` in `rust/og.sh`); Guard's `rust` job still builds all four on every pull request, as does the Rust `images` job when it runs. The nightly Rust run, which is the `streams` job only, now builds only `og-linux-x86_64`, the binary it runs. Container Test runs at most 8 smoke rows at once, so a change to every image no longer takes the runners the E2E legs wait for. The jobs that only build `og --release` lose their Rust cache, which did not speed them up, and Guard's `rust` job saves its cache on main only, so the E2E image and data caches fit the 10 GB budget. -- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from one rare deletion shape where the card is more cautious and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). +- The carrier list in `summary.json` keeps each hit's call quality and zygosity. It judged every hit at GQ 30 and DP 10, whatever floor the hits file states (`##PGP_CALL_FLOOR`), and it dropped the low-confidence mark the ClinVar section shows for the same hit. Each row of `sections.carrier.data` now has `zygosity` (`het`, `hom`, `hemizygous` or `unknown`), `gq`, `dp` and `low_confidence`, judged against the file's own floor. A homozygous or hemizygous P/LP row has no unchanged copy, so it is no carrier finding: it moves from `carriers` to a new list, `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that says it is not the pattern of a carrier, and the list's first line counts it apart (`2 with no unchanged copy`); the live page keeps its finding for it, and its carrier headline (the Python server's and `og live serve`'s) asks for attention. Two different heterozygous hits in one recessive gene are now counted as copies, with the phase rule of the secondary-findings card: each row gets `pair` (`two hits` when read-backed phase puts them on different copies, `possible two hits` when the phase is unknown; none when they sit on one copy) and `phase`, which says why. The carrier list and the secondary-findings card now count a gene's hits the same way, twice: with every call, and with the confident calls alone. A pair that the confident calls prove stays `two hits` on the list and `biallelic` on the card, even when another hit of the gene is a low-confidence call; so does a confident homozygous call or a confident deletion pair. When the confident hits count two copies of unknown phase, the pair is `possible two hits` on the list and `possibly biallelic` on the card, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)` on the list and `possibly biallelic (low-confidence call)` on the card. On the card a low-confidence call is one below step 06's call floor or a weak HIGH-impact call (`weak_call`). A deletion plus a low-confidence call reads `possibly biallelic (low-confidence call)` under `two_hits` and on the card's two-hit line. A combined allele counts as confident when any call of it is, and it then counts with the copies, GT and phase set of that confident call, beside a deletion too. The list's `pair` counts heterozygous hits only. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two give the gene the same answer, apart from rare deletion shapes where the card is more cautious (a combined allele across a deletion's end) and from a call the card judges by its HIGH-impact record (a lower call floor in the clinical VCF, or a HIGH-impact call of a part of a combined allele): on the list, that answer is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. Output change: rows move from `carriers` to `hom_or_hemizygous`, and fields are added; no field is renamed or removed. `tests/schema/summary.schema.json` now describes the carrier section. Part of #411 (clin-15, clin-19). - A step you selected that produced nothing now says so. A report-only Nextflow step (TelomereHunter, VNtyper, the CHIP genes and the others in `nextflow.config`) is dropped when it fails, after one retry when the exit was a memory kill. Its section had no file, so the report listed it as not run, the same as a step nobody asked for. `HTML_REPORT` now records the run's `--tools` list, and `og summary collect` lists selected sections with no file under Steps Not Run as "(selected, no result)", with a note naming the tool and the step. Y haplogroup, Y tree placement, and Y-STR markers get this label only for samples declared male. `summary.json` gets a new top-level list, `selected_no_result`, with those section keys. It is present only when the run recorded its tool list, so a bash run's summary is unchanged. The section's state stays `missing`. - One section that cannot be written no longer stops the whole report. Step 24, the Nextflow `HTML_REPORT` module and `scripts/generate-report.sh` ran `bin/render_report.py`, and a section whose data it could not read stopped it with a Python error: the run got no text report and no HTML report at all. The three now run `og report render` (`rust/crates/og-render`), so no Python runs for the reports. A section that cannot be written says so in its own place, `[could not be read: ...]` in the text report and an Unreadable card in the HTML report, and every other section is still written; `og report render` prints one `WARNING` line on stderr that counts and names those parts, and still exits 0. A panic inside a section writer counts the same way, so the release build now unwinds on a panic (`rust/Cargo.toml`); a panic anywhere else still aborts og at once, through the panic hook og installs first. A search index or charts file that cannot be made is written empty and named in the same `WARNING` line. On the 164 report-render parity summaries (154 before, and 10 new ones that reach each state of the mosaic sex-loss, raw-data export and structural-variant sections) both reports are byte for byte the Python's, whole, with two changes on purpose: a gene the ACMG card names is listed once in the closing gene list, not twice (the `acmg_sf` section repeats the card the clinical section holds), and a run whose BAM has no unplaced unmapped reads says the viral screen was not assessed instead of "no read". The checks of `tests/test_render_report.py` are cargo tests (`rust/og/tests/report_checks.rs`, and `rust/crates/og-render/tests/section_failure.rs` for a section that panics), and the Python file is gone. `bin/render_report.py`, `bin/report_charts.py` and `bin/results_index.py` stay only for the Python live site. - Nextflow's `docker` profile now runs each task as you, as the step scripts do, not as root. Before, every task ran with `--user root:root`, so a file a task wrote outside its work directory, beside an input under `GENOME_DIR`, stayed root's (Nextflow's `docker.fixOwnership` gives back only the work directory). Tasks now run with `-u` and your UID and GID, with `HOME=/tmp`. `CPSR` and `CNVPYTOR` still run as root, with `HOME=/root` as before: PCGR has not been shown to run unprivileged, which is why step 17 runs it as root too, and the CNVpytor module copies its resources into its image. A file those two write outside their work directory stays root's. The ids are written as bash's `${UID}:${GROUPS}`, which have no space. The PRS module, which hands the run's options on to pgsc_calc, now also drops a user flag with its whole value: a config's common `-u $(id -u):$(id -g)` gave pgsc_calc a stray `-g)` before. pgsc_calc's containers now also get `HOME=/tmp`. A sample folder written by an older run can hold root-owned files that a task running as you cannot overwrite: [troubleshooting](docs/troubleshooting.md#permission-denied-writing-to-mounted-volumes) gives the `chown` that takes it back. `tests/test_prs_runopts.sh` checks the profile's user and the PRS module's user flag drop, and the e2e case `prs-runopts-and-trace-1` checks the docker run line of every task of a stub run. diff --git a/docs/results/secondary-findings.md b/docs/results/secondary-findings.md index 742dabaa3..921caad0f 100644 --- a/docs/results/secondary-findings.md +++ b/docs/results/secondary-findings.md @@ -14,7 +14,7 @@ The most common "pathogenic" finding in any genome is **heterozygous carrier sta **Your own carrier list (step 24 report).** The ClinVar card of both reports is followed by a carrier list for this one sample, with no partner needed: every step 6 ClinVar hit in the 3,292 recessive and X-linked genes of `assets/carrier_genes.tsv` (the list of the [couple screen](../39-couple.md#the-carrier-list)). An allele that list marks as a hypomorph (for example BTD p.Asp444His or the GALT Duarte variants) or a pseudodeficiency allele (HEXA c.739C>T and c.745C>T, which lower the enzyme test result but cause no Tay-Sachs disease) is listed as set aside, never as a carrier finding on its own. A hit that is a combined allele of step 6 or a part of one keeps the note the ClinVar table prints for it (`combined_allele` in `summary.json`), and so does a secondary finding: an unphased combined allele says its parts may sit on different copies. -Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. One rare shape reads more cautiously on the card: a weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So the card can count a call the list does not have: a HIGH-impact variant that is no ClinVar hit, or the HIGH-impact call of a part of a combined allele, which makes that allele confident on the card while the list marks it low confidence. When the clinical VCF states a lower call floor than the hits file, a call can also be low confidence on the list and confident on the card. A HIGH-impact call that is weak on allele balance alone never lowers a hit whose ClinVar row is confident. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. +Each row of the list keeps its zygosity (`zygosity`: `het`, `hom`, `hemizygous`, or `unknown` when no alt copy is called) and step 6's call quality: `gq`, `dp` and `low_confidence`. The mark is judged against the floor the hits file states (`##PGP_CALL_FLOOR`, GQ 30 and DP 10 by default), so it is the same mark the ClinVar table shows for the hit. A carrier has one changed copy and one unchanged copy. A row called homozygous, or hemizygous (on a male's X, or a hit called homozygous inside a deletion), has no unchanged copy, so it is not a carrier finding: `summary.json` lists it apart under `hom_or_hemizygous`. Both reports still print it in the carrier list, on a line of its own that ends "two changed copies, not the pattern of a carrier" or "the only copy changed, not the pattern of a carrier", and the list's first line counts it apart from the carriers ("6 finding(s), 2 with no unchanged copy"). The live page keeps its finding for it, and its carrier headline asks for attention. Two different heterozygous hits in one recessive gene are counted as copies, with the rule of the secondary-findings card below. Read-backed phase on different copies gives the field `pair` the value `two hits`. Unknown phase gives `possible two hits`. Both on one copy (cis) gives no `pair`: one copy is hit. The `phase` field says why. The hits are counted twice: all of them, and the confident ones alone. A pair the confident hits prove stays `two hits`, even when another hit of the gene is a low-confidence call. When the confident hits count two copies but their phase is unknown, the pair is `possible two hits`, even when a low-confidence call would prove it. Any other pair that needs a low-confidence call is `possible two hits (low-confidence call)`. A combined allele counts as confident when any call of it is, and its phase then comes from that confident call, in `pair` and beside a deletion in `two_hits`. `pair` counts heterozygous hits only: a homozygous row or a deletion is not part of it. The secondary-findings card below counts the same way. For a recessive gene that the card counts by two copies (MUTYH, ATP7B, CYP27A1, GAA, RPE65, CASQ2, TRDN, and BTD apart from its hypomorph), the two lists give the gene the same answer. On the card that answer is its `pair`. Here it is the best of `pair`, the gene's `two_hits` verdict and its `hom_or_hemizygous` rows. `two hits` here is `biallelic` there, `possible two hits` is `possibly biallelic`, and the two low-confidence words match. Rare shapes read more cautiously on the card. A combined allele that starts inside a deletion and ends past it, in trans with it by read-backed phase, is `possibly biallelic` there, because the card judges it at its start, a heterozygous call inside the deletion. Here its part past the deletion makes it `biallelic` in `two_hits`. A weak homozygous call of a combined allele, a confident heterozygous call of a part of it and a deletion give the low-confidence word there and `possibly biallelic` here. A gene with another rule on the card, such as HFE or the X-linked ABCD1, can read differently on the two lists. The card also reads the HIGH-impact calls of the clinical VCF, and the list does not. So the card can count a call the list does not have: a HIGH-impact variant that is no ClinVar hit, or the HIGH-impact call of a part of a combined allele, which makes that allele confident on the card while the list marks it low confidence. When the clinical VCF states a lower call floor than the hits file, a call can also be low confidence on the list and confident on the card. A HIGH-impact call that is weak on allele balance alone never lowers a hit whose ClinVar row is confident. The reports do not show `zygosity`, `gq`, `dp`, `low_confidence`, `pair` or `phase` yet. **Secondary findings follow each gene's ACMG rule.** The secondary-findings card (step 23's section of the report; in summary.json also `sections.acmg_sf`, written from step 6's hits on every run, VEP cache or not) applies the reporting rule of each of the 84 ACMG SF v3.3 genes (Lee et al., Genet Med 2025;27(8):101454, Table 1), written gene by gene in `assets/acmg_sf.tsv`: From 23eb52aff7e08525164eb4a99bf315e0fbc561d1 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 00:50:56 +0100 Subject: [PATCH 33/40] ci(e2e): say the panel measure time applies only on a run that is not traced --- scripts/ci/e2e-case-times.tsv | 5 +++-- 1 file changed, 3 insertions(+), 2 deletions(-) diff --git a/scripts/ci/e2e-case-times.tsv b/scripts/ci/e2e-case-times.tsv index 71ca018c4..630ff747c 100644 --- a/scripts/ci/e2e-case-times.tsv +++ b/scripts/ci/e2e-case-times.tsv @@ -18,8 +18,9 @@ # times again and prints a new file in its summary; its traced needs are an # upper bound to check by hand (docs/testing.md). # prs-3-panel-measure takes 0 s except on a run dispatched on a branch other -# than main, where it measures the 1000 Genomes panel for about 2900 s; there -# .github/workflows/e2e.yml gives it that time through E2E_SECONDS. +# than main and not traced, where it measures the 1000 Genomes panel for about +# 2900 s; there .github/workflows/e2e.yml gives it that time through +# E2E_SECONDS. 01-fixture base 17 - 10-validate-setup base 7 - 20-align-02 base 116 - From 0b4756f9ed8d9c0e658d0bffd3269be20c0761b3 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:29:25 +0100 Subject: [PATCH 34/40] feat(admix): fit ancestry fractions on fixed group frequencies, checked against the optimum With the groups' allele frequencies fixed, the log-likelihood of a person's fractions is concave on the simplex, so the maximum is unique. og-admix now finds it with the EM update and SQUAREM steps that never lower the likelihood, stops when no fraction moves by more than 1e-9, and checks the KKT conditions. A run that stops short is an error, not an answer. The module also cuts 5 cM blocks per chromosome and draws the SNV weights and the reference people for a bootstrap replicate. Bead: lin-49 Bead: D5 --- rust/crates/og-admix/src/lib.rs | 5 +- rust/crates/og-admix/src/project.rs | 604 +++++++++++++++++++++++++++- 2 files changed, 605 insertions(+), 4 deletions(-) diff --git a/rust/crates/og-admix/src/lib.rs b/rust/crates/og-admix/src/lib.rs index 39a0478b2..98113979b 100644 --- a/rust/crates/og-admix/src/lib.rs +++ b/rust/crates/og-admix/src/lib.rs @@ -10,8 +10,9 @@ //! bytes on every machine. //! - [`simulate`]: an admixed diploid genome with known truth, built from //! held-out people's haplotypes; every engine's truth tests start from it. -//! - [`paint`] and [`project`]: our own local-ancestry painting and the -//! projection of ancestry fractions (empty until their units land). +//! - [`paint`]: our own local-ancestry painting. +//! - [`project`]: the ancestry fractions projected on fixed group +//! frequencies, in place of `admixture -P`, and its block bootstrap. use std::fmt; use std::io; diff --git a/rust/crates/og-admix/src/project.rs b/rust/crates/og-admix/src/project.rs index 39710102e..3f5a43cfe 100644 --- a/rust/crates/og-admix/src/project.rs +++ b/rust/crates/og-admix/src/project.rs @@ -1,2 +1,602 @@ -//! Ancestry fractions projected on the panel's frequencies, in place of -//! ADMIXTURE. Empty until its unit of the 1.0.0 plan lands. +//! Ancestry fractions projected on fixed group frequencies, in place of +//! `admixture -P` (step 26b). +//! +//! **The model.** At SNV j a person carries g_j copies (0, 1 or 2) of the +//! allele the frequencies count, and group k carries it at frequency +//! f_jk. With ancestry fractions q on the simplex (q_k >= 0, sum 1), each +//! copy is the allele with probability p_j = sum_k q_k f_jk, so the +//! log-likelihood is +//! +//! ```text +//! L(q) = sum_j w_j [ g_j ln p_j + (2 - g_j) ln(1 - p_j) ] +//! ``` +//! +//! (w_j is how many times a bootstrap replicate drew SNV j, 1 otherwise; +//! the binomial constant is left out, as ADMIXTURE leaves it out). Each +//! p_j is linear in q and ln is concave, so L is concave on the simplex: +//! every local maximum is the global one, and with frequencies whose +//! columns are not linearly dependent the maximum is unique. Any solver +//! that converges finds it, which is why the answer can match ADMIXTURE's +//! projection up to where ADMIXTURE stops. +//! +//! **The solver.** The EM update for q with f fixed is +//! `q_k <- q_k r_k`, where +//! +//! ```text +//! r_k = sum_j w_j [ g_j f_jk / p_j + (2 - g_j)(1 - f_jk) / (1 - p_j) ] / (2 sum_j w_j) +//! ``` +//! +//! is the gradient of L over 2 sum_j w_j. It keeps q on the simplex and +//! never lowers L. SQUAREM (Varadhan and Roland 2008, the SqS3 step +//! length) extrapolates from two EM steps; the step is shortened toward +//! the plain EM step until every fraction stays above 0, and the +//! extrapolated point is kept only when its L is at least that of the +//! first EM step, so L never goes down. The run stops when one EM step +//! moves no fraction by more than [`TOLERANCE`]. +//! +//! **The check.** At the maximum the Karush-Kuhn-Tucker conditions hold: +//! r_k = 1 for every group with q_k > 0 and r_k <= 1 for every group with +//! q_k = 0. [`project`] measures both at the answer (the largest +//! q_k |r_k - 1| and the largest r_k - 1) and returns an error when either +//! is above its tolerance, so a run cut short, or one stuck short of the +//! maximum, is never reported as an answer. +//! +//! **The bootstrap.** [`blocks`] cuts the SNVs into blocks of +//! [`BLOCK_CM`] on the genetic map, per chromosome, so no block holds two +//! chromosomes. A replicate draws as many blocks as there are, with +//! replacement ([`draw_weights`]), and draws each group's reference people +//! again ([`draw_people`]) to count its frequencies again, so the range +//! also holds the uncertainty of the frequencies themselves. + +use crate::rng::Rng; +use crate::{Error, Result}; +use std::collections::BTreeMap; + +/// The run stops when an EM step moves no fraction by more than this. +pub const TOLERANCE: f64 = 1e-9; +/// The most passes over the SNVs before the run gives up. +pub const MAX_ITERATIONS: usize = 100_000; +/// The largest q_k |r_k - 1| the answer may have (complementary slackness). +pub const SLACK_TOLERANCE: f64 = 1e-7; +/// The largest r_k - 1 the answer may have (no group would gain). +pub const GAIN_TOLERANCE: f64 = 1e-4; +/// The length of a bootstrap block on the genetic map, in cM. +pub const BLOCK_CM: f64 = 5.0; + +/// One projection: K groups, and per SNV the copies of the counted allele, +/// the K frequencies (row-major, SNV by group) and an optional weight. +#[derive(Debug, Clone, Copy)] +pub struct Problem<'a> { + pub k: usize, + pub genotypes: &'a [u8], + pub freqs: &'a [f64], + pub weights: Option<&'a [u32]>, +} + +/// How far a run may go. +#[derive(Debug, Clone, Copy, PartialEq)] +pub struct Options { + pub tolerance: f64, + pub max_iterations: usize, +} + +impl Default for Options { + fn default() -> Self { + Options { + tolerance: TOLERANCE, + max_iterations: MAX_ITERATIONS, + } + } +} + +/// The answer of a projection. +#[derive(Debug, Clone, PartialEq)] +pub struct Fit { + /// The fractions, one per group, summing to 1. + pub q: Vec, + /// L at `q`. + pub loglik: f64, + /// Passes over the SNVs. + pub iterations: usize, + /// The largest q_k |r_k - 1| at `q`. + pub slack: f64, + /// The largest r_k - 1 at `q`. + pub gain: f64, +} + +impl<'a> Problem<'a> { + /// Checks the shapes and the values: genotypes 0 to 2, every frequency + /// strictly between 0 and 1, at least one SNV with weight. + pub fn new( + k: usize, + genotypes: &'a [u8], + freqs: &'a [f64], + weights: Option<&'a [u32]>, + ) -> Result> { + if k == 0 { + return Err(Error("a projection needs at least one group".into())); + } + if freqs.len() != genotypes.len() * k { + return Err(Error(format!( + "{} frequencies for {} SNVs of {k} groups", + freqs.len(), + genotypes.len() + ))); + } + if let Some(w) = weights + && w.len() != genotypes.len() + { + return Err(Error(format!( + "{} weights for {} SNVs", + w.len(), + genotypes.len() + ))); + } + if let Some(j) = genotypes.iter().position(|&g| g > 2) { + return Err(Error(format!( + "SNV {}: {} copies; a genotype holds 0, 1 or 2", + j + 1, + genotypes[j] + ))); + } + if let Some(i) = freqs.iter().position(|&f| !(f > 0.0 && f < 1.0)) { + return Err(Error(format!( + "SNV {}: frequency {} of group {} is not strictly between 0 and 1", + i / k + 1, + freqs[i], + i % k + 1 + ))); + } + let p = Problem { + k, + genotypes, + freqs, + weights, + }; + if p.total() == 0.0 { + return Err(Error("a projection needs at least one SNV".into())); + } + Ok(p) + } + + fn weight(&self, j: usize) -> f64 { + self.weights.map_or(1.0, |w| f64::from(w[j])) + } + + /// The copies counted, 2 sum_j w_j. + fn total(&self) -> f64 { + 2.0 * (0..self.genotypes.len()) + .map(|j| self.weight(j)) + .sum::() + } + + /// L at `q`, and r (the gradient over 2 sum w) in `ratio`. + pub fn evaluate(&self, q: &[f64], ratio: &mut [f64]) -> f64 { + let k = self.k; + ratio.iter_mut().for_each(|r| *r = 0.0); + let (mut base, mut ll, mut total) = (0.0, 0.0, 0.0); + for (j, &g) in self.genotypes.iter().enumerate() { + let w = self.weight(j); + if w == 0.0 { + continue; + } + let row = &self.freqs[j * k..j * k + k]; + let p: f64 = q.iter().zip(row).map(|(a, b)| a * b).sum(); + let g = f64::from(g); + let (mut a, mut b) = (0.0, 0.0); + if g > 0.0 { + a = g / p; + ll += w * g * p.ln(); + } + if g < 2.0 { + b = (2.0 - g) / (1.0 - p); + ll += w * (2.0 - g) * (1.0 - p).ln(); + } + let d = w * (a - b); + for (r, f) in ratio.iter_mut().zip(row) { + *r += d * f; + } + base += w * b; + total += 2.0 * w; + } + for r in ratio.iter_mut() { + *r = (*r + base) / total; + } + ll + } + + /// One EM step from `q` into `next`; L at `q`. + fn em(&self, q: &[f64], next: &mut [f64], ratio: &mut [f64]) -> f64 { + let ll = self.evaluate(q, ratio); + for ((n, a), r) in next.iter_mut().zip(q).zip(ratio.iter()) { + *n = a * r; + } + normalise(next); + ll + } +} + +/// Scales `q` to sum 1. +fn normalise(q: &mut [f64]) { + let s: f64 = q.iter().sum(); + if s > 0.0 { + q.iter_mut().for_each(|x| *x /= s); + } +} + +fn max_diff(a: &[f64], b: &[f64]) -> f64 { + a.iter() + .zip(b) + .map(|(x, y)| (x - y).abs()) + .fold(0.0, f64::max) +} + +fn dot(a: &[f64], b: &[f64]) -> f64 { + a.iter().zip(b).map(|(x, y)| x * y).sum() +} + +/// The KKT measures at `q`: (largest q_k |r_k - 1|, largest r_k - 1). +pub fn kkt(q: &[f64], ratio: &[f64]) -> (f64, f64) { + let slack = q + .iter() + .zip(ratio) + .map(|(a, r)| a * (r - 1.0).abs()) + .fold(0.0, f64::max); + let gain = ratio + .iter() + .map(|r| r - 1.0) + .fold(f64::NEG_INFINITY, f64::max); + (slack, gain) +} + +/// The fractions that maximise L, from equal fractions, by EM with SQUAREM; +/// an error when the run ends before the KKT conditions hold. +pub fn project(p: &Problem<'_>, opts: &Options) -> Result { + let k = p.k; + let mut q = vec![1.0 / k as f64; k]; + let (mut q1, mut q2, mut qx, mut q3) = (vec![0.0; k], vec![0.0; k], vec![0.0; k], vec![0.0; k]); + let mut ratio = vec![0.0; k]; + let (mut r, mut v) = (vec![0.0; k], vec![0.0; k]); + let mut evals = 0usize; + let mut converged = false; + while evals < opts.max_iterations { + p.em(&q, &mut q1, &mut ratio); + evals += 1; + if max_diff(&q1, &q) < opts.tolerance { + q.copy_from_slice(&q1); + converged = true; + break; + } + if evals >= opts.max_iterations { + q.copy_from_slice(&q1); + break; + } + let l1 = p.em(&q1, &mut q2, &mut ratio); + evals += 1; + for i in 0..k { + r[i] = q1[i] - q[i]; + v[i] = q2[i] - q1[i] - r[i]; + } + let (rr, vv) = (dot(&r, &r), dot(&v, &v)); + let mut alpha = if vv > 0.0 { -(rr / vv).sqrt() } else { -1.0 }; + alpha = alpha.min(-1.0); + // Shorten the step toward the plain EM step (alpha -1, which is + // q2) until every fraction stays above 0. + loop { + if alpha > -1.0 - 1e-6 { + qx.copy_from_slice(&q2); + break; + } + for i in 0..k { + qx[i] = q[i] - 2.0 * alpha * r[i] + alpha * alpha * v[i]; + } + if qx.iter().all(|&x| x > 0.0) { + normalise(&mut qx); + break; + } + alpha = (alpha - 1.0) / 2.0; + } + if evals >= opts.max_iterations { + q.copy_from_slice(&q2); + break; + } + let lx = p.em(&qx, &mut q3, &mut ratio); + evals += 1; + // EM never lowers L, so EM(qx) is at least L(qx); q2 is at least + // L(q1). Either way L does not go down. + if lx.is_finite() && lx >= l1 { + q.copy_from_slice(&q3); + } else { + q.copy_from_slice(&q2); + } + } + let loglik = p.evaluate(&q, &mut ratio); + let (slack, gain) = kkt(&q, &ratio); + let fit = Fit { + q, + loglik, + iterations: evals, + slack, + gain, + }; + if !converged || slack > SLACK_TOLERANCE || gain > GAIN_TOLERANCE { + return Err(Error(format!( + "the projection stopped after {} passes short of the maximum: the KKT conditions do not hold (largest q|r - 1| {:e}, largest r - 1 {:e}{})", + fit.iterations, + fit.slack, + fit.gain, + if converged { + String::new() + } else { + format!( + "; no step below {:e} within {} passes", + opts.tolerance, opts.max_iterations + ) + } + ))); + } + Ok(fit) +} + +/// The bootstrap blocks: the SNVs grouped by chromosome and by +/// `floor(cM / size)`, so no block holds two chromosomes; `chrom[j]` is any +/// number that names SNV j's chromosome. Blocks come in (chromosome, cM) +/// order, each with its SNVs in input order; empty blocks do not exist. +pub fn blocks(chrom: &[u32], cm: &[f64], size: f64) -> Vec> { + let mut by: BTreeMap<(u32, i64), Vec> = BTreeMap::new(); + for (j, (&c, &x)) in chrom.iter().zip(cm).enumerate() { + by.entry((c, (x / size).floor() as i64)) + .or_default() + .push(j); + } + by.into_values().collect() +} + +/// A replicate's weight of each of `snvs` SNVs: as many block draws, with +/// replacement, as there are blocks. +pub fn draw_weights(blocks: &[Vec], snvs: usize, rng: &mut Rng) -> Vec { + let mut w = vec![0u32; snvs]; + if blocks.is_empty() { + return w; + } + for _ in 0..blocks.len() { + let b = rng.below(blocks.len() as u64) as usize; + for &j in &blocks[b] { + w[j] += 1; + } + } + w +} + +/// Each of `people` people's draw count when each group's members (person +/// indices) are drawn again, with replacement, as many times as the group +/// has members. A person in no group is drawn 0 times. +pub fn draw_people(groups: &[Vec], people: usize, rng: &mut Rng) -> Vec { + let mut w = vec![0u32; people]; + for members in groups { + for _ in 0..members.len() { + w[members[rng.below(members.len() as u64) as usize]] += 1; + } + } + w +} + +#[cfg(test)] +mod tests { + use super::*; + + /// A simulated K-group problem with fractions `q` and `snvs` SNVs. + /// Each group's frequency is 0.02 or 0.98, drawn at random, and the + /// copies follow p by error diffusion per frequency pattern instead of + /// independent draws: each pattern's allele count is then 2 n p rounded, + /// so the planted q is the maximum up to rounding, and the test measures + /// the solver, not the luck of the draw. + fn simulate(q: &[f64], snvs: usize, seed: u64) -> (Vec, Vec) { + let k = q.len(); + let mut rng = Rng::new(seed); + let mut acc = vec![0.0f64; 1 << k]; + let mut f = Vec::with_capacity(snvs * k); + let mut g = Vec::with_capacity(snvs); + for _ in 0..snvs { + let bits = rng.below(1 << k) as usize; + let row: Vec = (0..k) + .map(|i| if bits >> i & 1 == 1 { 0.98 } else { 0.02 }) + .collect(); + let p: f64 = q.iter().zip(&row).map(|(a, b)| a * b).sum(); + let before = acc[bits].floor(); + acc[bits] += 2.0 * p; + g.push((acc[bits].floor() - before) as u8); + f.extend(row); + } + (g, f) + } + + #[test] + fn recovers_planted_fractions() { + // Red-first truth test: three groups, 5,000 SNVs, the planted q + // within 0.01. The red control swaps two frequency columns, so the + // answer comes out with those two fractions swapped and fails. + let truth = [0.6, 0.3, 0.1]; + let (g, mut f) = simulate(&truth, 5_000, 7); + if crate::PLANTED { + for row in f.chunks_mut(3) { + row.swap(0, 1); + } + } + let p = Problem::new(3, &g, &f, None).unwrap(); + let fit = project(&p, &Options::default()).unwrap(); + for (got, want) in fit.q.iter().zip(truth) { + assert!((got - want).abs() <= 0.01, "q {:?} vs {truth:?}", fit.q); + } + assert!((fit.q.iter().sum::() - 1.0).abs() < 1e-12); + assert!(fit.slack <= SLACK_TOLERANCE && fit.gain <= GAIN_TOLERANCE); + } + + #[test] + fn a_truncated_run_fails_the_kkt_check() { + let (g, f) = simulate(&[0.6, 0.3, 0.1], 5_000, 7); + let p = Problem::new(3, &g, &f, None).unwrap(); + let opts = Options { + max_iterations: 3, + ..Options::default() + }; + let e = project(&p, &opts).unwrap_err().0; + assert!( + e.contains("KKT conditions do not hold") && e.contains("within 3 passes"), + "{e}" + ); + // A plain EM run of the same length is far from the maximum too. + let mut q = vec![1.0 / 3.0; 3]; + let (mut next, mut ratio) = (vec![0.0; 3], vec![0.0; 3]); + for _ in 0..3 { + p.em(&q.clone(), &mut next, &mut ratio); + q.copy_from_slice(&next); + } + p.evaluate(&q, &mut ratio); + assert!(kkt(&q, &ratio).0 > SLACK_TOLERANCE); + } + + #[test] + fn the_answer_is_the_maximum() { + // L at the answer is at least L at every point of a grid on the + // simplex, and a group absent from the person ends at 0 with no + // gain from growing it. + let truth = [0.75, 0.25, 0.0]; + let (g, f) = simulate(&truth, 4_000, 3); + let p = Problem::new(3, &g, &f, None).unwrap(); + let fit = project(&p, &Options::default()).unwrap(); + let mut ratio = vec![0.0; 3]; + for a in 0..=20 { + for b in 0..=(20 - a) { + let q = [a as f64 / 20.0, b as f64 / 20.0, (20 - a - b) as f64 / 20.0]; + let l = p.evaluate(&q, &mut ratio); + assert!( + fit.loglik >= l - 1e-9 * l.abs(), + "{q:?}: {l} > {}", + fit.loglik + ); + } + } + assert!(fit.q[2] < 0.01, "{:?}", fit.q); + } + + #[test] + fn plain_em_and_squarem_agree() { + let (g, f) = simulate(&[0.2, 0.5, 0.3], 3_000, 11); + let p = Problem::new(3, &g, &f, None).unwrap(); + let fit = project(&p, &Options::default()).unwrap(); + let mut q = vec![1.0 / 3.0; 3]; + let (mut next, mut ratio) = (vec![0.0; 3], vec![0.0; 3]); + let mut last = f64::NEG_INFINITY; + for _ in 0..200_000 { + let l = p.em(&q.clone(), &mut next, &mut ratio); + assert!(l >= last - 1e-9 * l.abs(), "EM lowered L"); + last = l; + if max_diff(&next, &q) < 1e-12 { + break; + } + q.copy_from_slice(&next); + } + assert!(max_diff(&q, &fit.q) < 1e-6, "{q:?} vs {:?}", fit.q); + assert!( + fit.iterations < 2_000, + "SQUAREM took {} passes", + fit.iterations + ); + } + + #[test] + fn weights_count_as_repeated_snvs() { + let (g, f) = simulate(&[0.5, 0.5], 400, 5); + let w: Vec = (0..400).map(|j| (j % 3) as u32).collect(); + let (mut g2, mut f2) = (Vec::new(), Vec::new()); + for j in 0..400 { + for _ in 0..w[j] { + g2.push(g[j]); + f2.extend_from_slice(&f[j * 2..j * 2 + 2]); + } + } + let a = project( + &Problem::new(2, &g, &f, Some(&w)).unwrap(), + &Options::default(), + ) + .unwrap(); + let b = project( + &Problem::new(2, &g2, &f2, None).unwrap(), + &Options::default(), + ) + .unwrap(); + assert!(max_diff(&a.q, &b.q) < 1e-7); + assert!((a.loglik - b.loglik).abs() < 1e-6 * b.loglik.abs()); + } + + #[test] + fn bad_input_is_an_error() { + assert!(Problem::new(2, &[0, 3], &[0.5; 4], None).is_err()); + assert!(Problem::new(2, &[0, 1], &[0.5, 0.5, 1.0, 0.5], None).is_err()); + assert!(Problem::new(2, &[0, 1], &[0.5; 3], None).is_err()); + assert!(Problem::new(2, &[0, 1], &[0.5; 4], Some(&[0, 0])).is_err()); + assert!(Problem::new(0, &[], &[], None).is_err()); + } + + /// Blocks cut by SNV count, the bootstrap before this one: the red + /// control of the chromosome test. + fn blocks_by_count(n: usize, per: usize) -> Vec> { + (0..n) + .collect::>() + .chunks(per) + .map(<[usize]>::to_vec) + .collect() + } + + #[test] + fn no_block_spans_two_chromosomes() { + // Two chromosomes of 7 and 5 SNVs, 0 to 12 cM: blocks of 5 cM. + let chrom = [1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 2]; + let cm = [0.0, 1.0, 4.9, 5.0, 6.0, 11.0, 12.0, 0.5, 2.0, 7.0, 8.0, 9.9]; + let b = if crate::PLANTED { + blocks_by_count(12, 4) + } else { + blocks(&chrom, &cm, BLOCK_CM) + }; + for block in &b { + let c = chrom[block[0]]; + assert!( + block.iter().all(|&j| chrom[j] == c), + "block {block:?} spans two chromosomes" + ); + } + assert_eq!( + b, + vec![ + vec![0, 1, 2], + vec![3, 4], + vec![5, 6], + vec![7, 8], + vec![9, 10, 11] + ] + ); + let mut rng = Rng::new(1); + let w = draw_weights(&b, 12, &mut rng); + assert!(w.iter().any(|&x| x > 0)); + // A replicate draws 5 blocks: its SNV count is the sum of 5 block sizes. + let sizes: Vec = b.iter().map(Vec::len).collect(); + let total: u32 = w.iter().sum(); + assert!( + (sizes.iter().min().unwrap() * 5..=sizes.iter().max().unwrap() * 5) + .contains(&(total as usize)) + ); + } + + #[test] + fn people_draws_stay_in_their_group() { + let groups = vec![vec![0, 2, 4], vec![1, 3]]; + let mut rng = Rng::new(9); + for _ in 0..50 { + let w = draw_people(&groups, 6, &mut rng); + assert_eq!(w[0] + w[2] + w[4], 3); + assert_eq!(w[1] + w[3], 2); + assert_eq!(w[5], 0); + } + } +} From dfa5d35e0a72bd86843b15b9e1cdd1a279fd3e94 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:29:25 +0100 Subject: [PATCH 35/40] feat(ancestry): og ancestry-fine project, with a block and reference-panel bootstrap og ancestry-fine project reads the person's genotypes at the model's SNVs, projects them on each level's group frequencies, and writes the .Q and boot.Q files report reads, plus a fit.tsv per level. Each bootstrap replicate draws 5 cM blocks within chromosomes and draws each group's reference people again from ref.geno, so the range includes how well the panel knows each group. One seed gives the same bytes for any thread count. A model without ref.geno refuses the bootstrap with one line that says to run setup again. report takes --fractions DIR and keeps --admixture DIR as an alias; its sentence now names the projection. Bead: lin-49 Bead: lin-52 Bead: D14 --- rust/crates/og-ancestry/src/project.rs | 959 +++++++++++++++++- rust/crates/og-ancestry/src/report.rs | 41 +- .../report-no-painting/S_ancestry_fine.txt | 24 + .../ancestry-fine/report-no-painting/stdout | 24 + .../report/out/S_ancestry_fine.txt | 29 + .../parity/golden/ancestry-fine/report/stdout | 29 + 6 files changed, 1092 insertions(+), 14 deletions(-) create mode 100644 tests/parity/golden/ancestry-fine/report-no-painting/S_ancestry_fine.txt create mode 100644 tests/parity/golden/ancestry-fine/report-no-painting/stdout create mode 100644 tests/parity/golden/ancestry-fine/report/out/S_ancestry_fine.txt create mode 100644 tests/parity/golden/ancestry-fine/report/stdout diff --git a/rust/crates/og-ancestry/src/project.rs b/rust/crates/og-ancestry/src/project.rs index ff633027b..770f68964 100644 --- a/rust/crates/og-ancestry/src/project.rs +++ b/rust/crates/og-ancestry/src/project.rs @@ -1,13 +1,958 @@ //! `og ancestry-fine project`: a person's ancestry fractions projected on -//! the panel's frequencies, in place of ADMIXTURE. +//! the groups' frequencies of the model, with a block bootstrap of the +//! genome and of the reference people. It replaces `admixture -P`; the +//! model and the solver are described in [`og_admix::project`]. //! -//! Not ported yet: until its unit of the 1.0.0 plan lands, the verb says so -//! on stderr and exits 2, before reading any argument. +//! Inputs: the genotypes step 26b writes from the gVCF (`--vcf`), and the +//! model folder setup.sh writes (`--model`): `ref.bim`, `levels.tsv` and +//! each level's `.P` (the frequency of the `.bim`'s A2, the VCF REF, +//! per group); for the bootstrap also `ref.geno`, `ref.fam`, the panel's +//! `samples.tsv` beside the model folder, and the genetic maps (`--maps`). +//! +//! A SNV counts when the person has a called genotype of the `.bim`'s two +//! alleles there; the last such record at a position decides it. With +//! fewer than `--min-sites` (100) the command stops. +//! +//! The bootstrap cuts the genotyped SNVs into blocks of 5 cM on the genetic +//! map, per chromosome, so no block holds two chromosomes. Each replicate +//! draws as many blocks as there are, with replacement, draws each group's +//! reference people again from `ref.geno`, counts the frequencies again and +//! projects again. Replicate r draws from its own stream of `--seed`, so +//! the same seed gives the same bytes whatever `--threads` is. A model +//! without `ref.geno` (made before og counted the frequencies) has no +//! people to draw: the bootstrap stops and says to run setup again. +//! +//! In `--out-dir`, per level: `_..Q` (one row of K fractions +//! in `levels.tsv` order, ADMIXTURE's layout), `_.boot.Q` (one row +//! per replicate) and `_.fit.tsv` (how the fit went); and +//! `_sites.txt`, the SNVs genotyped. Everything is written under +//! temporary names and renamed into place once every level and replicate +//! is done. +use crate::freqs::a2_freq; +use crate::report::{LevelRow, read_levels}; +use crate::{ArgError, Args, Fail, Level, Pending, Result, Spec, repr}; +use og_admix::geno::RefGeno; +use og_admix::map::GeneticMap; +use og_admix::project::{self, BLOCK_CM, Options, Problem}; +use og_admix::rng::Rng; +use std::collections::HashMap; use std::io::Write; +use std::path::{Path, PathBuf}; + +pub(crate) const SPEC: Spec = Spec { + verb: "project", + usage: "usage: og ancestry-fine project --model DIR --vcf genotypes.vcf.gz --sample S --out-dir DIR [--maps DIR] [--bootstrap B] [--seed N] [--threads N] [--min-sites N] [--max-iterations N]\n", + options: &[ + "--model", + "--vcf", + "--sample", + "--out-dir", + "--maps", + "--bootstrap", + "--seed", + "--threads", + "--min-sites", + "--max-iterations", + ], + required: &["--model", "--vcf", "--sample", "--out-dir"], +}; + +/// `og ancestry-fine project ARGS`: the exit code. +pub fn cli(args: &[String], out: &mut dyn Write, err: &mut dyn Write) -> u8 { + let a = match Args::parse(&SPEC, args).and_then(|a| { + for name in [ + "--bootstrap", + "--seed", + "--threads", + "--min-sites", + "--max-iterations", + ] { + a.int(name, 0)?; + } + Ok(a) + }) { + Ok(a) => a, + Err(ArgError::Help) => { + let _ = write!(out, "{}", SPEC.usage); + return 0; + } + Err(ArgError::Usage(msg)) => { + let _ = write!(err, "{}", SPEC.usage); + let _ = writeln!(err, "og ancestry-fine {}: error: {msg}", SPEC.verb); + return 2; + } + }; + match main(&a, out) { + Ok(()) => 0, + Err(Fail(msg)) => { + let _ = out.flush(); + let _ = writeln!(err, "ERROR: {msg}"); + 1 + } + } +} + +/// The reference `.bim`: its text in one buffer, and each SNV as offsets +/// into it, so a panel of any size costs a few dozen bytes per SNV. +struct Bim { + text: String, + rows: Vec, +} + +/// One SNV: the chromosome without `chr`, the alleles A1 and A2 as spans +/// of [`Bim::text`], and the position. +#[derive(Debug, Clone, Copy)] +struct BimRow { + chrom: (u32, u32), + a1: (u32, u32), + a2: (u32, u32), + pos: i64, +} + +impl Bim { + fn at(&self, (a, b): (u32, u32)) -> &str { + &self.text[a as usize..b as usize] + } +} + +/// plink2 writes chr22 as 22 in a `.bim`; the VCFs say chr22. +fn norm_chrom(c: &str) -> &str { + c.strip_prefix("chr").unwrap_or(c) +} + +fn read_bim(path: &Path) -> Result { + let mut bim = Bim { + text: String::new(), + rows: Vec::new(), + }; + let mut n = 0u64; + let too_big = || Fail(format!("{}: larger than 4 GB", path.display())); + crate::for_each_line(path, |line| { + n += 1; + let c: Vec<&str> = crate::split_ws(line).collect(); + if c.len() < 6 { + return Ok(()); + } + let pos = crate::int(c[3]).ok_or_else(|| { + Fail(format!( + "{}: line {n}: position is not a whole number: {}", + path.display(), + repr(c[3]) + )) + })?; + let mut span = |s: &str| -> Result<(u32, u32)> { + let a = bim.text.len(); + bim.text.push_str(s); + Ok(( + u32::try_from(a).map_err(|_| too_big())?, + u32::try_from(bim.text.len()).map_err(|_| too_big())?, + )) + }; + let row = BimRow { + chrom: span(norm_chrom(c[0]))?, + a1: span(c[4])?, + a2: span(c[5])?, + pos, + }; + bim.rows.push(row); + Ok(()) + })?; + Ok(bim) +} + +/// A GT of exactly two called alleles, phased or not, as written. +fn gt_alleles(gt: &str) -> Option<[&str; 2]> { + let mut parts = gt.split(['/', '|']); + let (a, b) = (parts.next()?, parts.next()?); + if parts.next().is_some() || a == "." || b == "." { + return None; + } + Some([a, b]) +} + +/// The copies of A2 in a genotype (the record's alleles and the two +/// allele indices as written) for a `.bim` row with alleles A1, A2; `None` +/// for no call: an index that is no allele, or an allele the `.bim` does +/// not have. +pub fn a2_copies(alleles: &[&str], idx: [&str; 2], a1: &str, a2: &str) -> Option { + let (mut n1, mut n2) = (0u8, 0u8); + for i in idx { + let i = crate::int(i)?; + let called = *alleles.get(usize::try_from(i).ok()?)?; + n1 += u8::from(called == a1); + n2 += u8::from(called == a2); + } + (n1 + n2 == 2).then_some(n2) +} + +/// The A2 copies at each `.bim` row, streamed from the VCF: the last +/// record with a called GT at a row's position decides it. +fn genotypes_at(bim: &Bim, vcf: &Path) -> Result>> { + // Every row by (chromosome, position), sorted, so a record finds its + // rows by binary search (a .bim may list two SNVs at one position). + let mut names: HashMap<&str, u32> = HashMap::new(); + let mut index: Vec<(u32, i64, u32)> = Vec::with_capacity(bim.rows.len()); + for (i, r) in bim.rows.iter().enumerate() { + let next = u32::try_from(names.len()).expect("fewer chromosomes than rows"); + let c = *names.entry(bim.at(r.chrom)).or_insert(next); + let i = u32::try_from(i).map_err(|_| Fail("more than 4 billion SNVs".into()))?; + index.push((c, r.pos, i)); + } + index.sort_unstable(); + let mut out: Vec> = vec![None; bim.rows.len()]; + let mut n = 0u64; + crate::for_each_line(vcf, |line| { + n += 1; + if line.starts_with('#') { + return Ok(()); + } + let c: Vec<&str> = line.split('\t').collect(); + if c.len() < 10 { + return Ok(()); + } + let Some(gt_at) = c[8].split(':').position(|f| f == "GT") else { + return Ok(()); + }; + let Some(idx) = c[9].split(':').nth(gt_at).and_then(gt_alleles) else { + return Ok(()); + }; + let pos = crate::int(c[1]).ok_or_else(|| { + Fail(format!( + "{}: line {n}: POS is not a whole number: {}", + vcf.display(), + repr(c[1]) + )) + })?; + let Some(&chrom) = names.get(norm_chrom(c[0])) else { + return Ok(()); + }; + let from = index.partition_point(|&(ch, p, _)| (ch, p) < (chrom, pos)); + let rows = index[from..] + .iter() + .take_while(|&&(ch, p, _)| (ch, p) == (chrom, pos)); + let mut alleles = vec![c[3]]; + if c[4] != "." { + alleles.extend(c[4].split(',')); + } + for &(_, _, i) in rows { + let r = &bim.rows[i as usize]; + out[i as usize] = a2_copies(&alleles, idx, bim.at(r.a1), bim.at(r.a2)); + } + Ok(()) + })?; + Ok(out) +} + +/// One level's frequencies at the kept SNVs (row-major, SNV by group), +/// streamed from `.P`; it must have one row of K numbers per `.bim` +/// SNV. +fn read_p(path: &Path, k: usize, keep: &[usize], bim_rows: usize) -> Result> { + let mut out = Vec::with_capacity(keep.len() * k); + let (mut rows, mut next) = (0usize, keep.iter().peekable()); + crate::for_each_line(path, |line| { + if next.peek() == Some(&&rows) { + next.next(); + let before = out.len(); + for x in crate::split_ws(line) { + out.push(pycompat::num::parse_float(x).map_err(|_| { + Fail(format!( + "{}: line {}: {} is not a number", + path.display(), + rows + 1, + repr(x) + )) + })?); + } + if out.len() - before != k { + return Err(Fail(format!( + "{}: line {}: {} values, not {k}", + path.display(), + rows + 1, + out.len() - before + ))); + } + } + rows += 1; + Ok(()) + })?; + if rows != bim_rows { + return Err(Fail(format!( + "{} has {rows} rows but ref.bim {bim_rows} SNVs", + path.display() + ))); + } + Ok(out) +} + +/// A level of the model: its row of `levels.tsv` and its frequencies. +struct LevelModel { + row: LevelRow, + level: Level, + k: usize, + freqs: Vec, + /// The people of each group, as `ref.geno` numbers them (bootstrap only). + groups: Vec>, +} + +/// The group of each `ref.fam` person at each level, from the panel's +/// `samples.tsv` beside the model folder. +fn assign_groups(model: &Path, levels: &mut [LevelModel], people: usize) -> Result<()> { + let fam_path = model.join("ref.fam"); + let mut ids = Vec::new(); + crate::for_each_line(&fam_path, |line| { + let c: Vec<&str> = crate::split_ws(line).collect(); + if c.len() >= 2 { + ids.push(c[1].to_owned()); + } + Ok(()) + })?; + if ids.len() != people { + return Err(Fail(format!( + "{} lists {} people but ref.geno holds {people}: the model is damaged; run scripts/setup.sh --ancestry-fine-panel again", + fam_path.display(), + ids.len() + ))); + } + let samples_path = model + .parent() + .map_or_else(|| PathBuf::from("samples.tsv"), |p| p.join("samples.tsv")); + let lines = crate::read_lines(&samples_path)?; + let header: Vec<&str> = lines + .first() + .map(|l| l.split('\t').collect()) + .unwrap_or_default(); + if header != crate::panel::HEADER { + return Err(Fail(format!( + "{} does not start with the header of samples.tsv", + samples_path.display() + ))); + } + let mut by_id: HashMap<&str, Vec<&str>> = HashMap::new(); + for line in &lines[1..] { + let f: Vec<&str> = line.split('\t').collect(); + if f.len() >= 4 { + by_id.insert(f[0], f); + } + } + for lm in levels.iter_mut() { + lm.groups = vec![Vec::new(); lm.k]; + for (i, id) in ids.iter().enumerate() { + let code = by_id.get(id.as_str()).map(|f| f[lm.level.column()]); + let g = code.and_then(|c| lm.row.codes.iter().position(|x| x == c)); + let Some(g) = g else { + return Err(Fail(format!( + "reference person {id} of ref.fam has no {} group of levels.tsv in {}: the model and the samples table do not match; run scripts/setup.sh --ancestry-fine-panel again", + lm.row.name, + samples_path.display() + ))); + }; + lm.groups[g].push(i); + } + } + Ok(()) +} + +/// The groups' A2 frequencies at the kept SNVs (`sites`, `ref.geno` rows) +/// with person i counted `people_w[i]` times; a SNV of weight 0 gets 0.5 +/// in every group (it is never read). +fn group_freqs( + geno: &RefGeno, + sites: &[usize], + snv_w: Option<&[u32]>, + groups: &[Vec], + people_w: Option<&[u32]>, +) -> Vec { + let k = groups.len(); + // (person, weight, group) of everyone drawn at least once. + let mut members: Vec<(usize, u32, usize)> = Vec::new(); + for (g, people) in groups.iter().enumerate() { + for &i in people { + let w = people_w.map_or(1, |w| w[i]); + if w > 0 { + members.push((i, w, g)); + } + } + } + let mut out = vec![0.5; sites.len() * k]; + let (mut alt, mut called) = (vec![0u32; k], vec![0u32; k]); + for (s, &site) in sites.iter().enumerate() { + if snv_w.is_some_and(|w| w[s] == 0) { + continue; + } + alt.iter_mut().for_each(|x| *x = 0); + called.iter_mut().for_each(|x| *x = 0); + for &(i, w, g) in &members { + if let Some(c) = geno.get(site, i) { + alt[g] += w * u32::from(c); + called[g] += 2 * w; + } + } + for g in 0..k { + out[s * k + g] = a2_freq(alt[g], called[g]); + } + } + out +} + +/// What every bootstrap replicate reads. +struct Boot<'a> { + seed: u64, + blocks: &'a [Vec], + genotypes: &'a [u8], + levels: &'a [LevelModel], + geno: &'a RefGeno, + keep: &'a [usize], + opts: &'a Options, +} + +/// Replicate `r`'s fractions at every level. +fn replicate(b: &Boot<'_>, r: u64) -> Result>> { + let mut rng = Rng::stream(b.seed, &format!("replicate {r}")); + let snv_w = project::draw_weights(b.blocks, b.genotypes.len(), &mut rng); + let mut out = Vec::with_capacity(b.levels.len()); + for lm in b.levels { + let people_w = project::draw_people(&lm.groups, b.geno.people(), &mut rng); + let freqs = group_freqs(b.geno, b.keep, Some(&snv_w), &lm.groups, Some(&people_w)); + let p = Problem::new(lm.k, b.genotypes, &freqs, Some(&snv_w)).map_err(|e| Fail(e.0))?; + let fit = project::project(&p, b.opts).map_err(|e| { + Fail(format!( + "{} level, bootstrap replicate {r}: {}", + lm.row.name, e.0 + )) + })?; + out.push(fit.q); + } + Ok(out) +} + +fn q_line(q: &[f64]) -> String { + let cells: Vec = q.iter().map(|x| format!("{x:.6}")).collect(); + cells.join(" ") + "\n" +} + +pub(crate) fn main(a: &Args, out: &mut dyn Write) -> Result<()> { + let model = Path::new(a.req("--model")); + let vcf = Path::new(a.req("--vcf")); + let sample = a.req("--sample"); + if sample.is_empty() || sample.contains(['/', '\t', '\n']) { + return Err(Fail(format!( + "--sample {}: not a sample name", + repr(sample) + ))); + } + let nonneg = |name: &str, default: i64| -> Result { + let v = a.int(name, default).unwrap_or(default); + if v < 0 { + return Err(Fail(format!("{name} {v}: must be 0 or more"))); + } + Ok(v) + }; + let boot = nonneg("--bootstrap", 100)? as u64; + let seed = nonneg("--seed", 1)? as u64; + let threads = nonneg("--threads", 1)?.max(1) as usize; + let min_sites = nonneg("--min-sites", 100)? as usize; + let max_iterations = nonneg("--max-iterations", project::MAX_ITERATIONS as i64)? as usize; + let opts = Options { + max_iterations, + ..Options::default() + }; + + let model_s = model.to_string_lossy().into_owned(); + let rows = read_levels(&model_s)?; + let bim_path = model.join("ref.bim"); + let bim = read_bim(&bim_path)?; + if bim.rows.is_empty() { + return Err(Fail(format!("{} has no SNV", bim_path.display()))); + } + let calls = genotypes_at(&bim, vcf)?; + let (keep, genotypes): (Vec, Vec) = calls + .iter() + .enumerate() + .filter_map(|(i, g)| g.map(|g| (i, g))) + .unzip(); + if keep.len() < min_sites { + return Err(Fail(format!( + "only {} of the {} reference SNVs have a genotype in {} (at least {min_sites} needed)", + keep.len(), + bim.rows.len(), + vcf.display() + ))); + } + let mut levels = Vec::new(); + for row in rows { + let level = Level::parse(&row.name) + .ok_or_else(|| Fail(format!("{model_s}/levels.tsv: unknown level {}", row.name)))?; + let k = usize::try_from(row.k) + .ok() + .filter(|&k| k > 0 && k == row.codes.len()) + .ok_or_else(|| { + Fail(format!( + "{model_s}/levels.tsv: level {} has K {} and {} group codes", + row.name, + row.k, + row.codes.len() + )) + })?; + let freqs = read_p( + &model.join(format!("{}.P", row.name)), + k, + &keep, + bim.rows.len(), + )?; + levels.push(LevelModel { + row, + level, + k, + freqs, + groups: Vec::new(), + }); + } + + // The bootstrap's inputs: the blocks on the genetic map, and the + // reference people of each group. + let mut blocks = Vec::new(); + let mut geno = RefGeno::new(0); + if boot > 0 { + let geno_path = model.join("ref.geno"); + if !geno_path.is_file() { + return Err(Fail(format!( + "{} is missing: the model was made before og counted the group frequencies, so the bootstrap has no reference people to draw; run scripts/setup.sh --ancestry-fine-panel again", + geno_path.display() + ))); + } + geno = RefGeno::load(&geno_path).map_err(|e| Fail(e.0))?; + if geno.sites() != bim.rows.len() { + return Err(Fail(format!( + "{} holds {} SNVs but ref.bim {}: the model is damaged; run scripts/setup.sh --ancestry-fine-panel again", + geno_path.display(), + geno.sites(), + bim.rows.len() + ))); + } + assign_groups(model, &mut levels, geno.people())?; + // ref.geno must give the model's own frequencies, or the bootstrap + // would measure the spread around another model. + for lm in &levels { + let full = group_freqs(&geno, &keep, None, &lm.groups, None); + if let Some((i, d)) = full + .iter() + .zip(&lm.freqs) + .map(|(x, y)| (x - y).abs()) + .enumerate() + .max_by(|a, b| a.1.total_cmp(&b.1)) + .filter(|&(_, d)| d > 1.000_001e-6) + { + return Err(Fail(format!( + "{} does not give {model_s}/{}.P (off by {d:.6} at SNV {} of ref.bim): the model is damaged; run scripts/setup.sh --ancestry-fine-panel again", + geno_path.display(), + lm.row.name, + keep[i / lm.k] + 1 + ))); + } + } + let maps = Path::new(a.get("--maps").ok_or_else(|| { + Fail( + "the bootstrap cuts blocks on the genetic map: give --maps (or --bootstrap 0)" + .into(), + ) + })?); + let mut names: HashMap<&str, (u32, GeneticMap)> = HashMap::new(); + let (mut chrom, mut cm) = ( + Vec::with_capacity(keep.len()), + Vec::with_capacity(keep.len()), + ); + for &i in &keep { + let r = bim.rows[i]; + let c = bim.at(r.chrom); + if !names.contains_key(c) { + let path = maps.join(format!("chr{c}.map")); + if !path.is_file() { + return Err(Fail(format!( + "{} is missing: the bootstrap cuts blocks on the genetic map; run scripts/setup.sh --ancestry-fine-panel again", + path.display() + ))); + } + let map = GeneticMap::read(&path).map_err(|e| Fail(e.0))?; + let id = u32::try_from(names.len()).expect("few chromosomes"); + names.insert(c, (id, map)); + } + let (id, map) = &names[c]; + chrom.push(*id); + cm.push(map.cm_at(r.pos)); + } + blocks = project::blocks(&chrom, &cm, BLOCK_CM); + } + + // The fractions, then the replicates on `threads` threads. + let mut fits = Vec::with_capacity(levels.len()); + for lm in &levels { + let p = Problem::new(lm.k, &genotypes, &lm.freqs, None).map_err(|e| Fail(e.0))?; + let fit = project::project(&p, &opts) + .map_err(|e| Fail(format!("{} level: {}", lm.row.name, e.0)))?; + fits.push(fit); + } + let shared = Boot { + seed, + blocks: &blocks, + genotypes: &genotypes, + levels: &levels, + geno: &geno, + keep: &keep, + opts: &opts, + }; + let mut reps: Vec>>>> = (0..boot).map(|_| None).collect(); + std::thread::scope(|s| { + let chunks: Vec<_> = (0..threads) + .map(|t| { + let shared = &shared; + s.spawn(move || { + (1..=boot) + .filter(|r| (r - 1) % threads as u64 == t as u64) + .map(|r| (r, replicate(shared, r))) + .collect::>() + }) + }) + .collect(); + for h in chunks { + for (r, res) in h.join().expect("a bootstrap thread panicked") { + reps[(r - 1) as usize] = Some(res); + } + } + }); + let reps: Vec>> = reps + .into_iter() + .map(|r| r.expect("every replicate ran")) + .collect::>()?; + + let dir = PathBuf::from(a.req("--out-dir")); + std::fs::create_dir_all(&dir).map_err(|e| crate::cannot_write(&dir, &e))?; + let mut pending = Pending::new(); + let mut said = Vec::new(); + for (l, (lm, fit)) in levels.iter().zip(&fits).enumerate() { + let base = format!("{sample}_{}", lm.row.name); + pending.put( + dir.join(format!("{base}.{}.Q", lm.k)), + q_line(&fit.q).as_bytes(), + )?; + let boot_q: String = reps.iter().map(|r| q_line(&r[l])).collect(); + pending.put(dir.join(format!("{base}.boot.Q")), boot_q.as_bytes())?; + let fit_tsv = format!( + "key\tvalue\nlevel\t{}\ngroups\t{}\nsnvs\t{}\npasses\t{}\nloglik\t{:.6}\nkkt_slack\t{:e}\nkkt_gain\t{:e}\nblock_cm\t{BLOCK_CM}\nblocks\t{}\nreplicates\t{boot}\nreference_resampling\t{}\nseed\t{seed}\n", + lm.row.name, + lm.k, + keep.len(), + fit.iterations, + fit.loglik, + fit.slack, + fit.gain, + blocks.len(), + if boot > 0 { "yes" } else { "no" } + ); + pending.put(dir.join(format!("{base}.fit.tsv")), fit_tsv.as_bytes())?; + said.push(format!( + "{}: {} groups, {} passes, {boot} bootstrap replicates of {} blocks", + lm.row.name, + lm.k, + fit.iterations, + blocks.len() + )); + } + let sites = format!( + "{} of the {} SNVs of the model genotyped", + keep.len(), + bim.rows.len() + ); + pending.put( + dir.join(format!("{sample}_sites.txt")), + format!("{sites}\n").as_bytes(), + )?; + pending.commit_all()?; + let w = |e: std::io::Error| Fail(format!("cannot write stdout: {e}")); + writeln!(out, "{sites}").map_err(w)?; + for line in said { + writeln!(out, "{line}").map_err(w)?; + } + Ok(()) +} + +#[cfg(test)] +mod tests { + use super::*; + use crate::testutil::{Dir, run}; + + #[test] + fn genotype_indexes_must_name_alleles() { + assert_eq!(a2_copies(&["A", "G"], ["0", "1"], "G", "A"), Some(1)); + assert_eq!(a2_copies(&["A", "G"], ["0", "0"], "G", "A"), Some(2)); + assert_eq!(a2_copies(&["A", "G"], ["1", "1"], "G", "A"), Some(0)); + assert_eq!(a2_copies(&["A", "G"], ["0", "-1"], "G", "A"), None); + assert_eq!(a2_copies(&["A"], ["0", "2"], "G", "A"), None); + assert_eq!(a2_copies(&["A", "G"], ["x", "1"], "G", "A"), None); + assert_eq!(a2_copies(&["A", "T"], ["0", "1"], "G", "A"), None); + assert_eq!(gt_alleles("0/1/1"), None); + assert_eq!(gt_alleles("./1"), None); + assert_eq!(gt_alleles("1"), None); + } + + /// A model of `snvs` SNVs on chr21 and chr22 (1 cM per Mb), K groups of + /// `per` people each with frequencies 0.1 apart, and a person with + /// fractions `q`. + struct World { + d: Dir, + } + + const GROUPS: [&str; 3] = ["AFR", "WEA", "EAS"]; + + fn world(name: &str, snvs: usize, per: usize, q: [f64; 3], seed: u64) -> World { + let d = Dir::new(name); + let mut rng = Rng::new(seed); + let k = GROUPS.len(); + let people = k * per; + let mut samples = String::from("sample\tpopulation\tcontinent\tregion\treference\tpaint\n"); + let mut fam = String::new(); + for group in GROUPS { + for i in 0..per { + let id = format!("{group}{i}"); + samples.push_str(&format!("{id}\tX\t{group}\t{group}\t1\t0\n")); + fam.push_str(&format!("0\t{id}\t0\t0\t0\t-9\n")); + } + } + let mut bim = String::new(); + let mut p_text = String::new(); + let mut vcf = String::from( + "##fileformat=VCFv4.2\n#CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\tFORMAT\tS\n", + ); + let mut geno = RefGeno::new(people); + for j in 0..snvs { + let chrom = if j < snvs / 2 { 21 } else { 22 }; + let pos = 1_000 + (j % (snvs / 2)) as i64 * 20_000; + // The frequency of the ALT (A1) per group, then the people. + let f: Vec = (0..k) + .map(|_| { + let x = rng.uniform().powi(2); + if rng.below(2) == 0 { x } else { 1.0 - x } + }) + .collect(); + let mut row = Vec::with_capacity(people); + let mut counts = vec![(0u32, 0u32); k]; + for (g, fg) in f.iter().enumerate() { + for _ in 0..per { + let c = u8::from(rng.uniform() < *fg) + u8::from(rng.uniform() < *fg); + counts[g].0 += u32::from(c); + counts[g].1 += 2; + row.push(Some(c)); + } + } + geno.push_site(&row).unwrap(); + let cells: Vec = counts + .iter() + .map(|&(alt, called)| format!("{:.6}", a2_freq(alt, called))) + .collect(); + p_text.push_str(&(cells.join(" ") + "\n")); + bim.push_str(&format!("{chrom}\t{chrom}:{pos}\t0\t{pos}\tG\tA\n")); + // The person's ALT copies from its fractions. + let p_alt: f64 = q.iter().zip(&f).map(|(a, b)| a * b).sum(); + let alt = u8::from(rng.uniform() < p_alt) + u8::from(rng.uniform() < p_alt); + let gt = ["0/0", "0/1", "1/1"][alt as usize]; + vcf.push_str(&format!("chr{chrom}\t{pos}\t.\tA\tG\t.\t.\t.\tGT\t{gt}\n")); + } + d.put("panel/samples.tsv", &samples); + d.put("panel/model/ref.fam", &fam); + d.put("panel/model/ref.bim", &bim); + d.put("panel/model/continent.P", &p_text); + d.put( + "panel/model/levels.tsv", + &format!("continent\t{k}\t{}\n", GROUPS.join(",")), + ); + let mut bytes = Vec::new(); + geno.write(&mut bytes).unwrap(); + std::fs::write(d.0.join("panel/model/ref.geno"), bytes).unwrap(); + for c in [21, 22] { + d.put( + &format!("panel/maps/chr{c}.map"), + &format!("chr{c} . 0.0 1\nchr{c} . 100.0 100000001\n"), + ); + } + d.put("g.vcf", &vcf); + World { d } + } + + impl World { + fn project(&self, extra: &[&str]) -> (u8, String, String) { + let (model, vcf, maps, out) = ( + self.d.path("panel/model"), + self.d.path("g.vcf"), + self.d.path("panel/maps"), + self.d.path("out"), + ); + let mut args = vec![ + "project", + "--model", + &model, + "--vcf", + &vcf, + "--sample", + "S", + "--maps", + &maps, + "--out-dir", + &out, + ]; + args.extend_from_slice(extra); + run(&args) + } + + fn q(&self, name: &str) -> Vec> { + self.d + .read(&format!("out/{name}")) + .lines() + .map(|l| l.split(' ').map(|x| x.parse().unwrap()).collect()) + .collect() + } + } + + fn spread(rows: &[Vec], k: usize) -> f64 { + let col: Vec = rows.iter().map(|r| r[k]).collect(); + let lo = crate::report::percentile(&col, 0.025).unwrap(); + let hi = crate::report::percentile(&col, 0.975).unwrap(); + hi - lo + } + + #[test] + fn the_command_projects_and_bootstraps() { + let w = world("proj-cmd", 2_000, 30, [0.7, 0.2, 0.1], 5); + let (rc, out, err) = w.project(&["--bootstrap", "20", "--threads", "3"]); + assert_eq!((rc, err.as_str()), (0, "")); + assert!( + out.starts_with("2000 of the 2000 SNVs of the model genotyped\ncontinent: 3 groups, "), + "{out}" + ); + let q = &w.q("S_continent.3.Q")[0]; + for (got, want) in q.iter().zip([0.7, 0.2, 0.1]) { + assert!((got - want).abs() < 0.05, "{q:?}"); + } + let boot = w.q("S_continent.boot.Q"); + assert_eq!(boot.len(), 20); + assert!( + boot.iter() + .all(|r| r.len() == 3 && (r.iter().sum::() - 1.0).abs() < 1e-5) + ); + let fit = w.d.read("out/S_continent.fit.tsv"); + // 2 chromosomes of 20 Mb at 1 cM per Mb: 4 blocks of 5 cM each, 8 in all. + assert!( + fit.contains("\nblocks\t8\n") && fit.contains("\nreplicates\t20\n"), + "{fit}" + ); + assert_eq!( + w.d.read("out/S_sites.txt"), + "2000 of the 2000 SNVs of the model genotyped\n" + ); + // The same seed gives the same bytes, whatever the threads. + let first = w.d.read("out/S_continent.boot.Q"); + let (rc, _, _) = w.project(&["--bootstrap", "20", "--threads", "1"]); + assert_eq!(rc, 0); + let again = w.d.read("out/S_continent.boot.Q"); + assert_eq!(first, again); + // And another seed gives other replicates. + let (rc, _, _) = w.project(&["--bootstrap", "20", "--seed", "2"]); + assert_eq!(rc, 0); + assert_ne!(first, w.d.read("out/S_continent.boot.Q")); + } + + #[test] + fn drawing_the_people_again_widens_a_small_group() { + // A group of 10 people: its frequencies are uncertain, and the + // range with the people drawn again is wider than with the model's + // frequencies fixed (the same blocks, the same seed). + let w = world("proj-small", 2_000, 10, [0.5, 0.3, 0.2], 9); + let (rc, _, err) = w.project(&["--bootstrap", "60"]); + assert_eq!((rc, err.as_str()), (0, "")); + let resampled = w.q("S_continent.boot.Q"); + // Fixed frequencies: the same block draws, through the engine. + let model = w.d.0.join("panel/model"); + let bim = read_bim(&model.join("ref.bim")).unwrap(); + let calls = genotypes_at(&bim, &w.d.0.join("g.vcf")).unwrap(); + let (keep, g): (Vec, Vec) = calls + .iter() + .enumerate() + .filter_map(|(i, c)| c.map(|c| (i, c))) + .unzip(); + let f = read_p(&model.join("continent.P"), 3, &keep, bim.rows.len()).unwrap(); + let chrom: Vec = keep.iter().map(|&i| u32::from(i >= 1_000)).collect(); + let cm: Vec = keep.iter().map(|&i| bim.rows[i].pos as f64 / 1e6).collect(); + let blocks = project::blocks(&chrom, &cm, BLOCK_CM); + let fixed: Vec> = (1..=60u64) + .map(|r| { + let mut rng = Rng::stream(1, &format!("replicate {r}")); + let sw = project::draw_weights(&blocks, g.len(), &mut rng); + let p = Problem::new(3, &g, &f, Some(&sw)).unwrap(); + project::project(&p, &Options::default()).unwrap().q + }) + .collect(); + let (wide, narrow) = (spread(&resampled, 0), spread(&fixed, 0)); + assert!( + wide > narrow * 1.2, + "with people drawn again {wide}, fixed {narrow}" + ); + } + + #[test] + fn what_stops_the_command() { + let w = world("proj-stop", 400, 10, [0.6, 0.3, 0.1], 3); + let (rc, _, err) = w.project(&["--min-sites", "500", "--bootstrap", "0"]); + assert_eq!(rc, 1); + assert!( + err.contains("only 400 of the 400 reference SNVs have a genotype in"), + "{err}" + ); + // Without ref.geno: no bootstrap, one line to run setup again; with + // --bootstrap 0 the fractions still come. + std::fs::remove_file(w.d.0.join("panel/model/ref.geno")).unwrap(); + let (rc, _, err) = w.project(&["--bootstrap", "5"]); + assert_eq!(rc, 1); + assert!( + err.starts_with("ERROR: ") + && err.ends_with("run scripts/setup.sh --ancestry-fine-panel again\n") + && err.lines().count() == 1, + "{err}" + ); + assert!(!w.d.0.join("out").exists(), "a failure writes nothing"); + let (rc, _, err) = w.project(&["--bootstrap", "0"]); + assert_eq!((rc, err.as_str()), (0, "")); + assert_eq!(w.d.read("out/S_continent.boot.Q"), ""); + // A .P of the wrong length. + w.d.put("panel/model/continent.P", "0.5 0.5 0.5\n"); + let (rc, _, err) = w.project(&["--bootstrap", "0"]); + assert_eq!(rc, 1); + assert!( + err.contains("continent.P has 1 rows but ref.bim 400 SNVs"), + "{err}" + ); + // A truncated run fails its KKT check, and says so. + let w = world("proj-kkt", 400, 10, [0.6, 0.3, 0.1], 3); + let (rc, _, err) = w.project(&["--bootstrap", "0", "--max-iterations", "3"]); + assert_eq!(rc, 1); + assert!( + err.contains("continent level: the projection stopped after 3 passes"), + "{err}" + ); + } -/// `og ancestry-fine project ARGS`: not ported yet, so one line on stderr and exit 2. -pub fn cli(_args: &[String], _out: &mut dyn Write, err: &mut dyn Write) -> u8 { - let _ = writeln!(err, "og ancestry-fine project: not ported yet"); - 2 + #[test] + fn a_damaged_model_is_refused() { + // ref.geno that does not give the .P: one person's genotypes + // changed. + let w = world("proj-damaged", 400, 10, [0.6, 0.3, 0.1], 4); + let mut bytes = std::fs::read(w.d.0.join("panel/model/ref.geno")).unwrap(); + let at = 28 + 5 * 8; // SNV 6, people 1 to 4 (8 bytes a row for 30 people) + bytes[at] ^= 0b0101_0101; + std::fs::write(w.d.0.join("panel/model/ref.geno"), bytes).unwrap(); + let (rc, _, err) = w.project(&["--bootstrap", "2"]); + assert_eq!(rc, 1); + assert!( + err.contains("does not give") && err.contains("the model is damaged"), + "{err}" + ); + } } diff --git a/rust/crates/og-ancestry/src/report.rs b/rust/crates/og-ancestry/src/report.rs index 308d9d9f4..396a9cc82 100644 --- a/rust/crates/og-ancestry/src/report.rs +++ b/rust/crates/og-ancestry/src/report.rs @@ -1,5 +1,7 @@ -//! `report`: the step's outputs, from ADMIXTURE's `.Q` and bootstrap -//! replicates of each level and RFMix's `.msp.tsv` of each chromosome. +//! `report`: the step's outputs, from the `.Q` and the bootstrap replicates +//! of each level (`og ancestry-fine project`, folder `--fractions`; the older +//! name `--admixture` still works) and RFMix's `.msp.tsv` of each +//! chromosome. //! //! - `_ancestry_fine.tsv`: each group's fraction with its bootstrap //! standard error and 2.5 to 97.5 percentile range, each continental @@ -21,16 +23,17 @@ use std::path::{Path, PathBuf}; pub(crate) const SPEC: Spec = Spec { verb: "report", - usage: "usage: og ancestry-fine report --sample S --model DIR --admixture DIR [--paint DIR] [--panel NAME] --out DIR\n", + usage: "usage: og ancestry-fine report --sample S --model DIR --fractions DIR [--paint DIR] [--panel NAME] --out DIR\n", options: &[ "--sample", "--model", + "--fractions", "--admixture", "--paint", "--panel", "--out", ], - required: &["--sample", "--model", "--admixture", "--out"], + required: &["--sample", "--model", "--out"], }; /// GRCh38 lengths of chr1 to chr22, for the painting picture. @@ -463,7 +466,7 @@ pub fn text_block(s: &Summary<'_>) -> String { Level::Region => "Regional", }; out.push(format!( - "{name} groups (ADMIXTURE projection on {} groups, {} bootstrap replicates):", + "{name} groups (projection on the frequencies of {} groups, {} bootstrap replicates):", rows.len(), s.n_boot.get(&level).copied().unwrap_or(0) )); @@ -562,7 +565,14 @@ fn tsv_rows(path: &Path) -> Result>> { pub(crate) fn main(a: &Args, out: &mut dyn Write) -> Result<()> { let sample = a.req("--sample"); let model = a.req("--model"); - let adm = a.req("--admixture"); + // --admixture is the name of --fractions before og projected the + // fractions itself; it still works. + let adm = a + .get("--fractions") + .or_else(|| a.get("--admixture")) + .ok_or_else(|| { + Fail("--fractions DIR is required (the folder og ancestry-fine project wrote)".into()) + })?; let paint = a.get("--paint").unwrap_or(""); let panel = a.get("--panel").unwrap_or(""); let levels = read_levels(model)?; @@ -754,7 +764,7 @@ mod tests { "S", "--model", &model, - "--admixture", + "--fractions", &adm, "--paint", &paint, @@ -809,6 +819,10 @@ mod tests { text.contains("West Eurasia (Europe, Middle East, North Africa) 90% (80% to 90%)") ); assert!(text.contains("not a nationality") && text.contains("Greek and")); + assert!( + text.contains("Continental groups (projection on the frequencies of 3 groups, 11 bootstrap replicates):"), + "{text}" + ); assert!(text.contains( "Left out of the model: Oceania (continental and regional group). The panel has fewer than 10 unrelated" )); @@ -817,6 +831,7 @@ mod tests { assert_eq!(&png[..8], b"\x89PNG\r\n\x1a\n"); assert_eq!(&png[16..24], &[0, 0, 3, 232, 0, 0, 1, 168]); // Without a painting the text says none. + // (and the folder's older name, --admixture, still reads it). std::fs::remove_file(d.0.join("paint/failed.txt")).unwrap(); std::fs::remove_file(d.0.join("paint/chr20.msp.tsv")).unwrap(); let (rc, stdout, _) = run(&[ @@ -834,6 +849,18 @@ mod tests { ]); assert_eq!(rc, 0); assert!(stdout.contains("Chromosome painting: none. No chromosome had enough")); + // Neither name of the folder: a message, no output. + let (rc, _, err) = run(&[ + "report", + "--sample", + "S", + "--model", + &model, + "--out", + &d.path("none"), + ]); + assert_eq!(rc, 1); + assert!(err.contains("--fractions DIR is required"), "{err}"); } #[test] diff --git a/tests/parity/golden/ancestry-fine/report-no-painting/S_ancestry_fine.txt b/tests/parity/golden/ancestry-fine/report-no-painting/S_ancestry_fine.txt new file mode 100644 index 000000000..73d2792d9 --- /dev/null +++ b/tests/parity/golden/ancestry-fine/report-no-painting/S_ancestry_fine.txt @@ -0,0 +1,24 @@ +Fine-grained ancestry of S (step 26b) +Reference panel: ; . + +Left out of the model: Oceania (continental and regional group), Southern Africa (regional group). The panel has fewer than 10 unrelated +reference people for it, too few to stand for a population, so the model has no such group and +any ancestry from it is spread over the groups below. + +Continental groups (projection on the frequencies of 3 groups, 0 bootstrap replicates): + West Eurasia (Europe, Middle East, North Africa) 90% + East Asia 5% + Africa 5% + +Regional groups (projection on the frequencies of 4 groups, 0 bootstrap replicates): + Iberia 60% + Italy 39% + +Chromosome painting: none. No chromosome had enough genotyped SNVs spanning 5 cM. + +What this means: each name is a group of reference populations we put together and named, +not a nationality. The fractions say which groups your genome is most similar to; the range +after each is the 2.5 to 97.5 percentile of the bootstrap. Continental groups are well apart; +neighbouring regions are not: splits within Iberia are weak for every method, and Greek and +Southern Italian ancestry overlap (the panel has no Greek population at all). Read a regional +fraction with its range, never as one exact percentage. See docs/26b-ancestry-fine.md. diff --git a/tests/parity/golden/ancestry-fine/report-no-painting/stdout b/tests/parity/golden/ancestry-fine/report-no-painting/stdout new file mode 100644 index 000000000..73d2792d9 --- /dev/null +++ b/tests/parity/golden/ancestry-fine/report-no-painting/stdout @@ -0,0 +1,24 @@ +Fine-grained ancestry of S (step 26b) +Reference panel: ; . + +Left out of the model: Oceania (continental and regional group), Southern Africa (regional group). The panel has fewer than 10 unrelated +reference people for it, too few to stand for a population, so the model has no such group and +any ancestry from it is spread over the groups below. + +Continental groups (projection on the frequencies of 3 groups, 0 bootstrap replicates): + West Eurasia (Europe, Middle East, North Africa) 90% + East Asia 5% + Africa 5% + +Regional groups (projection on the frequencies of 4 groups, 0 bootstrap replicates): + Iberia 60% + Italy 39% + +Chromosome painting: none. No chromosome had enough genotyped SNVs spanning 5 cM. + +What this means: each name is a group of reference populations we put together and named, +not a nationality. The fractions say which groups your genome is most similar to; the range +after each is the 2.5 to 97.5 percentile of the bootstrap. Continental groups are well apart; +neighbouring regions are not: splits within Iberia are weak for every method, and Greek and +Southern Italian ancestry overlap (the panel has no Greek population at all). Read a regional +fraction with its range, never as one exact percentage. See docs/26b-ancestry-fine.md. diff --git a/tests/parity/golden/ancestry-fine/report/out/S_ancestry_fine.txt b/tests/parity/golden/ancestry-fine/report/out/S_ancestry_fine.txt new file mode 100644 index 000000000..58641bcb9 --- /dev/null +++ b/tests/parity/golden/ancestry-fine/report/out/S_ancestry_fine.txt @@ -0,0 +1,29 @@ +Fine-grained ancestry of S (step 26b) +Reference panel: test; 37 of the 40 SNVs ADMIXTURE uses genotyped + +Left out of the model: Oceania (continental and regional group), Southern Africa (regional group). The panel has fewer than 10 unrelated +reference people for it, too few to stand for a population, so the model has no such group and +any ancestry from it is spread over the groups below. + +Continental groups (projection on the frequencies of 3 groups, 11 bootstrap replicates): + West Eurasia (Europe, Middle East, North Africa) 90% (80% to 90%) + East Asia 5% (5% to 5%) + Africa 5% (5% to 15%) + +Regional groups (projection on the frequencies of 4 groups, 7 bootstrap replicates): + Iberia 60% (55% to 67%) + Italy 39% (32% to 44%) + +Chromosome painting (RFMix, continental groups) of chr2, chr20, chrX: share of the 546.0 Mb painted on the two haplotypes + West Eurasia (Europe, Middle East, North Africa) 59% + East Asia 18% + Oceania 18% + Africa 5% + Not painted: RFMix failed on chr3, chr19 (the step's log has its last lines). + +What this means: each name is a group of reference populations we put together and named, +not a nationality. The fractions say which groups your genome is most similar to; the range +after each is the 2.5 to 97.5 percentile of the bootstrap. Continental groups are well apart; +neighbouring regions are not: splits within Iberia are weak for every method, and Greek and +Southern Italian ancestry overlap (the panel has no Greek population at all). Read a regional +fraction with its range, never as one exact percentage. See docs/26b-ancestry-fine.md. diff --git a/tests/parity/golden/ancestry-fine/report/stdout b/tests/parity/golden/ancestry-fine/report/stdout new file mode 100644 index 000000000..58641bcb9 --- /dev/null +++ b/tests/parity/golden/ancestry-fine/report/stdout @@ -0,0 +1,29 @@ +Fine-grained ancestry of S (step 26b) +Reference panel: test; 37 of the 40 SNVs ADMIXTURE uses genotyped + +Left out of the model: Oceania (continental and regional group), Southern Africa (regional group). The panel has fewer than 10 unrelated +reference people for it, too few to stand for a population, so the model has no such group and +any ancestry from it is spread over the groups below. + +Continental groups (projection on the frequencies of 3 groups, 11 bootstrap replicates): + West Eurasia (Europe, Middle East, North Africa) 90% (80% to 90%) + East Asia 5% (5% to 5%) + Africa 5% (5% to 15%) + +Regional groups (projection on the frequencies of 4 groups, 7 bootstrap replicates): + Iberia 60% (55% to 67%) + Italy 39% (32% to 44%) + +Chromosome painting (RFMix, continental groups) of chr2, chr20, chrX: share of the 546.0 Mb painted on the two haplotypes + West Eurasia (Europe, Middle East, North Africa) 59% + East Asia 18% + Oceania 18% + Africa 5% + Not painted: RFMix failed on chr3, chr19 (the step's log has its last lines). + +What this means: each name is a group of reference populations we put together and named, +not a nationality. The fractions say which groups your genome is most similar to; the range +after each is the 2.5 to 97.5 percentile of the bootstrap. Continental groups are well apart; +neighbouring regions are not: splits within Iberia are weak for every method, and Greek and +Southern Italian ancestry overlap (the panel has no Greek population at all). Read a regional +fraction with its range, never as one exact percentage. See docs/26b-ancestry-fine.md. From 92447ad8389f731b530bbba53b61f38245387a34 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:29:25 +0100 Subject: [PATCH 36/40] feat(ancestry): step 26b projects with og and no longer runs ADMIXTURE Step 26b and the Nextflow module now call og ancestry-fine project. ANCESTRY_FINE_FRACTIONS replaces ANCESTRY_FINE_PREPARE and ANCESTRY_FINE_ADMIXTURE, work/fractions replaces work/admixture, and og ancestry-fine sample-bed with its generated ADMIXTURE script is gone, with its parity cases. The e2e case checks the fit.tsv of each level. Bead: lin-49 Bead: D1 --- CHANGELOG.md | 1 + assets/steps.tsv | 2 +- conf/containers.config | 3 +- modules/local/ancestry_fine/main.nf | 73 +-- rust/crates/og-ancestry/src/lib.rs | 32 +- .../og-ancestry/src/run_admixture.sh.in | 29 - rust/crates/og-ancestry/src/sample_bed.rs | 567 ------------------ rust/og/src/main.rs | 4 +- scripts/26b-ancestry-fine.sh | 48 +- scripts/ci/gen-containers-config.sh | 3 +- tests/e2e/ancestry-fine-grained-1.sh | 15 +- tests/parity/cases.tsv | 5 - .../sample-bed-gz/run_admixture.sh | 29 - .../ancestry-fine/sample-bed-p-missing/stderr | 1 - .../adm/S_continent.3.P.in.absent | 0 .../adm/S_continent.bed.absent | 0 .../adm/S_continent.bim.absent | 0 .../adm/S_continent.fam.absent | 0 .../sample-bed/adm/run_admixture.sh | 29 - .../inputs/ancestry-fine/sb-gz/continent.P | 40 -- .../inputs/ancestry-fine/sb-gz/g.vcf.gz | Bin 320 -> 0 bytes .../parity/inputs/ancestry-fine/sb-gz/ref.bim | 40 -- .../ancestry-fine/sb-min-sites/continent.P | 40 -- .../inputs/ancestry-fine/sb-min-sites/g.vcf | 44 -- .../inputs/ancestry-fine/sb-min-sites/ref.bim | 40 -- .../inputs/ancestry-fine/sb-p-missing/g.vcf | 44 -- .../inputs/ancestry-fine/sb-p-missing/ref.bim | 40 -- .../ancestry-fine/sb-p-rows/continent.P | 40 -- .../inputs/ancestry-fine/sb-p-rows/g.vcf | 44 -- .../inputs/ancestry-fine/sb-p-rows/ref.bim | 40 -- .../inputs/ancestry-fine/sb-p-rows/region.P | 39 -- .../inputs/ancestry-fine/sb/continent.P | 40 -- tests/parity/inputs/ancestry-fine/sb/g.vcf | 44 -- tests/parity/inputs/ancestry-fine/sb/ref.bim | 40 -- tests/parity/inputs/ancestry-fine/sb/region.P | 40 -- tests/shellcheck-baseline.txt | 1 - tests/test_ancestry_fine_report.py | 41 -- workflows/clinical.nf | 18 +- 38 files changed, 70 insertions(+), 1446 deletions(-) delete mode 100644 rust/crates/og-ancestry/src/run_admixture.sh.in delete mode 100644 rust/crates/og-ancestry/src/sample_bed.rs delete mode 100644 tests/parity/golden/ancestry-fine/sample-bed-gz/run_admixture.sh delete mode 100644 tests/parity/golden/ancestry-fine/sample-bed-p-missing/stderr delete mode 100644 tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.3.P.in.absent delete mode 100644 tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.bed.absent delete mode 100644 tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.bim.absent delete mode 100644 tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.fam.absent delete mode 100644 tests/parity/golden/ancestry-fine/sample-bed/adm/run_admixture.sh delete mode 100644 tests/parity/inputs/ancestry-fine/sb-gz/continent.P delete mode 100644 tests/parity/inputs/ancestry-fine/sb-gz/g.vcf.gz delete mode 100644 tests/parity/inputs/ancestry-fine/sb-gz/ref.bim delete mode 100644 tests/parity/inputs/ancestry-fine/sb-min-sites/continent.P delete mode 100644 tests/parity/inputs/ancestry-fine/sb-min-sites/g.vcf delete mode 100644 tests/parity/inputs/ancestry-fine/sb-min-sites/ref.bim delete mode 100644 tests/parity/inputs/ancestry-fine/sb-p-missing/g.vcf delete mode 100644 tests/parity/inputs/ancestry-fine/sb-p-missing/ref.bim delete mode 100644 tests/parity/inputs/ancestry-fine/sb-p-rows/continent.P delete mode 100644 tests/parity/inputs/ancestry-fine/sb-p-rows/g.vcf delete mode 100644 tests/parity/inputs/ancestry-fine/sb-p-rows/ref.bim delete mode 100644 tests/parity/inputs/ancestry-fine/sb-p-rows/region.P delete mode 100644 tests/parity/inputs/ancestry-fine/sb/continent.P delete mode 100644 tests/parity/inputs/ancestry-fine/sb/g.vcf delete mode 100644 tests/parity/inputs/ancestry-fine/sb/ref.bim delete mode 100644 tests/parity/inputs/ancestry-fine/sb/region.P diff --git a/CHANGELOG.md b/CHANGELOG.md index b4d7fcd81..b15247cac 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -23,6 +23,7 @@ Each release's notes. From 1.0.0 on, a major or minor release has hand-written n - Step 49 (CHIP) now gives FilterMutectCalls a contamination estimate. Before, it filtered Mutect2's calls without one, so another person's DNA in the sample, whose alleles sit at a low VAF, could pass as a small clone and read `chip`. When step 29's common-sites VCF `somatic/small_exac_common_3.hg38.vcf.gz` is installed with its `.tbi`, `scripts/49-chip.sh` and the Nextflow `CHIP_MUTECT2` run GetPileupSummaries at its 59,295 sites across the genome and CalculateContamination, and pass `--contamination-table` and `--tumor-segmentation` to FilterMutectCalls. The pileups do not stop at the CHIP exons, which hold only 8 of those sites, too few for an estimate. A call that contamination explains is then marked `contamination` by FilterMutectCalls and reads `filtered`. FilterMutectCalls weighs each allele by its gnomAD population frequency, so the estimate does its work only with `somatic/af-only-gnomad.hg38.vcf.gz` installed too. Without the common-sites VCF the log says there is no contamination estimate, and with it but without gnomAD the log warns that the estimate changes few calls. A new optional parameter, `--chip_common_sites`, gives the VCF to the Nextflow pipeline, and `run-all.sh` passes it when the file is installed. The bash step also keeps `chip/_chip_contamination.table`. No column, option or file name changes. Part of #411 (trait-62). - The live site's family page and its pedigree drawing are now built by `og live family`, in Rust. `bin/owngenome_live_family.py` asks `og` for a family's state, its `family.json`, the list of files it serves and `pedigree.svg`, and no longer reads the family's tables itself; `bin/pedigree_svg.py` and `bin/family_report.py` are gone. The page shows the same thing: `family.json` and the drawing were compared with the old code on the demo family and the test families, field by field and number by number, and matched. The live site therefore needs `og` (`scripts/setup.sh --og` installs it); without it a family's `family.json` answers 500, its `pedigree.svg` answers 503, and the run list marks each family unreadable. A family file that cannot be read still gives no page and an unreadable family. - `setup.sh --ancestry-fine-panel` no longer runs plink2 and a supervised ADMIXTURE at install to fit each reference group's allele frequencies. When every reference person's group is given, the frequencies ADMIXTURE climbs to are each group's own allele frequencies, so the new `og ancestry-fine freqs` counts them exactly from the LD-pruned VCF, clamped to ADMIXTURE's bounds (1e-5 and 1 - 1e-5). On a reduced panel of 1,954 SNVs and 2,866 reference people, no frequency differs from ADMIXTURE's by more than 0.0004, the columns come in the same order, `ref.bim` and `ref.fam` are byte for byte what plink2 wrote, and the fit takes 3 seconds. Step 26b still projects your genome with `admixture -P` on these frequencies, so its results do not change. `model/` keeps `ref.bim`, `ref.fam`, `continent.P`, `region.P`, `levels.tsv` and `paint_map.tsv` in the same formats. It gains `ref.geno`, the reference people's genotypes for the projection's bootstrap, and loses `ref.bed`, which nothing read. `og ancestry-fine freqs --exclude FILE` leaves people out of the fit. `og ancestry-fine order`, which read the column order from ADMIXTURE's `.Q`, is gone: the order is now the order in which the groups first appear in the VCF, as ADMIXTURE numbers them. The next `--ancestry-fine-panel` run fits the model again in seconds and keeps the panel's genotypes. +- Step 26b no longer runs ADMIXTURE. The new `og ancestry-fine project` finds your ancestry fractions in `og`: it keeps each group's allele frequencies fixed, finds the fractions that make your genotypes most likely, and stops with an error when the answer fails the optimum's conditions (KKT), where ADMIXTURE could stop short and say nothing. Each bootstrap replicate now draws 5 cM blocks of SNVs, never one that spans two chromosomes, and draws each group's reference people again from `model/ref.geno`, so a group with few people gets a wider range. ADMIXTURE kept the groups' frequencies fixed in its bootstrap, so its ranges left out how well each group's frequencies are known. The same seed gives the same ranges for any thread count. `work/fractions/` replaces `work/admixture/`, and each level gains a `_.fit.tsv` with the passes, the log-likelihood, the KKT check and the bootstrap settings. `og ancestry-fine report` takes `--fractions DIR`, and `--admixture DIR` still works. In the Nextflow pipeline, `ANCESTRY_FINE_FRACTIONS` replaces `ANCESTRY_FINE_PREPARE` and `ANCESTRY_FINE_ADMIXTURE`, and `og ancestry-fine sample-bed` is gone. On a model fitted before `ref.geno` existed, the step stops with one line that says to run `setup.sh --ancestry-fine-panel` again, which refits it in seconds. - Step 40 (the 23andMe and AncestryDNA export) no longer writes a weak reference call as a genotype. A reference block or a `0/0` record with `GQ` under 20, or with a filter other than `PASS`, `.` or `RefCall`, was written as two reference bases, so a block with no reads behind it read as a confident `AA`. Such a site is now `--` (`0 0`), and the summary counts it under a new reason, `no_call: weak reference call (GQ below 20, or filtered)`. A call without `GQ` and every variant call read as before. A gVCF of several samples is now read only for the column `--sample` names, and refused when none or two match; before, the step read the first column, which could be another person's. A gVCF of one sample is read as before. No option or file name changes. Part of #411 (plat-66, plat-67, plat-70, D10). - A live page that cannot load its data now says so, with a Try again button. A person page whose `results.json` failed read as a finished report with no results. A home page whose `runs.json` failed, or got no answer, showed only the server's plain list of runs. A family page whose `family.json` held no family (`{}`) stayed blank. Each page now names what could not be loaded, and Try again asks for it again. A person page that cannot read its run's state, or reads a state with no plugin data, stays closed as before, but its heading reads "Results not loaded" instead of "Results about a child", it says it could not read the run's state and keeps its results closed, and it names no role. Before the run's first state arrives, the wire, run health and re-check panels read "Waiting for the run's data." instead of saying that there is nothing yet. - The local genome viewer runs on `og` and no longer needs `python3` on the host. `scripts/owngenome-view.sh` starts `og view serve` (through `bin/og`, or `OG`), which serves the same page, config and byte ranges on 127.0.0.1 as `assets/viewer/serve.py` did. Two requests it answered before are now refused. A locus whose end comes before its start (`chr1:13000-12000`) stops the script with exit 2 and the reason, instead of opening a view igv.js cannot show. A request with a `Forwarded`, `X-Forwarded-*` or `X-Real-IP` header gets 403: the viewer has no password, so a reverse proxy in front of it would hand the sample to anyone who reaches the proxy; an ssh port forward still works. The default SV track is now Manta's diploid SVs (step 4), else step 22's consensus, which keeps only the calls two callers agree on. `docs/viewer.md` says that every account on the machine can reach 127.0.0.1. No option of the script, file or output name changes; `og view serve` takes the flags `serve.py` took, plus `--assets`, the page's folder. The live site's viewer also opens Manta's diploid SVs first; the rest of it is unchanged until its server moves to `og`. Part of #411 (plat-11, plat-12). diff --git a/assets/steps.tsv b/assets/steps.tsv index d300d8f51..983d501d9 100644 --- a/assets/steps.tsv +++ b/assets/steps.tsv @@ -48,7 +48,7 @@ step label tool recorded processes sections upstream hours hours_from hours_low 24 HTML report html_report no HTML_REPORT 0.05 estimate 25 PRS prs yes PRS_PREPARE,PRS_SCORE_SITES,PRS,PRS_SUMMARY prs 03 1.47 measured 1 pgs:* 26 Ancestry (pgsc_calc) ancestry yes PRS 25 -26b Fine-grained ancestry ancestry_fine yes ANCESTRY_FINE_GENOTYPE,ANCESTRY_FINE_PREPARE,ANCESTRY_FINE_ADMIXTURE,ANCESTRY_FINE_PHASE,ANCESTRY_FINE_PAINT,ANCESTRY_FINE_REPORT ancestry_fine 03 +26b Fine-grained ancestry ancestry_fine yes ANCESTRY_FINE_GENOTYPE,ANCESTRY_FINE_FRACTIONS,ANCESTRY_FINE_PHASE,ANCESTRY_FINE_PAINT,ANCESTRY_FINE_REPORT ancestry_fine 03 27 CPIC lookup cpic yes CPIC_LOOKUP cpic 06,07,32,36 0.01 measured 0.0008 PHARMCAT_IMAGE 28 MultiQC multiqc yes MULTIQC 16b 0.01 measured 0.0008 29 Somatic (Mutect2) yes 02 6 estimate diff --git a/conf/containers.config b/conf/containers.config index f425b71d2..6d0dd4c68 100644 --- a/conf/containers.config +++ b/conf/containers.config @@ -2,11 +2,10 @@ // change the tag in versions.env, then run that script again. process { withName: 'ALIGN_MINIMAP2' { container = 'quay.io/biocontainers/mulled-v2-66534bcbb7031a148b13e2ad42583020b9cd25c4:ad4c240457048f1d3cc0bd8c8fa39bf27d222eb7-0' } - withName: 'ANCESTRY_FINE_ADMIXTURE' { container = 'quay.io/biocontainers/admixture:1.3.0--0' } + withName: 'ANCESTRY_FINE_FRACTIONS' { container = 'python:3.15.2@sha256:d7a732b20de2f5d3cf977cbcf69aacf30dc928a37908ff9fdb7bb3503024c91a' } withName: 'ANCESTRY_FINE_GENOTYPE' { container = 'staphb/bcftools:1.24' } withName: 'ANCESTRY_FINE_PAINT' { container = 'quay.io/biocontainers/rfmix:2.03.r0.9505bfa--h503566f_8' } withName: 'ANCESTRY_FINE_PHASE' { container = 'quay.io/biocontainers/beagle:5.5_27Feb25.75f--hdfd78af_0' } - withName: 'ANCESTRY_FINE_PREPARE' { container = 'python:3.15.2@sha256:d7a732b20de2f5d3cf977cbcf69aacf30dc928a37908ff9fdb7bb3503024c91a' } withName: 'ANCESTRY_FINE_REPORT' { container = 'python:3.15.2@sha256:d7a732b20de2f5d3cf977cbcf69aacf30dc928a37908ff9fdb7bb3503024c91a' } withName: 'ANCIENT_GENO' { container = 'python:3.15.2@sha256:d7a732b20de2f5d3cf977cbcf69aacf30dc928a37908ff9fdb7bb3503024c91a' } withName: 'ANCIENT_PCA' { container = 'quay.io/biocontainers/eigensoft:9.0.0--h519d32d_0' } diff --git a/modules/local/ancestry_fine/main.nf b/modules/local/ancestry_fine/main.nf index f293cb557..a988ec1c9 100644 --- a/modules/local/ancestry_fine/main.nf +++ b/modules/local/ancestry_fine/main.nf @@ -8,18 +8,16 @@ ANCESTRY_FINE_GENOTYPE the panel's SNVs in the sample, from the gVCF (or from a VCF that holds reference calls) - ANCESTRY_FINE_PREPARE the one-person ADMIXTURE input, the groups' - frequencies at its SNVs and the chromosomes to - paint (og ancestry-fine) - ANCESTRY_FINE_ADMIXTURE ADMIXTURE -P: the fractions at each level and - their block bootstrap + ANCESTRY_FINE_FRACTIONS the fractions at each level, projected on the + groups' frequencies, with their bootstrap, and + the chromosomes to paint (og ancestry-fine) ANCESTRY_FINE_PHASE Beagle phasing against the panel ANCESTRY_FINE_PAINT RFMix painting with the continental groups ANCESTRY_FINE_REPORT the fractions table, the painting (BED, PNG) and the text summary - ADMIXTURE is free for academic use; RFMix for academic research use only, - and any other use, a personal one included, needs a licence from Stanford. + RFMix is for academic research use only, and any other use, a personal one + included, needs a licence from Stanford. Equivalent to: scripts/26b-ancestry-fine.sh ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ @@ -106,16 +104,16 @@ process ANCESTRY_FINE_GENOTYPE { """ } -process ANCESTRY_FINE_PREPARE { +process ANCESTRY_FINE_FRACTIONS { tag "$meta.id" - label 'process_single' + label 'process_low' input: tuple val(meta), path(genotypes), path(genotypes_index), path(counts) path panel output: - tuple val(meta), path("admixture"), emit: admixture_input + tuple val(meta), path("fractions"), emit: fractions tuple val(meta), path("${meta.id}_chroms.txt"), emit: chroms path "versions.yml", emit: versions @@ -124,12 +122,12 @@ process ANCESTRY_FINE_PREPARE { script: def boot = task.ext.bootstrap != null ? task.ext.bootstrap : 100 + // As scripts/26b-ancestry-fine.sh: each level's fractions (.Q), their + // bootstrap replicates (.boot.Q) and how the fit went (.fit.tsv). """ set -euo pipefail - levels=() - while IFS=\$'\\t' read -r level k _; do levels+=(--level "\${level}:\${k}:${panel}/model/\${level}.P"); done < ${panel}/model/levels.tsv - og ancestry-fine sample-bed --bim ${panel}/model/ref.bim --vcf ${genotypes} \\ - --sample ${meta.id} "\${levels[@]}" --bootstrap ${boot} --out-dir admixture + og ancestry-fine project --model ${panel}/model --maps ${panel}/maps --vcf ${genotypes} \\ + --sample ${meta.id} --bootstrap ${boot} --seed 1 --threads ${task.cpus} --out-dir fractions # The chromosomes to phase and paint, as the bash step picks them. og ancestry-fine chroms --counts ${counts} --maps ${panel}/maps > ${meta.id}_chroms.txt @@ -138,53 +136,12 @@ process ANCESTRY_FINE_PREPARE { stub: """ - mkdir -p admixture + mkdir -p fractions touch ${meta.id}_chroms.txt printf '"%s":\\n python: %s\\n' "${task.process}" "${task.container.replaceFirst(/^[^:@]+[:@]/, '')}" > versions.yml """ } -process ANCESTRY_FINE_ADMIXTURE { - tag "$meta.id" - label 'process_low' - - input: - tuple val(meta), path(admixture_in, stageAs: 'in/*') - - output: - tuple val(meta), path("admixture"), emit: admixture - path "versions.yml", emit: versions - - when: - task.ext.when == null || task.ext.when - - script: - // run_admixture.sh (written by ANCESTRY_FINE_PREPARE): the projection of - // each level, then its bootstrap replicates. - """ - set -eu - mkdir -p admixture - cp -L in/admixture/* admixture/ - cd admixture - sh run_admixture.sh ${task.cpus} - cd .. - - cat <<-END_VERSIONS > versions.yml - "${task.process}": - admixture: ${task.container.replaceFirst(/^[^:@]+[:@]/, '')} - END_VERSIONS - """ - - stub: - """ - mkdir -p admixture - cat <<-END_VERSIONS > versions.yml - "${task.process}": - admixture: ${task.container.replaceFirst(/^[^:@]+[:@]/, '')} - END_VERSIONS - """ -} - process ANCESTRY_FINE_PHASE { tag "$meta.id" label 'process_medium' @@ -284,7 +241,7 @@ process ANCESTRY_FINE_REPORT { publishDir { "${params.outdir}/${meta.id}/ancestry_fine" }, mode: params.publish_dir_mode input: - tuple val(meta), path(admixture, stageAs: 'adm/*'), path(painting, stageAs: 'pnt/*') + tuple val(meta), path(fractions, stageAs: 'frc/*'), path(painting, stageAs: 'pnt/*') path panel val panel_name @@ -301,7 +258,7 @@ process ANCESTRY_FINE_REPORT { script: """ og ancestry-fine report --sample ${meta.id} --model ${panel}/model \\ - --admixture adm/admixture --paint pnt/paint --panel ${panel_name} --out . + --fractions frc/fractions --paint pnt/paint --panel ${panel_name} --out . printf '"%s":\\n python: %s\\n' "${task.process}" "${task.container.replaceFirst(/^[^:@]+[:@]/, '')}" > versions.yml """ diff --git a/rust/crates/og-ancestry/src/lib.rs b/rust/crates/og-ancestry/src/lib.rs index 933cfd685..d6e1907ea 100644 --- a/rust/crates/og-ancestry/src/lib.rs +++ b/rust/crates/og-ancestry/src/lib.rs @@ -1,19 +1,19 @@ //! Step 26b, fine-grained ancestry (`docs/26b-ancestry-fine.md`): the -//! commands around ADMIXTURE and RFMix, as `og ancestry-fine `. +//! commands of the step, as `og ancestry-fine `. //! //! - [`panel`]: `panel-map` writes the panel's sample table once, at setup; //! `check-map` refuses a table given with `ANCESTRY_FINE_SAMPLE_MAP` that //! has a group too small to model. -//! - [`sample_bed`]: ADMIXTURE's input for one person, and the bootstrap -//! script the ADMIXTURE image runs. //! - [`chroms`]: the chromosomes long enough for RFMix to paint. //! - [`report`]: the fractions table, the painting (BED and PNG) and the //! plain-text summary. //! - [`freqs`]: each reference group's allele frequencies, counted at //! install in place of a supervised ADMIXTURE run. -//! - [`project`], [`paint`]: `og ancestry-fine project|paint`, the engines -//! that replace ADMIXTURE's projection and RFMix. Not ported yet: each -//! says so and exits 2. +//! - [`project`]: `og ancestry-fine project`, the fractions at each level +//! projected on the groups' frequencies, with their block bootstrap (in +//! place of ADMIXTURE). +//! - [`paint`]: `og ancestry-fine paint`, the engine that replaces RFMix. +//! Not ported yet: it says so and exits 2. //! - [`simulate`]: `og ancestry-fine simulate`, an admixed genome with known //! truth that those engines test against. //! - [`compare`]: `og archaic compare|genomes`, Chen et al.'s Neanderthal @@ -39,7 +39,6 @@ pub mod paint; pub mod panel; pub mod project; pub mod report; -pub mod sample_bed; pub mod simulate; use std::fmt; @@ -298,21 +297,6 @@ fn for_each_line(path: &Path, mut f: impl FnMut(&str) -> Result<()>) -> Result<( Ok(()) } -/// The raw lines of a text file with their endings (`f.readlines()`), -/// read by `f`, one at a time. -fn for_each_raw_line(path: &Path, mut f: impl FnMut(&str) -> Result<()>) -> Result<()> { - let input = og_io::open(path).map_err(|e| cannot_read(path, &e))?; - let mut lines = og_io::Lines::new(input, og_io::Utf8::Strict); - let mut line = String::new(); - while lines - .read_line(&mut line) - .map_err(|e| cannot_read(path, &e))? - { - f(&line)?; - } - Ok(()) -} - /// Python's `s.split()`: runs of whitespace separate, none at the ends. fn split_ws(s: &str) -> impl Iterator { s.split(pycompat::num::py_isspace).filter(|w| !w.is_empty()) @@ -554,7 +538,7 @@ fn is_negative_number(s: &str) -> bool { /// A verb's body: the parsed options and stdout. type Run = fn(&Args, &mut dyn io::Write) -> Result<()>; -const USAGE: &str = "usage: og ancestry-fine {panel-map,check-map,sample-bed,chroms,report,freqs,project,paint,simulate} ...\n"; +const USAGE: &str = "usage: og ancestry-fine {panel-map,check-map,chroms,report,freqs,project,paint,simulate} ...\n"; /// `og ancestry-fine [args]`: the exit code. Output goes to `out`, /// messages to `err`. @@ -579,7 +563,6 @@ pub fn cli(args: &[String], out: &mut dyn io::Write, err: &mut dyn io::Write) -> "panel-map" => (&panel::PANEL_MAP, panel::panel_map_main), "check-map" => (&panel::CHECK_MAP, panel::check_map_main), "freqs" => (&freqs::SPEC, freqs::main), - "sample-bed" => (&sample_bed::SPEC, sample_bed::main), "chroms" => (&chroms::SPEC, chroms::main), "report" => (&report::SPEC, report::main), "-h" | "--help" => { @@ -759,7 +742,6 @@ mod tests { for verb in [ "panel-map", "check-map", - "sample-bed", "chroms", "report", "freqs", diff --git a/rust/crates/og-ancestry/src/run_admixture.sh.in b/rust/crates/og-ancestry/src/run_admixture.sh.in deleted file mode 100644 index c4e2a5ac1..000000000 --- a/rust/crates/og-ancestry/src/run_admixture.sh.in +++ /dev/null @@ -1,29 +0,0 @@ -#!/bin/sh -# Written by og ancestry-fine sample-bed. Usage: sh run_admixture.sh THREADS -set -eu -t=${1:-1} -while read -r level k; do - admixture -P -j"$t" "@S@_${level}.bed" "$k" > "@S@_${level}.log" 2>&1 \ - || { tail -n 20 "@S@_${level}.log"; exit 1; } - : > "@S@_${level}.boot.Q" - r=1 - while [ "$r" -le @B@ ]; do - awk -v r="$r" -v nb=@NB@ -v k="$k" ' - FNR == 1 { f++ } - f == 1 { g[n++] = $0; next } - f == 2 { m[n2++] = $0; next } - f == 3 { p[n3++] = $0; next } - END { - srand(r); bs = int((n + nb - 1) / nb); nblk = int((n + bs - 1) / bs); printf "S S 0 0 0 -9" > "rep.ped" - for (b = 0; b < nb; b++) { - s = int(rand() * nblk) * bs - for (i = s; i < s + bs && i < n; i++) { printf " %s", g[i] > "rep.ped"; print m[i] > "rep.map"; print p[i] > ("rep." k ".P.in") } - } - printf "\n" > "rep.ped" - }' "@S@.geno" "@S@.map" "@S@_${level}.${k}.P.in" - admixture -P "rep.ped" "$k" > rep.log 2>&1 || { tail -n 20 rep.log; exit 1; } - cat "rep.${k}.Q" >> "@S@_${level}.boot.Q" - rm -f rep.ped rep.map "rep.${k}.P.in" "rep.${k}.P" "rep.${k}.Q" - r=$((r + 1)) - done -done < levels.txt diff --git a/rust/crates/og-ancestry/src/sample_bed.rs b/rust/crates/og-ancestry/src/sample_bed.rs deleted file mode 100644 index e2280ef2a..000000000 --- a/rust/crates/og-ancestry/src/sample_bed.rs +++ /dev/null @@ -1,567 +0,0 @@ -//! `sample-bed`: ADMIXTURE's input for one person. -//! -//! A `.bed`/`.bim`/`.fam` of the reference `.bim`'s SNVs the person has a -//! genotype for, in the `.bim`'s order and allele coding, and each level's -//! frequencies (`.P.in`, which `admixture -P` reads) for the same SNVs. -//! ADMIXTURE stops on a SNV without a genotype, so a missing site, or a -//! genotype with an allele the `.bim` does not have, is left out. Also -//! `run_admixture.sh` ([`BOOT_SH`]), which the ADMIXTURE image runs (it has -//! sh and awk, no python): the projection at each level, then B bootstrap -//! replicates of it. ADMIXTURE's own `-B` crashes with `-P`, so a replicate -//! is a draw, with replacement, of up to 100 blocks of neighbouring SNVs, -//! written as a PLINK `.ped` (allele 2 is the `.bim`'s A1) and projected -//! the same way. -//! -//! The VCF streams: only the records at a `.bim` position are kept, so its -//! size does not matter. Every output is written under a temporary name and -//! renamed into place only after every input has been read and checked; -//! `run_admixture.sh` comes last, so a run that stops halfway leaves no -//! script for the next command to run on partial input. - -use crate::{Args, Fail, Pending, Result, Spec}; -use std::collections::HashMap; -use std::io::Write; -use std::path::{Path, PathBuf}; - -pub(crate) const SPEC: Spec = Spec { - verb: "sample-bed", - usage: "usage: og ancestry-fine sample-bed --bim ref.bim --vcf genotypes.vcf.gz --sample S --level LEVEL:K:P [--level ...] [--bootstrap B] [--min-sites N] --out-dir DIR\n", - options: &[ - "--bim", - "--vcf", - "--sample", - "--level", - "--bootstrap", - "--min-sites", - "--out-dir", - ], - required: &["--bim", "--vcf", "--sample", "--level", "--out-dir"], -}; - -/// The bootstrap script; `@S@`, `@B@` and `@NB@` are the sample, the -/// number of replicates and the number of blocks per replicate. -pub const BOOT_SH: &str = include_str!("run_admixture.sh.in"); - -/// The reference `.bim`: its text in one buffer, and each SNV as offsets -/// into it, so a panel of any size costs a few dozen bytes per SNV. -pub struct Bim { - text: String, - rows: Vec, -} - -/// One SNV: the line (with its ending), the chromosome without `chr`, the -/// alleles A1 and A2 as spans of [`Bim::text`], and the position. -#[derive(Debug, Clone, Copy)] -struct BimRow { - line: (u32, u32), - chrom: (u32, u32), - a1: (u32, u32), - a2: (u32, u32), - pos: i64, -} - -impl Bim { - pub fn len(&self) -> usize { - self.rows.len() - } - - pub fn is_empty(&self) -> bool { - self.rows.is_empty() - } - - fn at(&self, (a, b): (u32, u32)) -> &str { - &self.text[a as usize..b as usize] - } - - /// Row `i`'s line as read, with its ending. - pub fn line(&self, i: usize) -> &str { - self.at(self.rows[i].line) - } -} - -/// plink2 writes chr22 as 22 in a `.bim`; the VCFs say chr22. -fn norm_chrom(c: &str) -> &str { - c.strip_prefix("chr").unwrap_or(c) -} - -pub fn read_bim(path: &Path) -> Result { - let mut bim = Bim { - text: String::new(), - rows: Vec::new(), - }; - let mut n = 0u64; - let too_big = || Fail(format!("{}: larger than 4 GB", path.display())); - crate::for_each_raw_line(path, |line| { - n += 1; - let c: Vec<&str> = crate::split_ws(line).collect(); - if c.len() < 6 { - return Ok(()); - } - let pos = crate::int(c[3]).ok_or_else(|| { - Fail(format!( - "{}: line {n}: position is not a whole number: {}", - path.display(), - crate::repr(c[3]) - )) - })?; - let base = bim.text.len(); - let span = |s: &str| -> Result<(u32, u32)> { - // Each field is a slice of `line`, so its offset is exact. - let a = base + (s.as_ptr() as usize - line.as_ptr() as usize); - let b = a + s.len(); - Ok(( - u32::try_from(a).map_err(|_| too_big())?, - u32::try_from(b).map_err(|_| too_big())?, - )) - }; - let row = BimRow { - line: span(line)?, - chrom: span(norm_chrom(c[0]))?, - a1: span(c[4])?, - a2: span(c[5])?, - pos, - }; - bim.text.push_str(line); - bim.rows.push(row); - Ok(()) - })?; - Ok(bim) -} - -/// A GT of exactly two called alleles, phased or not, as written. -fn gt_alleles(gt: &str) -> Option<[&str; 2]> { - let mut parts = gt.split(['/', '|']); - let (a, b) = (parts.next()?, parts.next()?); - if parts.next().is_some() || a == "." || b == "." { - return None; - } - Some([a, b]) -} - -/// The PLINK `.bed` code of a genotype (REF and ALT alleles, the two allele -/// indices as written) for a `.bim` row with alleles A1, A2: 0 homozygous -/// A1, 2 heterozygous, 3 homozygous A2; `None` for no call (an index that -/// is no allele, or an allele the `.bim` does not have). -pub fn bed_code(alleles: &[&str], idx: [&str; 2], a1: &str, a2: &str) -> Option { - let (mut n1, mut n2) = (0, 0); - for i in idx { - let i = crate::int(i)?; - let called = *alleles.get(usize::try_from(i).ok()?)?; - n1 += usize::from(called == a1); - n2 += usize::from(called == a2); - } - if n1 + n2 != 2 { - return None; - } - Some(match n1 { - 2 => 0, - 1 => 2, - _ => 3, - }) -} - -/// The `.bed` code of each `.bim` row, streamed from the VCF: the last -/// record with a called GT at a row's position decides it. Only one byte -/// per row is kept, whatever the VCF's size. -pub fn codes_at(bim: &Bim, vcf: &Path) -> Result>> { - // Every row by (chromosome, position), sorted, so a record finds its - // rows by binary search (a .bim may list two SNVs at one position). - // Chromosome names are numbered in order of first appearance. - let mut names: HashMap<&str, u32> = HashMap::new(); - let mut index: Vec<(u32, i64, u32)> = Vec::with_capacity(bim.len()); - for (i, r) in bim.rows.iter().enumerate() { - let next = u32::try_from(names.len()).expect("fewer chromosomes than rows"); - let c = *names.entry(bim.at(r.chrom)).or_insert(next); - let i = u32::try_from(i).map_err(|_| Fail("more than 4 billion SNVs".into()))?; - index.push((c, r.pos, i)); - } - index.sort_unstable(); - let mut codes: Vec> = vec![None; bim.len()]; - let mut n = 0u64; - crate::for_each_line(vcf, |line| { - n += 1; - if line.starts_with('#') { - return Ok(()); - } - let c: Vec<&str> = line.split('\t').collect(); - if c.len() < 10 { - return Ok(()); - } - let Some(gt_at) = c[8].split(':').position(|f| f == "GT") else { - return Ok(()); - }; - let Some(idx) = c[9].split(':').nth(gt_at).and_then(gt_alleles) else { - return Ok(()); - }; - let pos = crate::int(c[1]).ok_or_else(|| { - Fail(format!( - "{}: line {n}: POS is not a whole number: {}", - vcf.display(), - crate::repr(c[1]) - )) - })?; - let Some(&chrom) = names.get(norm_chrom(c[0])) else { - return Ok(()); - }; - let from = index.partition_point(|&(ch, p, _)| (ch, p) < (chrom, pos)); - let rows = index[from..] - .iter() - .take_while(|&&(ch, p, _)| (ch, p) == (chrom, pos)); - let mut alleles = vec![c[3]]; - if c[4] != "." { - alleles.extend(c[4].split(',')); - } - for &(_, _, i) in rows { - let r = &bim.rows[i as usize]; - codes[i as usize] = bed_code(&alleles, idx, bim.at(r.a1), bim.at(r.a2)); - } - Ok(()) - })?; - Ok(codes) -} - -/// The called SNVs: (row indices, `.bed` codes). -pub fn kept(codes: &[Option]) -> (Vec, Vec) { - codes - .iter() - .enumerate() - .filter_map(|(i, c)| c.map(|c| (i, c))) - .unzip() -} - -/// The `.bed` file: magic, SNP-major, then one byte per SNV for one person. -pub fn bed_bytes(codes: &[u8]) -> Vec { - let mut out = Vec::with_capacity(3 + codes.len()); - out.extend_from_slice(&[0x6c, 0x1b, 0x01]); - out.extend_from_slice(codes); - out -} - -/// The allele pair of a `.bed` code in a PLINK "12" `.ped`: allele 2 is the -/// `.bim`'s A1 (ADMIXTURE's projection of the `.ped` equals the `.bed`'s -/// only this way round). -fn ped_alleles(code: u8) -> &'static str { - match code { - 0 => "2 2", - 2 => "1 2", - _ => "1 1", - } -} - -/// The script for sample `s`, `b` replicates of `nb` blocks. -pub fn boot_script(s: &str, b: i64, nb: usize) -> String { - BOOT_SH - .replace("@S@", s) - .replace("@B@", &b.to_string()) - .replace("@NB@", &nb.to_string()) -} - -pub(crate) fn main(a: &Args, out: &mut dyn Write) -> Result<()> { - let bim_arg = a.req("--bim"); - let vcf_arg = a.req("--vcf"); - let sample = a.req("--sample"); - let bootstrap = a.int("--bootstrap", 100).unwrap_or(100); - let min_sites = a.int("--min-sites", 100).unwrap_or(100); - let bim = read_bim(Path::new(bim_arg))?; - if bim.is_empty() { - return Err(Fail(format!("{bim_arg} has no SNV"))); - } - let (keep, codes) = kept(&codes_at(&bim, Path::new(vcf_arg))?); - if (keep.len() as i64) < min_sites { - return Err(Fail(format!( - "only {} of the {} reference SNVs have a genotype in {vcf_arg} (at least {min_sites} needed)", - keep.len(), - bim.len() - ))); - } - let dir = PathBuf::from(a.req("--out-dir")); - std::fs::create_dir_all(&dir).map_err(|e| crate::cannot_write(&dir, &e))?; - let at = |name: String| dir.join(name); - let bed = bed_bytes(&codes); - let mut pending = Pending::new(); - let mut levels = String::new(); - for spec in a.all("--level") { - let mut parts = spec.splitn(3, ':'); - let (Some(level), Some(k), Some(p_path)) = (parts.next(), parts.next(), parts.next()) - else { - return Err(Fail(format!("--level {spec}: not LEVEL:K:P_FILE"))); - }; - let base = format!("{sample}_{level}"); - // The .P rows of the kept SNVs, streamed into the output; the row - // count is checked before anything is renamed into place. - let p_out = at(format!("{base}.{k}.P.in")); - let shown = p_out.clone(); - let w = pending.create(p_out)?; - let (mut rows, mut next) = (0usize, keep.iter().peekable()); - crate::for_each_raw_line(Path::new(p_path), |line| { - if next.peek() == Some(&&rows) { - next.next(); - w.write_all(line.as_bytes()) - .map_err(|e| crate::cannot_write(&shown, &e))?; - } - rows += 1; - Ok(()) - })?; - if rows != bim.len() { - return Err(Fail(format!( - "{p_path} has {rows} rows but {bim_arg} {} SNVs", - bim.len() - ))); - } - pending.put(at(format!("{base}.bed")), &bed)?; - let bim_out = at(format!("{base}.bim")); - let shown = bim_out.clone(); - let w = pending.create(bim_out)?; - for &i in &keep { - w.write_all(bim.line(i).as_bytes()) - .map_err(|e| crate::cannot_write(&shown, &e))?; - } - pending.put( - at(format!("{base}.fam")), - format!("{sample} {sample} 0 0 0 -9\n").as_bytes(), - )?; - levels.push_str(&format!("{level} {k}\n")); - } - let geno_out = at(format!("{sample}.geno")); - let shown = geno_out.clone(); - let w = pending.create(geno_out)?; - for &c in &codes { - writeln!(w, "{}", ped_alleles(c)).map_err(|e| crate::cannot_write(&shown, &e))?; - } - let map_out = at(format!("{sample}.map")); - let shown = map_out.clone(); - let w = pending.create(map_out)?; - for &i in &keep { - let first4: Vec<&str> = crate::split_ws(bim.line(i)).take(4).collect(); - writeln!(w, "{}", first4.join(" ")).map_err(|e| crate::cannot_write(&shown, &e))?; - } - pending.put(at("levels.txt".to_owned()), levels.as_bytes())?; - let sites = format!( - "{} of the {} SNVs ADMIXTURE uses genotyped", - keep.len(), - bim.len() - ); - pending.put( - at(format!("{sample}_sites.txt")), - format!("{sites}\n").as_bytes(), - )?; - let nb = (keep.len() / 5).clamp(1, 100); - pending.put( - at("run_admixture.sh".to_owned()), - boot_script(sample, bootstrap, nb).as_bytes(), - )?; - pending.commit_all()?; - writeln!(out, "{sites}").map_err(|e| Fail(format!("cannot write stdout: {e}"))) -} - -#[cfg(test)] -mod tests { - use super::*; - use crate::testutil::{Dir, run}; - - const BIM: &str = "22\t22:100\t0\t100\tG\tA\n22\t22:200\t0\t200\tT\tC\n22\t22:300\t0\t300\tA\tG\n22\t22:400\t0\t400\tC\tT\n22\t22:500\t0\t500\tC\tA\n"; - const VCF: &str = "##fileformat=VCFv4.2\n#CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\tFORMAT\tS\n\ - chr22\t100\t.\tA\tG\t.\t.\t.\tGT\t1/1\n\ - chr22\t200\t.\tC\tT\t.\t.\t.\tGT\t0|1\n\ - chr22\t300\t.\tG\tA\t.\t.\t.\tGT\t0/0\n\ - chr22\t400\t.\tT\tG\t.\t.\t.\tGT\t0/1\n"; - - #[test] - fn codes_of_each_genotype() { - let d = Dir::new("bed-codes"); - let bim = read_bim(Path::new(&d.put("ref.bim", BIM))).unwrap(); - let (keep, codes) = kept(&codes_at(&bim, Path::new(&d.put("g.vcf", VCF))).unwrap()); - assert_eq!( - keep, - [0, 1, 2], - "chr22 meets 22; another ALT and a missing site are left out" - ); - assert_eq!(bed_bytes(&codes), b"\x6c\x1b\x01\x00\x02\x03"); - } - - #[test] - fn a_later_called_record_wins_and_an_uncalled_one_does_not() { - let d = Dir::new("bed-later"); - let bim = read_bim(Path::new(&d.put("ref.bim", "22\ta\t0\t100\tG\tA\n"))).unwrap(); - let v = "chr22\t100\t.\tA\tG\t.\t.\t.\tGT\t0/0\nchr22\t100\t.\tA\tG\t.\t.\t.\tGT\t1/1\nchr22\t100\t.\tA\tG\t.\t.\t.\tGT\t./.\n"; - let codes = codes_at(&bim, Path::new(&d.put("g.vcf", v))).unwrap(); - assert_eq!(codes, [Some(0)]); - } - - #[test] - fn genotype_indexes_must_name_alleles() { - assert_eq!(bed_code(&["A", "G"], ["0", "1"], "G", "A"), Some(2)); - assert_eq!(bed_code(&["A", "G"], ["0", "-1"], "G", "A"), None); - assert_eq!(bed_code(&["A"], ["0", "2"], "G", "A"), None); - assert_eq!(bed_code(&["A", "G"], ["x", "1"], "G", "A"), None); - assert_eq!(gt_alleles("0/1/1"), None); - assert_eq!(gt_alleles("./1"), None); - assert_eq!(gt_alleles("1"), None); - } - - #[test] - fn two_snvs_at_one_position_each_get_their_code() { - let d = Dir::new("bed-twice"); - let bim = read_bim(Path::new(&d.put( - "ref.bim", - "22 a 0 100 G A -22 b 0 100 T A -", - ))) - .unwrap(); - let v = "chr22\t100\t.\tA\tG,T\t.\t.\t.\tGT\t0/2\n"; - assert_eq!( - codes_at(&bim, Path::new(&d.put("g.vcf", v))).unwrap(), - [None, Some(2)] - ); - assert_eq!(bim.line(1), "22\tb\t0\t100\tT\tA\n"); - } - - #[test] - fn the_command_writes_every_input_of_admixture() { - let d = Dir::new("bed-cmd"); - let bim = d.put("ref.bim", BIM); - let vcf = d.put("g.vcf", VCF); - let p = d.put( - "continent.P", - "0.0 0.9\n0.1 0.8\n0.2 0.7\n0.3 0.6\n0.4 0.5\n", - ); - let out = d.path("adm"); - let level = format!("continent:2:{p}"); - let (rc, stdout, err) = run(&[ - "sample-bed", - "--bim", - &bim, - "--vcf", - &vcf, - "--sample", - "S", - "--level", - &level, - "--bootstrap", - "7", - "--min-sites", - "3", - "--out-dir", - &out, - ]); - assert_eq!((rc, err.as_str()), (0, "")); - assert_eq!(stdout, "3 of the 5 SNVs ADMIXTURE uses genotyped\n"); - assert_eq!( - d.read("adm/S_continent.2.P.in"), - "0.0 0.9\n0.1 0.8\n0.2 0.7\n" - ); - assert_eq!(d.read("adm/S_continent.bim").lines().count(), 3); - assert_eq!(d.read("adm/S.geno"), "2 2\n1 2\n1 1\n"); - assert_eq!( - d.read("adm/S.map"), - "22 22:100 0 100\n22 22:200 0 200\n22 22:300 0 300\n" - ); - assert_eq!(d.read("adm/levels.txt"), "continent 2\n"); - let sh = d.read("adm/run_admixture.sh"); - assert!(sh.contains("-le 7 ]") && sh.contains("S_${level}.bed") && sh.contains("nb=1 ")); - // Too few genotyped SNVs, and a .P of the wrong length: nothing new - // is written, and what was there stays. - let fresh = d.path("fresh"); - let (rc, _, err) = run(&[ - "sample-bed", - "--bim", - &bim, - "--vcf", - &vcf, - "--sample", - "S", - "--level", - &level, - "--out-dir", - &fresh, - ]); - assert_eq!(rc, 1); - assert!( - err.contains("only 3 of the 5 reference SNVs have a genotype in"), - "{err}" - ); - let short = d.put("short.P", "0.1 0.9\n"); - let (rc, _, err) = run(&[ - "sample-bed", - "--bim", - &bim, - "--vcf", - &vcf, - "--sample", - "S", - "--level", - &level, - "--level", - &format!("region:2:{short}"), - "--min-sites", - "3", - "--out-dir", - &fresh, - ]); - assert_eq!(rc, 1); - assert!( - err.ends_with(&format!("{short} has 1 rows but {bim} 5 SNVs\n")), - "{err}" - ); - assert_eq!( - std::fs::read_dir(&fresh).unwrap().count(), - 0, - "a failure leaves no partial input" - ); - let (rc, _, err) = run(&[ - "sample-bed", - "--bim", - &bim, - "--vcf", - &vcf, - "--sample", - "S", - "--level", - "continent", - "--min-sites", - "3", - "--out-dir", - &fresh, - ]); - assert_eq!( - (rc, err.as_str()), - (1, "ERROR: --level continent: not LEVEL:K:P_FILE\n") - ); - } - - #[test] - fn the_bootstrap_draws_only_blocks_that_hold_snvs() { - // 4 SNVs in 3 blocks round up to blocks of 2, so there are 2 blocks - // and every replicate holds 3 x 2 SNVs. - let awk = BOOT_SH - .split_once("-v k=\"$k\" '") - .and_then(|(_, rest)| rest.split_once("' \"@S@.geno\"")) - .map(|(prog, _)| prog) - .unwrap(); - let d = Dir::new("bed-boot"); - d.put("g", "1 0\n1 1\n1 2\n1 3\n"); - d.put("m", "22 s0 0 0\n22 s1 0 1\n22 s2 0 2\n22 s3 0 3\n"); - d.put("p", "0.0 0.5\n0.1 0.5\n0.2 0.5\n0.3 0.5\n"); - for r in 1..=20 { - let ok = std::process::Command::new("awk") - .args([ - "-v", - &format!("r={r}"), - "-v", - "nb=3", - "-v", - "k=2", - awk, - "g", - "m", - "p", - ]) - .current_dir(&d.0) - .status() - .unwrap(); - assert!(ok.success()); - assert_eq!(d.read("rep.map").lines().count(), 6, "seed {r}"); - } - } -} diff --git a/rust/og/src/main.rs b/rust/og/src/main.rs index c8fdc269a..f8e0f3a94 100644 --- a/rust/og/src/main.rs +++ b/rust/og/src/main.rs @@ -97,7 +97,7 @@ Pipeline helpers (the steps run these): og family plan|prepare|check|report|segments [args] og family ibd [args] og consumer build-sites|export|check [args] - og ancestry-fine panel-map|check-map|sample-bed|chroms|report [args] + og ancestry-fine panel-map|check-map|chroms|report [args] og ancestry-fine freqs [args] og ancestry-fine project [args] og ancestry-fine paint [args] @@ -187,7 +187,7 @@ const OWN_HELP: &[&str] = &[ "qc sex-loss", "report render", "couple screen|genes", - "ancestry-fine panel-map|check-map|freqs|sample-bed|chroms|report|simulate", + "ancestry-fine panel-map|check-map|freqs|project|chroms|report|simulate", "archaic table|strict|genotypes|report", "vntyper report", "locityper report", diff --git a/scripts/26b-ancestry-fine.sh b/scripts/26b-ancestry-fine.sh index 8e891222e..1072ed969 100755 --- a/scripts/26b-ancestry-fine.sh +++ b/scripts/26b-ancestry-fine.sh @@ -8,19 +8,20 @@ # scripts/setup.sh --ancestry-fine-panel: # 1. genotypes the panel's SNVs from the gVCF (so the sites where you match # the reference count), or from a VCF that holds reference calls; -# 2. ADMIXTURE projects you on the allele frequencies of the panel's groups -# at two levels (continental and regional groups; 5 and 17 on the -# default panel, which leaves Oceania out), and a block bootstrap of the -# SNVs gives the spread of each fraction; +# 2. og ancestry-fine project projects you on the allele frequencies of the +# panel's groups at two levels (continental and regional groups; 5 and +# 17 on the default panel, which leaves Oceania out), and a bootstrap of +# 5 cM blocks of the genome and of the reference people gives the spread +# of each fraction; # 3. Beagle phases your genotypes against the panel; # 4. RFMix paints each segment of each haplotype with the continental group # it is most similar to; # 5. og ancestry-fine report writes the fractions table, the painting # (BED and PNG) and a plain-text summary. # A group name is ours: a set of reference populations, not a nationality. -# docs/26b-ancestry-fine.md says where the resolution ends. ADMIXTURE is free -# for academic use; RFMix for academic research use only, and any other use, -# a personal one included, needs a licence from Stanford. +# docs/26b-ancestry-fine.md says where the resolution ends. RFMix is for +# academic research use only, and any other use, a personal one included, +# needs a licence from Stanford. # # Without the panel the step says so in one line and exits 0. # Env: ANCESTRY_FINE_DIR (another panel folder inside GENOME_DIR, or none to @@ -34,7 +35,7 @@ THREADS=${THREADS:-4} # shellcheck source=lib/common.sh . "$(dirname "$0")/lib/common.sh" validate_sample "$SAMPLE" -require_image BCFTOOLS_IMAGE PYTHON_IMAGE ADMIXTURE_IMAGE BEAGLE_IMAGE RFMIX_IMAGE +require_image BCFTOOLS_IMAGE PYTHON_IMAGE BEAGLE_IMAGE RFMIX_IMAGE PANEL=${ANCESTRY_FINE_DIR:-${GENOME_DIR}/reference/ancestry_fine/${ANCESTRY_FINE_PANEL}} S="${GENOME_DIR}/${SAMPLE}" @@ -56,14 +57,14 @@ case "$BOOT" in ''|*[!0-9]*) echo "ERROR: ANCESTRY_FINE_BOOTSTRAP must be a whol echo "============================================" echo " Step 26b: Fine-grained ancestry (${ANCESTRY_FINE_PANEL})" -echo " Tools: ADMIXTURE, Beagle, RFMix" +echo " Tools: og (fractions), Beagle, RFMix" echo " Sample: ${SAMPLE}" echo " Output: ${OUT}" echo "============================================" echo "" rm -rf "$WORK" "${OUT}/${SAMPLE}_ancestry_fine".* "${OUT}/${SAMPLE}_painting".* -mkdir -p "${WORK}/admixture" "${WORK}/phase" "${WORK}/paint" +mkdir -p "${WORK}/fractions" "${WORK}/phase" "${WORK}/paint" W=$(cpath "$WORK") # --- 1. The panel's SNVs in this sample --------------------------------------------- @@ -129,19 +130,16 @@ run_in --cpus 1 --memory 2g "$BCFTOOLS_IMAGE" bash -euo pipefail -c \ CHROMS=$(run_in --cpus 1 --memory 1g -v "${PGP_ROOT}/bin:/pgp-bin:ro" "$PYTHON_IMAGE" \ /pgp-bin/og ancestry-fine chroms --counts "${W}/counts.tsv" --maps "${P}/maps") -# --- 2. ADMIXTURE: projection on the groups' frequencies ---------------------------- -# sample-bed writes the inputs and run_admixture.sh, which projects the sample -# at each level and then runs the bootstrap replicates (ADMIXTURE's own -B -# crashes with -P). -echo "[2/5] ADMIXTURE projection, ${BOOT} bootstrap replicates..." -LEVELS=() -while IFS=$'\t' read -r level k _; do LEVELS+=("--level" "${level}:${k}:${P}/model/${level}.P"); done < "${PANEL}/model/levels.tsv" -run_in --cpus 1 --memory 2g -v "${PGP_ROOT}/bin:/pgp-bin:ro" "$PYTHON_IMAGE" \ - /pgp-bin/og ancestry-fine sample-bed --bim "${P}/model/ref.bim" --vcf "${W}/genotypes.vcf.gz" \ - --sample "$SAMPLE" "${LEVELS[@]}" --bootstrap "$BOOT" --out-dir "${W}/admixture" -# shellcheck disable=SC2016 # $1 and $2 belong to the inner sh -run_in --cpus "$THREADS" --memory 4g "$ADMIXTURE_IMAGE" sh -c 'cd "$1" && sh run_admixture.sh "$2"' _ "${W}/admixture" "$THREADS" \ - || { echo "ERROR: ADMIXTURE failed (log above)" >&2; exit 1; } +# --- 2. The fractions: projection on the groups' frequencies -------------------- +# og ancestry-fine project writes each level's fractions (.Q), its bootstrap +# replicates (.boot.Q) and how the fit went (.fit.tsv). A model made before og +# counted the group frequencies has no ref.geno: the bootstrap then stops +# with one line saying to run setup.sh --ancestry-fine-panel again. +echo "[2/5] Projecting on the groups' frequencies, ${BOOT} bootstrap replicates..." +run_in --cpus "$THREADS" --memory 4g -v "${PGP_ROOT}/bin:/pgp-bin:ro" "$PYTHON_IMAGE" \ + /pgp-bin/og ancestry-fine project --model "${P}/model" --maps "${P}/maps" --vcf "${W}/genotypes.vcf.gz" \ + --sample "$SAMPLE" --bootstrap "$BOOT" --seed 1 --threads "$THREADS" --out-dir "${W}/fractions" \ + || { echo "ERROR: the projection failed (message above)" >&2; exit 1; } if [ -z "$CHROMS" ]; then echo "[3/5] No chromosome has 100 genotyped SNVs spanning 5 cM: no phasing and no painting." @@ -181,7 +179,7 @@ echo "[5/5] Writing the fractions, the painting and the summary..." echo "" run_in --cpus 1 --memory 2g -v "${PGP_ROOT}/bin:/pgp-bin:ro" "$PYTHON_IMAGE" \ /pgp-bin/og ancestry-fine report --sample "$SAMPLE" --model "${P}/model" \ - --admixture "${W}/admixture" --paint "${W}/paint" --panel "$ANCESTRY_FINE_PANEL" --out "$(cpath "$OUT")" + --fractions "${W}/fractions" --paint "${W}/paint" --panel "$ANCESTRY_FINE_PANEL" --out "$(cpath "$OUT")" for f in "${OUT}/${SAMPLE}_ancestry_fine.tsv" "${OUT}/${SAMPLE}_painting.png"; do [ -s "$f" ] || { echo "ERROR: step 26b wrote no ${f}" >&2; exit 1; } done @@ -189,5 +187,5 @@ echo "" echo " Input: the ${INPUT_KIND}" echo " Fractions: ${OUT}/${SAMPLE}_ancestry_fine.tsv" echo " Painting: ${OUT}/${SAMPLE}_painting.bed and ${SAMPLE}_painting.png" -echo " Intermediate files (genotypes, phased haplotypes, ADMIXTURE and RFMix output): ${WORK}" +echo " Intermediate files (genotypes, fractions and their fit, phased haplotypes, RFMix output): ${WORK}" echo " See docs/26b-ancestry-fine.md for what the names mean and where the resolution ends." diff --git a/scripts/ci/gen-containers-config.sh b/scripts/ci/gen-containers-config.sh index 3f16adb22..21c946a61 100755 --- a/scripts/ci/gen-containers-config.sh +++ b/scripts/ci/gen-containers-config.sh @@ -31,11 +31,10 @@ export LC_ALL=C # one sort order for the table, the file and comm # holds its image. A new process needs a row here. TABLE=' ALIGN_MINIMAP2 MINIMAP2_SAMTOOLS_IMAGE -ANCESTRY_FINE_ADMIXTURE ADMIXTURE_IMAGE +ANCESTRY_FINE_FRACTIONS PYTHON_IMAGE ANCESTRY_FINE_GENOTYPE BCFTOOLS_IMAGE ANCESTRY_FINE_PAINT RFMIX_IMAGE ANCESTRY_FINE_PHASE BEAGLE_IMAGE -ANCESTRY_FINE_PREPARE PYTHON_IMAGE ANCESTRY_FINE_REPORT PYTHON_IMAGE ANCIENT_GENO PYTHON_IMAGE ANCIENT_PCA EIGENSOFT_IMAGE diff --git a/tests/e2e/ancestry-fine-grained-1.sh b/tests/e2e/ancestry-fine-grained-1.sh index 2aa95a2a6..2bc851fc0 100755 --- a/tests/e2e/ancestry-fine-grained-1.sh +++ b/tests/e2e/ancestry-fine-grained-1.sh @@ -3,7 +3,7 @@ # bucket by setup.sh --ancestry-fine-panel for the fixture's slices plus # chr22:20-35 Mb (the slices are too short to paint: RFMix needs 5 cM): # - without the panel, step 26b says so in one line and exits 0; -# - the panel installs: both ADMIXTURE levels, painting references, and +# - the panel installs: both levels of the model, painting references, and # neither person of the synthetic mix in it. Oceania, which has one # unrelated person in the panel's metadata, is left out of the model at # both levels (5 continental and 17 regional groups), and the install log @@ -78,11 +78,11 @@ check "Oceania has no reference person and no painting reference" \ awk -F'\t' '$3 == "OCE" && ($5 == 1 || $6 == 1) {bad = 1} END {exit bad}' "${PANEL}/samples.tsv" check "the install log names Oceania as left out" \ has 'Left out of the model, fewer than 10 unrelated reference people: Oceania \(continental and regional group\)' "$(cat "$STEP_LOG")" -check_ge "SNVs for ADMIXTURE" "$(wc -l < "${PANEL}/model/ref.bim" 2>/dev/null | tr -d ' ')" 500 +check_ge "SNVs of the model" "$(wc -l < "${PANEL}/model/ref.bim" 2>/dev/null | tr -d ' ')" 500 check_ge "painting references" "$(wc -l < "${PANEL}/model/paint_map.tsv" 2>/dev/null | tr -d ' ')" 150 check "the two people of the mix are not in the panel" \ awk -F'\t' -v a="$A" -v b="$B" '$1 == a || $1 == b {bad = 1} END {exit bad}' "${PANEL}/samples.tsv" -printf '#### Step 26b reduced panel (fixture slices plus %s:%s-%s)\n\n%s s to install, %s on disk, %s SNVs, %s for ADMIXTURE\n\n' \ +printf '#### Step 26b reduced panel (fixture slices plus %s:%s-%s)\n\n%s s to install, %s on disk, %s SNVs, %s in the model\n\n' \ "$LONG_CHR" "$LONG_START" "$LONG_END" "$T_SETUP" "$(du -sh "$PANEL" | cut -f1)" \ "$(wc -l < "${PANEL}/panel/sites.tsv" | tr -d ' ')" "$(wc -l < "${PANEL}/model/ref.bim" | tr -d ' ')" >> "$E2E_NOTES" @@ -95,7 +95,7 @@ cat "${G}/${SAMPLE}/ancestry_fine/${SAMPLE}_ancestry_fine.tsv" 2>/dev/null check "it read the gVCF" has 'Input: the gvcf' "$(cat "$STEP_LOG")" SUM=$(awk -F'\t' '$1 == "continent" {s += $4} END {printf "%.3f", s}' "${G}/${SAMPLE}/ancestry_fine/${SAMPLE}_ancestry_fine.tsv" 2>/dev/null) check "the continental fractions sum to 1 (${SUM})" between "$SUM" 0.99 1.01 -# Only about a quarter of the panel's SNVs for ADMIXTURE fall in the fixture's +# Only about a quarter of the model's SNVs fall in the fixture's # slices and are called in the gVCF, too few to name a group: this run checks # the shape of the output, and HG002T below checks where the genome lands. check_ge "SNVs of the panel genotyped from the gVCF" \ @@ -135,6 +135,13 @@ check "HG002T: the report says Oceania was left out of the model" \ has '^Left out of the model: Oceania \(continental and regional group\)' "$(cat "${G}/HG002T/ancestry_fine/HG002T_ancestry_fine.txt" 2>/dev/null)" check "HG002T: and the table has its left_out rows" \ awk -F'\t' '$1 == "left_out" && $2 == "OCE" {n++} END {exit n != 2}' "${G}/HG002T/ancestry_fine/HG002T_ancestry_fine.tsv" +# og ancestry-fine project wrote each level's fit, after a bootstrap that drew +# the reference people again. +for l in continent region; do + check "HG002T: the ${l} fit drew 100 replicates with the reference people drawn again" \ + awk -F'\t' '$1 == "replicates" {r = $2} $1 == "reference_resampling" {s = $2} END {exit !(r == 100 && s == "yes")}' \ + "${G}/HG002T/ancestry_fine/work/fractions/HG002T_${l}.fit.tsv" +done T_LOG="${G}/HG002T/ancestry_fine/work/paint/${LONG_CHR}.log" check "HG002T: RFMix painted ${LONG_CHR} with no failure" test ! -e "${G}/HG002T/ancestry_fine/work/paint/failed.txt" check "HG002T: RFMix's log of ${LONG_CHR} is there" test -s "$T_LOG" diff --git a/tests/parity/cases.tsv b/tests/parity/cases.tsv index fdc0742b8..bb335b3cf 100644 --- a/tests/parity/cases.tsv +++ b/tests/parity/cases.tsv @@ -280,11 +280,6 @@ ancestry-fine check-map-problems ancestry-fine/cm-problems/samples.tsv check-map ancestry-fine check-map-short-row ancestry-fine/cm-short/samples.tsv check-map --map samples.tsv - bytes;*.png=png-pixels PYTHON_IMAGE ancestry-fine check-map-flag ancestry-fine/cm-flag/samples.tsv check-map --map samples.tsv - bytes;*.png=png-pixels PYTHON_IMAGE ancestry-fine check-map-no-reference ancestry-fine/cm-empty/samples.tsv check-map --map samples.tsv - bytes;*.png=png-pixels PYTHON_IMAGE -ancestry-fine sample-bed ancestry-fine/sb/continent.P,ancestry-fine/sb/g.vcf,ancestry-fine/sb/ref.bim,ancestry-fine/sb/region.P sample-bed --bim ref.bim --vcf g.vcf --sample S --level continent:3:continent.P --level region:2:region.P --bootstrap 7 --min-sites 10 --out-dir adm adm/S_continent.bed,adm/S_continent.bim,adm/S_continent.fam,adm/S_continent.3.P.in,adm/S_region.bed,adm/S_region.2.P.in,adm/S.geno,adm/S.map,adm/levels.txt,adm/S_sites.txt,adm/run_admixture.sh bytes;*.png=png-pixels PYTHON_IMAGE -ancestry-fine sample-bed-gz ancestry-fine/sb-gz/continent.P,ancestry-fine/sb-gz/g.vcf.gz,ancestry-fine/sb-gz/ref.bim sample-bed --bim ref.bim --vcf g.vcf.gz --sample HG002 --level continent:3:continent.P --min-sites 10 --out-dir . HG002_continent.bed,HG002.geno,run_admixture.sh bytes;*.png=png-pixels PYTHON_IMAGE -ancestry-fine sample-bed-min-sites ancestry-fine/sb-min-sites/continent.P,ancestry-fine/sb-min-sites/g.vcf,ancestry-fine/sb-min-sites/ref.bim sample-bed --bim ref.bim --vcf g.vcf --sample S --level continent:3:continent.P --out-dir adm - bytes;*.png=png-pixels PYTHON_IMAGE -ancestry-fine sample-bed-p-rows ancestry-fine/sb-p-rows/continent.P,ancestry-fine/sb-p-rows/g.vcf,ancestry-fine/sb-p-rows/ref.bim,ancestry-fine/sb-p-rows/region.P sample-bed --bim ref.bim --vcf g.vcf --sample S --level continent:3:continent.P --level region:2:region.P --min-sites 10 --out-dir adm - bytes;*.png=png-pixels PYTHON_IMAGE -ancestry-fine sample-bed-p-missing ancestry-fine/sb-p-missing/g.vcf,ancestry-fine/sb-p-missing/ref.bim sample-bed --bim ref.bim --vcf g.vcf --sample S --level continent:3:continent.P --min-sites 10 --out-dir adm - bytes;*.png=png-pixels PYTHON_IMAGE ancestry-fine chroms ancestry-fine/chroms/chr19.map,ancestry-fine/chroms/chr2.map,ancestry-fine/chroms/chr20.map,ancestry-fine/chroms/chr22.map,ancestry-fine/chroms/counts.tsv chroms --counts counts.tsv --maps . - bytes;*.png=png-pixels PYTHON_IMAGE ancestry-fine chroms-thresholds ancestry-fine/chroms/chr19.map,ancestry-fine/chroms/chr2.map,ancestry-fine/chroms/chr20.map,ancestry-fine/chroms/chr22.map,ancestry-fine/chroms/counts.tsv chroms --counts counts.tsv --maps . --min-sites 50 --min-cm 1.5 - bytes;*.png=png-pixels PYTHON_IMAGE ancestry-fine report ancestry-fine/rep/S_continent.3.Q,ancestry-fine/rep/S_continent.boot.Q,ancestry-fine/rep/S_region.4.Q,ancestry-fine/rep/S_region.boot.Q,ancestry-fine/rep/S_sites.txt,ancestry-fine/rep/chr2.msp.tsv,ancestry-fine/rep/chr20.msp.tsv,ancestry-fine/rep/chrX.msp.tsv,ancestry-fine/rep/failed.txt,ancestry-fine/rep/levels.tsv,ancestry-fine/rep/samples.tsv report --sample S --model . --admixture . --paint . --panel test --out out out/S_ancestry_fine.tsv,out/S_painting.bed,out/S_painting.png,out/S_ancestry_fine.txt bytes;*.png=png-pixels PYTHON_IMAGE diff --git a/tests/parity/golden/ancestry-fine/sample-bed-gz/run_admixture.sh b/tests/parity/golden/ancestry-fine/sample-bed-gz/run_admixture.sh deleted file mode 100644 index 8e3d43d95..000000000 --- a/tests/parity/golden/ancestry-fine/sample-bed-gz/run_admixture.sh +++ /dev/null @@ -1,29 +0,0 @@ -#!/bin/sh -# Written by og ancestry-fine sample-bed. Usage: sh run_admixture.sh THREADS -set -eu -t=${1:-1} -while read -r level k; do - admixture -P -j"$t" "HG002_${level}.bed" "$k" > "HG002_${level}.log" 2>&1 \ - || { tail -n 20 "HG002_${level}.log"; exit 1; } - : > "HG002_${level}.boot.Q" - r=1 - while [ "$r" -le 100 ]; do - awk -v r="$r" -v nb=6 -v k="$k" ' - FNR == 1 { f++ } - f == 1 { g[n++] = $0; next } - f == 2 { m[n2++] = $0; next } - f == 3 { p[n3++] = $0; next } - END { - srand(r); bs = int((n + nb - 1) / nb); nblk = int((n + bs - 1) / bs); printf "S S 0 0 0 -9" > "rep.ped" - for (b = 0; b < nb; b++) { - s = int(rand() * nblk) * bs - for (i = s; i < s + bs && i < n; i++) { printf " %s", g[i] > "rep.ped"; print m[i] > "rep.map"; print p[i] > ("rep." k ".P.in") } - } - printf "\n" > "rep.ped" - }' "HG002.geno" "HG002.map" "HG002_${level}.${k}.P.in" - admixture -P "rep.ped" "$k" > rep.log 2>&1 || { tail -n 20 rep.log; exit 1; } - cat "rep.${k}.Q" >> "HG002_${level}.boot.Q" - rm -f rep.ped rep.map "rep.${k}.P.in" "rep.${k}.P" "rep.${k}.Q" - r=$((r + 1)) - done -done < levels.txt diff --git a/tests/parity/golden/ancestry-fine/sample-bed-p-missing/stderr b/tests/parity/golden/ancestry-fine/sample-bed-p-missing/stderr deleted file mode 100644 index 009862970..000000000 --- a/tests/parity/golden/ancestry-fine/sample-bed-p-missing/stderr +++ /dev/null @@ -1 +0,0 @@ -ERROR: cannot read continent.P: No such file or directory diff --git a/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.3.P.in.absent b/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.3.P.in.absent deleted file mode 100644 index e69de29bb..000000000 diff --git a/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.bed.absent b/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.bed.absent deleted file mode 100644 index e69de29bb..000000000 diff --git a/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.bim.absent b/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.bim.absent deleted file mode 100644 index e69de29bb..000000000 diff --git a/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.fam.absent b/tests/parity/golden/ancestry-fine/sample-bed-p-rows/adm/S_continent.fam.absent deleted file mode 100644 index e69de29bb..000000000 diff --git a/tests/parity/golden/ancestry-fine/sample-bed/adm/run_admixture.sh b/tests/parity/golden/ancestry-fine/sample-bed/adm/run_admixture.sh deleted file mode 100644 index a3672fcb7..000000000 --- a/tests/parity/golden/ancestry-fine/sample-bed/adm/run_admixture.sh +++ /dev/null @@ -1,29 +0,0 @@ -#!/bin/sh -# Written by og ancestry-fine sample-bed. Usage: sh run_admixture.sh THREADS -set -eu -t=${1:-1} -while read -r level k; do - admixture -P -j"$t" "S_${level}.bed" "$k" > "S_${level}.log" 2>&1 \ - || { tail -n 20 "S_${level}.log"; exit 1; } - : > "S_${level}.boot.Q" - r=1 - while [ "$r" -le 7 ]; do - awk -v r="$r" -v nb=6 -v k="$k" ' - FNR == 1 { f++ } - f == 1 { g[n++] = $0; next } - f == 2 { m[n2++] = $0; next } - f == 3 { p[n3++] = $0; next } - END { - srand(r); bs = int((n + nb - 1) / nb); nblk = int((n + bs - 1) / bs); printf "S S 0 0 0 -9" > "rep.ped" - for (b = 0; b < nb; b++) { - s = int(rand() * nblk) * bs - for (i = s; i < s + bs && i < n; i++) { printf " %s", g[i] > "rep.ped"; print m[i] > "rep.map"; print p[i] > ("rep." k ".P.in") } - } - printf "\n" > "rep.ped" - }' "S.geno" "S.map" "S_${level}.${k}.P.in" - admixture -P "rep.ped" "$k" > rep.log 2>&1 || { tail -n 20 rep.log; exit 1; } - cat "rep.${k}.Q" >> "S_${level}.boot.Q" - rm -f rep.ped rep.map "rep.${k}.P.in" "rep.${k}.P" "rep.${k}.Q" - r=$((r + 1)) - done -done < levels.txt diff --git a/tests/parity/inputs/ancestry-fine/sb-gz/continent.P b/tests/parity/inputs/ancestry-fine/sb-gz/continent.P deleted file mode 100644 index 304db1995..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-gz/continent.P +++ /dev/null @@ -1,40 +0,0 @@ -0.000 0.5 0.99 -0.010 0.5 0.98 -0.020 0.5 0.97 -0.030 0.5 0.96 -0.040 0.5 0.95 -0.050 0.5 0.94 -0.060 0.5 0.93 -0.070 0.5 0.92 -0.080 0.5 0.91 -0.090 0.5 0.90 -0.100 0.5 0.89 -0.110 0.5 0.88 -0.120 0.5 0.87 -0.130 0.5 0.86 -0.140 0.5 0.85 -0.150 0.5 0.84 -0.160 0.5 0.83 -0.170 0.5 0.82 -0.180 0.5 0.81 -0.190 0.5 0.80 -0.200 0.5 0.79 -0.210 0.5 0.78 -0.220 0.5 0.77 -0.230 0.5 0.76 -0.240 0.5 0.75 -0.250 0.5 0.74 -0.260 0.5 0.73 -0.270 0.5 0.72 -0.280 0.5 0.71 -0.290 0.5 0.70 -0.300 0.5 0.69 -0.310 0.5 0.68 -0.320 0.5 0.67 -0.330 0.5 0.66 -0.340 0.5 0.65 -0.350 0.5 0.64 -0.360 0.5 0.63 -0.370 0.5 0.62 -0.380 0.5 0.61 -0.390 0.5 0.60 diff --git a/tests/parity/inputs/ancestry-fine/sb-gz/g.vcf.gz b/tests/parity/inputs/ancestry-fine/sb-gz/g.vcf.gz deleted file mode 100644 index b2dab157debb0690bacc799eabd4b29dfd58e4e8..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 320 zcmV-G0l)qqiwFP!00002|9z7|YlAQpfX}ag!|TxGMjX@bZ z^~cYNNu-8{;N>&#OTuRmTs}VEF5lO$m!I7^FMlb-RggdS?E$*>1a$%ZzJ#pN@bsKD zP}Ys!_fQ|p7Rt6iWExJZ*Y_(TNFfA-kU>7Y|DQ^OjHID*q&ZZMikqc4(hBs9M#4}v zQa#LelW&&N(mPulFTG(D8oKs*?XD7!*U=5@O+DweYf&t{ZZgWH*WDE&=S4Mn^~21J z5gJb1O=G+?yW7IG&usUVOy;APZdh;XIk8=<*s>Jcjxz0p(^GWY;e&KL`-BZhu>mPI zAax&5(Lrh$n~(D3W2O=t5BcJ;bA6Ow>&{ASc%(c#wm&Jc*%6x^vDs1L@jA+8M@)7S SVw2t7FZ>5Sux-*b1pokrZl3-C diff --git a/tests/parity/inputs/ancestry-fine/sb-gz/ref.bim b/tests/parity/inputs/ancestry-fine/sb-gz/ref.bim deleted file mode 100644 index e0a640116..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-gz/ref.bim +++ /dev/null @@ -1,40 +0,0 @@ -22 22:1000 0.00 1000 C A -22 22:1100 0.01 1100 G C -22 22:1200 0.02 1200 T G -22 22:1300 0.03 1300 A T -22 22:1400 0.04 1400 C A -22 22:1500 0.05 1500 G C -22 22:1600 0.06 1600 T G -22 22:1700 0.07 1700 A T -22 22:1800 0.08 1800 C A -22 22:1900 0.09 1900 G C -22 22:2000 0.10 2000 T G -22 22:2100 0.11 2100 A T -22 22:2200 0.12 2200 C A -22 22:2300 0.13 2300 G C -22 22:2400 0.14 2400 T G -22 22:2500 0.15 2500 A T -22 22:2600 0.16 2600 C A -22 22:2700 0.17 2700 G C -22 22:2800 0.18 2800 T G -22 22:2900 0.19 2900 A T -22 22:3000 0.20 3000 C A -22 22:3100 0.21 3100 G C -22 22:3200 0.22 3200 T G -22 22:3300 0.23 3300 A T -22 22:3400 0.24 3400 C A -22 22:3500 0.25 3500 G C -22 22:3600 0.26 3600 T G -22 22:3700 0.27 3700 A T -22 22:3800 0.28 3800 C A -22 22:3900 0.29 3900 G C -22 22:4000 0.30 4000 T G -22 22:4100 0.31 4100 A T -22 22:4200 0.32 4200 C A -22 22:4300 0.33 4300 G C -22 22:4400 0.34 4400 T G -22 22:4500 0.35 4500 A T -22 22:4600 0.36 4600 C A -22 22:4700 0.37 4700 G C -22 22:4800 0.38 4800 T G -22 22:4900 0.39 4900 A T diff --git a/tests/parity/inputs/ancestry-fine/sb-min-sites/continent.P b/tests/parity/inputs/ancestry-fine/sb-min-sites/continent.P deleted file mode 100644 index 304db1995..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-min-sites/continent.P +++ /dev/null @@ -1,40 +0,0 @@ -0.000 0.5 0.99 -0.010 0.5 0.98 -0.020 0.5 0.97 -0.030 0.5 0.96 -0.040 0.5 0.95 -0.050 0.5 0.94 -0.060 0.5 0.93 -0.070 0.5 0.92 -0.080 0.5 0.91 -0.090 0.5 0.90 -0.100 0.5 0.89 -0.110 0.5 0.88 -0.120 0.5 0.87 -0.130 0.5 0.86 -0.140 0.5 0.85 -0.150 0.5 0.84 -0.160 0.5 0.83 -0.170 0.5 0.82 -0.180 0.5 0.81 -0.190 0.5 0.80 -0.200 0.5 0.79 -0.210 0.5 0.78 -0.220 0.5 0.77 -0.230 0.5 0.76 -0.240 0.5 0.75 -0.250 0.5 0.74 -0.260 0.5 0.73 -0.270 0.5 0.72 -0.280 0.5 0.71 -0.290 0.5 0.70 -0.300 0.5 0.69 -0.310 0.5 0.68 -0.320 0.5 0.67 -0.330 0.5 0.66 -0.340 0.5 0.65 -0.350 0.5 0.64 -0.360 0.5 0.63 -0.370 0.5 0.62 -0.380 0.5 0.61 -0.390 0.5 0.60 diff --git a/tests/parity/inputs/ancestry-fine/sb-min-sites/g.vcf b/tests/parity/inputs/ancestry-fine/sb-min-sites/g.vcf deleted file mode 100644 index 419ce3d10..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-min-sites/g.vcf +++ /dev/null @@ -1,44 +0,0 @@ -##fileformat=VCFv4.2 -#CHROM POS ID REF ALT QUAL FILTER INFO FORMAT S -chr22 1000 . A C . . . GT 1/1 -chr22 1100 . C G . . . GT 0|1 -chr22 1200 . G T . . . GT 0/0 -chr22 1300 . T A . . . GT 1|0 -chr22 1400 . A C . . . GT 0/0 -chr22 1500 . C G . . . GT ./. -chr22 1600 . G T . . . GT 0/1 -chr22 1700 . T A . . . GT 1/1 -chr22 1800 . A C . . . GT 0/0 -chr22 1900 . C G . . . GT 0/1 -chr22 2000 . G T . . . GT 1/1 -chr22 2100 . T A . . . GT 0|1 -chr22 2200 . A C . . . GT 0/0 -chr22 2300 . C T,G . . . GT 2/2 -chr22 2400 . G T . . . GT 0/0 -chr22 2500 . T A . . . GT ./. -chr22 2600 . A C . . . GT 0/1 -chr22 2700 . C N . . . GT 0/1 -chr22 2800 . G T . . . GT 0/0 -chr22 2900 . T A . . . GT 0/1 -chr22 3000 . A C . . . GT 1/1 -chr22 3200 . G T . . . GT 0/0 -chr22 3300 . T . . . . DP:GT 9:0/0 -chr22 3400 . A C . . . GT 0/0 -chr22 3500 . C G . . . GT ./. -chr22 3600 . G T . . . GT 0/1 -chr22 3700 . T A . . . DP 9 -chr22 3800 . A C . . . GT 0/0 -chr22 3900 . C G . . . GT 1 -chr22 4000 . G T . . . GT 1/1 -chr22 4100 . T A . . . GT 0/0 -chr22 4100 . T A . . . GT 1/1 -chr22 4100 . T A . . . GT ./. -chr22 4200 . A C . . . GT 0/0 -chr22 4300 . C G . . . GT 1|0 -chr22 4400 . G T . . . GT 0/0 -chr22 4500 . T A . . . GT ./. -chr22 4600 . A C . . . GT 0/1 -chr22 4700 . C G . . . GT 1/1 -chr22 4800 . G T . . . GT 0/0 -chr22 4900 . T A . . . GT 0/1 -chr21 5000 . A G . . . GT 0/1 diff --git a/tests/parity/inputs/ancestry-fine/sb-min-sites/ref.bim b/tests/parity/inputs/ancestry-fine/sb-min-sites/ref.bim deleted file mode 100644 index e0a640116..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-min-sites/ref.bim +++ /dev/null @@ -1,40 +0,0 @@ -22 22:1000 0.00 1000 C A -22 22:1100 0.01 1100 G C -22 22:1200 0.02 1200 T G -22 22:1300 0.03 1300 A T -22 22:1400 0.04 1400 C A -22 22:1500 0.05 1500 G C -22 22:1600 0.06 1600 T G -22 22:1700 0.07 1700 A T -22 22:1800 0.08 1800 C A -22 22:1900 0.09 1900 G C -22 22:2000 0.10 2000 T G -22 22:2100 0.11 2100 A T -22 22:2200 0.12 2200 C A -22 22:2300 0.13 2300 G C -22 22:2400 0.14 2400 T G -22 22:2500 0.15 2500 A T -22 22:2600 0.16 2600 C A -22 22:2700 0.17 2700 G C -22 22:2800 0.18 2800 T G -22 22:2900 0.19 2900 A T -22 22:3000 0.20 3000 C A -22 22:3100 0.21 3100 G C -22 22:3200 0.22 3200 T G -22 22:3300 0.23 3300 A T -22 22:3400 0.24 3400 C A -22 22:3500 0.25 3500 G C -22 22:3600 0.26 3600 T G -22 22:3700 0.27 3700 A T -22 22:3800 0.28 3800 C A -22 22:3900 0.29 3900 G C -22 22:4000 0.30 4000 T G -22 22:4100 0.31 4100 A T -22 22:4200 0.32 4200 C A -22 22:4300 0.33 4300 G C -22 22:4400 0.34 4400 T G -22 22:4500 0.35 4500 A T -22 22:4600 0.36 4600 C A -22 22:4700 0.37 4700 G C -22 22:4800 0.38 4800 T G -22 22:4900 0.39 4900 A T diff --git a/tests/parity/inputs/ancestry-fine/sb-p-missing/g.vcf b/tests/parity/inputs/ancestry-fine/sb-p-missing/g.vcf deleted file mode 100644 index 419ce3d10..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-p-missing/g.vcf +++ /dev/null @@ -1,44 +0,0 @@ -##fileformat=VCFv4.2 -#CHROM POS ID REF ALT QUAL FILTER INFO FORMAT S -chr22 1000 . A C . . . GT 1/1 -chr22 1100 . C G . . . GT 0|1 -chr22 1200 . G T . . . GT 0/0 -chr22 1300 . T A . . . GT 1|0 -chr22 1400 . A C . . . GT 0/0 -chr22 1500 . C G . . . GT ./. -chr22 1600 . G T . . . GT 0/1 -chr22 1700 . T A . . . GT 1/1 -chr22 1800 . A C . . . GT 0/0 -chr22 1900 . C G . . . GT 0/1 -chr22 2000 . G T . . . GT 1/1 -chr22 2100 . T A . . . GT 0|1 -chr22 2200 . A C . . . GT 0/0 -chr22 2300 . C T,G . . . GT 2/2 -chr22 2400 . G T . . . GT 0/0 -chr22 2500 . T A . . . GT ./. -chr22 2600 . A C . . . GT 0/1 -chr22 2700 . C N . . . GT 0/1 -chr22 2800 . G T . . . GT 0/0 -chr22 2900 . T A . . . GT 0/1 -chr22 3000 . A C . . . GT 1/1 -chr22 3200 . G T . . . GT 0/0 -chr22 3300 . T . . . . DP:GT 9:0/0 -chr22 3400 . A C . . . GT 0/0 -chr22 3500 . C G . . . GT ./. -chr22 3600 . G T . . . GT 0/1 -chr22 3700 . T A . . . DP 9 -chr22 3800 . A C . . . GT 0/0 -chr22 3900 . C G . . . GT 1 -chr22 4000 . G T . . . GT 1/1 -chr22 4100 . T A . . . GT 0/0 -chr22 4100 . T A . . . GT 1/1 -chr22 4100 . T A . . . GT ./. -chr22 4200 . A C . . . GT 0/0 -chr22 4300 . C G . . . GT 1|0 -chr22 4400 . G T . . . GT 0/0 -chr22 4500 . T A . . . GT ./. -chr22 4600 . A C . . . GT 0/1 -chr22 4700 . C G . . . GT 1/1 -chr22 4800 . G T . . . GT 0/0 -chr22 4900 . T A . . . GT 0/1 -chr21 5000 . A G . . . GT 0/1 diff --git a/tests/parity/inputs/ancestry-fine/sb-p-missing/ref.bim b/tests/parity/inputs/ancestry-fine/sb-p-missing/ref.bim deleted file mode 100644 index e0a640116..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-p-missing/ref.bim +++ /dev/null @@ -1,40 +0,0 @@ -22 22:1000 0.00 1000 C A -22 22:1100 0.01 1100 G C -22 22:1200 0.02 1200 T G -22 22:1300 0.03 1300 A T -22 22:1400 0.04 1400 C A -22 22:1500 0.05 1500 G C -22 22:1600 0.06 1600 T G -22 22:1700 0.07 1700 A T -22 22:1800 0.08 1800 C A -22 22:1900 0.09 1900 G C -22 22:2000 0.10 2000 T G -22 22:2100 0.11 2100 A T -22 22:2200 0.12 2200 C A -22 22:2300 0.13 2300 G C -22 22:2400 0.14 2400 T G -22 22:2500 0.15 2500 A T -22 22:2600 0.16 2600 C A -22 22:2700 0.17 2700 G C -22 22:2800 0.18 2800 T G -22 22:2900 0.19 2900 A T -22 22:3000 0.20 3000 C A -22 22:3100 0.21 3100 G C -22 22:3200 0.22 3200 T G -22 22:3300 0.23 3300 A T -22 22:3400 0.24 3400 C A -22 22:3500 0.25 3500 G C -22 22:3600 0.26 3600 T G -22 22:3700 0.27 3700 A T -22 22:3800 0.28 3800 C A -22 22:3900 0.29 3900 G C -22 22:4000 0.30 4000 T G -22 22:4100 0.31 4100 A T -22 22:4200 0.32 4200 C A -22 22:4300 0.33 4300 G C -22 22:4400 0.34 4400 T G -22 22:4500 0.35 4500 A T -22 22:4600 0.36 4600 C A -22 22:4700 0.37 4700 G C -22 22:4800 0.38 4800 T G -22 22:4900 0.39 4900 A T diff --git a/tests/parity/inputs/ancestry-fine/sb-p-rows/continent.P b/tests/parity/inputs/ancestry-fine/sb-p-rows/continent.P deleted file mode 100644 index 304db1995..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-p-rows/continent.P +++ /dev/null @@ -1,40 +0,0 @@ -0.000 0.5 0.99 -0.010 0.5 0.98 -0.020 0.5 0.97 -0.030 0.5 0.96 -0.040 0.5 0.95 -0.050 0.5 0.94 -0.060 0.5 0.93 -0.070 0.5 0.92 -0.080 0.5 0.91 -0.090 0.5 0.90 -0.100 0.5 0.89 -0.110 0.5 0.88 -0.120 0.5 0.87 -0.130 0.5 0.86 -0.140 0.5 0.85 -0.150 0.5 0.84 -0.160 0.5 0.83 -0.170 0.5 0.82 -0.180 0.5 0.81 -0.190 0.5 0.80 -0.200 0.5 0.79 -0.210 0.5 0.78 -0.220 0.5 0.77 -0.230 0.5 0.76 -0.240 0.5 0.75 -0.250 0.5 0.74 -0.260 0.5 0.73 -0.270 0.5 0.72 -0.280 0.5 0.71 -0.290 0.5 0.70 -0.300 0.5 0.69 -0.310 0.5 0.68 -0.320 0.5 0.67 -0.330 0.5 0.66 -0.340 0.5 0.65 -0.350 0.5 0.64 -0.360 0.5 0.63 -0.370 0.5 0.62 -0.380 0.5 0.61 -0.390 0.5 0.60 diff --git a/tests/parity/inputs/ancestry-fine/sb-p-rows/g.vcf b/tests/parity/inputs/ancestry-fine/sb-p-rows/g.vcf deleted file mode 100644 index 419ce3d10..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-p-rows/g.vcf +++ /dev/null @@ -1,44 +0,0 @@ -##fileformat=VCFv4.2 -#CHROM POS ID REF ALT QUAL FILTER INFO FORMAT S -chr22 1000 . A C . . . GT 1/1 -chr22 1100 . C G . . . GT 0|1 -chr22 1200 . G T . . . GT 0/0 -chr22 1300 . T A . . . GT 1|0 -chr22 1400 . A C . . . GT 0/0 -chr22 1500 . C G . . . GT ./. -chr22 1600 . G T . . . GT 0/1 -chr22 1700 . T A . . . GT 1/1 -chr22 1800 . A C . . . GT 0/0 -chr22 1900 . C G . . . GT 0/1 -chr22 2000 . G T . . . GT 1/1 -chr22 2100 . T A . . . GT 0|1 -chr22 2200 . A C . . . GT 0/0 -chr22 2300 . C T,G . . . GT 2/2 -chr22 2400 . G T . . . GT 0/0 -chr22 2500 . T A . . . GT ./. -chr22 2600 . A C . . . GT 0/1 -chr22 2700 . C N . . . GT 0/1 -chr22 2800 . G T . . . GT 0/0 -chr22 2900 . T A . . . GT 0/1 -chr22 3000 . A C . . . GT 1/1 -chr22 3200 . G T . . . GT 0/0 -chr22 3300 . T . . . . DP:GT 9:0/0 -chr22 3400 . A C . . . GT 0/0 -chr22 3500 . C G . . . GT ./. -chr22 3600 . G T . . . GT 0/1 -chr22 3700 . T A . . . DP 9 -chr22 3800 . A C . . . GT 0/0 -chr22 3900 . C G . . . GT 1 -chr22 4000 . G T . . . GT 1/1 -chr22 4100 . T A . . . GT 0/0 -chr22 4100 . T A . . . GT 1/1 -chr22 4100 . T A . . . GT ./. -chr22 4200 . A C . . . GT 0/0 -chr22 4300 . C G . . . GT 1|0 -chr22 4400 . G T . . . GT 0/0 -chr22 4500 . T A . . . GT ./. -chr22 4600 . A C . . . GT 0/1 -chr22 4700 . C G . . . GT 1/1 -chr22 4800 . G T . . . GT 0/0 -chr22 4900 . T A . . . GT 0/1 -chr21 5000 . A G . . . GT 0/1 diff --git a/tests/parity/inputs/ancestry-fine/sb-p-rows/ref.bim b/tests/parity/inputs/ancestry-fine/sb-p-rows/ref.bim deleted file mode 100644 index e0a640116..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-p-rows/ref.bim +++ /dev/null @@ -1,40 +0,0 @@ -22 22:1000 0.00 1000 C A -22 22:1100 0.01 1100 G C -22 22:1200 0.02 1200 T G -22 22:1300 0.03 1300 A T -22 22:1400 0.04 1400 C A -22 22:1500 0.05 1500 G C -22 22:1600 0.06 1600 T G -22 22:1700 0.07 1700 A T -22 22:1800 0.08 1800 C A -22 22:1900 0.09 1900 G C -22 22:2000 0.10 2000 T G -22 22:2100 0.11 2100 A T -22 22:2200 0.12 2200 C A -22 22:2300 0.13 2300 G C -22 22:2400 0.14 2400 T G -22 22:2500 0.15 2500 A T -22 22:2600 0.16 2600 C A -22 22:2700 0.17 2700 G C -22 22:2800 0.18 2800 T G -22 22:2900 0.19 2900 A T -22 22:3000 0.20 3000 C A -22 22:3100 0.21 3100 G C -22 22:3200 0.22 3200 T G -22 22:3300 0.23 3300 A T -22 22:3400 0.24 3400 C A -22 22:3500 0.25 3500 G C -22 22:3600 0.26 3600 T G -22 22:3700 0.27 3700 A T -22 22:3800 0.28 3800 C A -22 22:3900 0.29 3900 G C -22 22:4000 0.30 4000 T G -22 22:4100 0.31 4100 A T -22 22:4200 0.32 4200 C A -22 22:4300 0.33 4300 G C -22 22:4400 0.34 4400 T G -22 22:4500 0.35 4500 A T -22 22:4600 0.36 4600 C A -22 22:4700 0.37 4700 G C -22 22:4800 0.38 4800 T G -22 22:4900 0.39 4900 A T diff --git a/tests/parity/inputs/ancestry-fine/sb-p-rows/region.P b/tests/parity/inputs/ancestry-fine/sb-p-rows/region.P deleted file mode 100644 index 5a3121d65..000000000 --- a/tests/parity/inputs/ancestry-fine/sb-p-rows/region.P +++ /dev/null @@ -1,39 +0,0 @@ -0.00 0.99 -0.01 0.98 -0.02 0.97 -0.03 0.96 -0.04 0.95 -0.05 0.94 -0.06 0.93 -0.07 0.92 -0.08 0.91 -0.09 0.90 -0.10 0.89 -0.11 0.88 -0.12 0.87 -0.13 0.86 -0.14 0.85 -0.15 0.84 -0.16 0.83 -0.17 0.82 -0.18 0.81 -0.19 0.80 -0.20 0.79 -0.21 0.78 -0.22 0.77 -0.23 0.76 -0.24 0.75 -0.25 0.74 -0.26 0.73 -0.27 0.72 -0.28 0.71 -0.29 0.70 -0.30 0.69 -0.31 0.68 -0.32 0.67 -0.33 0.66 -0.34 0.65 -0.35 0.64 -0.36 0.63 -0.37 0.62 -0.38 0.61 diff --git a/tests/parity/inputs/ancestry-fine/sb/continent.P b/tests/parity/inputs/ancestry-fine/sb/continent.P deleted file mode 100644 index 304db1995..000000000 --- a/tests/parity/inputs/ancestry-fine/sb/continent.P +++ /dev/null @@ -1,40 +0,0 @@ -0.000 0.5 0.99 -0.010 0.5 0.98 -0.020 0.5 0.97 -0.030 0.5 0.96 -0.040 0.5 0.95 -0.050 0.5 0.94 -0.060 0.5 0.93 -0.070 0.5 0.92 -0.080 0.5 0.91 -0.090 0.5 0.90 -0.100 0.5 0.89 -0.110 0.5 0.88 -0.120 0.5 0.87 -0.130 0.5 0.86 -0.140 0.5 0.85 -0.150 0.5 0.84 -0.160 0.5 0.83 -0.170 0.5 0.82 -0.180 0.5 0.81 -0.190 0.5 0.80 -0.200 0.5 0.79 -0.210 0.5 0.78 -0.220 0.5 0.77 -0.230 0.5 0.76 -0.240 0.5 0.75 -0.250 0.5 0.74 -0.260 0.5 0.73 -0.270 0.5 0.72 -0.280 0.5 0.71 -0.290 0.5 0.70 -0.300 0.5 0.69 -0.310 0.5 0.68 -0.320 0.5 0.67 -0.330 0.5 0.66 -0.340 0.5 0.65 -0.350 0.5 0.64 -0.360 0.5 0.63 -0.370 0.5 0.62 -0.380 0.5 0.61 -0.390 0.5 0.60 diff --git a/tests/parity/inputs/ancestry-fine/sb/g.vcf b/tests/parity/inputs/ancestry-fine/sb/g.vcf deleted file mode 100644 index e26fa2118..000000000 --- a/tests/parity/inputs/ancestry-fine/sb/g.vcf +++ /dev/null @@ -1,44 +0,0 @@ -##fileformat=VCFv4.2 -#CHROM POS ID REF ALT QUAL FILTER INFO FORMAT S -chr22 1000 . A C . . . GT 1/1 -chr22 1100 . C G . . . GT 0|1 -chr22 1200 . G T . . . GT 0/0 -chr22 1300 . T A . . . GT 1|0 -chr22 1400 . A C . . . GT 0/0 -chr22 1500 . C G . . . GT ./. -chr22 1600 . G T . . . GT 0/1 -chr22 1700 . T A . . . GT 1/1 -chr22 1800 . A C . . . GT 0/0 -chr22 1900 . C G . . . GT 0/1 -chr22 2000 . G T . . . GT 1/1 -chr22 2100 . T A . . . GT 0|1 -chr22 2200 . A C . . . GT 0/0 -chr22 2300 . C T,G . . . GT 2/2 -chr22 2400 . G T . . . GT 0/0 -chr22 2500 . T A . . . GT ./. -chr22 2600 . A C . . . GT 0/1 -chr22 2700 . C N . . . GT 0/1 -chr22 2800 . G T . . . GT 0/0 -chr22 2900 . T A . . . GT 0/1 -chr22 3000 . A C . . . GT 1/1 -chr22 3200 . G T . . . GT 0/0 -chr22 3300 . T . . . . DP:GT 9:0/0 -chr22 3400 . A C . . . GT 0/0 -chr22 3500 . C G . . . GT ./. -chr22 3600 . G T . . . GT 0/1 -chr22 3700 . T A . . . DP 9 -chr22 3800 . A C . . . GT 0/0 -chr22 3900 . C G . . . GT 1 -chr22 4000 . G T . . . GT 1/1 -chr22 4100 . T A . . . GT 0/0 -chr22 4100 . T A . . . GT 1/1 -chr22 4100 . T A . . . GT ./. -chr22 4200 . A C . . . GT 0/0 -chr22 4300 . C G . . . GT 1|0 -chr22 4400 . G T . . . GT 0/0 -chr22 4500 . T A . . . GT ./. -chr22 4600 . A C . . . GT 0/1 -chr22 4700 . C G . . . GT 1/1 -chr22 4800 . G T . . . GT 0/0 -chr22 4900 . T A . . . GT 0/1 -chr21 5000 . A G . . . GT 0/1 diff --git a/tests/parity/inputs/ancestry-fine/sb/ref.bim b/tests/parity/inputs/ancestry-fine/sb/ref.bim deleted file mode 100644 index e0a640116..000000000 --- a/tests/parity/inputs/ancestry-fine/sb/ref.bim +++ /dev/null @@ -1,40 +0,0 @@ -22 22:1000 0.00 1000 C A -22 22:1100 0.01 1100 G C -22 22:1200 0.02 1200 T G -22 22:1300 0.03 1300 A T -22 22:1400 0.04 1400 C A -22 22:1500 0.05 1500 G C -22 22:1600 0.06 1600 T G -22 22:1700 0.07 1700 A T -22 22:1800 0.08 1800 C A -22 22:1900 0.09 1900 G C -22 22:2000 0.10 2000 T G -22 22:2100 0.11 2100 A T -22 22:2200 0.12 2200 C A -22 22:2300 0.13 2300 G C -22 22:2400 0.14 2400 T G -22 22:2500 0.15 2500 A T -22 22:2600 0.16 2600 C A -22 22:2700 0.17 2700 G C -22 22:2800 0.18 2800 T G -22 22:2900 0.19 2900 A T -22 22:3000 0.20 3000 C A -22 22:3100 0.21 3100 G C -22 22:3200 0.22 3200 T G -22 22:3300 0.23 3300 A T -22 22:3400 0.24 3400 C A -22 22:3500 0.25 3500 G C -22 22:3600 0.26 3600 T G -22 22:3700 0.27 3700 A T -22 22:3800 0.28 3800 C A -22 22:3900 0.29 3900 G C -22 22:4000 0.30 4000 T G -22 22:4100 0.31 4100 A T -22 22:4200 0.32 4200 C A -22 22:4300 0.33 4300 G C -22 22:4400 0.34 4400 T G -22 22:4500 0.35 4500 A T -22 22:4600 0.36 4600 C A -22 22:4700 0.37 4700 G C -22 22:4800 0.38 4800 T G -22 22:4900 0.39 4900 A T diff --git a/tests/parity/inputs/ancestry-fine/sb/region.P b/tests/parity/inputs/ancestry-fine/sb/region.P deleted file mode 100644 index 79fba27cd..000000000 --- a/tests/parity/inputs/ancestry-fine/sb/region.P +++ /dev/null @@ -1,40 +0,0 @@ -0.00 0.99 -0.01 0.98 -0.02 0.97 -0.03 0.96 -0.04 0.95 -0.05 0.94 -0.06 0.93 -0.07 0.92 -0.08 0.91 -0.09 0.90 -0.10 0.89 -0.11 0.88 -0.12 0.87 -0.13 0.86 -0.14 0.85 -0.15 0.84 -0.16 0.83 -0.17 0.82 -0.18 0.81 -0.19 0.80 -0.20 0.79 -0.21 0.78 -0.22 0.77 -0.23 0.76 -0.24 0.75 -0.25 0.74 -0.26 0.73 -0.27 0.72 -0.28 0.71 -0.29 0.70 -0.30 0.69 -0.31 0.68 -0.32 0.67 -0.33 0.66 -0.34 0.65 -0.35 0.64 -0.36 0.63 -0.37 0.62 -0.38 0.61 -0.39 0.60 diff --git a/tests/shellcheck-baseline.txt b/tests/shellcheck-baseline.txt index 2417c91a9..ffe3a210c 100644 --- a/tests/shellcheck-baseline.txt +++ b/tests/shellcheck-baseline.txt @@ -6,7 +6,6 @@ # One line per finding: path, code, then the text of the line with its # blanks squeezed, separated by tabs. The text stands in for the line # number, so a line keeps matching when lines above it move. -rust/crates/og-ancestry/src/run_admixture.sh.in SC2170 while [ "$r" -le @B@ ]; do scripts/12-mito-haplogroup.sh SC2016 'bcftools view -f PASS "$1" | bcftools norm -m-any -Oz -o "$2" && bcftools index -f -t "$2"' \ scripts/12-mito-haplogroup.sh SC2016 'bcftools view -r chrM "$1" -Oz -o "$2" && bcftools index -f -t "$2"' \ scripts/12-mito-haplogroup.sh SC2016 '{ echo ">chrM"; dd if="$1" bs=1 skip="$2" count="$3" status=none; } > "$4.ref.fa" diff --git a/tests/test_ancestry_fine_report.py b/tests/test_ancestry_fine_report.py index 78fabbbbd..486bce611 100755 --- a/tests/test_ancestry_fine_report.py +++ b/tests/test_ancestry_fine_report.py @@ -8,9 +8,6 @@ check-map panel-map's table passes; one Oceanian put back as reference and painting reference, a short row, a flag other than 0 or 1 and a table with no reference person each stop it - sample-bed the .bed code of each genotype (ALT is the .bim's A1), chr22 in - the VCF meets 22 in the .bim, the .P.in and .ped rows of the - kept SNVs, and the bootstrap draws only blocks that hold SNVs chroms a chromosome is painted only with 100 SNVs spanning 5 cM report fractions with the bootstrap range, merged painting rows, the painted shares, a PNG of the right size, the left-out group @@ -89,44 +86,6 @@ def run_all(tmp): write(os.path.join(tmp, f"{name}.tsv"), text) expect(f"check-map: stops on the {name} table", og("check-map", "--map", os.path.join(tmp, f"{name}.tsv")).returncode, 1) - # --- sample-bed ----------------------------------------------------------------- - write(os.path.join(tmp, "ref.bim"), "".join(f"22\t22:{p}\t0\t{p}\t{alt}\t{ref}\n" for p, ref, alt in - [(100, "A", "G"), (200, "C", "T"), (300, "G", "A"), (400, "T", "C"), (500, "A", "C")])) - write(os.path.join(tmp, "g.vcf"), "##fileformat=VCFv4.2\n#CHROM\tPOS\tID\tREF\tALT\tQUAL\tFILTER\tINFO\tFORMAT\tS\n" - "chr22\t100\t.\tA\tG\t.\t.\t.\tGT\t1/1\n" # hom ALT: code 0 - "chr22\t200\t.\tC\tT\t.\t.\t.\tGT\t0|1\n" # het: code 2 - "chr22\t300\t.\tG\tA\t.\t.\t.\tGT\t0/0\n" # hom REF: code 3 - "chr22\t400\t.\tT\tG\t.\t.\t.\tGT\t0/1\n") # another ALT: left out; 500 missing: left out - write(os.path.join(tmp, "continent.P"), "".join(f"0.{i} 0.{9 - i}\n" for i in range(5))) - adm = os.path.join(tmp, "adm") - r = og("sample-bed", "--bim", os.path.join(tmp, "ref.bim"), "--vcf", os.path.join(tmp, "g.vcf"), "--sample", "S", - "--level", f"continent:2:{os.path.join(tmp, 'continent.P')}", "--bootstrap", "7", "--min-sites", "3", - "--out-dir", adm) - expect("sample-bed: exits 0 and counts the genotyped SNVs", (r.returncode, r.stdout), - (0, "3 of the 5 SNVs ADMIXTURE uses genotyped\n")) - expect("sample-bed: .bed magic, then hom ALT 0, het 2, hom REF 3", - open(os.path.join(adm, "S_continent.bed"), "rb").read(), b"\x6c\x1b\x01\x00\x02\x03") - expect("sample-bed: the .P.in rows of the kept SNVs only", - open(os.path.join(adm, "S_continent.2.P.in")).read(), "0.0 0.9\n0.1 0.8\n0.2 0.7\n") - expect("sample-bed: .ped allele pairs (2 is A1): hom ALT, het, hom REF", - open(os.path.join(adm, "S.geno")).read(), "2 2\n1 2\n1 1\n") - sh = open(os.path.join(adm, "run_admixture.sh")).read() - expect("sample-bed: run_admixture.sh runs 7 replicates of sample S", ("-le 7 ]" in sh, "S_${level}.bed" in sh), (True, True)) - # The block bootstrap draws only blocks that hold SNVs: 4 SNVs in 3 blocks - # round up to blocks of 2, so there are 2 blocks and every replicate holds - # 3 x 2 SNVs. - awk_prog = sh.split("-v k=\"$k\" '", 1)[1].split("' \"S.geno\"", 1)[0] - boot = os.path.join(tmp, "boot") - os.makedirs(boot) - write(os.path.join(boot, "g"), "".join(f"1 {i}\n" for i in range(4))) - write(os.path.join(boot, "m"), "".join(f"22 s{i} 0 {i}\n" for i in range(4))) - write(os.path.join(boot, "p"), "".join(f"0.{i} 0.5\n" for i in range(4))) - sizes = set() - for seed in range(1, 21): - subprocess.run(["awk", "-v", f"r={seed}", "-v", "nb=3", "-v", "k=2", awk_prog, "g", "m", "p"], cwd=boot, check=True) - sizes.add(len(open(os.path.join(boot, "rep.map")).readlines())) - expect("sample-bed: every bootstrap replicate draws 3 non-empty blocks of 2 SNVs (20 seeds)", sizes, {6}) - # --- chroms --------------------------------------------------------------------- maps = os.path.join(tmp, "maps") os.makedirs(maps) diff --git a/workflows/clinical.nf b/workflows/clinical.nf index 47cd3e984..ee5582944 100644 --- a/workflows/clinical.nf +++ b/workflows/clinical.nf @@ -28,8 +28,7 @@ include { MITO_EXTRACT_CHRM } from '../modules/local/mito_haplogroup/main' include { MITO_HAPLOGROUP } from '../modules/local/mito_haplogroup/main' include { HAPLOCHECK } from '../modules/local/mito_haplogroup/main' include { ANCESTRY_FINE_GENOTYPE } from '../modules/local/ancestry_fine/main' -include { ANCESTRY_FINE_PREPARE } from '../modules/local/ancestry_fine/main' -include { ANCESTRY_FINE_ADMIXTURE } from '../modules/local/ancestry_fine/main' +include { ANCESTRY_FINE_FRACTIONS } from '../modules/local/ancestry_fine/main' include { ANCESTRY_FINE_PHASE } from '../modules/local/ancestry_fine/main' include { ANCESTRY_FINE_PAINT } from '../modules/local/ancestry_fine/main' include { ANCESTRY_FINE_REPORT } from '../modules/local/ancestry_fine/main' @@ -177,7 +176,7 @@ workflow CLINICAL { } // - // ANCESTRY_FINE — step 26b: ADMIXTURE fractions and an RFMix painting + // ANCESTRY_FINE — step 26b: og ancestry fractions and an RFMix painting // against the fine-grained panel. With a gVCF the panel's SNVs are // genotyped from it, as in PRS; without one the VCF must hold reference // calls, or ANCESTRY_FINE_GENOTYPE stops (the bash step's rule). @@ -189,28 +188,27 @@ workflow CLINICAL { .filter { row -> row[1] != null } .map { row -> row[4] != null ? [row[1], row[4], row[5], 'gvcf'] : [row[1], row[2], row[3], 'vcf'] } ANCESTRY_FINE_GENOTYPE(ch_af_input, ch_ancestry_fine_panel, ch_reference, ch_reference_fai) - ANCESTRY_FINE_PREPARE(ANCESTRY_FINE_GENOTYPE.out.genotypes, ch_ancestry_fine_panel) - ANCESTRY_FINE_ADMIXTURE(ANCESTRY_FINE_PREPARE.out.admixture_input) + ANCESTRY_FINE_FRACTIONS(ANCESTRY_FINE_GENOTYPE.out.genotypes, ch_ancestry_fine_panel) ANCESTRY_FINE_PHASE( ANCESTRY_FINE_GENOTYPE.out.genotypes .map { meta, g, gi, _counts -> [meta.id, meta, g, gi] } - .join(ANCESTRY_FINE_PREPARE.out.chroms.map { meta, c -> [meta.id, c] }) + .join(ANCESTRY_FINE_FRACTIONS.out.chroms.map { meta, c -> [meta.id, c] }) .map { _id, meta, g, gi, c -> [meta, g, gi, c] }, ch_ancestry_fine_panel ) ANCESTRY_FINE_PAINT(ANCESTRY_FINE_PHASE.out.phased, ch_ancestry_fine_panel) ANCESTRY_FINE_REPORT( - ANCESTRY_FINE_ADMIXTURE.out.admixture + ANCESTRY_FINE_FRACTIONS.out.fractions .map { meta, d -> [meta.id, meta, d] } .join(ANCESTRY_FINE_PAINT.out.painting.map { meta, d -> [meta.id, d] }) - .map { _id, meta, adm, paint -> [meta, adm, paint] }, + .map { _id, meta, frc, paint -> [meta, frc, paint] }, ch_ancestry_fine_panel, params.ancestry_fine_panel ? file(params.ancestry_fine_panel).name : '' ) ch_ancestry_fine = ANCESTRY_FINE_REPORT.out.fractions ch_ancestry_fine_png = ANCESTRY_FINE_REPORT.out.painting_png - ch_versions = ch_versions.mix(ANCESTRY_FINE_GENOTYPE.out.versions, ANCESTRY_FINE_PREPARE.out.versions, - ANCESTRY_FINE_ADMIXTURE.out.versions, ANCESTRY_FINE_PHASE.out.versions, + ch_versions = ch_versions.mix(ANCESTRY_FINE_GENOTYPE.out.versions, ANCESTRY_FINE_FRACTIONS.out.versions, + ANCESTRY_FINE_PHASE.out.versions, ANCESTRY_FINE_PAINT.out.versions, ANCESTRY_FINE_REPORT.out.versions) } From f1decb9f70896eeecd1d207a5e6b0b969e7160cd Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 01:59:57 +0100 Subject: [PATCH 37/40] test(e2e): tell ShellCheck the fit check's $1 and $2 are awk's The new fit.tsv check passes an awk program through check, so ShellCheck cannot see it is awk and reports SC2016. Disable it on that line with the reason, as the script does elsewhere, instead of growing the baseline. Bead: lin-52 --- tests/e2e/ancestry-fine-grained-1.sh | 1 + 1 file changed, 1 insertion(+) diff --git a/tests/e2e/ancestry-fine-grained-1.sh b/tests/e2e/ancestry-fine-grained-1.sh index 2bc851fc0..99bd91308 100755 --- a/tests/e2e/ancestry-fine-grained-1.sh +++ b/tests/e2e/ancestry-fine-grained-1.sh @@ -138,6 +138,7 @@ check "HG002T: and the table has its left_out rows" \ # og ancestry-fine project wrote each level's fit, after a bootstrap that drew # the reference people again. for l in continent region; do + # shellcheck disable=SC2016 # $1 and $2 are awk's fields check "HG002T: the ${l} fit drew 100 replicates with the reference people drawn again" \ awk -F'\t' '$1 == "replicates" {r = $2} $1 == "reference_resampling" {s = $2} END {exit !(r == 100 && s == "yes")}' \ "${G}/HG002T/ancestry_fine/work/fractions/HG002T_${l}.fit.tsv" From 4a5223f7905b4bc8763ddbfd310d57e3c3cd4f4c Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 03:28:28 +0100 Subject: [PATCH 38/40] fix(admix): refuse a projection that is not a finite number A frequency such as 1e-310 is strictly between 0 and 1, so the problem accepts it, but 2 / 1e-310 overflows. The EM step then turns the fractions into NaN, f64::max drops the NaN, the step size reads 0 and the run passed as converged with NaN fractions and log-likelihood. project now refuses a fit whose fractions, log-likelihood or KKT measures are not finite. The new test failed before the change. Bead: lin-49 --- rust/crates/og-admix/src/project.rs | 25 ++++++++++++++++++++++++- 1 file changed, 24 insertions(+), 1 deletion(-) diff --git a/rust/crates/og-admix/src/project.rs b/rust/crates/og-admix/src/project.rs index 3f5a43cfe..aba6bf814 100644 --- a/rust/crates/og-admix/src/project.rs +++ b/rust/crates/og-admix/src/project.rs @@ -250,7 +250,8 @@ pub fn kkt(q: &[f64], ratio: &[f64]) -> (f64, f64) { } /// The fractions that maximise L, from equal fractions, by EM with SQUAREM; -/// an error when the run ends before the KKT conditions hold. +/// an error when the fit is not finite or the run ends before the KKT +/// conditions hold. pub fn project(p: &Problem<'_>, opts: &Options) -> Result { let k = p.k; let mut q = vec![1.0 / k as f64; k]; @@ -319,6 +320,18 @@ pub fn project(p: &Problem<'_>, opts: &Options) -> Result { slack, gain, }; + // A NaN passes every comparison below (and f64::max drops it), so a + // fit that is not finite is refused first. + if !(fit.q.iter().all(|x| x.is_finite()) + && fit.loglik.is_finite() + && slack.is_finite() + && gain.is_finite()) + { + return Err(Error(format!( + "the projection is not a finite number after {} passes (log-likelihood {}, fractions {:?}): a group frequency is too close to 0 or 1", + fit.iterations, fit.loglik, fit.q + ))); + } if !converged || slack > SLACK_TOLERANCE || gain > GAIN_TOLERANCE { return Err(Error(format!( "the projection stopped after {} passes short of the maximum: the KKT conditions do not hold (largest q|r - 1| {:e}, largest r - 1 {:e}{})", @@ -539,6 +552,16 @@ mod tests { assert!(Problem::new(0, &[], &[], None).is_err()); } + #[test] + fn a_nonfinite_fit_is_refused() { + // A frequency of 1e-310 is strictly between 0 and 1, but 2 / 1e-310 + // overflows: the EM step turns q into NaN, and f64::max drops the + // NaN, so the step size reads 0 and the run looks converged. + let p = Problem::new(1, &[2], &[1e-310], None).unwrap(); + let e = project(&p, &Options::default()).unwrap_err(); + assert!(e.0.contains("not a finite number"), "{}", e.0); + } + /// Blocks cut by SNV count, the bootstrap before this one: the red /// control of the chromosome test. fn blocks_by_count(n: usize, per: usize) -> Vec> { From be109593a368bd4e386d953fa5ba70ae300d7bf7 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 03:28:28 +0100 Subject: [PATCH 39/40] docs(ancestry): say the last called record decides a SNV in project The module doc said only a record with the .bim's two alleles decides a SNV. The code, like the sample-bed command it replaces, lets the last record with a called GT decide, and leaves the SNV out when that record holds another allele. The doc now states the rule the code follows. Bead: lin-52 --- rust/crates/og-ancestry/src/project.rs | 8 +++++--- 1 file changed, 5 insertions(+), 3 deletions(-) diff --git a/rust/crates/og-ancestry/src/project.rs b/rust/crates/og-ancestry/src/project.rs index 770f68964..fea16b3f0 100644 --- a/rust/crates/og-ancestry/src/project.rs +++ b/rust/crates/og-ancestry/src/project.rs @@ -9,9 +9,11 @@ //! per group); for the bootstrap also `ref.geno`, `ref.fam`, the panel's //! `samples.tsv` beside the model folder, and the genetic maps (`--maps`). //! -//! A SNV counts when the person has a called genotype of the `.bim`'s two -//! alleles there; the last such record at a position decides it. With -//! fewer than `--min-sites` (100) the command stops. +//! At each position the last VCF record with a called GT decides the SNV: +//! it counts when that genotype holds only the `.bim`'s two alleles, and +//! is left out when it holds another one, even after an earlier record +//! that matched. With fewer than `--min-sites` (100) SNVs the command +//! stops. //! //! The bootstrap cuts the genotyped SNVs into blocks of 5 cM on the genetic //! map, per chromosome, so no block holds two chromosomes. Each replicate From dfdd4624cbc688667dc1967878b382c944c3a296 Mon Sep 17 00:00:00 2001 From: GeiserX <9169332+GeiserX@users.noreply.github.com> Date: Sun, 22 Nov 2026 04:47:31 +0100 Subject: [PATCH 40/40] test(live): write the demo weblog again for the 26b fractions process The demo weblog is generated from assets/steps.tsv, which now lists ANCESTRY_FINE_FRACTIONS in place of ANCESTRY_FINE_PREPARE and ANCESTRY_FINE_ADMIXTURE, so test_live_demo.py's check that the fixture is what make_demo_events.py writes failed. This is the generator's output; only that process set changed, and the later hashes and times shift with it. Bead: lin-49 --- tests/fixtures/live/demo-001.weblog.jsonl | 251 +++++++++++----------- 1 file changed, 124 insertions(+), 127 deletions(-) diff --git a/tests/fixtures/live/demo-001.weblog.jsonl b/tests/fixtures/live/demo-001.weblog.jsonl index 3a20ce729..6a35fe17a 100644 --- a/tests/fixtures/live/demo-001.weblog.jsonl +++ b/tests/fixtures/live/demo-001.weblog.jsonl @@ -190,38 +190,37 @@ {"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000074","memory":2147483648,"name":"OWNGENOME:PRS (DEMO-001)","process":"OWNGENOME:PRS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":74},"utcTime":"2026-01-03T01:04:54Z"} {"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000075","memory":2147483648,"name":"OWNGENOME:PRS_SUMMARY (DEMO-001)","process":"OWNGENOME:PRS_SUMMARY","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":75},"utcTime":"2026-01-03T01:04:54Z"} {"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000076","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_GENOTYPE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_GENOTYPE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":76},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000077","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PREPARE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PREPARE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":77},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000078","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_ADMIXTURE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_ADMIXTURE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":78},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000079","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PHASE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PHASE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":79},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000080","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PAINT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PAINT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":80},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000081","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_REPORT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":81},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000082","memory":2147483648,"name":"OWNGENOME:PYPGX (DEMO-001)","process":"OWNGENOME:PYPGX","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":82},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000083","memory":2147483648,"name":"OWNGENOME:CYP2D6_DEPTH (DEMO-001)","process":"OWNGENOME:CYP2D6_DEPTH","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":83},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000084","memory":2147483648,"name":"OWNGENOME:Y_POSITIONS (DEMO-001)","process":"OWNGENOME:Y_POSITIONS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":84},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000085","memory":2147483648,"name":"OWNGENOME:Y_PILEUP (DEMO-001)","process":"OWNGENOME:Y_PILEUP","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":85},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000086","memory":2147483648,"name":"OWNGENOME:Y_HAPLOGROUP (DEMO-001)","process":"OWNGENOME:Y_HAPLOGROUP","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":86},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000087","memory":2147483648,"name":"OWNGENOME:Y_PRIVATE (DEMO-001)","process":"OWNGENOME:Y_PRIVATE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":87},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000088","memory":2147483648,"name":"OWNGENOME:CONSUMER_EXPORT (DEMO-001)","process":"OWNGENOME:CONSUMER_EXPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":88},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000089","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_REGIONS (DEMO-001)","process":"OWNGENOME:BLOODTYPE_REGIONS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":89},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000090","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_DEPTH (DEMO-001)","process":"OWNGENOME:BLOODTYPE_DEPTH","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":90},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000091","memory":2147483648,"name":"OWNGENOME:BLOODTYPE (DEMO-001)","process":"OWNGENOME:BLOODTYPE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":91},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000092","memory":2147483648,"name":"OWNGENOME:TRAITS_SITES (DEMO-001)","process":"OWNGENOME:TRAITS_SITES","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":92},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000093","memory":2147483648,"name":"OWNGENOME:TRAITS_PHASE (DEMO-001)","process":"OWNGENOME:TRAITS_PHASE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":93},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000094","memory":2147483648,"name":"OWNGENOME:TRAITS (DEMO-001)","process":"OWNGENOME:TRAITS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":94},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000095","memory":2147483648,"name":"OWNGENOME:ARCHAIC_GENOTYPES (DEMO-001)","process":"OWNGENOME:ARCHAIC_GENOTYPES","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":95},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000096","memory":2147483648,"name":"OWNGENOME:ARCHAIC_IBDMIX (DEMO-001)","process":"OWNGENOME:ARCHAIC_IBDMIX","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":96},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000097","memory":2147483648,"name":"OWNGENOME:ARCHAIC_REPORT (DEMO-001)","process":"OWNGENOME:ARCHAIC_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":97},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000098","memory":2147483648,"name":"OWNGENOME:ANCIENT_SITES (DEMO-001)","process":"OWNGENOME:ANCIENT_SITES","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":98},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000099","memory":2147483648,"name":"OWNGENOME:ANCIENT_GENO (DEMO-001)","process":"OWNGENOME:ANCIENT_GENO","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":99},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000100","memory":2147483648,"name":"OWNGENOME:ANCIENT_PCA (DEMO-001)","process":"OWNGENOME:ANCIENT_PCA","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":100},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000101","memory":2147483648,"name":"OWNGENOME:ANCIENT_REPORT (DEMO-001)","process":"OWNGENOME:ANCIENT_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":101},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000102","memory":2147483648,"name":"OWNGENOME:EXOMISER_PREPARE (DEMO-001)","process":"OWNGENOME:EXOMISER_PREPARE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":102},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000103","memory":2147483648,"name":"OWNGENOME:EXOMISER (DEMO-001)","process":"OWNGENOME:EXOMISER","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":103},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000104","memory":2147483648,"name":"OWNGENOME:EXOMISER_REPORT (DEMO-001)","process":"OWNGENOME:EXOMISER_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":104},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000105","memory":2147483648,"name":"OWNGENOME:MOCHA_PREP (DEMO-001)","process":"OWNGENOME:MOCHA_PREP","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":105},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000106","memory":2147483648,"name":"OWNGENOME:MOCHA_PHASE (DEMO-001)","process":"OWNGENOME:MOCHA_PHASE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":106},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000107","memory":2147483648,"name":"OWNGENOME:MOCHA_CALL (DEMO-001)","process":"OWNGENOME:MOCHA_CALL","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":107},"utcTime":"2026-01-03T01:04:54Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000108","memory":2147483648,"name":"OWNGENOME:MOCHA_REPORT (DEMO-001)","process":"OWNGENOME:MOCHA_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":108},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000077","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_FRACTIONS (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_FRACTIONS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":77},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000078","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PHASE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PHASE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":78},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000079","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PAINT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PAINT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":79},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000080","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_REPORT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":80},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000081","memory":2147483648,"name":"OWNGENOME:PYPGX (DEMO-001)","process":"OWNGENOME:PYPGX","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":81},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000082","memory":2147483648,"name":"OWNGENOME:CYP2D6_DEPTH (DEMO-001)","process":"OWNGENOME:CYP2D6_DEPTH","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":82},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000083","memory":2147483648,"name":"OWNGENOME:Y_POSITIONS (DEMO-001)","process":"OWNGENOME:Y_POSITIONS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":83},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000084","memory":2147483648,"name":"OWNGENOME:Y_PILEUP (DEMO-001)","process":"OWNGENOME:Y_PILEUP","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":84},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000085","memory":2147483648,"name":"OWNGENOME:Y_HAPLOGROUP (DEMO-001)","process":"OWNGENOME:Y_HAPLOGROUP","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":85},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000086","memory":2147483648,"name":"OWNGENOME:Y_PRIVATE (DEMO-001)","process":"OWNGENOME:Y_PRIVATE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":86},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000087","memory":2147483648,"name":"OWNGENOME:CONSUMER_EXPORT (DEMO-001)","process":"OWNGENOME:CONSUMER_EXPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":87},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000088","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_REGIONS (DEMO-001)","process":"OWNGENOME:BLOODTYPE_REGIONS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":88},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000089","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_DEPTH (DEMO-001)","process":"OWNGENOME:BLOODTYPE_DEPTH","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":89},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000090","memory":2147483648,"name":"OWNGENOME:BLOODTYPE (DEMO-001)","process":"OWNGENOME:BLOODTYPE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":90},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000091","memory":2147483648,"name":"OWNGENOME:TRAITS_SITES (DEMO-001)","process":"OWNGENOME:TRAITS_SITES","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":91},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000092","memory":2147483648,"name":"OWNGENOME:TRAITS_PHASE (DEMO-001)","process":"OWNGENOME:TRAITS_PHASE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":92},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000093","memory":2147483648,"name":"OWNGENOME:TRAITS (DEMO-001)","process":"OWNGENOME:TRAITS","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":93},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000094","memory":2147483648,"name":"OWNGENOME:ARCHAIC_GENOTYPES (DEMO-001)","process":"OWNGENOME:ARCHAIC_GENOTYPES","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":94},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000095","memory":2147483648,"name":"OWNGENOME:ARCHAIC_IBDMIX (DEMO-001)","process":"OWNGENOME:ARCHAIC_IBDMIX","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":95},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000096","memory":2147483648,"name":"OWNGENOME:ARCHAIC_REPORT (DEMO-001)","process":"OWNGENOME:ARCHAIC_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":96},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000097","memory":2147483648,"name":"OWNGENOME:ANCIENT_SITES (DEMO-001)","process":"OWNGENOME:ANCIENT_SITES","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":97},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000098","memory":2147483648,"name":"OWNGENOME:ANCIENT_GENO (DEMO-001)","process":"OWNGENOME:ANCIENT_GENO","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":98},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000099","memory":2147483648,"name":"OWNGENOME:ANCIENT_PCA (DEMO-001)","process":"OWNGENOME:ANCIENT_PCA","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":99},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000100","memory":2147483648,"name":"OWNGENOME:ANCIENT_REPORT (DEMO-001)","process":"OWNGENOME:ANCIENT_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":100},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000101","memory":2147483648,"name":"OWNGENOME:EXOMISER_PREPARE (DEMO-001)","process":"OWNGENOME:EXOMISER_PREPARE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":101},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000102","memory":2147483648,"name":"OWNGENOME:EXOMISER (DEMO-001)","process":"OWNGENOME:EXOMISER","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":102},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000103","memory":2147483648,"name":"OWNGENOME:EXOMISER_REPORT (DEMO-001)","process":"OWNGENOME:EXOMISER_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":103},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000104","memory":2147483648,"name":"OWNGENOME:MOCHA_PREP (DEMO-001)","process":"OWNGENOME:MOCHA_PREP","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":104},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000105","memory":2147483648,"name":"OWNGENOME:MOCHA_PHASE (DEMO-001)","process":"OWNGENOME:MOCHA_PHASE","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":105},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000106","memory":2147483648,"name":"OWNGENOME:MOCHA_CALL (DEMO-001)","process":"OWNGENOME:MOCHA_CALL","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":106},"utcTime":"2026-01-03T01:04:54Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000107","memory":2147483648,"name":"OWNGENOME:MOCHA_REPORT (DEMO-001)","process":"OWNGENOME:MOCHA_REPORT","status":"SUBMITTED","submit":1767402294000,"tag":"DEMO-001","task_id":107},"utcTime":"2026-01-03T01:04:54Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000059","memory":2147483648,"name":"OWNGENOME:CLINVAR_SCREEN (DEMO-001)","process":"OWNGENOME:CLINVAR_SCREEN","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":59},"utcTime":"2026-01-03T01:04:55Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000062","memory":2147483648,"name":"OWNGENOME:PHARMCAT_PREPROCESS (DEMO-001)","process":"OWNGENOME:PHARMCAT_PREPROCESS","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":62},"utcTime":"2026-01-03T01:04:55Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000064","memory":2147483648,"name":"OWNGENOME:ROH (DEMO-001)","process":"OWNGENOME:ROH","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":64},"utcTime":"2026-01-03T01:04:55Z"} @@ -230,15 +229,15 @@ {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000070","memory":2147483648,"name":"OWNGENOME:CPSR (DEMO-001)","process":"OWNGENOME:CPSR","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":70},"utcTime":"2026-01-03T01:04:55Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000072","memory":2147483648,"name":"OWNGENOME:PRS_PREPARE (DEMO-001)","process":"OWNGENOME:PRS_PREPARE","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":72},"utcTime":"2026-01-03T01:04:55Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000076","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_GENOTYPE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_GENOTYPE","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":76},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000082","memory":2147483648,"name":"OWNGENOME:PYPGX (DEMO-001)","process":"OWNGENOME:PYPGX","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":82},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000084","memory":2147483648,"name":"OWNGENOME:Y_POSITIONS (DEMO-001)","process":"OWNGENOME:Y_POSITIONS","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":84},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000088","memory":2147483648,"name":"OWNGENOME:CONSUMER_EXPORT (DEMO-001)","process":"OWNGENOME:CONSUMER_EXPORT","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":88},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000089","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_REGIONS (DEMO-001)","process":"OWNGENOME:BLOODTYPE_REGIONS","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":89},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000092","memory":2147483648,"name":"OWNGENOME:TRAITS_SITES (DEMO-001)","process":"OWNGENOME:TRAITS_SITES","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":92},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000095","memory":2147483648,"name":"OWNGENOME:ARCHAIC_GENOTYPES (DEMO-001)","process":"OWNGENOME:ARCHAIC_GENOTYPES","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":95},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000098","memory":2147483648,"name":"OWNGENOME:ANCIENT_SITES (DEMO-001)","process":"OWNGENOME:ANCIENT_SITES","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":98},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000102","memory":2147483648,"name":"OWNGENOME:EXOMISER_PREPARE (DEMO-001)","process":"OWNGENOME:EXOMISER_PREPARE","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":102},"utcTime":"2026-01-03T01:04:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000105","memory":2147483648,"name":"OWNGENOME:MOCHA_PREP (DEMO-001)","process":"OWNGENOME:MOCHA_PREP","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":105},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000081","memory":2147483648,"name":"OWNGENOME:PYPGX (DEMO-001)","process":"OWNGENOME:PYPGX","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":81},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000083","memory":2147483648,"name":"OWNGENOME:Y_POSITIONS (DEMO-001)","process":"OWNGENOME:Y_POSITIONS","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":83},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000087","memory":2147483648,"name":"OWNGENOME:CONSUMER_EXPORT (DEMO-001)","process":"OWNGENOME:CONSUMER_EXPORT","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":87},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000088","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_REGIONS (DEMO-001)","process":"OWNGENOME:BLOODTYPE_REGIONS","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":88},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000091","memory":2147483648,"name":"OWNGENOME:TRAITS_SITES (DEMO-001)","process":"OWNGENOME:TRAITS_SITES","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":91},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000094","memory":2147483648,"name":"OWNGENOME:ARCHAIC_GENOTYPES (DEMO-001)","process":"OWNGENOME:ARCHAIC_GENOTYPES","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":94},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000097","memory":2147483648,"name":"OWNGENOME:ANCIENT_SITES (DEMO-001)","process":"OWNGENOME:ANCIENT_SITES","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":97},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000101","memory":2147483648,"name":"OWNGENOME:EXOMISER_PREPARE (DEMO-001)","process":"OWNGENOME:EXOMISER_PREPARE","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":101},"utcTime":"2026-01-03T01:04:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000104","memory":2147483648,"name":"OWNGENOME:MOCHA_PREP (DEMO-001)","process":"OWNGENOME:MOCHA_PREP","start":1767402295000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":104},"utcTime":"2026-01-03T01:04:55Z"} {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402300000,"cpus":2,"exit":0,"hash":"de/000065","memory":2147483648,"name":"OWNGENOME:MITO_EXTRACT_CHRM (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MITO_EXTRACT_CHRM","realtime":5000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":65},"utcTime":"2026-01-03T01:05:00Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000066","memory":2147483648,"name":"OWNGENOME:MITO_HAPLOGROUP (DEMO-001)","process":"OWNGENOME:MITO_HAPLOGROUP","start":1767402301000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":66},"utcTime":"2026-01-03T01:05:01Z"} {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402302000,"cpus":2,"exit":137,"hash":"de/000059","memory":2147483648,"name":"OWNGENOME:CLINVAR_SCREEN (DEMO-001)","peak_rss":2126008811,"process":"OWNGENOME:CLINVAR_SCREEN","realtime":7000,"start":1767402295000,"status":"FAILED","submit":1767402294000,"tag":"DEMO-001","task_id":59},"utcTime":"2026-01-03T01:05:02Z"} @@ -254,71 +253,69 @@ {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000063","memory":2147483648,"name":"OWNGENOME:PHARMCAT (DEMO-001)","process":"OWNGENOME:PHARMCAT","start":1767402320000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":63},"utcTime":"2026-01-03T01:05:20Z"} {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402345000,"cpus":2,"exit":0,"hash":"de/000061","memory":2147483648,"name":"OWNGENOME:CLINVAR_CDNA_CHECK (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CLINVAR_CDNA_CHECK","realtime":25000,"start":1767402320000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":61},"utcTime":"2026-01-03T01:05:45Z"} {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402345000,"cpus":2,"exit":0,"hash":"de/000063","memory":2147483648,"name":"OWNGENOME:PHARMCAT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:PHARMCAT","realtime":25000,"start":1767402320000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":63},"utcTime":"2026-01-03T01:05:45Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000109","memory":2147483648,"name":"OWNGENOME:COUPLE_CARRIER (DEMO-001)","process":"OWNGENOME:COUPLE_CARRIER","status":"SUBMITTED","submit":1767402345000,"tag":"DEMO-001","task_id":109},"utcTime":"2026-01-03T01:05:45Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000109","memory":2147483648,"name":"OWNGENOME:COUPLE_CARRIER (DEMO-001)","process":"OWNGENOME:COUPLE_CARRIER","start":1767402346000,"status":"RUNNING","submit":1767402345000,"tag":"DEMO-001","task_id":109},"utcTime":"2026-01-03T01:05:46Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402394000,"cpus":2,"exit":0,"hash":"de/000076","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_GENOTYPE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_GENOTYPE","realtime":99000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":76},"utcTime":"2026-01-03T01:06:34Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000077","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PREPARE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PREPARE","start":1767402395000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":77},"utcTime":"2026-01-03T01:06:35Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402444000,"cpus":2,"exit":0,"hash":"de/000084","memory":2147483648,"name":"OWNGENOME:Y_POSITIONS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_POSITIONS","realtime":149000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":84},"utcTime":"2026-01-03T01:07:24Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402444000,"cpus":2,"exit":0,"hash":"de/000098","memory":2147483648,"name":"OWNGENOME:ANCIENT_SITES (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_SITES","realtime":149000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":98},"utcTime":"2026-01-03T01:07:24Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402444000,"cpus":2,"exit":0,"hash":"de/000105","memory":2147483648,"name":"OWNGENOME:MOCHA_PREP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_PREP","realtime":149000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":105},"utcTime":"2026-01-03T01:07:24Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000085","memory":2147483648,"name":"OWNGENOME:Y_PILEUP (DEMO-001)","process":"OWNGENOME:Y_PILEUP","start":1767402445000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":85},"utcTime":"2026-01-03T01:07:25Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000099","memory":2147483648,"name":"OWNGENOME:ANCIENT_GENO (DEMO-001)","process":"OWNGENOME:ANCIENT_GENO","start":1767402445000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":99},"utcTime":"2026-01-03T01:07:25Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000106","memory":2147483648,"name":"OWNGENOME:MOCHA_PHASE (DEMO-001)","process":"OWNGENOME:MOCHA_PHASE","start":1767402445000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":106},"utcTime":"2026-01-03T01:07:25Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000077","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PREPARE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_PREPARE","realtime":99000,"start":1767402395000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":77},"utcTime":"2026-01-03T01:08:14Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000089","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_REGIONS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:BLOODTYPE_REGIONS","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":89},"utcTime":"2026-01-03T01:08:14Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000092","memory":2147483648,"name":"OWNGENOME:TRAITS_SITES (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:TRAITS_SITES","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":92},"utcTime":"2026-01-03T01:08:14Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000095","memory":2147483648,"name":"OWNGENOME:ARCHAIC_GENOTYPES (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ARCHAIC_GENOTYPES","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":95},"utcTime":"2026-01-03T01:08:14Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000102","memory":2147483648,"name":"OWNGENOME:EXOMISER_PREPARE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:EXOMISER_PREPARE","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":102},"utcTime":"2026-01-03T01:08:14Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000078","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_ADMIXTURE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_ADMIXTURE","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":78},"utcTime":"2026-01-03T01:08:15Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000090","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_DEPTH (DEMO-001)","process":"OWNGENOME:BLOODTYPE_DEPTH","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":90},"utcTime":"2026-01-03T01:08:15Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000093","memory":2147483648,"name":"OWNGENOME:TRAITS_PHASE (DEMO-001)","process":"OWNGENOME:TRAITS_PHASE","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":93},"utcTime":"2026-01-03T01:08:15Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000096","memory":2147483648,"name":"OWNGENOME:ARCHAIC_IBDMIX (DEMO-001)","process":"OWNGENOME:ARCHAIC_IBDMIX","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":96},"utcTime":"2026-01-03T01:08:15Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000103","memory":2147483648,"name":"OWNGENOME:EXOMISER (DEMO-001)","process":"OWNGENOME:EXOMISER","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":103},"utcTime":"2026-01-03T01:08:15Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402530000,"cpus":2,"exit":0,"hash":"de/000082","memory":2147483648,"name":"OWNGENOME:PYPGX (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:PYPGX","realtime":235000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":82},"utcTime":"2026-01-03T01:08:50Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000083","memory":2147483648,"name":"OWNGENOME:CYP2D6_DEPTH (DEMO-001)","process":"OWNGENOME:CYP2D6_DEPTH","start":1767402531000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":83},"utcTime":"2026-01-03T01:08:51Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402594000,"cpus":2,"exit":0,"hash":"de/000078","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_ADMIXTURE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_ADMIXTURE","realtime":99000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":78},"utcTime":"2026-01-03T01:09:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402594000,"cpus":2,"exit":0,"hash":"de/000085","memory":2147483648,"name":"OWNGENOME:Y_PILEUP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_PILEUP","realtime":149000,"start":1767402445000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":85},"utcTime":"2026-01-03T01:09:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402594000,"cpus":2,"exit":0,"hash":"de/000099","memory":2147483648,"name":"OWNGENOME:ANCIENT_GENO (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_GENO","realtime":149000,"start":1767402445000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":99},"utcTime":"2026-01-03T01:09:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402594000,"cpus":2,"exit":0,"hash":"de/000106","memory":2147483648,"name":"OWNGENOME:MOCHA_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_PHASE","realtime":149000,"start":1767402445000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":106},"utcTime":"2026-01-03T01:09:54Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000079","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PHASE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PHASE","start":1767402595000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":79},"utcTime":"2026-01-03T01:09:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000086","memory":2147483648,"name":"OWNGENOME:Y_HAPLOGROUP (DEMO-001)","process":"OWNGENOME:Y_HAPLOGROUP","start":1767402595000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":86},"utcTime":"2026-01-03T01:09:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000100","memory":2147483648,"name":"OWNGENOME:ANCIENT_PCA (DEMO-001)","process":"OWNGENOME:ANCIENT_PCA","start":1767402595000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":100},"utcTime":"2026-01-03T01:09:55Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000107","memory":2147483648,"name":"OWNGENOME:MOCHA_CALL (DEMO-001)","process":"OWNGENOME:MOCHA_CALL","start":1767402595000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":107},"utcTime":"2026-01-03T01:09:55Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000079","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_PHASE","realtime":99000,"start":1767402595000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":79},"utcTime":"2026-01-03T01:11:34Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000090","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_DEPTH (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:BLOODTYPE_DEPTH","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":90},"utcTime":"2026-01-03T01:11:34Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000093","memory":2147483648,"name":"OWNGENOME:TRAITS_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:TRAITS_PHASE","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":93},"utcTime":"2026-01-03T01:11:34Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000096","memory":2147483648,"name":"OWNGENOME:ARCHAIC_IBDMIX (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ARCHAIC_IBDMIX","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":96},"utcTime":"2026-01-03T01:11:34Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000103","memory":2147483648,"name":"OWNGENOME:EXOMISER (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:EXOMISER","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":103},"utcTime":"2026-01-03T01:11:34Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000080","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PAINT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PAINT","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":80},"utcTime":"2026-01-03T01:11:35Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000091","memory":2147483648,"name":"OWNGENOME:BLOODTYPE (DEMO-001)","process":"OWNGENOME:BLOODTYPE","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":91},"utcTime":"2026-01-03T01:11:35Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000094","memory":2147483648,"name":"OWNGENOME:TRAITS (DEMO-001)","process":"OWNGENOME:TRAITS","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":94},"utcTime":"2026-01-03T01:11:35Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000097","memory":2147483648,"name":"OWNGENOME:ARCHAIC_REPORT (DEMO-001)","process":"OWNGENOME:ARCHAIC_REPORT","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":97},"utcTime":"2026-01-03T01:11:35Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000104","memory":2147483648,"name":"OWNGENOME:EXOMISER_REPORT (DEMO-001)","process":"OWNGENOME:EXOMISER_REPORT","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":104},"utcTime":"2026-01-03T01:11:35Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402744000,"cpus":2,"exit":0,"hash":"de/000086","memory":2147483648,"name":"OWNGENOME:Y_HAPLOGROUP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_HAPLOGROUP","realtime":149000,"start":1767402595000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":86},"utcTime":"2026-01-03T01:12:24Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402744000,"cpus":2,"exit":0,"hash":"de/000100","memory":2147483648,"name":"OWNGENOME:ANCIENT_PCA (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_PCA","realtime":149000,"start":1767402595000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":100},"utcTime":"2026-01-03T01:12:24Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402744000,"cpus":2,"exit":0,"hash":"de/000107","memory":2147483648,"name":"OWNGENOME:MOCHA_CALL (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_CALL","realtime":149000,"start":1767402595000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":107},"utcTime":"2026-01-03T01:12:24Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000087","memory":2147483648,"name":"OWNGENOME:Y_PRIVATE (DEMO-001)","process":"OWNGENOME:Y_PRIVATE","start":1767402745000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":87},"utcTime":"2026-01-03T01:12:25Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000101","memory":2147483648,"name":"OWNGENOME:ANCIENT_REPORT (DEMO-001)","process":"OWNGENOME:ANCIENT_REPORT","start":1767402745000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":101},"utcTime":"2026-01-03T01:12:25Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000108","memory":2147483648,"name":"OWNGENOME:MOCHA_REPORT (DEMO-001)","process":"OWNGENOME:MOCHA_REPORT","start":1767402745000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":108},"utcTime":"2026-01-03T01:12:25Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402767000,"cpus":2,"exit":0,"hash":"de/000083","memory":2147483648,"name":"OWNGENOME:CYP2D6_DEPTH (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CYP2D6_DEPTH","realtime":236000,"start":1767402531000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":83},"utcTime":"2026-01-03T01:12:47Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000110","memory":2147483648,"name":"OWNGENOME:PGX_CONSENSUS (DEMO-001)","process":"OWNGENOME:PGX_CONSENSUS","status":"SUBMITTED","submit":1767402767000,"tag":"DEMO-001","task_id":110},"utcTime":"2026-01-03T01:12:47Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000110","memory":2147483648,"name":"OWNGENOME:PGX_CONSENSUS (DEMO-001)","process":"OWNGENOME:PGX_CONSENSUS","start":1767402768000,"status":"RUNNING","submit":1767402767000,"tag":"DEMO-001","task_id":110},"utcTime":"2026-01-03T01:12:48Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402785000,"cpus":2,"exit":0,"hash":"de/000110","memory":2147483648,"name":"OWNGENOME:PGX_CONSENSUS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:PGX_CONSENSUS","realtime":17000,"start":1767402768000,"status":"COMPLETED","submit":1767402767000,"tag":"DEMO-001","task_id":110},"utcTime":"2026-01-03T01:13:05Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000111","memory":2147483648,"name":"OWNGENOME:CPIC_LOOKUP (DEMO-001)","process":"OWNGENOME:CPIC_LOOKUP","status":"SUBMITTED","submit":1767402785000,"tag":"DEMO-001","task_id":111},"utcTime":"2026-01-03T01:13:05Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000111","memory":2147483648,"name":"OWNGENOME:CPIC_LOOKUP (DEMO-001)","process":"OWNGENOME:CPIC_LOOKUP","start":1767402786000,"status":"RUNNING","submit":1767402785000,"tag":"DEMO-001","task_id":111},"utcTime":"2026-01-03T01:13:06Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402794000,"cpus":2,"exit":0,"hash":"de/000080","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PAINT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_PAINT","realtime":99000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":80},"utcTime":"2026-01-03T01:13:14Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000081","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_REPORT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_REPORT","start":1767402795000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":81},"utcTime":"2026-01-03T01:13:15Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402804000,"cpus":2,"exit":0,"hash":"de/000111","memory":2147483648,"name":"OWNGENOME:CPIC_LOOKUP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CPIC_LOOKUP","realtime":18000,"start":1767402786000,"status":"COMPLETED","submit":1767402785000,"tag":"DEMO-001","task_id":111},"utcTime":"2026-01-03T01:13:24Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000081","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_REPORT","realtime":99000,"start":1767402795000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":81},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000087","memory":2147483648,"name":"OWNGENOME:Y_PRIVATE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_PRIVATE","realtime":149000,"start":1767402745000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":87},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000088","memory":2147483648,"name":"OWNGENOME:CONSUMER_EXPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CONSUMER_EXPORT","realtime":599000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":88},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000091","memory":2147483648,"name":"OWNGENOME:BLOODTYPE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:BLOODTYPE","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":91},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000094","memory":2147483648,"name":"OWNGENOME:TRAITS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:TRAITS","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":94},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000097","memory":2147483648,"name":"OWNGENOME:ARCHAIC_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ARCHAIC_REPORT","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":97},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000101","memory":2147483648,"name":"OWNGENOME:ANCIENT_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_REPORT","realtime":149000,"start":1767402745000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":101},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000104","memory":2147483648,"name":"OWNGENOME:EXOMISER_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:EXOMISER_REPORT","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":104},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000108","memory":2147483648,"name":"OWNGENOME:MOCHA_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_REPORT","realtime":149000,"start":1767402745000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":108},"utcTime":"2026-01-03T01:14:54Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402945000,"cpus":2,"exit":0,"hash":"de/000109","memory":2147483648,"name":"OWNGENOME:COUPLE_CARRIER (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:COUPLE_CARRIER","realtime":599000,"start":1767402346000,"status":"COMPLETED","submit":1767402345000,"tag":"DEMO-001","task_id":109},"utcTime":"2026-01-03T01:15:45Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000108","memory":2147483648,"name":"OWNGENOME:COUPLE_CARRIER (DEMO-001)","process":"OWNGENOME:COUPLE_CARRIER","status":"SUBMITTED","submit":1767402345000,"tag":"DEMO-001","task_id":108},"utcTime":"2026-01-03T01:05:45Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000108","memory":2147483648,"name":"OWNGENOME:COUPLE_CARRIER (DEMO-001)","process":"OWNGENOME:COUPLE_CARRIER","start":1767402346000,"status":"RUNNING","submit":1767402345000,"tag":"DEMO-001","task_id":108},"utcTime":"2026-01-03T01:05:46Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402414000,"cpus":2,"exit":0,"hash":"de/000076","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_GENOTYPE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_GENOTYPE","realtime":119000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":76},"utcTime":"2026-01-03T01:06:54Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000077","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_FRACTIONS (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_FRACTIONS","start":1767402415000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":77},"utcTime":"2026-01-03T01:06:55Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402444000,"cpus":2,"exit":0,"hash":"de/000083","memory":2147483648,"name":"OWNGENOME:Y_POSITIONS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_POSITIONS","realtime":149000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":83},"utcTime":"2026-01-03T01:07:24Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402444000,"cpus":2,"exit":0,"hash":"de/000097","memory":2147483648,"name":"OWNGENOME:ANCIENT_SITES (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_SITES","realtime":149000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":97},"utcTime":"2026-01-03T01:07:24Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402444000,"cpus":2,"exit":0,"hash":"de/000104","memory":2147483648,"name":"OWNGENOME:MOCHA_PREP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_PREP","realtime":149000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":104},"utcTime":"2026-01-03T01:07:24Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000084","memory":2147483648,"name":"OWNGENOME:Y_PILEUP (DEMO-001)","process":"OWNGENOME:Y_PILEUP","start":1767402445000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":84},"utcTime":"2026-01-03T01:07:25Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000098","memory":2147483648,"name":"OWNGENOME:ANCIENT_GENO (DEMO-001)","process":"OWNGENOME:ANCIENT_GENO","start":1767402445000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":98},"utcTime":"2026-01-03T01:07:25Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000105","memory":2147483648,"name":"OWNGENOME:MOCHA_PHASE (DEMO-001)","process":"OWNGENOME:MOCHA_PHASE","start":1767402445000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":105},"utcTime":"2026-01-03T01:07:25Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000088","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_REGIONS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:BLOODTYPE_REGIONS","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":88},"utcTime":"2026-01-03T01:08:14Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000091","memory":2147483648,"name":"OWNGENOME:TRAITS_SITES (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:TRAITS_SITES","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":91},"utcTime":"2026-01-03T01:08:14Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000094","memory":2147483648,"name":"OWNGENOME:ARCHAIC_GENOTYPES (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ARCHAIC_GENOTYPES","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":94},"utcTime":"2026-01-03T01:08:14Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402494000,"cpus":2,"exit":0,"hash":"de/000101","memory":2147483648,"name":"OWNGENOME:EXOMISER_PREPARE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:EXOMISER_PREPARE","realtime":199000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":101},"utcTime":"2026-01-03T01:08:14Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000089","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_DEPTH (DEMO-001)","process":"OWNGENOME:BLOODTYPE_DEPTH","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":89},"utcTime":"2026-01-03T01:08:15Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000092","memory":2147483648,"name":"OWNGENOME:TRAITS_PHASE (DEMO-001)","process":"OWNGENOME:TRAITS_PHASE","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":92},"utcTime":"2026-01-03T01:08:15Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000095","memory":2147483648,"name":"OWNGENOME:ARCHAIC_IBDMIX (DEMO-001)","process":"OWNGENOME:ARCHAIC_IBDMIX","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":95},"utcTime":"2026-01-03T01:08:15Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000102","memory":2147483648,"name":"OWNGENOME:EXOMISER (DEMO-001)","process":"OWNGENOME:EXOMISER","start":1767402495000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":102},"utcTime":"2026-01-03T01:08:15Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402530000,"cpus":2,"exit":0,"hash":"de/000081","memory":2147483648,"name":"OWNGENOME:PYPGX (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:PYPGX","realtime":235000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":81},"utcTime":"2026-01-03T01:08:50Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000082","memory":2147483648,"name":"OWNGENOME:CYP2D6_DEPTH (DEMO-001)","process":"OWNGENOME:CYP2D6_DEPTH","start":1767402531000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":82},"utcTime":"2026-01-03T01:08:51Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402534000,"cpus":2,"exit":0,"hash":"de/000077","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_FRACTIONS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_FRACTIONS","realtime":119000,"start":1767402415000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":77},"utcTime":"2026-01-03T01:08:54Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000078","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PHASE (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PHASE","start":1767402535000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":78},"utcTime":"2026-01-03T01:08:55Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402594000,"cpus":2,"exit":0,"hash":"de/000084","memory":2147483648,"name":"OWNGENOME:Y_PILEUP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_PILEUP","realtime":149000,"start":1767402445000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":84},"utcTime":"2026-01-03T01:09:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402594000,"cpus":2,"exit":0,"hash":"de/000098","memory":2147483648,"name":"OWNGENOME:ANCIENT_GENO (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_GENO","realtime":149000,"start":1767402445000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":98},"utcTime":"2026-01-03T01:09:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402594000,"cpus":2,"exit":0,"hash":"de/000105","memory":2147483648,"name":"OWNGENOME:MOCHA_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_PHASE","realtime":149000,"start":1767402445000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":105},"utcTime":"2026-01-03T01:09:54Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000085","memory":2147483648,"name":"OWNGENOME:Y_HAPLOGROUP (DEMO-001)","process":"OWNGENOME:Y_HAPLOGROUP","start":1767402595000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":85},"utcTime":"2026-01-03T01:09:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000099","memory":2147483648,"name":"OWNGENOME:ANCIENT_PCA (DEMO-001)","process":"OWNGENOME:ANCIENT_PCA","start":1767402595000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":99},"utcTime":"2026-01-03T01:09:55Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000106","memory":2147483648,"name":"OWNGENOME:MOCHA_CALL (DEMO-001)","process":"OWNGENOME:MOCHA_CALL","start":1767402595000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":106},"utcTime":"2026-01-03T01:09:55Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402654000,"cpus":2,"exit":0,"hash":"de/000078","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_PHASE","realtime":119000,"start":1767402535000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":78},"utcTime":"2026-01-03T01:10:54Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000079","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PAINT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_PAINT","start":1767402655000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":79},"utcTime":"2026-01-03T01:10:55Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000089","memory":2147483648,"name":"OWNGENOME:BLOODTYPE_DEPTH (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:BLOODTYPE_DEPTH","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":89},"utcTime":"2026-01-03T01:11:34Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000092","memory":2147483648,"name":"OWNGENOME:TRAITS_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:TRAITS_PHASE","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":92},"utcTime":"2026-01-03T01:11:34Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000095","memory":2147483648,"name":"OWNGENOME:ARCHAIC_IBDMIX (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ARCHAIC_IBDMIX","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":95},"utcTime":"2026-01-03T01:11:34Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402694000,"cpus":2,"exit":0,"hash":"de/000102","memory":2147483648,"name":"OWNGENOME:EXOMISER (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:EXOMISER","realtime":199000,"start":1767402495000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":102},"utcTime":"2026-01-03T01:11:34Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000090","memory":2147483648,"name":"OWNGENOME:BLOODTYPE (DEMO-001)","process":"OWNGENOME:BLOODTYPE","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":90},"utcTime":"2026-01-03T01:11:35Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000093","memory":2147483648,"name":"OWNGENOME:TRAITS (DEMO-001)","process":"OWNGENOME:TRAITS","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":93},"utcTime":"2026-01-03T01:11:35Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000096","memory":2147483648,"name":"OWNGENOME:ARCHAIC_REPORT (DEMO-001)","process":"OWNGENOME:ARCHAIC_REPORT","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":96},"utcTime":"2026-01-03T01:11:35Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000103","memory":2147483648,"name":"OWNGENOME:EXOMISER_REPORT (DEMO-001)","process":"OWNGENOME:EXOMISER_REPORT","start":1767402695000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":103},"utcTime":"2026-01-03T01:11:35Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402744000,"cpus":2,"exit":0,"hash":"de/000085","memory":2147483648,"name":"OWNGENOME:Y_HAPLOGROUP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_HAPLOGROUP","realtime":149000,"start":1767402595000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":85},"utcTime":"2026-01-03T01:12:24Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402744000,"cpus":2,"exit":0,"hash":"de/000099","memory":2147483648,"name":"OWNGENOME:ANCIENT_PCA (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_PCA","realtime":149000,"start":1767402595000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":99},"utcTime":"2026-01-03T01:12:24Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402744000,"cpus":2,"exit":0,"hash":"de/000106","memory":2147483648,"name":"OWNGENOME:MOCHA_CALL (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_CALL","realtime":149000,"start":1767402595000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":106},"utcTime":"2026-01-03T01:12:24Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000086","memory":2147483648,"name":"OWNGENOME:Y_PRIVATE (DEMO-001)","process":"OWNGENOME:Y_PRIVATE","start":1767402745000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":86},"utcTime":"2026-01-03T01:12:25Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000100","memory":2147483648,"name":"OWNGENOME:ANCIENT_REPORT (DEMO-001)","process":"OWNGENOME:ANCIENT_REPORT","start":1767402745000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":100},"utcTime":"2026-01-03T01:12:25Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000107","memory":2147483648,"name":"OWNGENOME:MOCHA_REPORT (DEMO-001)","process":"OWNGENOME:MOCHA_REPORT","start":1767402745000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":107},"utcTime":"2026-01-03T01:12:25Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402767000,"cpus":2,"exit":0,"hash":"de/000082","memory":2147483648,"name":"OWNGENOME:CYP2D6_DEPTH (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CYP2D6_DEPTH","realtime":236000,"start":1767402531000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":82},"utcTime":"2026-01-03T01:12:47Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000109","memory":2147483648,"name":"OWNGENOME:PGX_CONSENSUS (DEMO-001)","process":"OWNGENOME:PGX_CONSENSUS","status":"SUBMITTED","submit":1767402767000,"tag":"DEMO-001","task_id":109},"utcTime":"2026-01-03T01:12:47Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000109","memory":2147483648,"name":"OWNGENOME:PGX_CONSENSUS (DEMO-001)","process":"OWNGENOME:PGX_CONSENSUS","start":1767402768000,"status":"RUNNING","submit":1767402767000,"tag":"DEMO-001","task_id":109},"utcTime":"2026-01-03T01:12:48Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402774000,"cpus":2,"exit":0,"hash":"de/000079","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_PAINT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_PAINT","realtime":119000,"start":1767402655000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":79},"utcTime":"2026-01-03T01:12:54Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000080","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_REPORT (DEMO-001)","process":"OWNGENOME:ANCESTRY_FINE_REPORT","start":1767402775000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":80},"utcTime":"2026-01-03T01:12:55Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402785000,"cpus":2,"exit":0,"hash":"de/000109","memory":2147483648,"name":"OWNGENOME:PGX_CONSENSUS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:PGX_CONSENSUS","realtime":17000,"start":1767402768000,"status":"COMPLETED","submit":1767402767000,"tag":"DEMO-001","task_id":109},"utcTime":"2026-01-03T01:13:05Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000110","memory":2147483648,"name":"OWNGENOME:CPIC_LOOKUP (DEMO-001)","process":"OWNGENOME:CPIC_LOOKUP","status":"SUBMITTED","submit":1767402785000,"tag":"DEMO-001","task_id":110},"utcTime":"2026-01-03T01:13:05Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000110","memory":2147483648,"name":"OWNGENOME:CPIC_LOOKUP (DEMO-001)","process":"OWNGENOME:CPIC_LOOKUP","start":1767402786000,"status":"RUNNING","submit":1767402785000,"tag":"DEMO-001","task_id":110},"utcTime":"2026-01-03T01:13:06Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402804000,"cpus":2,"exit":0,"hash":"de/000110","memory":2147483648,"name":"OWNGENOME:CPIC_LOOKUP (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CPIC_LOOKUP","realtime":18000,"start":1767402786000,"status":"COMPLETED","submit":1767402785000,"tag":"DEMO-001","task_id":110},"utcTime":"2026-01-03T01:13:24Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000080","memory":2147483648,"name":"OWNGENOME:ANCESTRY_FINE_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCESTRY_FINE_REPORT","realtime":119000,"start":1767402775000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":80},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000086","memory":2147483648,"name":"OWNGENOME:Y_PRIVATE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:Y_PRIVATE","realtime":149000,"start":1767402745000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":86},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000087","memory":2147483648,"name":"OWNGENOME:CONSUMER_EXPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CONSUMER_EXPORT","realtime":599000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":87},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000090","memory":2147483648,"name":"OWNGENOME:BLOODTYPE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:BLOODTYPE","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":90},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000093","memory":2147483648,"name":"OWNGENOME:TRAITS (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:TRAITS","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":93},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000096","memory":2147483648,"name":"OWNGENOME:ARCHAIC_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ARCHAIC_REPORT","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":96},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000100","memory":2147483648,"name":"OWNGENOME:ANCIENT_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:ANCIENT_REPORT","realtime":149000,"start":1767402745000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":100},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000103","memory":2147483648,"name":"OWNGENOME:EXOMISER_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:EXOMISER_REPORT","realtime":199000,"start":1767402695000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":103},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402894000,"cpus":2,"exit":0,"hash":"de/000107","memory":2147483648,"name":"OWNGENOME:MOCHA_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:MOCHA_REPORT","realtime":149000,"start":1767402745000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":107},"utcTime":"2026-01-03T01:14:54Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767402945000,"cpus":2,"exit":0,"hash":"de/000108","memory":2147483648,"name":"OWNGENOME:COUPLE_CARRIER (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:COUPLE_CARRIER","realtime":599000,"start":1767402346000,"status":"COMPLETED","submit":1767402345000,"tag":"DEMO-001","task_id":108},"utcTime":"2026-01-03T01:15:45Z"} {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767403089000,"cpus":2,"exit":0,"hash":"de/000070","memory":2147483648,"name":"OWNGENOME:CPSR (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CPSR","realtime":794000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":70},"utcTime":"2026-01-03T01:18:09Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000071","memory":2147483648,"name":"OWNGENOME:CPSR_CDNA_CHECK (DEMO-001)","process":"OWNGENOME:CPSR_CDNA_CHECK","start":1767403090000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":71},"utcTime":"2026-01-03T01:18:10Z"} {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767403405000,"cpus":2,"exit":0,"hash":"de/000072","memory":2147483648,"name":"OWNGENOME:PRS_PREPARE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:PRS_PREPARE","realtime":1110000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":72},"utcTime":"2026-01-03T01:23:25Z"} @@ -332,26 +329,26 @@ {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767410097000,"cpus":4,"exit":0,"hash":"de/000068","memory":8589934592,"name":"OWNGENOME:VEP_NORM (DEMO-001)","peak_rss":3435973836,"process":"OWNGENOME:VEP_NORM","realtime":7802000,"start":1767402295000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":68},"utcTime":"2026-01-03T03:14:57Z"} {"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":4,"hash":"de/000069","memory":8589934592,"name":"OWNGENOME:VEP (DEMO-001)","process":"OWNGENOME:VEP","start":1767410098000,"status":"RUNNING","submit":1767402294000,"tag":"DEMO-001","task_id":69},"utcTime":"2026-01-03T03:14:58Z"} {"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767417900000,"cpus":4,"exit":0,"hash":"de/000069","memory":8589934592,"name":"OWNGENOME:VEP (DEMO-001)","peak_rss":3435973836,"process":"OWNGENOME:VEP","realtime":7802000,"start":1767410098000,"status":"COMPLETED","submit":1767402294000,"tag":"DEMO-001","task_id":69},"utcTime":"2026-01-03T05:25:00Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000112","memory":2147483648,"name":"OWNGENOME:CLINICAL_FILTER (DEMO-001)","process":"OWNGENOME:CLINICAL_FILTER","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":112},"utcTime":"2026-01-03T05:25:00Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000113","memory":2147483648,"name":"OWNGENOME:VCFANNO (DEMO-001)","process":"OWNGENOME:VCFANNO","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":113},"utcTime":"2026-01-03T05:25:00Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000114","memory":2147483648,"name":"OWNGENOME:VCFANNO_INDEX (DEMO-001)","process":"OWNGENOME:VCFANNO_INDEX","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":114},"utcTime":"2026-01-03T05:25:00Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000115","memory":2147483648,"name":"OWNGENOME:SLIVAR_PRIORITIZE (DEMO-001)","process":"OWNGENOME:SLIVAR_PRIORITIZE","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":115},"utcTime":"2026-01-03T05:25:00Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000116","memory":2147483648,"name":"OWNGENOME:SLIVAR (DEMO-001)","process":"OWNGENOME:SLIVAR","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":116},"utcTime":"2026-01-03T05:25:00Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000117","memory":2147483648,"name":"OWNGENOME:COMPHET_PHASE (DEMO-001)","process":"OWNGENOME:COMPHET_PHASE","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":117},"utcTime":"2026-01-03T05:25:00Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000112","memory":2147483648,"name":"OWNGENOME:CLINICAL_FILTER (DEMO-001)","process":"OWNGENOME:CLINICAL_FILTER","start":1767417901000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":112},"utcTime":"2026-01-03T05:25:01Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000113","memory":2147483648,"name":"OWNGENOME:VCFANNO (DEMO-001)","process":"OWNGENOME:VCFANNO","start":1767417901000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":113},"utcTime":"2026-01-03T05:25:01Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000115","memory":2147483648,"name":"OWNGENOME:SLIVAR_PRIORITIZE (DEMO-001)","process":"OWNGENOME:SLIVAR_PRIORITIZE","start":1767417901000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":115},"utcTime":"2026-01-03T05:25:01Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418042000,"cpus":2,"exit":0,"hash":"de/000115","memory":2147483648,"name":"OWNGENOME:SLIVAR_PRIORITIZE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:SLIVAR_PRIORITIZE","realtime":141000,"start":1767417901000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":115},"utcTime":"2026-01-03T05:27:22Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000116","memory":2147483648,"name":"OWNGENOME:SLIVAR (DEMO-001)","process":"OWNGENOME:SLIVAR","start":1767418043000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":116},"utcTime":"2026-01-03T05:27:23Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418173000,"cpus":2,"exit":0,"hash":"de/000112","memory":2147483648,"name":"OWNGENOME:CLINICAL_FILTER (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CLINICAL_FILTER","realtime":272000,"start":1767417901000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":112},"utcTime":"2026-01-03T05:29:33Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418184000,"cpus":2,"exit":0,"hash":"de/000116","memory":2147483648,"name":"OWNGENOME:SLIVAR (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:SLIVAR","realtime":141000,"start":1767418043000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":116},"utcTime":"2026-01-03T05:29:44Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000117","memory":2147483648,"name":"OWNGENOME:COMPHET_PHASE (DEMO-001)","process":"OWNGENOME:COMPHET_PHASE","start":1767418185000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":117},"utcTime":"2026-01-03T05:29:45Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418200000,"cpus":2,"exit":0,"hash":"de/000113","memory":2147483648,"name":"OWNGENOME:VCFANNO (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:VCFANNO","realtime":299000,"start":1767417901000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":113},"utcTime":"2026-01-03T05:30:00Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000114","memory":2147483648,"name":"OWNGENOME:VCFANNO_INDEX (DEMO-001)","process":"OWNGENOME:VCFANNO_INDEX","start":1767418201000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":114},"utcTime":"2026-01-03T05:30:01Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418326000,"cpus":2,"exit":0,"hash":"de/000117","memory":2147483648,"name":"OWNGENOME:COMPHET_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:COMPHET_PHASE","realtime":141000,"start":1767418185000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":117},"utcTime":"2026-01-03T05:32:06Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418500000,"cpus":2,"exit":0,"hash":"de/000114","memory":2147483648,"name":"OWNGENOME:VCFANNO_INDEX (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:VCFANNO_INDEX","realtime":299000,"start":1767418201000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":114},"utcTime":"2026-01-03T05:35:00Z"} -{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000118","memory":2147483648,"name":"OWNGENOME:HTML_REPORT (DEMO-001)","process":"OWNGENOME:HTML_REPORT","status":"SUBMITTED","submit":1767418500000,"tag":"DEMO-001","task_id":118},"utcTime":"2026-01-03T05:35:00Z"} -{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000118","memory":2147483648,"name":"OWNGENOME:HTML_REPORT (DEMO-001)","process":"OWNGENOME:HTML_REPORT","start":1767418501000,"status":"RUNNING","submit":1767418500000,"tag":"DEMO-001","task_id":118},"utcTime":"2026-01-03T05:35:01Z"} -{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767419100000,"cpus":2,"exit":0,"hash":"de/000118","memory":2147483648,"name":"OWNGENOME:HTML_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:HTML_REPORT","realtime":599000,"start":1767418501000,"status":"COMPLETED","submit":1767418500000,"tag":"DEMO-001","task_id":118},"utcTime":"2026-01-03T05:45:00Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000111","memory":2147483648,"name":"OWNGENOME:CLINICAL_FILTER (DEMO-001)","process":"OWNGENOME:CLINICAL_FILTER","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":111},"utcTime":"2026-01-03T05:25:00Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000112","memory":2147483648,"name":"OWNGENOME:VCFANNO (DEMO-001)","process":"OWNGENOME:VCFANNO","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":112},"utcTime":"2026-01-03T05:25:00Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000113","memory":2147483648,"name":"OWNGENOME:VCFANNO_INDEX (DEMO-001)","process":"OWNGENOME:VCFANNO_INDEX","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":113},"utcTime":"2026-01-03T05:25:00Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000114","memory":2147483648,"name":"OWNGENOME:SLIVAR_PRIORITIZE (DEMO-001)","process":"OWNGENOME:SLIVAR_PRIORITIZE","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":114},"utcTime":"2026-01-03T05:25:00Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000115","memory":2147483648,"name":"OWNGENOME:SLIVAR (DEMO-001)","process":"OWNGENOME:SLIVAR","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":115},"utcTime":"2026-01-03T05:25:00Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000116","memory":2147483648,"name":"OWNGENOME:COMPHET_PHASE (DEMO-001)","process":"OWNGENOME:COMPHET_PHASE","status":"SUBMITTED","submit":1767417900000,"tag":"DEMO-001","task_id":116},"utcTime":"2026-01-03T05:25:00Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000111","memory":2147483648,"name":"OWNGENOME:CLINICAL_FILTER (DEMO-001)","process":"OWNGENOME:CLINICAL_FILTER","start":1767417901000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":111},"utcTime":"2026-01-03T05:25:01Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000112","memory":2147483648,"name":"OWNGENOME:VCFANNO (DEMO-001)","process":"OWNGENOME:VCFANNO","start":1767417901000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":112},"utcTime":"2026-01-03T05:25:01Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000114","memory":2147483648,"name":"OWNGENOME:SLIVAR_PRIORITIZE (DEMO-001)","process":"OWNGENOME:SLIVAR_PRIORITIZE","start":1767417901000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":114},"utcTime":"2026-01-03T05:25:01Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418042000,"cpus":2,"exit":0,"hash":"de/000114","memory":2147483648,"name":"OWNGENOME:SLIVAR_PRIORITIZE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:SLIVAR_PRIORITIZE","realtime":141000,"start":1767417901000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":114},"utcTime":"2026-01-03T05:27:22Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000115","memory":2147483648,"name":"OWNGENOME:SLIVAR (DEMO-001)","process":"OWNGENOME:SLIVAR","start":1767418043000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":115},"utcTime":"2026-01-03T05:27:23Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418173000,"cpus":2,"exit":0,"hash":"de/000111","memory":2147483648,"name":"OWNGENOME:CLINICAL_FILTER (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:CLINICAL_FILTER","realtime":272000,"start":1767417901000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":111},"utcTime":"2026-01-03T05:29:33Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418184000,"cpus":2,"exit":0,"hash":"de/000115","memory":2147483648,"name":"OWNGENOME:SLIVAR (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:SLIVAR","realtime":141000,"start":1767418043000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":115},"utcTime":"2026-01-03T05:29:44Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000116","memory":2147483648,"name":"OWNGENOME:COMPHET_PHASE (DEMO-001)","process":"OWNGENOME:COMPHET_PHASE","start":1767418185000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":116},"utcTime":"2026-01-03T05:29:45Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418200000,"cpus":2,"exit":0,"hash":"de/000112","memory":2147483648,"name":"OWNGENOME:VCFANNO (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:VCFANNO","realtime":299000,"start":1767417901000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":112},"utcTime":"2026-01-03T05:30:00Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000113","memory":2147483648,"name":"OWNGENOME:VCFANNO_INDEX (DEMO-001)","process":"OWNGENOME:VCFANNO_INDEX","start":1767418201000,"status":"RUNNING","submit":1767417900000,"tag":"DEMO-001","task_id":113},"utcTime":"2026-01-03T05:30:01Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418326000,"cpus":2,"exit":0,"hash":"de/000116","memory":2147483648,"name":"OWNGENOME:COMPHET_PHASE (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:COMPHET_PHASE","realtime":141000,"start":1767418185000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":116},"utcTime":"2026-01-03T05:32:06Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767418500000,"cpus":2,"exit":0,"hash":"de/000113","memory":2147483648,"name":"OWNGENOME:VCFANNO_INDEX (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:VCFANNO_INDEX","realtime":299000,"start":1767418201000,"status":"COMPLETED","submit":1767417900000,"tag":"DEMO-001","task_id":113},"utcTime":"2026-01-03T05:35:00Z"} +{"event":"process_submitted","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000117","memory":2147483648,"name":"OWNGENOME:HTML_REPORT (DEMO-001)","process":"OWNGENOME:HTML_REPORT","status":"SUBMITTED","submit":1767418500000,"tag":"DEMO-001","task_id":117},"utcTime":"2026-01-03T05:35:00Z"} +{"event":"process_started","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"cpus":2,"hash":"de/000117","memory":2147483648,"name":"OWNGENOME:HTML_REPORT (DEMO-001)","process":"OWNGENOME:HTML_REPORT","start":1767418501000,"status":"RUNNING","submit":1767418500000,"tag":"DEMO-001","task_id":117},"utcTime":"2026-01-03T05:35:01Z"} +{"event":"process_completed","runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","trace":{"attempt":1,"complete":1767419100000,"cpus":2,"exit":0,"hash":"de/000117","memory":2147483648,"name":"OWNGENOME:HTML_REPORT (DEMO-001)","peak_rss":858993459,"process":"OWNGENOME:HTML_REPORT","realtime":599000,"start":1767418501000,"status":"COMPLETED","submit":1767418500000,"tag":"DEMO-001","task_id":117},"utcTime":"2026-01-03T05:45:00Z"} {"event":"completed","metadata":{"workflow":{"success":true}},"runId":"00000000-0000-0000-0000-00000000d001","runName":"demo_run","utcTime":"2026-01-03T05:45:30Z"} {"event":"pgp_run_finished","exit":0,"utcTime":"2026-01-03T05:46:00Z"}
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Structural variants (Manta): STALE: why: <b>&'"
    +
    Structural variants (Delly): STALE: why: <b>&'"
    +
    SV consensus merge: STALE: why: <b>&'"
    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    STALE: why: <b>&'"
    +
    StatusStale
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrY or chrXmaybe <b>
    +
    Why
    +

    From depth: estimated share of the cells that lost one X 5.0% (95% range ? to ?); to autosome depth ratio ?, None expected

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrYnot estimated
    +
    Whytoo few reads on chrY
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    STALE: from an older run <b>
    +
    chrYan extra copy, not a loss
    +
    Whydepth above 1
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Failed · file date 2021-03-04 05:06 UTC · link to this section

    +
    FAILED: step 33 failed
    +
    StatusFailed
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrYdetected
    +
    Whydepth below the floor
    +

    From depth: estimated share of the cells that lost the Y 28.8% (95% range 25.0% to 33.0%); chrY to autosome depth ratio 0.712, None expected

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Loss of chrY in a share of the blood cells of men, and of one chrX in women, becomes more common with age. Population studies link loss of Y with smoking and with higher rates of heart disease and some cancers; loss of X is less studied. That is a population-level association, not a diagnosis for one person. Below about 10% of the cells nothing can be told at 30x (docs/33-sample-qc.md).

    +
    chrXdetected
    +
    Whyallele fraction <off> & depth
    +

    From chrX allele fractions at 40 heterozygous sites: 12.5% (95% range 10.0% to ?)

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +
    STALE: older export
    +

    Sites with a genotype: 590000 of 0; '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar hits by review stars4 stars: 0 hits with 4 review stars4 stars03 stars: 2 hits with 3 review stars: BRCA1,NBR2 chr17:43057100 C>T, HFE chr6:26092913 G>A3 stars22 stars: 3 hits with 2 review stars: MUTYH chr1:45331556 C>T, HBA1 chr16:176700 G>A, SMN1 chr5:70951946 C>T2 stars31 star: 1 hit with 1 review star: BTD chr3:15645186 G>C1 star10 stars: 2 hits with 0 review stars: . chr2:100 A>G, GLA chrX:101398000 C>T0 stars2Low-confidence, not counted: 2 calls with GQ below 20 or DP below 8: listed in the hits, not counted in the starsLow-confidence, not counted2
    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, caller support not known (step 22's consensus cannot tell)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)N/A / N/A
    +
    Delly SVs (total / PASS)N/A / N/A
    +
    CNVpytor CNVsN/A
    +
    CNVpytor significant (e-val < 0.01)N/A
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 6 (single caller: 0, not known: 6; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:45338000-453400005MUTYHnot known (step 22's consensus cannot tell)on exon edges: 1:45338000-45340000
    DEL chr2:47386000-473880004EPCAMnot known (step 22's consensus cannot tell)nonechr2:47386000-47388000
    DUP 17:43000000-431000004BRCA1, NBR2not known (step 22's consensus cannot tell)benign-set AF 0.001 (gnomAD)17:43000000-43100000
    DEL 13:20180000-202000005GJB2, NOTAGENEnot known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 13:20180000-202000004GJB2, XYZ1not known (step 22's consensus cannot tell)none13:20180000-20200000
    DEL 3:15600000-157000005BTDnot known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common3:15600000-15700000
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    DEL 3:15600000-1570000053BTDnot namedno detail3:15600000-15700000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 8 finding(s), 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic: CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +
    STALE: why: <b>&'"
    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    STALE: why: <b>&'"
    +
    StatusStale
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    STALE: why: <b>&'"
    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    STALE: why: <b>&'"
    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +
    STALE: why: <b>&'"
    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    STALE: why: <b>&'"
    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +
    STALE: why: <b>&'"
    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Stale · file date 2021-03-04 05:06 UTC · link to this section

    +
    STALE: why: <b>&'"
    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · New since 2026-01-01T00:00:00Z · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    ProstatePGS215/6not applicable to the declared sex (male-specific score)
    BreastPGS327/940 (AFR)no published OR or HR for AFR
    HeightPGS431/260 (AFR)no published OR or HR for AFR; evaluated in EUR, AFR
    +

    Percentile: where the score falls among the AFR samples of the reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md. Rows on chrX were left out, because the sample's sex was not given: PGS3 (3). Give the sex to score them (docs/25-prs.md). No sex was declared, so these sex-specific scores are shown for any sex: PGS3 (female). Give the sex to mark a score of the other sex not applicable (docs/25-prs.md).

    +
    Polygenic risk score percentiles0255075100Prostate (PGS2): no percentile: not applicable to the declared sex (male-specific score)Prostate (PGS2)no percentileBreast (PGS3): 40 (AFR)Breast (PGS3)40Height (PGS4): 60 (AFR)Height (PGS4)60
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores (raw, not percentiles)

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentile
    CADPGS0000180.5100/120raw score only
    T2DPGS0000140.110/20raw score only
    +

    Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +

    Left out of the model: Oceania. The panel has fewer than 10 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomenone; not painted: RFMix failed on chr21
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +
    +
    +

    Y-STR Markers (HipSTR)

    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    Wide0%0% to 6%
    +

    Left out of the model: Oceania (continental and regional group), Papua (regional group), Odd (name) (x group), Plain. The panel has fewer than 12 unrelated reference people for it, so its ancestry is spread over the groups shown.

    +
    Painted genomeAfrica 30%, West Eurasia 70%
    + Chromosome painting: chromosomes 1 to 22, two haplotypes each, coloured by continental group +

    ■ Africa ■ West Eurasia (Europe, Middle East, North Africa) ■ Central and South Asia ■ East Asia ■ Americas (Native American) ■ Oceania ■ not painted

    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%Wide: Regional groups: 0% (bootstrap range 0% to 6%)Wide0%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Fine-Grained Ancestry

    +

    Step 26b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each name is a group of reference populations we put together and named, not a nationality. Continental groups are well apart; neighbouring regions are not: splits within Iberia are weak for every method, and Greek and Southern Italian ancestry overlap. Read a regional fraction with its bootstrap range. See docs/26b-ancestry-fine.md.

    +

    Continental groups

    + + + + +
    GroupFractionBootstrap range
    West Eurasia95%93% to 97%
    Africa5%.
    +

    Regional groups

    + + + +
    GroupFractionBootstrap range
    Iberia60%50% to 70%
    +
    Painted genomenone (no chromosome long enough)
    +
    Fine-grained ancestry, with bootstrap ranges0%25%50%75%100%Continental groupsWest Eurasia: Continental groups: 95% (bootstrap range 93% to 97%)West Eurasia95%Africa: Continental groups: 5%Africa5%Regional groupsIberia: Regional groups: 60% (bootstrap range 50% to 70%)Iberia60%
    +
    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    StatusComplete
    +
    HaplogroupH5a1
    +
    Contamination (haplocheck)no (level .)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/H5a1 (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/H5a1/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    HaplogroupR1b1a1b1a1a2*(xR-L21)
    +
    Markers40
    +
    QC-score0.98
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R1b1a1b1a1a2 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R1b1a1b1a1a2/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y Placement on the Current Public Tree

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    BranchR-Z2105
    +
    Level12
    +
    TreeISOGG 2026
    +

    Path SNPs: 30 derived, . ancestral, . no call; 400 SNPs called at depth . or more

    +
    LevelBranchDerivedAncestralNo callAncestral SNPs
    1A0-T1
    2R
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/y-dna/R-Z2105 (opens a website; the address carries the haplogroup)
    +
    YFull YTreehttps://www.yfull.com/tree/R-Z2105/ (opens a website; the address carries the haplogroup)
    + +
    +
    +

    Y-STR Markers (HipSTR)

    +

    Repeat counts read from the genome with HipSTR, in FamilyTreeDNA's Y-111 order. A count can differ from FamilyTreeDNA's by a fixed number of repeats at some markers, as labs count some repeat blocks differently: compare with a known result before trusting a difference. Multi-copy markers and repeats longer than the reads are not called. Every marker, with its reads and notes, is in y_str/<sample>_y_str.tsv; y_str/<sample>_y_str.csv is the same list for a spreadsheet.

    +

    Markers called: 1 high and 1 low confidence of 4; 1 no call, 1 not callable from short reads

    +
    PanelMarkerRepeatsConfidence
    Y-12DYS39313high
    Y-12DYS39024low
    Y-25DYS464.not callable
    +
    +
    +
    +
    +

    Archaic Ancestry (Neanderthal, Denisovan)

    +

    Step 43 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    An estimate from IBDmix against the Altai and Vindija Neanderthals and the Altai Denisovan: a segment counts when either copy carries it, and part of what any person gets is old shared ancestry, not gene flow (Africans get some too). Every segment: archaic/<sample>_archaic_segments.tsv; docs/43-archaic.md says where the numbers end.

    +
    Neanderthal2.00%
    +
    Denisovan0.01%
    +

    Neanderthal: 2.00% (50.0 Mb in 120 segments)

    +

    Denisovan: 0.01% (0.2 Mb in 3 segments)

    +

    Analysed: 2500.0 Mb of the autosomes; modern frequencies: 1000 Genomes CEU

    +

    Longest segments:

    +

    a

    +

    b

    +

    j

    +
    +
    +
    +
    +

    Ancient Populations

    +

    Step 44 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Closeness on this PCA is genetic similarity, not descent: a genome near an ancient group shares ancestry with it and does not descend from those people. qpAdm models are not part of step 44; docs/44-ancient.md says how to read the plot.

    +

    AADR v62: 500000 of . sites used; axes from . present-day West Eurasians, . ancient people in . groups projected.

    + + + + +
    #Ancient groupDatesCountryPlacePeople
    1Spain_BA2000 BCESpainx10
    2France_NFrance5
    + PC1 against PC2: present-day West Eurasians in grey, ancient people coloured by age, the sample marked +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores

    +

    Step 25 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    + + + + +
    ConditionPGSScoreVariants matchedPercentileEffect in your group
    CADPGS0000180.5100/12075 (EUR)HR 1.5 (EUR)
    T2DPGS0000140.110/20raw score only
    +

    Percentile: where the score falls among the EUR samples of the HGDP+1kGP reference panel, the group whose genetic ancestry is most similar to this sample's (pgsc_calc). The ancestry match is low-confidence: read the percentile with care. A percentile is not a risk. Effect: the odds ratio (OR) or hazard ratio (HR) a published evaluation of the score measured in people of the same reference group, in that evaluation's unit (its PGS Catalog PPM page says which). It describes the score in that group, not your own risk, and is shown only for a group the score was evaluated in. Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    Polygenic risk score percentiles0255075100CAD (PGS000018): 75 (EUR)CAD (PGS000018)75T2D (PGS000014): no percentileT2D (PGS000014)no percentile
    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-01-02 03:04 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Counts of the calls DeepVariant made against the reference. A whole genome usually holds 4 to 5 million, most of them common. PASS calls passed the caller's filter; a count says nothing about health on its own.

    +
    Total variants1
    +
    PASS variants1
    +
    SNPs0
    +
    Indels1
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searchedSeizure (HP:0001250), HP:0000001
    + + + + + +
    RankGeneInheritanceScoreSymptom matchVariantACMG (Exomiser)Linked diseaseViewer
    1GENE1AD0.90.8chr1-1-A-G 0/1
    missense p.X
    LPD1
    chr1-2-A-G 0/1
    stop p.Y
    PD1
    2GENE2AR0.50.4chr2-1-A-G 1/1
    splice c.1
    VUSD2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Structural Variants

    +

    Steps 04, 19, 18, 22, 05 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Filtered: e-value below 0.01, under half of the reads with mapping quality 0 (q0) and under half N bases (pN), no overlap with a centromere or heterochromatin band, and no chrY call when the declared sex is female.

    +

    Short reads find large deletions and duplications better than insertions and inversions, and the callers disagree on many events. The totals count every call, most of them common in the population; only the AnnotSV class 4 and 5 rows are graded for disease.

    +
    Manta SVs (total / PASS)3 / 1
    +
    Delly SVs (total / PASS)1 / 1
    +
    CNVpytor CNVs8
    +
    CNVpytor significant (e-val < 0.01)7
    +
    CNVpytor significant after filters4 (left out: 1 q0 0.5 or more, 1 over N gaps (pN 0.5 or more), 1 over a centromere or heterochromatin band); no declared sex, so chrY calls are kept
    +
    Consensus SVs (2+ callers)3
    +
    +
    +

    Structural Variants, Class 4 and 5 (AnnotSV)

    +

    A class 4 or 5 SV made by one caller, a deletion on the exon edges of a transcript (the reads of a processed transcript or cDNA aligned across an intron) or one at 1% or more in AnnotSV's benign set is unlikely to be a rare pathogenic SV: check the reads before acting on it (docs/05-annotsv.md). Step 05's rules (assets/sv_rule_regions.tsv and the read-depth check) move a class 4 or 5 call to class 3 when it lies in a coding tandem repeat, an immunoglobulin or T-cell receptor locus or the MHC, names a pseudogene by a disease gene's alias, or its read depth does not show the change; those calls are listed apart with the reason and are not counted here.

    +
    StatusComplete
    +

    Class 4-5 SVs: 3 (single caller: 0, not known: 3; deletions on exon edges: 1; common: 1)

    +

    Moved to class 3 by step 05's rules, not counted above: 1

    +
    SVClassGenesCallersChecksViewer
    DEL 1:1100-51005GENE1, GENE2not known (step 22's consensus cannot tell)on exon edges: exon 2; benign-set AF 0.001 (gnomAD)1:1100-5100
    DUP 2:150-8804GENE3not known (step 22's consensus cannot tell)none2:150-880
    DEL 9:1-1004G9not known (step 22's consensus cannot tell)benign-set AF 0.2 (gnomAD), common9:1-100
    +

    Moved to class 3 by step 05's rules

    +
    SVAnnotSV classClassGenesRuleWhyViewer
    INV 7:1-10043no genemhcthe MHC7:1-100
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called3 (ALU 2, L1 1)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFukuyamaARcallable30not seen
    TAF1SVAXDPXLnot callable2.
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Not graded: the repeat catalog gives these loci no thresholds (for MUC1, CEL, TYMS and PLIN4 the reference repeat is longer than 300 bases, so no short read spans it), so Stranger gives them no status. Not graded is not normal (docs/09-str-expansions.md).

    +

    RFC1: Stranger's catalog sizes the degenerate AARRG unit and flags a low count, so the motif decides. The motif count reads the reads at the locus; it cannot size a long expansion.

    +

    Repeat-expansion calls from short reads can be wrong at some loci, and a long expansion cannot be sized. Disease thresholds: docs/results/structural-and-repeats.md.

    +
    StatusComplete
    +
    Outside the normal range (Stranger)2
    +
    Not sized from short reads (not counted as normal)5
    +
    Not graded (no thresholds in the catalog)EXTRA1
    +
    CFTR intron 9 (legacy IVS8) TG and poly-T tractTG11/TG12 5T/7T
    +

    5T: 1 copy with the 5T poly-T tract, TG11 or TG12 on the 5T copy, not told by the counts (TG11-5T/TG12-7T or TG12-5T/TG11-7T). 5T lowers the splicing of exon 10 and is a variable-penetrance allele: with TG12 or TG13 on the same copy it more often causes CBAVD or another CFTR-related disorder when the other copy carries a CF-causing variant. One R117H copy and one 5T copy: phase unknown. R117H lies 17.6 kb from the tract, farther than a read pair spans, so whether they share a copy (in cis, a CF-causing allele of variable penetrance) or not (in trans) is not read; testing a parent tells them apart. (Deignan et al. 2020, PMID 32404922)

    +
    UGT1A1 promoter TA repeat*1/*28
    +

    *1/*28 (TA6/TA7, 7/8 TA units as ExpansionHunter counts them): 1 decreased-function allele (*28 and *37 are decreased function). PharmCAT (step 7) called *1/*28: the same number of *28 and *37 copies. (Gammal et al. 2016, PMID 26417955)

    +
    SLC6A4 5-HTTLPR promoter length polymorphismnot tested
    +

    not tested by any step. CPIC's 2023 SSRI guideline (Bousman et al. 2023, PMID 37032427) found that the data on SLC6A4 do not support its use in antidepressant prescribing, so a result would carry no recommendation. (Bousman et al. 2023, PMID 37032427)

    +

    FMR1 motif count: interrupted: AGG

    +

    RFC1 motif count: pathogenic: AAGGG dominant

    +
    LocusRepeat CountStrangerNotes
    DMPKnot in output
    HTT17/20normal,normalnormal max 26
    FMR158premutationlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 55-60; normal max 44; FMR1 motif count: interrupted: AGG
    C9ORF72.no call
    ATXN130/37not sizedsize not determined (flanking reads only), interval 30-30/35-40; normal max 35
    CFTR_T5/7
    CFTR_TG11/12
    EXTRA18/9not gradedlow confidence (fewer than 2 spanning reads, or the interval reaches the disease range), interval 8-8/9-9; no thresholds in the catalog (no published range)
    RFC1>=400/>=500full_mutationlonger than a read (in-repeat reads only): shown as at least the interval's lower end, interval 400-700/500-800
    UGT1A17/8normal
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnegative
    +

    Result: negative

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    none

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Length heteroplasmy in the D-loop poly-C tracts is found in most people and is usually technical; it is listed here and not counted as heteroplasmy.

    +

    A single large mtDNA deletion is often found in muscle and not in blood (except in Pearson syndrome), so a blood sample with none does not rule one out (docs/20-mtoolbox.md).

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    Heteroplasmic chrM sites00.51m.1m.4000m.8000m.12000m.16569position on chrM; height: allele fractionm.3243A>G: allele fraction 0.4chrM:302 A>AC,ACC (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.3; not counted as heteroplasmicchrM:16189 T>C (D-loop poly-C tract): length heteroplasmy in a D-loop poly-C tract, allele fraction 0.5; not counted as heteroplasmic
    +
    chrM variants (PASS)7
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts2
    +

    chrM:302 A>AC,ACC AF 0.3

    +

    chrM:16189 T>C AF 0.5

    +
    ClinVar pathogenic or likely pathogenic1
    +
    VariantAFClinVarReviewConditiongnomAD AF homgnomAD AF hetPoly-C tractViewer
    chrM:3243 A>G0.40PathogeniccriteriaMELAS00chrM:3243
    chrM:302 A>AC0.3.....yeschrM:302
    chrM:500 C>T0.99Uncertain_significance....chrM:500
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    ClinVar 2026-10-01; gnomAD not annotated: no file

    +
    Confirmed disease variants3
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    m.8344A>G (MT-TK) AF 0.30 filter weak_evidence MERRF (myoclonic epilepsy with ragged-red fibres); ClinVar 9579; PMID 2112427. Usually heteroplasmic; the level differs between tissues.

    +

    m.11778G>A (MT-ND4) AF 0.99 filter PASS Leber hereditary optic neuropathy (LHON); ClinVar 9708; PMID 3201231. Usually homoplasmic; not everyone who carries it loses vision.

    +
    Large deletions (eKLIPse)3
    +
    Named in the confirmed list1
    +

    m.8470_13446del (4977 bp) level 0.5% The common 4977 bp deletion, between two 13 bp direct repeats: Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia (CPEO), Pearson syndrome; ClinVar 430680 (m.8483_13459del); PMID 2711184, 2541333, 20301382

    +

    m.101_199del (None bp) level 2.5%

    +
    mtDNA copies per cellnot assessed
    +

    mtDNA copy number: not assessed (unknown)

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +
    Genetic sign of high Lp(a)Yes
    +

    KIV-2 repeats (both chromosomes): 35 (95% interval 30 to 40), low

    +

    ok

    +

    KIV-2 4925G>A null allele (rs1484919544): present, 4 of 200 reads carry it

    +

    .

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: A/G (1 risk allele)

    +

    rs3798220: T|C (1 risk allele)

    +

    Genetic signs of a high Lp(a): 2 risk alleles at rs10455872 and rs3798220 and a low KIV-2 repeat count. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls1
    +

    DNMT3A R882H: VAF 0.05 (3 of 60 reads), .

    +

    Detection limit: a clone of VAF about 10% or more is found 8 times in 10 at this depth (median 33x over the genes' coding exons). CHIP starts at a VAF of 2%: smaller clones are likely missed, so no call does not rule one out.

    +

    Too shallow or not on the reference: ASXL1, SRSF2.

    +

    1 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Loss of Chromosome Y or X

    +

    Step 33 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    Calls reported1
    +
    Cell-fraction floor0.05
    +
    TypeArmRegionMbCell fractionViewer
    Lossqchr20:1-2100.1chr20:1-2
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    Reported at a cell fraction of 0.05 or more at 30x (read-sampling floor ., minimum .; . heterozygous sites on .)

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Couple Carrier Screen

    +

    Step 39 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A screen, not a diagnosis: the couple report (couple_<a>_<b>.md in the family folder) lists the genes, variant types and repeats it does not see. These counts are of its gene table: a carrier deletion allele from read depth (step 35), and a possible shared risk it adds, is in that report only. See a genetic counsellor before acting on a result, or on its absence (docs/39-couple.md).

    +

    Partner: P2. Genes where both carry a change: 1; X-linked findings: 1; genes where only one partner carries a change: 2

    +

    Shared: CFTR (Cystic fibrosis): 1 in 4. This sample: c.1521_1523del (P). P2: c.350G>A (LP)

    +

    X-linked: DMD (Duchenne): 1 in 4 sons. This sample: c.10G>T (P). P2: .

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN12calledok
    SMN22called.
    HBA11called.
    HBA22called.
    PMS22called.
    +
    SMN1 by both toolsParaphase 2, Parascopy 1 (quality 31, filter PASS): they DISAGREE: check both before using either
    +
    Other Paraphase regions2 (1 with a call)
    +
    Variants on phased haplotypes3
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    The other loci of step 35's catalog (assets/paralog_loci.tsv): agCN is the copies of the gene and its paralogs together, read only with filter PASS and quality 20 or more; which copy gained or lost one is not said. Not assessed names the reason (most often: no read over the locus).

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 31, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not seen, 0 of 31 reads carry it, about 0 copies
    +
    SMN1 marker readingno read carries the G
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 25, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 45.5, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth). (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites). CYP21A2 copies, module total 4 of ., finding none
    +
    HP (haptoglobin) copies (from depth)2 (estimate 2.1). Reading: usual
    +
    LCE3B/LCE3C copies (from depth)1 (estimate 1.0). Reading: one deleted
    +
    CCL3L1/CCL3L3 copies (from depth)not assessed (low depth)
    +
    GenesCopies together (agCN)Reading
    GBA1, GBAP14 (2 region(s), quality 35.25 or more, filter PASS)agCN of GBA1 and its pseudogene GBAP1 together, usually 4; under 4 means a copy is missing, as a recombinant GBA1-GBAP1 allele (Gaucher disease) can leave; over 4, an extra copy
    STRC, STRCP1unreadable: S_strc_copy_number.tsv lacks the copy-number columns.
    mytablenot assessed: no read over the locus.
    pms2chr7:5970001-5980000 4 (quality 50, filter PASS); chr7:5980001-5990000 3 (quality 12, filter LowQual).
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)4 rows (3 called, 1 not assessed); 2 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    AZFcAZFcchrY:23000001-260000000 of 1deletion
    dupX1chr1:2-23 of 2duplication
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result0
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + +
    GeneDiplotypePhenotype
    UGT1A1*1/*28Intermediate
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    CYP2D6 Across Callers

    +

    Steps 32, 21 · Not run · link to this section

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)not run
    +
    pypgxnot run
    +
    Cyriusnot run
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Information about alleles, not a diagnosis: each line is an association reported in the cited study. Carrying an allele does not mean the condition or reaction will happen, and not carrying it does not rule it out. The genotypes are unphased.

    +

    HLA typing from short-read WGS is approximate. If either HLA-A or HLA-B allele has a T1K quality of 0 or less, that gene is not passed to PharmCAT (step 36).

    +

    KIR genotypes as T1K typed them. No step interprets them: they matter for transplant matching and some immune conditions, not for drug guidance.

    +
    HLA-AA*02:01:01 (quality 60) / A*01:01:01 (quality 50)
    +
    HLA-BB*57:01:01:02 (quality 0) / no confident call (5 candidates, quality 0); low confidence (T1K quality 0 or below), not passed to PharmCAT
    +
    HLA-CC*07:01:01 (quality 40)
    +
    HLA-DQA1DQA1*05:01:01 (quality 40) / DQA1*02:01 (quality 30)
    +
    HLA-DQB1DQB1*02:01:01 (quality 40) / DQB1*02:02:01 (quality 30)
    +
    HLA-DRB1DRB1*03:01:01 (quality 40) / DRB1*07:01:01 (quality nan)
    +
    HFEHFE*001 (quality 20) [T1K sequence allele, not the HFE C282Y/H63D genotype: that genotype comes from the variant calls (ClinVar section)]
    +

    Coeliac DQ: DQ2.5 present, likely cis (DRB1*03 present); DQ2.2 present; DQ8 absent

    +

    DQB1*02 copies: 2

    +

    A*31:01 absent: carbamazepine hypersensitivity reactions in Europeans (McCormack 2011, N Engl J Med)

    +

    C*06:02 absent: psoriasis (Nair 2006, Am J Hum Genet)

    +

    DQB1*06:02 absent: narcolepsy with cataplexy (Mignot 2001, Am J Hum Genet)

    +

    DRB1*15:01 absent: multiple sclerosis (Barcellos 2003, Am J Hum Genet)

    +

    DRB1*01:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:01 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:04 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:05 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*04:08 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    DRB1*14:02 absent: rheumatoid arthritis, shared epitope allele (Gregersen 1987, Arthritis Rheum)

    +

    B*15:02 not determined (HLA-B low confidence): carbamazepine Stevens-Johnson syndrome in Han Chinese (Chung 2004, Nature)

    +

    B*57:01 not determined (HLA-B low confidence): abacavir hypersensitivity; flucloxacillin liver injury (Mallal 2008, N Engl J Med; Daly 2009, Nat Genet)

    +

    B*58:01 not determined (HLA-B low confidence): allopurinol severe skin reactions (Hung 2005, Proc Natl Acad Sci U S A)

    +

    B*27 not determined (HLA-B low confidence): ankylosing spondylitis (Brewerton 1973, Lancet; Schlosstein 1973, N Engl J Med)

    +
    HLA databaseunknown
    +
    HLA-A: T1K vs OptiTypeagree: T1K A*02:01, OptiType A*02:01
    +
    HLA-B: T1K vs OptiTypeagree: T1K B*57:01, OptiType B*57:01 (ok)
    +
    KIR2DL1KIR2DL1*001 (quality 30) / KIR2DL1*002 (quality 20)
    +

    No allele called (absent, or too few reads): KIR3DL3

    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    Loci called4 of 5 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h1 + h2 (quality 30, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K (step 08): DRB1*03:01:01/DRB1*07:01:01
    KIRk1 + k2 (quality 20, 1 of 100 reads unexplained, weighted distance 0.1; filter pass)passT1K KIR pass (step 08): 1 genes typed
    CYP2D6not called: low depthfailpypgx (step 32) and Cyrius (step 21) did not run
    FCGRf + f (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter fail: q)failno other step calls FCGR
    ZZZz + z (quality 9, 1 of 1 reads unexplained, weighted distance 1; filter pass)passno other step calls this locus
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · file date 2021-03-04 05:06 UTC · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Long runs concentrated on one chromosome, with few elsewhere, are the sign of isodisomy: both copies of that chromosome from one parent. They can also be chance in a child of related parents. Which parent gave both copies cannot be told without the parents' samples, and a heterodisomy (two different copies from one parent) leaves no runs at all. The parents' genotypes confirm a UPD. Where an imprinted region is listed, a methylation test of that region tests for its imprinting disorder; on its own it does not prove a UPD (docs/11-roh-analysis.md).

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    Runs of homozygosity, ClinVar hits, structural variants and mosaic alterations on the chromosomes12345678910111213141516171819202122XYRun of homozygosity chr2:10000001-17000000: 7.0 MB run of homozygosity at chr2:10000001-17000000Run of homozygosity chr15:23000001-50000000: 27.0 MB run of homozygosity at chr15:23000001-50000000DEL 1:1100-5100 (AnnotSV class 5): AnnotSV class 5 DEL, -4000 bp, genotype 0/1, genes: GENE1, GENE2DUP 2:150-880 (AnnotSV class 4): AnnotSV class 4 DUP, 730 bp, genotype 1/1, genes: GENE3DEL 9:1-100 (AnnotSV class 4): AnnotSV class 4 DEL, 99 bp, genotype ., genes: G9MoChA Loss chr20:1-2: mosaic Loss over 10 Mb, cell fraction 0.1run of homozygosity, 5 MB or moreClinVar hitlow-confidence ClinVar callAnnotSV class 4 or 5 SVmosaic alteration (MoChA), a share of cells
    +
    StatusComplete
    +
    ROH total37.5 MB
    +
    ROH largest segment27.0 MB
    +
    Segments3
    +
    Autosomal ROH > 5 MB2
    +

    chr2:10000001-17000000 7.0MB

    +

    chr15:23000001-50000000 27.0MB

    +

    F_ROH: 0.0128 (34.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +

    ** chr15 carries 27.0 MB, more than 50% of the length in runs of 5 MB or more: both copies may come from one parent (uniparental isodisomy) **

    +

    Imprinted 15q11-q13 (SNRPN, UBE3A): from the mother: -; from the father: - (PMID 22237428;27615419)

    +

    Left out in centromere and heterochromatin bands: 46.5 MB

    +

    Segments on chrX/chrY, not counted: 1

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele3 / 1 / 1
    + + + + + + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    A/Gone copy
    .
    PMID 1
    Lp(a)LPA
    rs3798220
    T|Cone copy
    .
    PMID 1
    R117HCFTR
    rs78655421
    G/Aone copy
    .
    PMID 1
    xX
    rs1
    .no reads
    .
    PMID 1
    xX
    rs2
    C/Cother
    .
    PMID 1
    xX
    rs3
    C/TA low-quality call at this position (genotype quality 5, below 20): not read; check the reads.
    .
    PMID 1
    +

    Genotype rules (several sites read together)

    + + + + +
    TraitGene and sitesGenotypesResultReadingSource
    bitterTAS2R38
    rs1
    C/GPAV/AVI (not phased)taster
    .
    PMID 1
    kidneyAPOL1
    rs73885319, rs60910145
    A/G, T/TG0/G1
    With G2: G1/G2
    one G1
    With G2: Two APOL1 risk copies (G1/G2): the high-risk genotype of Genovese 2010, which went with focal segmental glomerulosclerosis and hypertension-attributed kidney failure in African Americans. A risk factor, not a diagnosis.
    G2 (rs71785313): 1 copy of the deletion called.
    .
    PMID 20647424
    +

    Every rule line: traits/S_genotype_rules.tsv

    +
    APOE and Alzheimer's disease: a risk factor, not a diagnosis. Many people choose not to learn their APOE result; docs/42-traits.md explains it. Open to show it. + + + +
    TraitGeneGenotypeReadingSource
    APOEAPOE
    rs429358
    T/Ce3/e4
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Blood Groups (predicted)

    +

    Step 41 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Predicted from the DNA at the variants that define each antigen, not typed from blood. RhD comes from the read depth over RHD; weak and partial D are not assessed. The evidence for each site is in bloodtype/<sample>_bloodtype_evidence.tsv.

    +
    ABOA
    +
    RhDRhD positive
    +
    SystemPredicted phenotypeGenotypeConfidence
    ABOAA1/O1high
    RhDRhD positive.medium
    Kell.K-/k+.
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content1.5
    +

    Intratelomeric reads: 40 (floor 2,000 at 30.0x)

    +
    Warningtoo few telomeric reads for a stable estimate; do not compare this value.
    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6inherited integrated HHV-6B likely
    +
    VirusCallReadsBreadthDepth / humanCopies per cell
    phiXspike-in5001.0..
    HHV-6Binherited integrated HHV-6 likely20000.991.01.0
    +
    +
    +
    +
    +

    Raw-Data Export (23andMe v5 layout)

    +

    Step 40 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    These files stay on this machine. Uploading one to a service shares your genotypes with it, and with the relatives it matches you to: docs/40-export-consumer.md says what to weigh first.

    +

    Sites with a genotype: 590000 of 600000 (98.3%); '--' at 10000

    +

    Homozygous reference from the gVCF's reference blocks: 0

    +

    Files: consumer_export/S_23andme.txt and consumer_export/.

    +

    '--' because: low depth 9000; filtered 1000

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • ClinVar screen
    • +
    • PharmCAT
    • +
    • pypgx
    • +
    • Cyrius (CYP2D6)
    • +
    • Cancer predisposition (CPSR)
    • +
    • Clinical variant filter
    • +
    • Variant prioritization (slivar)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    +
    +
    +
    +
    +
    +

    Genes and rsIDs in these results

    +

    Where in this report does a gene or an rsID come up?

    +
    +
    +
    +

    Every gene symbol and rsID a section of this report names, with the sections that name it and how many times. A gene listed here is a gene the results mention, not a finding: open the section to see what it says. The genes of the clinical filter (step 23) and variant prioritization (step 31) come from their tables, which the report counts but does not list.

    + +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Not run · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnot available
    +
    Inferred sex (indexcov)not available
    +
    Declared sexnot declared
    +
    Identity and contamination (step 33)Not run
    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    Loci with spliced reads (cDNA scan)1
    +
    Hits at a known lab-construct site (check the reads)1
    +
    Flagged by the cDNA read check1
    +
    ClinVar file dateunknown
    +

    gnomAD AF from vep/S_vep.vcf.gz: 2 hit(s) above 1%

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualitycDNA read checkViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF 0.008low-confidence call (GQ 15, DP 30): check the readsnot checked: not in the read-check tablechr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownnot checked: not in the read-check tablechr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF 0.06; common: unlikely to be a high-penetrance findingnot checkedchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF 0.002known lab-construct site (yes): possible cDNA/transgene contamination: check the reads (6 of 12 alt reads and 0 of 10 ref reads clipped at an exon edge)chr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownnot checked: not in the read-check tablechr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF 0.03; common: unlikely to be a high-penetrance findinglow-confidence call (GQ 40, DP 5): check the readsnot checked: not in the read-check tablechr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownnot checked: not in the read-check tablechr3:15645186
    chr2100AGhet...0gnomAD AF unknownnot checked: not in the read-check tablechr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownnot checked: not in the read-check tablechrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +

    Known Deep Intronic Sites and the cDNA Scan

    +

    Known pathogenic deep intronic sites, reported on every run: they lie far from any exon, so most filters miss them. 'ref' with a GQ is a reference call, 'ref (low confidence)' one below the call floor; 'no call' says nothing either way.

    +

    A locus with reads that jump from one exon to the next is spliced DNA: cDNA or plasmid contamination, or a processed copy of the gene the person carries. Check the reads before trusting a variant call there.

    + + + +
    GeneVariantPositionCallViewer
    CFTRc.3718-2477C>Tchr7:117639961 C>Tno callchr7:117639961
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +

    cDNA scan of every exon: 1 loci with reads across two or more exon junctions (2 genes with spliced reads)

    + + + +
    LocusJunctionsReadsViewer
    chr1:100-20025chr1:100-200
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants5
    +
    Genes3
    +
    . impact1
    +
    HIGH impact3
    +
    MODERATE impact1
    +
    Frequency unknown (not rare)1
    +
    Weak genotype calls2
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenic; biallelic with DEL chr1:45338000-45340000 (AnnotSV class 5, Manta): in trans: read-backed phase puts them on different copies (phase set 45331000)chr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    MSH2DEL chr2:47386000-47388000.AnnotSV class 4, single caller (Delly); through EPCAM exons 8 and 9, the 3' end (ENST00000263735); A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47386000-47388000
    BRCA1DUP chr17:43000000-43100000.AnnotSV class 4, single caller (CNVpytor)chr17:43000000-43100000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    Likely_Pathogenic1
    +
    VUS1
    +
    Benign1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 2

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1)

    +

    MSH2 2:47403000 A>G: final VUS, ClinVar B, CPSR's own LP

    +

    P/LP rows below the depth floor (DP below 8): 1

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); low-confidence call (DP 6): check the reads

    +

    cDNA read check of the P/LP rows (alt reads clipped at exon edges): 1 flagged

    +

    BRCA1 17:43057100 C>T: final Pathogenic (ClinVar), ClinVar Pathogenic, CPSR's own Likely_Benign (PVS1); reads: splice (5 of 5 alt reads and 0 of 9 ref reads clipped at an exon edge)

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Frequency unknown (not rare)1
    +
    Compound het candidates4 variants, 2 genes
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hemizygous (called homozygous inside one SMN1 copy (Parascopy, step 35)), ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic (low-confidence call): GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR), both copies may be hit: DEL chr13:20180000-20200000 (AnnotSV class 4, Manta) and chr13:20189473 C>T one copy, other copy not called ref (1/.); the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Possibly biallelic: HBA1 (Alpha-thalassemia; AR), both copies may be hit: 3 of 4 alpha-globin genes (read depth, step 35) and chr16:176700 G>A het; phase unknown, possibly in trans (no read-backed phase links the two calls)

    +

    Biallelic: MUTYH (MUTYH-related polyposis; AR), both copies may be hit: DEL chr1:45338000-45340000 (AnnotSV class 5, Manta) and chr1:45331556 C>T het; in trans: read-backed phase puts them on different copies (phase set 45331000)

    +

    Biallelic: SMN1 (Spinal muscular atrophy; AR), both copies may be hit: one SMN1 copy (Parascopy, step 35) and chr5:70951946 C>T hemizygous; the variant is called homozygous inside the deletion: hemizygous on the copy the deletion leaves if the deletion is real, homozygous if not; both copies carry it either way

    +

    Two hits across callers (a deletion plus a variant on the other copy): 5 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); step 35's HBA1/HBA2 count; Parascopy's SMN1 count (step 35)

    +
    +
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Steps 35b, 35 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copies1 (quality 30, filter PASS)
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copies3 (quality 30, filter PASS)
    +
    SMN1 and SMN2 together (agCN) at exon 74 (quality 40, filter PASS)
    +
    Readingone SMN1 copy: the pattern of an SMA carrier
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)3 (.; estimate .)
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    PharmCAT version3.4.0
    +
    PharmCAT vs pypgx conflicts1
    +
    +

    Files of this step, beside this report: PharmCAT HTML report

    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    StatusComplete
    +
    Genes with a non-normal phenotype1
    +
    Genes with more than one possible result1
    +
    Genes not called0
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +
    +

    Genes With a Non-Normal or Unresolved Phenotype (CPIC)

    + + + + +
    GeneDiplotypePhenotype
    CYP2D6*1/*4Intermediate Metabolizer
    CYP2C19*1/*17Rapid
    +
    WARNING: CYP2C19 has two possible phenotypes
    +
    WARNING: last
    +

    Drugs for each gene: cpic/S_cpic_recommendations.txt

    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +

    CYP2D6 depth check: ok; share of the depth at MAPQ >= 1 / >= 20: Cyrius's region with REP6 0.99 / not measured, gene body without REP6 not measured / 0.95

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    PharmCAT (step 36's call)*1/*4
    +
    pypgx*1/*2
    +
    Cyrius*2/*1
    +
    pypgx and Cyrius agreeyes
    +
    Step 36*1/*2
    +

    Passed to PharmCAT: pypgx and Cyrius agree

    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Coverage (mosdepth)
    • +
    • Gene callability (mosdepth)
    • +
    • Sex check (indexcov)
    • +
    • Sample identity and contamination (somalier, VerifyBamID2)
    • +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Paralog genes (Paraphase, PacBio HiFi)
    • +
    • HLA typing (T1K)
    • +
    • Polygenic risk scores
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Manta)
    • +
    • Structural variants (Delly)
    • +
    • Copy number (CNVpytor)
    • +
    • Repeat expansions (ExpansionHunter)
    • +
    • Telomere content (TelomereHunter)
    • +
    • Runs of homozygosity
    • +
    • Mitochondrial haplogroup
    • +
    • Y-chromosome haplogroup (Yleaf)
    • +
    • Y placement on the current public tree
    • +
    • Y-STR markers (HipSTR)
    • +
    • Raw-data export (23andMe v5 layout)
    • +
    • Blood groups (predicted)
    • +
    • Lp(a): LPA KIV-2 repeat count
    • +
    • MUC1 VNTR frameshifts (VNtyper)
    • +
    • Locityper second opinion at hard loci
    • +
    • Mitochondrial variants
    • +
    • Traits panel
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    • Viral DNA in the unmapped reads
    • +
    • Symptom-driven ranking (Exomiser)
    • +
    • Clonal haematopoiesis (CHIP)
    • +
    • Mobile element insertions (MEGAnE)
    • +
    • Mosaic chromosomal alterations (MoChA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • Mobile element insertions (Alu, L1 and SVA, the FKTN, TAF1 and BBS1 SVA insertions among them): not looked for (step 50, MEGAnE, is opt-in)
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +
    + +
    +
    +

    Genomic Analysis Report

    +
    + Sample: S  |  Generated: 2026-11-21 10:08 UTC  |  Latest run: 2020-01-01 00:00 UTC +
    +
    + Pipeline commit: unknown  |  ClinVar file: unknown  |  ClinVar in CPSR's bundle: unknown  |  HLA database: unknown +
    +
    + +
    +

    Quality

    +

    Can I trust this data?

    +
    +
    +
    +

    Quality Control

    +

    Steps 16b, 16, 33, 02 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +

    Mean depth is an average over the genome: some genes get far fewer reads, and the gene callability card lists those. The sex, identity and contamination checks catch a swapped or mixed sample, not every lab error.

    +
    Mean depthnanx
    +
    Inferred sex (indexcov)female
    +
    Declared sexfemale
    +
    Sex from the reads (somalier)male
    +
    Contamination (FREEMIX)0.0010 (warning above )
    +
    +
    +
    +
    +

    Genes This Genome Could Not Read Reliably

    +

    Step 16b · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A gene listed as not read could not be read reliably: too few of its reads were placed on it with confidence, so a 'no finding' in it says nothing. A gene with a caller of its own is left to that caller's section.

    +
    Genes read217 of 1572
    +
    Not read, no other caller1301
    +

    217 of the 1572 hard-to-read genes of assets/callability_genes.tsv were read: 90% or more of their bases had 10 or more reads of mapping quality 20 or more.

    +

    Not read, and no other step calls them (1301): OR4F5 (17%), OR4F29 (33%), OR4F16 (50%), AGRN (67%), ATAD3B (0%), MMP23B (0%), CDK11B (17%), SLC35E2B (33%), CDK11A (50%), TTC34 (67%), RPL22 (83%), MASP2 (0%), NPPA (17%), KIAA2013 (33%), PRAMEF1 (50%), PRAMEF11 (67%), HNRNPCL1 (83%), PRAMEF4 (0%), PRAMEF10 (17%), PRAMEF7 (33%), PRAMEF6 (50%), PRAMEF27 (67%), HNRNPCL3 (83%), HNRNPCL2 (0%), PRAMEF26 (17%), HNRNPCL4 (33%), PRAMEF9 (50%), PRAMEF13 (67%), PRAMEF18 (83%), PRAMEF8 (0%), PRAMEF33 (17%), PRAMEF15 (33%), PRAMEF14 (50%), PRAMEF19 (67%), PRAMEF17 (83%), CELA2B (0%), CLCNKA (17%), CLCNKB (33%), NBPF1 (50%), CROCC (67%), AKR7L (83%), NBPF3 (0%), CELA3B (17%), CELA3A (33%), HMGCL (50%), CNR2 (67%), RSRP1 (83%), PIGV (17%), XKR8 (33%), BMP8A (50%), BMP8B (67%), OXCT2 (83%), CYP4Z1 (0%), CYP4A22 (17%), GBP1 (33%), SETSIP (50%), AGL (67%), EXTL2 (83%), AMY2A (0%), NBPF4 (67%), NBPF6 (83%), LRIG2 (17%), VANGL1 (33%), IGSF3 (50%), SEC22B (83%), NBPF26 (0%), NOTCH2NLR (17%), PPIAL4A (33%), FAM72B (50%), SRGAP2C (67%), H3-7 (83%), PPIAL4E (0%), NBPF15 (17%), PPIAL4F (33%), SRGAP2B (50%), FAM72D (67%), PPIAL4D (83%), GPR89A (0%), RBM8A (17%), NBPF10 (33%), NOTCH2NLA (50%), PPIAL4H (67%), NBPF12 (83%), NBPF11 (0%), PPIAL4G (17%), NBPF14 (33%), NOTCH2NLB (50%), NUDT4B (67%), PDE4DIP (83%), NOTCH2NLC (0%), NBPF19 (17%), PPIAL4C (33%), H2BC18 (67%), H3C13 (83%), H3C14 (0%), H2AC18 (17%), H2AC19 (33%), H3C15 (50%), H4C15 (67%), HRNR (83%), LCE3E (0%), LCE3D (17%), S100A8 (33%), S100A7A (50%), S100A7 (67%), FLAD1 (83%), MTX1 (0%), HCN3 (33%), FCRL5 (50%), HSPA6 (83%), FCGR2B (33%), HSD17B7 (50%), CD247 (67%), XCL2 (83%), PRG4 (0%), PTPRC (50%), PPP1R12B (67%), KISS1 (83%), SRGAP2 (0%), CR1 (17%), CR1L (33%), ZC3H11B (50%), LBR (67%), LEFTY2 (83%), OR2T33 (0%), OR2T7 (17%), OR2T2 (33%), OR2T3 (50%), OR2T5 (67%), OR2G6 (83%), OR2T34 (0%), OR2T11 (17%), OR2T35 (33%), OR2T27 (50%), SNTG2 (67%), TPO (83%), KLF11 (0%), CCDC121 (17%), ABCG8 (33%), PCBP1 (50%), NAT8 (67%), C2orf78 (83%), CD8B (0%), RGPD1 (17%), PLGLB1 (33%), PLGLB2 (50%), RGPD2 (67%), RPIA (83%), TEKT4 (0%), FAHD2A (17%), TRIM43B (33%), TRIM43 (50%), ANKRD36C (67%), GPAT2 (83%), ANKRD36 (0%), ANKRD36B (17%), RGPD3 (33%), RGPD4 (50%), RANBP2 (67%), RGPD5 (83%), MALL (0%), MTLN (17%), LIMS4 (33%), RGPD6 (50%), ANAPC1 (67%), RGPD8 (83%), FOXD4L1 (0%), RABL2A (17%), RAB6C (33%), POTEF (50%), CCDC74B (67%), SMPD4 (83%), TUBA3E (0%), POTEI (17%), CFC1B (33%), CFC1 (50%), POTEJ (67%), PLEKHB2 (83%), RAB6D (0%), MZT2A (17%), TUBA3D (33%), CCDC74A (50%), ANKRD30BL (67%), NOSTRIN (83%), IFT70B (0%), CASP10 (17%), ALPP (33%), ALPG (50%), UGT1A6 (67%), UGT1A5 (83%), UGT1A3 (0%), MLPH (17%), OR6B2 (33%), AQP12B (50%), AQP12A (67%), ANO7 (83%), CHL1 (0%), EMC3 (17%), FANCD2 (33%), DAZL (50%), ZNF35 (67%), LZTFL1 (83%), MST1 (0%), MST1R (17%), HYAL1 (33%), FRG2C (50%), ZNF717 (67%), OR5H6 (0%), ROPN1 (17%), ROPN1B (33%), RPN1 (50%), ALG1L2 (67%), BFSP2 (83%), PRR23B (0%), SOX2 (17%), EIF2B5 (33%), KNG1 (50%), TM4SF19 (67%), ZNF595 (83%), PDE6B (0%), GAK (17%), FGFRL1 (33%), RNF212 (50%), UVSSA (67%), DOK7 (83%), HMX1 (0%), FAM90A26 (17%), USP17L10 (33%), USP17L11 (50%), USP17L12 (67%), USP17L13 (83%), USP17L17 (0%), USP17L18 (17%), USP17L19 (33%), USP17L20 (50%), USP17L21 (67%), USP17L22 (83%), USP17L24 (0%), USP17L25 (17%), USP17L26 (33%), USP17L5 (50%), USP17L27 (67%), USP17L28 (83%), USP17L30 (0%), DEFB131A (17%), DRD5 (33%), UGT2B10 (83%), UGT2B28 (0%), UGT2A1 (17%), UGT2A2 (33%), HTN3 (50%), HTN1 (67%), AFP (83%), PIGY (0%), PYURF (17%), CISD2 (33%), SLC9B1 (50%), KLHL2 (0%), GK3 (17%), HPF1 (33%), PDLIM3 (50%), FAT1 (67%), FRG1 (83%), FRG2 (0%), DUX4 (17%), SDHA (33%), PDCD6 (50%), ZDHHC11B (67%), ZDHHC11 (83%), TERT (0%), SLC6A3 (17%), TAF11L2 (33%), TAF11L3 (50%), TAF11L4 (67%), TAF11L5 (83%), TAF11L7 (0%), TAF11L8 (17%), TAF11L9 (33%), TAF11L10 (50%), TAF11L11 (67%), TAF11L12 (83%), TAF11L14 (0%), EMB (17%), MARVELD2 (33%), SERF1B (67%), NAIP (17%), SKIC3 (50%), LIX1 (67%), SAR1B (83%), DND1 (0%), PCDHA10 (17%), PCDHB7 (33%), PCDHB8 (50%), PCDHB11 (67%), PCDHB12 (83%), PPP1R2B (0%), NPM1 (17%), THOC3 (33%), SIMC1 (50%), FAM153A (67%), FAM153CP (83%), FLT4 (0%), OR4F3 (17%), DUSP22 (33%), TUBB2A (50%), H2AC13 (67%), H2AC14 (83%), OR2J1 (0%), OR2J2 (17%), HLA-G (33%), HLA-A (50%), MICA (67%), MICB (83%), ZBTB12 (17%), PBX2 (83%), HLA-DRB1 (0%), GSTA2 (17%), GSTA1 (33%), GSTA5 (50%), PRIM2 (67%), FKBP1C (83%), SLC17A5 (0%), SEC63 (17%), OR2A4 (33%), CTAGE9 (50%), PCMT1 (67%), RAET1G (83%), ULBP1 (0%), RAET1L (17%), ULBP3 (33%), SLC22A1 (50%), SMOC2 (83%), RBAK-RBAKDN (0%), RBAK (17%), SLC29A4 (33%), FSCN1 (50%), OCM (67%), CCZ1 (83%), RSPH10B2 (17%), CCZ1B (33%), NOD1 (50%), FKBP9 (67%), DPY19L1 (83%), SEPTIN7 (0%), SPDYE1 (17%), PPIA (33%), CDC14C (50%), PSPH (67%), CCT6A (83%), ZNF716 (0%), ZNF727 (17%), ZNF735 (33%), ZNF736 (50%), GUSB (67%), RABGEF1 (83%), TYW1 (0%), SPDYE21 (17%), TYW1B (33%), POM121 (50%), TRIM74 (67%), SPDYE8 (83%), SPDYE9 (0%), SPDYE10 (17%), NSUN5 (33%), TRIM50 (50%), CLIP2 (67%), GTF2IRD2 (0%), SPDYE12 (17%), CASTOR2 (33%), GTF2IRD2B (50%), SPDYE13 (67%), SPDYE14 (83%), TRIM73 (0%), POM121C (17%), SPDYE5 (33%), DTX2 (50%), UPK3B (67%), SPDYE16 (83%), SPDYE17 (0%), SPDYE18 (17%), STEAP1 (33%), ASNS (50%), OCM2 (67%), CYP3A7-CYP3A51P (83%), CYP3A4 (0%), STAG3 (17%), PVRIG (33%), SPDYE3 (50%), SAP25 (67%), ZAN (83%), MUC12 (0%), SPDYE6 (17%), POLR2J (33%), RASA4B (50%), POLR2J3 (67%), UPK3BL2 (83%), RASA4 (0%), UPK3BL1 (17%), POLR2J3-UPK3BL2 (33%), SPDYE2B (50%), POLR2J2 (67%), LAMB1 (83%), METTL2B (0%), KLF14 (17%), AKR1B10 (33%), AKR1B15 (50%), BRAF (67%), TRBV9 (83%), PRSS2 (0%), CTAGE15 (17%), TCAF2 (33%), TCAF2C (50%), CTAGE6 (67%), OR2F2 (83%), CTAGE4 (0%), OR2A42 (17%), OR2A7 (33%), CTAGE8 (50%), OR2A1 (67%), ARHGEF5 (83%), ACTR3C (0%), KMT2C (17%), ACTR3B (33%), OR4F21 (50%), FBXO25 (67%), ARHGEF10 (83%), FAM90A15 (17%), FAM90A3 (33%), FAM90A13 (50%), FAM90A5 (67%), FAM90A20 (83%), USP17L1 (0%), USP17L4 (17%), ZNF705G (33%), DEFB108C (50%), DEFB4B (67%), DEFB103B (83%), DEFB104B (0%), DEFB106B (17%), DEFB105B (33%), DEFB107B (50%), PRR23D1 (67%), FAM90A7 (83%), FAM90A23 (0%), FAM90A14 (17%), FAM90A18 (33%), FAM90A16 (50%), FAM90A8 (67%), FAM90A17 (83%), FAM90A9 (0%), FAM90A10 (17%), PRR23D2 (33%), DEFB107A (50%), DEFB105A (67%), DEFB106A (83%), SPAG11A (0%), DEFB103A (17%), DEFB4A (33%), ZNF705B (50%), USP17L8 (67%), USP17L3 (83%), FAM90A11 (0%), FAM90A24 (17%), FAM90A12 (33%), SLC35G5 (50%), DEFB130B (67%), ZNF705D (83%), USP17L2 (0%), DEFB109D (17%), FAM86B1 (33%), DEFB130A (50%), FAM86B2 (67%), RBPMS (83%), IMPA1 (0%), SLC10A5 (17%), CDH17 (33%), CYP11B1 (50%), CYP11B2 (67%), GPIHBP1 (83%), WASHC1 (0%), FOXD4 (17%), ZNG1A (33%), KCNV2 (50%), RLN2 (67%), RLN1 (83%), IFNA21 (0%), IFNA4 (17%), IFNA7 (33%), IFNA10 (50%), IFNA16 (67%), IFNA17 (83%), IFNA13 (0%), IFNA1 (17%), ANKRD18B (33%), PRSS3 (50%), GALT (67%), SPATA31F1 (83%), CNTNAP3 (0%), SPATA31A1 (17%), FOXD4L6 (33%), ZNG1F (50%), CNTNAP3B (67%), SPATA31A6 (83%), SPATA31A7 (0%), CNTNAP3C (17%), FOXD4L5 (33%), ZNG1E (50%), FOXD4L4 (67%), ZNF658 (83%), ANKRD20A1 (0%), ZNG1C (17%), FOXD4L3 (33%), PGM5 (50%), FXN (67%), TJP2 (83%), SPATA31D4 (0%), SPATA31D3 (17%), SPATA31D1 (33%), KIF27 (50%), SPATA31C1 (67%), SPATA31C2 (83%), SLC71A2 (0%), NUTM2G (17%), CTSV (33%), OR13C5 (50%), OR13C2 (67%), OR13C9 (83%), POLE3 (0%), ORM1 (17%), ORM2 (33%), SLC27A4 (50%), PKN3 (67%), ABO (0%), LCN1 (17%), OBP2A (33%), SOHLH1 (50%), INPP5E (67%), AJM1 (83%), GRIN1 (0%), TUBB8 (17%), AKR1C1 (33%), AKR1C2 (50%), DCLRE1C (67%), MRC1 (83%), ANKRD30A (0%), ZNF33A (17%), ZNF37A (33%), PLD5P1 (50%), ZNF33B (67%), BMS1 (83%), AGAP4 (0%), TIMM23 (17%), ANTXRL (33%), ANXA8L1 (50%), NPY4R (67%), GPRIN2 (83%), PTPN20 (0%), ANXA8 (17%), FAM25G (33%), AGAP9 (50%), SYT15B (67%), NPY4R2 (83%), PARG (0%), TIMM23B (17%), TIMM23B-AGAP6 (33%), AGAP6 (50%), WASHC2A (67%), ASAH2B (83%), EIF5AL1 (0%), NUTM2B (17%), NUTM2E (33%), TMEM254 (50%), PLAC9 (67%), ADIRF (83%), NUTM2A (0%), NUTM2D (17%), PAPSS2 (33%), PTEN (50%), LIPN (67%), BTRC (83%), SFR1 (0%), DHX32 (17%), FANK1 (33%), ECHS1 (50%), SPRN (67%), FRG2B (83%), SCGB1C1 (0%), IFITM3 (17%), DRD4 (33%), DEAF1 (50%), KRTAP5-2 (83%), KRTAP5-4 (0%), MRPL23 (17%), H19 (33%), SSU72L5 (50%), SSU72L2 (67%), SSU72L4 (83%), SSU72L1 (0%), OR51A4 (17%), OR51A2 (33%), HBG1 (50%), OR10A5 (67%), MRGPRX4 (83%), MDK (0%), SPI1 (17%), OR4C3 (33%), OR4C5 (50%), OR4A47 (67%), TRIM51G (83%), TRIM64C (0%), FOLH1 (17%), OR4C13 (33%), OR4C12 (50%), OR4C45 (67%), OR4C46 (83%), OR4A5 (0%), TRIM48 (17%), OR4A15 (33%), TRIM51 (50%), OR5F1 (67%), OR8H2 (83%), OR5M8 (0%), OR9G1 (17%), OR1S2 (33%), OR1S1 (50%), GLYATL1B (67%), PGA3 (83%), B3GAT3 (0%), ESRRA (17%), SLC22A12 (33%), RBM4B (50%), TPCN2 (67%), FGF3 (83%), KRTAP5-8 (0%), KRTAP5-10 (17%), KRTAP5-11 (33%), XNDC1N-ZNF705EP-ALG1L9P (50%), DEFB108B (67%), XNDC1N (83%), INTS4 (0%), NOX4 (17%), TRIM77 (33%), TRIM49 (50%), TRIM64B (67%), TRIM49D1 (83%), TRIM64 (0%), TRIM49C (17%), UBTFL1 (33%), CARD16 (50%), HSPA8 (67%), OR8B2 (83%), TMEM45B (0%), CD4 (17%), PEX5 (33%), APOBEC1 (50%), GDF3 (67%), NANOG (83%), FAM90A1 (0%), PRH1 (33%), PRR4 (50%), PRH2 (67%), TAS2R14 (83%), TAS2R31 (0%), TAS2R46 (17%), TAS2R43 (33%), TAS2R30 (50%), PRB4 (67%), PRB1 (83%), DDX11 (0%), H3-5 (17%), ALG10 (33%), ALG10B (50%), TUBA1B (67%), COX14 (83%), NACA (50%), DPY19L2 (67%), HNF1A (83%), HPD (0%), HCAR2 (17%), HCAR3 (33%), P2RX2 (50%), PGAM5 (67%), GOLGA3 (83%), C1QTNF9B (0%), C1QTNF9 (17%), PARP4 (33%), PABPC3 (50%), MRPS31 (67%), HNRNPA1L2 (83%), PRR20C (0%), PRR20B (17%), PRR20D (33%), PRR20E (50%), F7 (67%), PROZ (83%), POTEM (0%), POTEG (17%), OR11H2 (33%), OR4N2 (50%), OR4Q3 (67%), OR4M1 (83%), RNASE3 (0%), RNASE2 (17%), OR10G2 (33%), DHRS4 (50%), DHRS4L2 (67%), ARF6 (83%), ACOT2 (0%), NDUFB1 (17%), JAG2 (33%), BTBD6 (50%), IGHV3-21 (67%), GOLGA6L6 (83%), POTEB3 (0%), LINC02203 (17%), OR4M2B (33%), OR4N4C (50%), POTEB (67%), OR4M2-OT1 (83%), OR4N4 (0%), GOLGA6L22 (17%), GOLGA6L1 (33%), GOLGA6L26 (50%), GOLGA8S (67%), GOLGA6L2 (83%), HERC2 (0%), GOLGA6L24 (17%), GOLGA8F (33%), GOLGA8G (50%), GOLGA6L25 (67%), GOLGA8M (83%), GOLGA8J (0%), GOLGA8T (17%), GOLGA8R (50%), GOLGA8Q (67%), GOLGA8H (83%), GOLGA8O (0%), GOLGA8N (17%), GOLGA8A (33%), GOLGA8B (50%), NANOGP8 (67%), NDUFAF1 (83%), CKMT1B (0%), CATSPER2 (33%), CKMT1A (50%), TERB2 (67%), LDHAL6B (0%), GOLGA6B (17%), GOLGA6A (33%), ISLR2 (50%), GOLGA6C (67%), GOLGA6D (83%), ADAMTS7 (0%), EFL1 (17%), SAXO2 (33%), GOLGA6L10 (50%), GOLGA6L9 (67%), WHAMM (83%), OR4F4 (0%), MPG (17%), HBM (33%), AXIN1 (83%), SSTR5 (0%), TPSD1 (50%), GNPTG (67%), UNKL (83%), PKD1 (0%), PDPK1 (17%), EEF2KMT (33%), NPIPA3 (50%), NPIPA2 (67%), NOMO1 (83%), PDXDC1 (0%), RRN3 (17%), NPIPA5 (33%), MPV17L (50%), NOMO3 (67%), NPIPA6 (83%), NPIPA8 (0%), NPIPA9 (17%), NOMO2 (33%), SMG1 (50%), IQCK (67%), ACSM5 (83%), ACSM2B (0%), NPIPB3 (17%), NPIPB4 (50%), NPIPB5 (67%), NPIPB6 (83%), NPIPB7 (0%), SULT1A2 (17%), NPIPB8 (50%), EIF3C (67%), NPIPB9 (83%), NPIPB11 (0%), BOLA2-SMG1P6 (17%), BOLA2 (33%), SLX1B (50%), SULT1A4 (67%), NPIPB12 (83%), SLX1A (0%), SULT1A3 (17%), NPIPB13 (33%), PHKG2 (50%), VKORC1 (67%), KRABD5 (83%), TP53TG3 (0%), TP53TG3C (17%), TP53TG3E (33%), TP53TG3B (50%), TP53TG3F (67%), CCNYL1B (83%), CES1 (0%), MT1M (17%), MATCAP1 (33%), HSD11B2 (50%), CLEC18A (67%), PDPR (83%), EXOSC6 (0%), HPR (50%), NPIPB15 (67%), CLEC18B (83%), CA5A (0%), ZNF469 (17%), CDH15 (33%), ANKRD11 (50%), MC1R (67%), PRDM7 (83%), ABR (0%), SERPINF2 (17%), SRR (33%), OR1D5 (50%), P2RX5 (67%), ALOX15 (83%), ENO3 (0%), USP6 (17%), SLC35G6 (33%), ALOXE3 (50%), HES7 (67%), CDRT15 (83%), FBXW10B (0%), TRIM16 (17%), ZNF286A-TBC1D26 (33%), ZNF286A (50%), TBC1D26 (67%), UBB (83%), ATPAF2 (0%), EVPLL (17%), LGALS9C (33%), TBC1D28 (50%), FOXO3B (67%), FBXW10 (83%), GRAP (0%), GRAPL (17%), LGALS9B (33%), CDRT15L2 (50%), MEIS3P2 (67%), MAP2K3 (83%), KCNJ18 (0%), LGALS9 (17%), FOXN1 (33%), SUZ12 (50%), LRRC37B (67%), SLC35G3 (83%), CCL4 (0%), TBC1D3B (17%), CCL4L2 (50%), TBC1D3I (67%), TBC1D3G (83%), TBC1D3F (0%), TBC1D3K (17%), TBC1D3L (33%), TBC1D3D (50%), TBC1D3C (67%), TBC1D3E (83%), MRPL45 (0%), KRTAP1-1 (17%), KRTAP4-7 (33%), KRTAP4-8 (50%), KRTAP4-16 (67%), KRTAP4-9 (83%), KRTAP4-12 (0%), KRTAP9-7 (17%), KRT14 (33%), KRT16 (50%), KRT17 (67%), HSD17B1 (83%), G6PC3 (0%), ARHGAP27 (17%), PLEKHM1 (33%), ARL17B (50%), LRRC37A (67%), ARL17A (83%), NSF (0%), NPEPPS (17%), HOXB8 (33%), GIP (50%), DHX40 (67%), RPS6KB1 (83%), METTL2A (0%), TLK2 (17%), CSH2 (33%), GH2 (50%), CSH1 (67%), CSHL1 (83%), LRRC37A3 (0%), C17orf58 (17%), AMZ2 (33%), TMC6 (50%), CANT1 (67%), RNF213 (83%), ARL16 (0%), TUBB8B (17%), TYMS (33%), SLC35G4 (50%), POTEC (67%), ANKRD30B (83%), SLC25A52 (0%), KATNAL2 (17%), SERPINB4 (33%), SERPINB3 (50%), GALR1 (67%), CTDP1 (83%), BSG (0%), HCN2 (17%), KISS1R (33%), STK11 (50%), TCF3 (67%), ABHD17A (83%), GIPC3 (0%), TBXA2R (17%), CREB3L3 (33%), RFX2 (50%), C3 (67%), MBD3L2B (83%), MBD3L4 (0%), MBD3L2 (17%), STXBP2 (33%), TYK2 (50%), ZNF799 (67%), ZNF443 (83%), CYP4F3 (0%), CYP4F12 (17%), OR10H2 (33%), CALR3 (50%), MYO9B (67%), INSL3 (83%), ZNF738 (0%), ZNF100 (17%), ZNF208 (33%), ZNF676 (50%), ZNF729 (67%), ZNF492 (83%), ZNF728 (0%), RHPN2 (17%), GPI (33%), ZNF302 (50%), ZNF181 (67%), FFAR3 (83%), COX6B1 (0%), LGALS7 (17%), LGALS7B (33%), IFNL3 (50%), IFNL4 (67%), IFNL2 (83%), CYP2A7 (17%), CYP2G1P (33%), CYP2A13 (67%), CYP2F1 (83%), PSG8 (0%), PSG1 (17%), PSG6 (33%), PSG7 (50%), PSG11 (67%), PSG2 (83%), PSG4 (0%), PSG9 (17%), ETHE1 (50%), ZNF285 (67%), APOC1 (83%), APOC4 (0%), BLOC1S3 (17%), DMPK (33%), FUT1 (50%), BAX (67%), LHB (83%), CGB3 (0%), CGB2 (17%), CGB1 (33%), CGB5 (50%), CGB8 (67%), CGB7 (83%), PNKP (0%), SIGLEC16 (17%), KLK4 (33%), ETFB (50%), ZNF808 (67%), ZNF600 (83%), ZNF468 (0%), VN1R4 (17%), FAM90A27P (33%), ZNF765 (50%), ZNF761 (67%), ZNF813 (83%), PRKCG (0%), MBOAT7 (17%), LILRA6 (33%), LILRB2 (50%), LAIR1 (67%), LAIR2 (83%), LILRB1 (0%), KIR3DL3 (17%), KIR2DL3 (33%), KIR2DL1 (50%), KIR2DL4 (67%), KIR3DL1 (83%), KIR3DL2 (0%), NLRP7 (17%), NLRP2 (33%), GP6 (50%), TNNT1 (67%), TNNI3 (83%), RFPL4A (0%), RFPL4AL1 (17%), ZNF419 (33%), ZNF773 (50%), ZNF587B (67%), ZNF814 (83%), ZNF417 (0%), SLC27A5 (17%), SIRPB1 (33%), CST4 (50%), CST1 (67%), CST2 (83%), PLAGL2 (0%), SEMG1 (17%), PLTP (33%), CHRNA4 (50%), EEF1A2 (67%), PTK6 (83%), MYT1 (0%), PCMTD2 (17%), TPTE (33%), POTED (50%), KRTAP21-1 (67%), SMIM11 (83%), SMIM34 (0%), KCNE1 (17%), CBR3 (33%), NDUFV3 (50%), CBS (67%), U2AF1 (83%), SIK1 (0%), HSF2BP (17%), H2BC12L (33%), TRAPPC10 (50%), PWP2 (67%), GATD3 (83%), DNMT3L (0%), KRTAP10-1 (17%), KRTAP10-2 (33%), KRTAP10-4 (50%), KRTAP10-5 (67%), KRTAP10-6 (83%), KRTAP10-8 (0%), KRTAP10-9 (17%), KRTAP10-10 (33%), KRTAP12-2 (50%), KRTAP12-1 (67%), COL18A1 (83%), OR11H1 (0%), POTEH (17%), CCT8L2 (33%), USP18 (50%), GGTLC3 (67%), TMEM191B (83%), FAM246B (0%), DGCR6 (17%), PRODH (33%), FAM246C (50%), CCDC188 (67%), RTN4R (83%), TUBA3FP (0%), LRRC74B (17%), FAM246A (33%), RIMBP3B (50%), HIC2 (67%), TMEM191C (83%), GGTLC2 (0%), IGLL1 (17%), DRICH1 (33%), GSTT2B (50%), DDTL (67%), GSTT2 (83%), RFPL1 (0%), C22orf42 (17%), RFPL3 (33%), APOBEC3D (83%), APOBEC3H (0%), ATF4 (17%), NDUFA6 (33%), CYP2D7 (67%), RRP7A (83%), CYB5R3 (0%), A4GALT (17%), TTLL1 (33%), MLC1 (50%), TUBGCP6 (67%), ACR (83%), XG (0%), GYG2 (17%), ARSD (33%), MXRA5 (50%), PRKX (67%), VCX3A (83%), VCX2 (0%), VCX3B (17%), FAM9A (33%), FAM9C (50%), SUPT20HL2 (67%), SUPT20HL1 (83%), MAGEB6 (0%), DCAF8L1 (17%), FAM47B (33%), H2AL1Q (50%), FAM47C (67%), H2AL3 (83%), SPACA5B (0%), SSX5 (17%), SSX1 (33%), SSX3 (50%), SSX4 (67%), SSX4B (83%), GAGE12J (0%), GAGE13 (17%), GAGE2E (33%), GAGE12B (50%), GAGE12C (67%), GAGE12D (83%), GAGE12F (0%), GAGE12G (17%), GAGE12H (33%), GAGE2A (50%), GAGE1 (67%), CENPVL3 (83%), CENPVL1 (0%), MAGED4B (17%), MAGED4 (33%), XAGE1A (50%), XAGE1B (67%), SSX7 (83%), SSX2B (0%), SPANXN5 (17%), XAGE5 (33%), XAGE3 (50%), FAM156B (67%), FAM156A (83%), SPIN2B (0%), SPIN2A (17%), ZXDA (33%), CXorf49 (50%), CXorf49B (67%), DMRTC1B (83%), FAM236D (0%), DMRTC1 (17%), FAM236C (33%), FAM236A (50%), PABPC1L2B (67%), PABPC1L2A (83%), TGIF2LX (0%), PCDH11X (17%), TCEAL6 (33%), TCP11X1 (50%), NXF2 (67%), NXF2B (83%), RAB40AL (0%), TMSB15B (17%), H2BW1 (33%), H2BW2 (50%), TMSB15C (67%), PSMD10 (83%), CT47C1 (0%), RHOXF2B (17%), RHOXF2 (33%), CT47B1 (50%), CT47A12 (67%), CT47A11 (83%), CT47A9 (0%), CT47A8 (17%), CT47A7 (33%), CT47A6 (50%), CT47A5 (67%), CT47A4 (83%), CT47A2 (0%), CT47A1 (17%), RTL8B (33%), RTL8C (50%), RTL8A (67%), SMIM10L2B (83%), CT55 (0%), ETDA (17%), SMIM10L2A (33%), CT45A1 (50%), CT45A3 (67%), CT45A5 (83%), CT45A2 (0%), CT45A7 (17%), CT45A8 (33%), CT45A9 (50%), CT45A10 (67%), SAGE1 (83%), SPANXC (0%), SPANXA1 (17%), SPANXA2 (33%), SPANXD (50%), MAGEC1 (67%), SPANXN3 (83%), UBE2NL (0%), SPANXN1 (17%), CXorf51B (33%), CXorf51A (50%), EOLA1 (67%), HSFX3 (83%), HSFX2 (0%), HSFX1 (17%), MAGEA9 (33%), EOLA2 (50%), HSFX4 (67%), MAGEA3 (83%), MAGEA2B (0%), CSAG1 (17%), MAGEA12 (33%), MAGEA2 (50%), CSAG3 (67%), MAGEA6 (83%), PWWP4 (0%), SLC6A8 (17%), BCAP31 (33%), OPN1LW (50%), OPN1MW (67%), OPN1MW2 (83%), TEX28 (0%), CTAG1A (17%), CTAG1B (33%), CTAG2 (50%), H2AB1 (67%), F8A1 (83%), F8A2 (0%), F8A3 (17%), H2AB3 (33%), IL9R (50%), WASH6P (67%), TGIF2LY (not on this reference), PCDH11Y (not on this reference), TSPY2 (not on this reference), TSPY4 (not on this reference), TSPY8 (not on this reference), TSPY3 (not on this reference), TSPY1 (not on this reference), TSPY9 (not on this reference), TSPY10 (not on this reference), VCY (not on this reference), VCY1B (not on this reference), CDY2B (not on this reference), CDY2A (not on this reference), HSFY1 (not on this reference), HSFY2 (not on this reference), RBMY1B (not on this reference), RBMY1A1 (not on this reference), RBMY1D (not on this reference), RBMY1E (not on this reference), RBMY1F (not on this reference), RBMY1J (not on this reference), BPY2 (not on this reference), DAZ1 (not on this reference), DAZ2 (not on this reference), CDY1B (not on this reference), BPY2B (not on this reference), DAZ3 (not on this reference), DAZ4 (not on this reference), BPY2C (not on this reference), CDY1 (not on this reference), C4B_2 (not on this reference), GSTT1 (not on this reference), GSTTP2 (not on this reference), GTF2H2C_2 (not on this reference), HLA-DRB3 (not on this reference), HLA-DRB4 (not on this reference), KIR2DL2 (not on this reference), KIR2DL5A (not on this reference), KIR2DL5B (not on this reference), KIR2DS1 (not on this reference), KIR2DS2 (not on this reference), KIR2DS3 (not on this reference), KIR2DS5 (not on this reference), KIR3DS1 (not on this reference), LILRA3 (not on this reference), OR8U8 (not on this reference), OR8U9 (not on this reference), OR9G9 (not on this reference), TAS2R45 (not on this reference)

    +

    Not read here, called by a step of their own (54): RHCE (0%) by parascopy, AMY1A (17%) by parascopy, AMY1B (33%) by parascopy, AMY1C (50%) by parascopy, GSTM1 (0%) by pypgx, NOTCH2 (67%) by parascopy, FCGR1A (50%) by parascopy, GBA1 (17%) by parascopy, FCGR2A (67%) by parascopy, FCGR2C (0%) by parascopy, FCGR3B (17%) by parascopy, CFHR3 (17%) by parascopy, CFHR1 (33%) by parascopy, PROS1 (83%) by parascopy, UGT2B17 (50%) by pypgx, UGT2B15 (67%) by pypgx, GYPE (67%) by parascopy, GYPB (83%) by parascopy, GTF2H2C (50%) by parascopy, SMN2 (83%) by parascopy, SMN1 (0%) by parascopy, GTF2H2 (33%) by parascopy, HSPA1B (0%) by parascopy, C4A (33%) by parascopy, C4B (50%) by parascopy, CYP21A2 (67%) by cn_loci:CYP21A2, LPA (67%) by cn_loci:LPA_KIV2, PMS2 (0%) by parascopy, GTF2I (83%) by parascopy, DEFA1B (0%) by parascopy, CEL (83%) by parascopy, MUC5B (67%) by parascopy, KLRC2 (17%) by parascopy, KRT6B (0%) by parascopy, KRT6C (17%) by parascopy, KRT6A (33%) by parascopy, CHRFAM7A (33%) by parascopy, STRC (17%) by parascopy, SORD (83%) by parascopy, HBA2 (50%) by cn_loci:HBA, HBA1 (67%) by cn_loci:HBA, TPSB2 (17%) by parascopy, TPSAB1 (33%) by parascopy, OTOA (33%) by parascopy, SULT1A1 (33%) by pypgx, HYDIN (17%) by parascopy, HP (33%) by cn_loci:HP, CCL3L3 (33%) by cn_loci:CCL3L1, CYP2A6 (0%) by pypgx, CYP2B6 (50%) by pypgx, CD177 (33%) by parascopy, APOBEC3A (50%) by parascopy, APOBEC3B (67%) by parascopy, CYP2D6 (50%) by pypgx

    +
    +
    +
    +
    +

    Variant Calling

    +

    Step 03 · Not run · link to this section

    +
    StatusNot run
    +
    +
    +
    +
    +
    +

    Clinical

    +

    Is there anything to take to a doctor?

    +
    +
    +
    +

    ClinVar Screening

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Check every P/LP hit's population frequency, a heterozygous hit in a dominant gene as well as a homozygous one: a hit above 1% in gnomAD is unlikely to be a high-penetrance finding, and a hit whose frequency is unknown has not been checked.

    +
    ClinVar matches8
    +
    Low-confidence calls (GQ below 20 or DP below 8), not counted2
    +
    By stars (4/3/2/1/0)0 / 2 / 3 / 1 / 2
    +
    ClinVar file dateunknown
    +

    gnomAD AF: unknown for every hit (no VEP output (step 13) in this folder)

    +
    +
    +

    ClinVar Hits (best-reviewed first, 10 of 10)

    + + + + + + + + + + + + + +
    ChrPositionRefAltGenotypeGeneSignificanceReview statusStarsCombined allelegnomAD frequencyCall qualityViewer
    chr7117559590ATCTAhetCFTRPathogenicpractice guideline4gnomAD AF unknownlow-confidence call (GQ 15, DP 30): check the readschr7:117559590
    chr1743057100CThetBRCA1,NBR2Pathogenicreviewed by expert panel3part of a combined allele: chr17:43057100 C>T, chr17:43057102 A>G; unphased, so the parts may sit on different haplotypesgnomAD AF unknownchr17:43057100
    chr626092913GAhetHFEPathogenicreviewed by expert panel3gnomAD AF unknownchr6:26092913
    chr145331556CThetMUTYHPathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr1:45331556
    chr16176700GAhetHBA1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr16:176700
    chr570951946CThomSMN1Pathogeniccriteria provided, multiple submitters, no conflicts2gnomAD AF unknownchr5:70951946
    chr1320189473CTone copy, other copy not called ref (1/.)GJB2Likely pathogeniccriteria provided, single submitter1combined allele of chr13:20189473 C>T + chr13:20189475 G>AgnomAD AF unknownlow-confidence call (GQ 40, DP 5): check the readschr13:20189473
    chr315645186GChetBTDPathogenic/Likely pathogeniccriteria provided, conflicting classifications1gnomAD AF unknownchr3:15645186
    chr2100AGhet...0gnomAD AF unknownchr2:100
    chrX101398000CT1GLAPathogenicno assertion criteria provided0possibly one allele with chrX:101398004 G>A: check ClinVar for a combined recordgnomAD AF unknownchrX:101398000
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Clinical Variant Filter

    +

    Step 23 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Total interesting variants6
    +
    +
    +

    Secondary-Findings Genes (ACMG SF v3.3)

    +

    A list to review with a clinician, not a diagnosis. Each gene's ACMG SF v3.3 reporting rule (assets/acmg_sf.tsv) is applied: one variant in a dominant gene; two in a recessive gene such as MUTYH, BTD or ATP7B, even when their phase is unknown; HFE only as homozygous p.C282Y. A variant the rule does not report is listed apart with the reason. A rare HIGH-impact record is not a ClinVar classification.

    + + + + + + + + +
    GeneVariantGenotypeEvidenceViewer
    MUTYHchr1:45331556 C>ThetClinVar Pathogenicchr1:45331556
    BRCA1chr17:43057100 C>ThetClinVar Pathogenicchr17:43057100
    GLAchrX:101398000 C>T1ClinVar PathogenicchrX:101398000
    MUTYHchr1:45332000 G>Ahetstop_gainedchr1:45332000
    MYBPC3chr11:47332000 G>Ahetsplice_donor_variant,intron_variantchr11:47332000
    MSH2chr2:47414000 A>AThetframeshift_variant; weak call (alt reads 0.07 of the depth on a heterozygote): check the reads; A deletion of the 3' end of EPCAM silences MSH2 and counts as an MSH2 finding.chr2:47414000
    +

    HFE chr6:26092913 G>A het (ClinVar): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    BTD chr3:15645186 G>C het (ClinVar): not reported, one heterozygous variant; BTD is reported with P and LP (2 variants)

    +

    HFE chr6:26093000 C>T hom (HIGH impact): not reported, HFE is reported only for: HFE p.C282Y homozygotes only

    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Cancer Predisposition

    +

    Step 17 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    CPSR grades variants in cancer predisposition genes with ACMG rules. A pathogenic or likely pathogenic row is something to take to a clinical geneticist, not a diagnosis. No row does not rule out an inherited cancer risk: large deletions, genes outside its panel and family history are not part of this screen.

    +
    CPSR reportComplete
    +
    Pathogenic1
    +
    .1
    +

    ClinVar release in CPSR's bundle: unknown; step 6 used the ClinVar file of unknown

    +

    Final P/LP rows that CPSR's own rules class benign or likely benign: 1

    +

    Rows where ClinVar and CPSR's own class disagree on P/LP: 0

    +

    P/LP rows below the depth floor (DP below 8): 0

    +
    +

    Files of this step, beside this report: the cpsr folder, which holds the CPSR HTML report

    +
    +
    +
    +

    Variant Prioritization (slivar)

    +

    Step 31 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A pair can hit both copies of the gene only in trans. cis: one copy carries both variants. unknown: fewer than 2 reads or read pairs cover both positions, the reads disagree, or there is no BAM; the pairs table gives the reason. A parent's genome or long reads can phase it. Every pair: slivar/<sample>_compound_het_pairs.tsv

    +
    Prioritized variants2
    +
    Pairs in trans / cis / unknown23 / 1 / 1
    + + + + + + + + + + + + + + + + + + + + + + +
    GenePair in transReadsViewer
    G1chr1:10 A>G + chr1:15 C>T1 of 2chr1:10-15
    G2chr1:20 A>G + chr1:25 C>T2 of 3chr1:20-25
    G3chr1:30 A>G + chr1:35 C>T3 of 4chr1:30-35
    G4chr1:40 A>G + chr1:45 C>T4 of 5chr1:40-45
    G5chr1:50 A>G + chr1:55 C>T5 of 6chr1:50-55
    G6chr1:60 A>G + chr1:65 C>T6 of 7chr1:60-65
    G7chr1:70 A>G + chr1:75 C>T7 of 8chr1:70-75
    G8chr1:80 A>G + chr1:85 C>T8 of 9chr1:80-85
    G9chr1:90 A>G + chr1:95 C>T9 of 10chr1:90-95
    G10chr1:100 A>G + chr1:105 C>T10 of 11chr1:100-105
    G11chr1:110 A>G + chr1:115 C>T11 of 12chr1:110-115
    G12chr1:120 A>G + chr1:125 C>T12 of 13chr1:120-125
    G13chr1:130 A>G + chr1:135 C>T13 of 14chr1:130-135
    G14chr1:140 A>G + chr1:145 C>T14 of 15chr1:140-145
    G15chr1:150 A>G + chr1:155 C>T15 of 16chr1:150-155
    G16chr1:160 A>G + chr1:165 C>T16 of 17chr1:160-165
    G17chr1:170 A>G + chr1:175 C>T17 of 18chr1:170-175
    G18chr1:180 A>G + chr1:185 C>T18 of 19chr1:180-185
    G19chr1:190 A>G + chr1:195 C>T19 of 20chr1:190-195
    G20chr1:200 A>G + chr1:205 C>T20 of 21chr1:200-205
    +

    The Viewer column opens the reads at each row in the genome viewer on this computer (start it first: scripts/owngenome-view.sh <sample>, docs/viewer.md).

    +
    +
    +
    +
    +

    Symptom-Driven Ranking (Exomiser)

    +

    Step 48 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    A ranking to bring to a clinical geneticist, not a diagnosis: a high score means a rare, likely damaging variant in a gene linked to symptoms like these, not that it causes them, and an empty or low list does not rule a genetic cause out. Coding and splice variants only (docs/48-exomiser.md).

    +
    Symptoms searched.
    +
    Ranked genesnone passed Exomiser's filters
    +

    Exomiser's own report: exomiser/S_exomiser.html

    +
    +

    Files of this step, beside this report: Exomiser ranking table

    +
    +
    +
    +

    Mobile Element Insertions

    +

    Step 50 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Alu, L1 and SVA copies the genome carries and the reference does not, found and genotyped by MEGAnE (Kojima et al. 2023) from short read pairs. Most are common and harmless; the catalog rows are insertions known to cause disease. Not callable: too few reads in that window to tell. Not seen is not proof of absence: short reads find an SVA's edges, not its body. Call filtered out: MEGAnE called an insertion there but flagged it (LC is low confidence), so it is not a finding, and not proof of absence either. Every call: mei/<sample>_mei.tsv.

    +
    Insertions called0 (none)
    +
    GeneElementConditionInheritanceStatusDepthCall
    FKTNSVAFARcallable30seen
    +
    +
    +
    +
    +

    Repeat Expansions

    +

    Step 09 · Failed · link to this section

    +
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/str_intermediate_ranges.tsv'
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    MUC1 VNTR Frameshifts (VNtyper)

    +

    Step 52 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The MUC1 repeat is long and GC-rich, and short reads cover it unevenly. VNtyper looks only for known frameshifts in it: a negative result lowers the chance of those and does not rule out ADTKD-MUC1, and a positive one needs a clinical test (SNaPshot for dupC) to confirm it.

    +
    Resultnot assessed
    +

    Result: not assessed

    +

    .

    +

    VNtyper's coverage check: .

    +

    .

    +

    .

    +
    +
    +
    +
    +

    Mitochondrial Analysis

    +

    Step 20 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    ClinVar and gnomAD v3.1 (chrM sites) annotate the calls in step 20. MITOMAP (mitomap.org) has the curated disease status of mtDNA variants; it is a manual lookup, as it refuses scripted requests.

    +
    chrM variants (PASS)1
    +
    Heteroplasmic (AF 0.05 to 0.95, outside the D-loop poly-C tracts)1
    +
    Length heteroplasmy in the D-loop poly-C tracts0
    +

    ClinVar and gnomAD: not annotated (mito/S_chrM_annotated.tsv is older than the chrM calls: rerun step 20)

    +
    Confirmed disease variants1
    +

    m.3243A>G (MT-TL1) AF 0.40 filter PASS MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes); maternally inherited diabetes and deafness; ClinVar 9589; PMID 2102678. Usually heteroplasmic; the level differs between tissues and is often lower in blood than in muscle or urine.

    +

    Large deletions: not looked for (no deletion table (mito/<id>_chrM_deletions.tsv): step 20 ran before it looked for large deletions, eKLIPse wrote no table (see the step's log), or the Nextflow MITO_DELETIONS task failed (see the Nextflow log))

    +

    mtDNA copy number: not counted (no copy-number table (mito/<id>_mtdna_copies.tsv): step 20 ran before it counted mtDNA copies, or the Nextflow MITO_DELETIONS task failed (see the Nextflow log))

    +
    +
    +
    +
    +

    Lp(a): LPA KIV-2 Repeat Count

    +

    Step 46 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    The KIV-2 repeat count from read depth is a research estimate, not an Lp(a) level: the level is a blood test, and the count explains only part of the difference between people.

    +

    KIV-2 repeats: too little depth

    +

    .

    +

    KIV-2 4925G>A null allele (rs1484919544): not assessed

    +

    LPA KIV-2 4925G>A: not assessed, step 46 wrote no S_lpa_kiv2_4925.tsv (a run from before this reader, or the check did not run).

    +

    A null allele lowers the Lp(a) made from the copies it sits on; the Lp(a) blood test is the measure.

    +

    rs10455872: . (not read)

    +

    Not determined: neither the KIV-2 count nor the two risk variants could be read. Measure Lp(a) in blood.

    +

    .

    +
    +
    +
    +
    +

    Clonal Haematopoiesis (CHIP)

    +

    Step 49 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Clonal haematopoiesis is common with age and most people with it never get a blood cancer: a call here is not a diagnosis. A call is a change in a CHIP gene's published classes, found by Mutect2 without a matched normal; one at a VAF of 35% or more is left out as possibly inherited. docs/49-chip.md says how to read it.

    +
    CHIP calls0
    +

    No CHIP call.

    +

    No CHIP gene has the depth to find a clone: no result either way.

    +

    Too shallow or not on the reference: DNMT3A.

    +

    0 other protein changes listed, not counted: chip/S_chip.tsv.

    +
    +
    +
    +
    +

    Mosaic Chromosomal Alterations (MoChA)

    +

    Step 51 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Large gains, losses and copy-neutral losses of heterozygosity (CN-LOH) carried by a share of the blood cells, from MoChA on the phased heterozygous sites of chr1 to chr22. In a UK Biobank study they became more common with age and went with a higher risk of a later blood cancer (Loh et al. 2018). That is a population-level association, not a diagnosis; an event is confirmed on a new blood sample. Below the floor nothing is reported, and an event above it can still be missed. Every MoChA call, with the reason it was or was not reported: mosaic/<sample>_mocha.tsv.

    +
    StatusNot assessed
    +

    too shallow

    +
    +
    +
    +
    +
    +

    Carrier

    +

    What could I pass on to a child?

    +
    +
    +
    +

    Carrier List (this sample)

    +

    Step 06 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Carrier list: the ClinVar P/LP hits of this sample in the genes of assets/carrier_genes.tsv (autosomal recessive and X-linked conditions), one person, no partner needed. A carrier of one recessive change is usually healthy; the result matters for a child when a partner carries a change in the same gene (step 39). A hypomorph or pseudodeficiency allele is set aside.

    +

    Carrier list (3292 genes): 6 finding(s), 2 with no unchanged copy, 1 set aside

    +

    MUTYH (MUTYH-related polyposis; AR): chr1:45331556 C>T het, ClinVar Pathogenic

    +

    HFE (Symptomatic form of HFE-related hemochromatosis; AR): chr6:26092913 G>A het, ClinVar Pathogenic

    +

    CFTR (Cystic fibrosis; AR): chr7:117559590 ATCT>A het, ClinVar Pathogenic

    +

    GJB2 (Nonsyndromic hearing loss, recessive (DFNB1A); AR): chr13:20189473 C>T one copy, other copy not called ref (1/.), ClinVar Likely pathogenic

    +

    BRCA1 (Fanconi anemia; AR): chr17:43057100 C>T het, ClinVar Pathogenic

    +

    HBA1 (Alpha-thalassemia; AR): chr16:176700 G>A het, ClinVar Pathogenic

    +

    GLA (Fabry disease; XL): chrX:101398000 C>T hemizygous, ClinVar Pathogenic: the only copy changed, not the pattern of a carrier

    +

    SMN1 (Spinal muscular atrophy; AR): chr5:70951946 C>T hom, ClinVar Pathogenic: two changed copies, not the pattern of a carrier

    +

    Set aside: BTD chr3:15645186 G>C het: p.Asp444His (p.Asp424His on NM_001370658.1), partial biotinidase deficiency is a hypomorph allele, not a carrier finding on its own

    +

    Possibly biallelic (low-confidence call): CFTR (Cystic fibrosis; AR), both copies may be hit: CFTR_del deletion, 1 of 2 copies (read depth, step 35) and chr7:117559590 ATCT>A het; the variant's call is below the call floor (low confidence), so confirm it first; a heterozygous call inside a called deletion: one of the two calls may be wrong; check the reads

    +

    Two hits across callers (a deletion plus a variant on the other copy): 1 gene(s); deletions read from AnnotSV class 4 and 5 deletions (step 05); step 35's interval table (read depth); not read: step 35's HBA1/HBA2 count: not assessed: S_hba_copy_number.tsv has no status row; Parascopy's SMN1 count: not resolved

    +
    +
    +
    +
    +

    Paralog Genes (Paraphase)

    +

    Steps 35b, 35 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Paraphase reads PacBio HiFi reads only. A 'no call' means it saw one haplotype and the depth did not settle one copy or two. A research estimate, not a diagnostic test: confirm a result (for example an HBA deletion or one SMN1 copy) with a clinical laboratory.

    +
    StatusComplete
    +
    GeneCopy numberCallDetail
    SMN1xcalled.
    +
    SMN1 by both toolsParaphase no call, Parascopy no row covers SMN1 exon 7: no comparison: one of them has no call
    +
    Variants on phased haplotypes0
    +
    +
    +

    SMN1/SMN2 Copy Number (Parascopy)

    +

    Parascopy reads short reads at SMN1 and SMN2 and at the other loci of its catalog. A quality under 20 or a filter other than PASS leaves a copy unresolved. HBA1 and HBA2, CYP21A2 and the gene-dosage loci have no Parascopy model: step 35 counts them from read depth against flanking sequence (CYP21A2 also from six sites where it differs from its pseudogene CYP21A1P), which cannot say which chromosome lost or gained a copy. The copy-number intervals (ClinGen's recurrent CNV regions, carrier deletion alleles, the AZF regions) are read from depth too. A research estimate, not a diagnostic test: confirm a result with a clinical laboratory (MLPA or qPCR; gap-PCR for alpha-thalassaemia).

    +
    StatusComplete
    +
    SMN1 copiesno row covers exon 7
    +
    SMN1 g.27134T>G silent-carrier marker (rs143838139)not assessed
    +
    SMN1 marker readingSMN1 g.27134T>G: not assessed, step 35 wrote no S_smn1_marker.tsv (a run from before this reader, or the check did not run).
    +
    SMN1 marker caveatThe marker raises the chance that two SMN1 copies sit on one chromosome (2+0, a silent carrier); it does not prove 2+0, and a carrier test in a clinical laboratory confirms it.
    +
    SMN2 copiesno row covers exon 7
    +
    SMN1 and SMN2 together (agCN) at exon 7. (quality ., filter .)
    +
    ReadingSMN1 and SMN2 not assessed: no model: no carrier reading
    +
    HBA1 and HBA2 together (alpha-globin genes, from depth)not assessed: S_hba_copy_number.tsv has no status row
    +
    CYP21A2 (RCCX module, from depth and six PSV sites)not assessed (step 35's <id>_cyp21a2_psv.tsv is not in this run's output)
    +
    Gene-dosage loci (HP, LCE3B/LCE3C, CCL3L1)not assessed (step 35's <id>_cn_dosage.tsv is not in this run's output)
    +
    Copy-number intervals (ClinGen recurrent regions, carrier deletions, AZF; from depth)3 rows (3 called); 3 with a deletion or a duplication
    +
    RegionRowPlaceCopiesChange
    CFTR regionCFTR_delchr7:117500001-1176000001 of 2deletion
    xDUP1chr1:2-1003 of 2duplication
    xGJB6chr13:x-21 of 2deletion
    +
    +
    +
    +
    +
    +

    Medicines

    +

    How might I respond to medicines?

    +
    +
    +
    +

    Pharmacogenomics

    +

    Step 07 · Complete · file date 2021-03-04 05:07 UTC · link to this section

    +

    PharmCAT calls star alleles and phenotypes from the variants this genome holds in the genes it covers. A variant it cannot see (a deletion, a duplication, a hybrid gene outside CYP2D6) is not in its answer. Its drug guidance is for a prescriber to read with you: never change a medicine on this report alone.

    +
    PharmCAT reportComplete
    +
    +
    +
    +
    +

    CPIC Drug Recommendations

    +

    Step 27 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +

    CPIC recommendations follow the phenotype PharmCAT called. They are guidance for prescribers, not a prescription. A gene that was not called has no recommendation here, and that is not the same as a typical response.

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was not run in the run of 2020-01-01 00:00 UTC
    +
    StatusStale
    +
    Genes with a non-normal phenotype0
    +
    Genes with more than one possible result0
    +
    Genes not called1
    +
    Genes called without a function phenotype (no drug guidance)0
    +
    TipRecommendations per gene: cpic/S_cpic_recommendations.txt
    +
    +

    Files of this step, beside this report: CPIC recommendations per gene (text)

    +
    +
    +
    +

    pypgx Pharmacogenomics

    +

    Steps 32, 21 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +
    Genes called3/6
    +
    CYP2D6 diplotype*1/*2
    +

    Not assessable on this reference: CYP2E1 (see docs/32-pypgx.md)

    +

    Low-confidence: UGT1A1 Indeterminate rests on chr2:1:A:G: check the reads

    +

    Low-confidence: SLCO1B1 *1/*5 rests on a low-GQ variant: check the reads

    +
    +
    +

    PGx Copy Number

    +
    CYP2D6Normal (pypgx, read depth)
    +
    CYP2A6not called: pypgx failed (pypgx, read depth)
    +
    CYP2B6not called: the CYP2D6 depth check failed (pypgx, read depth)
    +
    SLCO1B1not called: pypgx gave no copy-number call (pypgx, read depth)
    +
    +
    +

    CYP2D6 Across Callers

    +

    CYP2D6 sits beside its look-alike CYP2D7, and short reads often cannot tell them apart, so pypgx, Cyrius and step 36 can disagree or give no call. A disagreement or a missing call means the gene was not read reliably here; a clinical CYP2D6 test settles it.

    +
    CPIC drug-gene recommendations: STALE: from an earlier run (2019-06-01 12:30 UTC); step 27 was not run in the run of 2020-01-01 00:00 UTC
    +
    PharmCAT (step 36's call)not called
    +
    pypgx*1/*2
    +
    Cyrius*1/*2 (not usable: Filter LowQ)
    +
    pypgx and Cyrius agreefewer than two usable calls
    +
    Probable (one caller: pypgx)*1/*2, Normal Metabolizer; not passed to PharmCAT, so no drug guidance rests on it
    +
    +
    +
    +
    +

    HLA Typing

    +

    Step 08 · Failed · link to this section

    +
    could not be read: FileNotFoundError: [Errno 2] No such file or directory: 'bin/hla_alleles.tsv'
    +
    StatusUnreadable
    +
    +
    +
    +
    +

    Locityper Second Opinion at Hard Loci

    +

    Step 53 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +

    A second opinion beside the primary caller, never the call itself. Locityper (Prodanov et al. 2025, Nat Genet, PMID 41107551) picks the two haplotypes of the HPRC pangenome panel that best explain the reads at each locus; it names haplotypes of panel people (<sample>.1 or .2), not alleles, so the two callers are shown side by side and not compared. Filter: the authors' HLA and KIR benchmark filter (no warning, weighted distance of 30 or less, fewer than 1000 or 20% unexplained reads). Every column: locityper/<sample>_locityper.tsv.

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 53 was skipped in the run of 2020-01-01 00:00 UTC
    +
    Loci called3 of 3 (3 pass the filter)
    +
    LocusLocityperFilterPrimary caller
    HLA-DRB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    HLA-DQB1h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passT1K (step 08) did not run
    CYP2D6h + h (quality 1, 1 of 1 reads unexplained, weighted distance 1; filter pass)passpypgx (step 32): *1/*2; Cyrius (step 21): *1/*2 (not usable: Filter LowQ)
    +
    +
    +
    +
    +
    +

    Ancestry

    +

    Where do my ancestors come from?

    +
    +
    +
    +

    Mitochondrial Haplogroup

    +

    Step 12 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +

    Nothing is uploaded by this pipeline. The docs link lists the files each service reads, which steps 12 and 37 write when they run, and what an upload shares.

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 12 was skipped in the run of 2020-01-01 00:00 UTC
    +
    StatusStale
    +
    HaplogroupU5a
    +
    Contamination (haplocheck)not checked (needs step 20's Mutect2 chrM calls)
    +
    FamilyTreeDNA Discover (free, no upload)https://discover.familytreedna.com/mtdna/U5a (opens a website; the address carries the haplogroup)
    +
    YFull MTreehttps://www.yfull.com/mtree/U5a/ (opens a website; the address carries the haplogroup)
    + +
    +
    +
    +
    +

    Y-Chromosome Haplogroup

    +

    Steps 37, 45 · Part not run · file date 2021-03-04 05:06 UTC · link to this section

    +
    Haplogroupinsufficient markers
    +
    Markers.
    +
    QC-score.
    +
    +
    +

    Y Placement on the Current Public Tree

    +

    A second placement, on a public tree release newer than the one Yleaf carries, walked from the reads by og y tree-place. The two can differ in depth and in name: branches get renamed and split between releases, and the position tables differ. A branch is taken when it has more derived than ancestral SNPs, and an ancestral call above it blocks the branches below unless the SNPs below outvote that one site. Every level is in y_haplogroup/<sample>_y_tree_path.tsv; docs/37-y-haplogroup.md says how the walk works.

    +
    Branchno branch has a derived call
    +
    Level.
    +
    Tree.
    +

    Path SNPs: . derived, . ancestral, . no call; . SNPs called at depth . or more

    +
    +
    +
    +
    +

    Runs of Homozygosity

    +

    Step 11 · Complete · file date 2019-06-01 12:30 UTC · link to this section

    +

    F_ROH is the share of the autosomes (outside the bands) in runs of 5 MB or more.

    +

    Autosomes only: chrX and chrY are left out, and so is the part of a segment in a centromere or heterochromatin band (GRCh38 cytoband acen, gvar, stalk), where few markers map. No population allele frequencies were used (bcftools roh --AF-dflt 0.4): read the total and the short segments as rough; the long segments are the signal.

    +
    StatusComplete
    +
    ROH total7.0 MB
    +
    ROH largest segment7.0 MB
    +
    Segments1
    +
    Autosomal ROH > 5 MB1
    +

    chr2:10000001-17000000 7.0MB

    +

    F_ROH: 0.0294 (7.0 MB in runs of 5 MB or more); nearest: no band (one chromosome holds most of the runs)

    +
    +
    +
    +
    +
    +

    Traits and scores

    +

    What do studies say about my traits and risk scores?

    +
    +
    +
    +

    Traits

    +

    Step 42 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Each reading is what the cited studies found on average in the people they studied, not a diagnosis. A row marked ancestry reads differently in other populations; its note says how.

    +
    Read / no genotype / other allele0 / 1 / 0
    + + + +
    TraitGeneGenotypeReadingSource
    Lp(a)LPA
    rs10455872
    .no reads
    .
    PMID 1
    +

    Every row with its note: traits/S_traits.tsv

    +
    +
    +
    +
    +

    Polygenic Risk Scores (raw, not percentiles)

    +

    Step 25 · Stale · file date 2019-06-01 12:30 UTC · link to this section

    +
    STALE: from an earlier run (2019-06-01 12:30 UTC); step 25 was failed (exit 2) in the run of 2020-01-01 00:00 UTC
    + + + +
    ConditionPGSScoreVariants matchedPercentile
    XPGS1/raw score only
    +

    Raw score only: no ancestry reference panel was installed, so there is no percentile and the sum cannot be compared with anyone (scripts/setup.sh --ancestry-panel adds it). Most PRS scores were developed in European-ancestry populations and predict less well for other ancestries, even with an ancestry-adjusted percentile. See docs/25-prs.md.

    +
    +
    +
    +
    +

    Telomere content (relative)

    +

    Step 10 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    Relative telomere content (intratelomeric reads per million reads with 48-52% GC), not a telomere length: compare it only with samples of a similar age sequenced on the same platform (docs/10-telomere-analysis.md).

    +
    Telomere content334
    +

    Intratelomeric reads: 61,873; depth unknown (no total_reads or read_lengths in the summary): not checked

    +
    +
    +
    +
    +
    +

    Other and exports

    +

    What else did the run find or write?

    +
    +
    +
    +

    Viral DNA in the Unmapped Reads

    +

    Step 47 · Complete · file date 2021-03-04 05:06 UTC · link to this section

    +

    From the reads that do not map to the human genome, realigned to a fixed set of human viral genomes. Not a test for an infection: most adults carry herpesviruses that stay in their cells, and reagents carry viral DNA too. HHV-6 integration follows Liu et al. 2020 (depth over the viral genome at 0.30 of the human depth or more). Every genome: viral/<sample>_viral.tsv.

    +
    HHV-6not assessed (no human depth)
    +

    No read on any viral genome.

    +
    +
    +
    +
    +
    +

    What this report leaves out

    +

    Which steps did not run, and what does no step look at?

    +
    +
    +
    +

    Steps Not Run

    +
      +
    • Mosaic loss of chromosome Y or X
    • +
    • Variant calling
    • +
    • Fine-grained ancestry (ADMIXTURE, RFMix)
    • +
    • Structural variants (Delly)
    • +
    • Y-STR markers (HipSTR)
    • +
    • Blood groups (predicted)
    • +
    • Archaic ancestry (IBDmix)
    • +
    • Ancient populations (AADR PCA)
    • +
    +
    +
    +
    +
    +

    Not Assessed by This Pipeline

    +
      +
    • Mosaic and low-fraction small variants (only chrM heteroplasmy is reported, and with step 49 the CHIP genes)
    • +
    • Methylation and imprinting
    • +
    • Repeat expansions outside the ExpansionHunter catalog
    • +
    • Phase: two variants in one gene are compound-het candidates, not confirmed
    • +
    • Variants of uncertain significance (not interpreted)
    • +
    • Polygenic score percentiles: no ancestry reference panel was used, so the scores are raw sums
    • +
    • HBA1/HBA2 copy number (alpha-thalassaemia deletions): neither step 35's read-depth count (short reads) nor step 35b (Paraphase, PacBio HiFi) made a call
    • +
    • MUC1 VNTR frameshifts (ADTKD-MUC1): step 52 (VNtyper, opt-in) gave no reading; no standard caller sees them
    • +
    • Autosomal mosaic chromosomal alterations (large gains, losses and copy-neutral LOH in a share of the blood cells): step 51 (MoChA) did not assess this sample
    • +
    +
    +
    +
    +
    +
    + Disclaimer: This report is for educational and research purposes only. + It is not a clinical diagnosis. Always discuss genomic findings with a qualified healthcare + professional before making any medical decisions. Variants of Uncertain Significance (VUS) + are not clinically actionable. +
    + + +
    +